paper_id	term_1	term_2	id	sentence_index	segment_length	Term1	Term2	Sentence	True Negative	True Positive
28734827	hlh30	vit1	28734827	5	157	@TERM$1	@TERM$2	we further show that the size and number of intestinal lipid droplets under starvation are altered in  @TERM$1  animals which can be rescued by knockdown of  @TERM$2 	0.9999858	1.4194275e-05
28734827	hlh30	vit1	28734827	4	158	@TERM$1	@TERM$2	we demonstrate that premature death of  @TERM$1  animals under starvation can be prevented by knockdown of either  @TERM$2  or vit5 encoding two different lipoproteins	0.9999819	1.8126897e-05
28734827	vit1	vit5	28734827	4	158	@TERM$1	@TERM$2	we demonstrate that premature death of hlh30 animals under starvation can be prevented by knockdown of either  @TERM$1  or  @TERM$2  encoding two different lipoproteins	0.9999989	1.0178584e-06
28734827	hlh30	vit5	28734827	4	158	@TERM$1	@TERM$2	we demonstrate that premature death of  @TERM$1  animals under starvation can be prevented by knockdown of either vit1 or  @TERM$2  encoding two different lipoproteins	0.9999869	1.31111565e-05
30788345	figure s8	aac	30788345	285	171	@TERM$1	@TERM$2	e idh1 mutants glutamate become depleted in worms  @TERM$1  connecting a malfunctioning tca cycle with cellular  @TERM$2  contentpredicted exchange fluxes for glutamate inside t	0.9999931	6.910712e-06
30788345	spermidine	cadaverine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either agmatine or ornithine and gives rise to  @TERM$1  the precursor of spermine figure s7a while  @TERM$2  is the product of lysine decarboxylation mccann 1982	0.9999987	1.2957046e-06
30788345	agmatine	cadaverine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either  @TERM$1  or ornithine and gives rise to spermidine the precursor of spermine figure s7a while  @TERM$2  is the product of lysine decarboxylation mccann 1982	0.99999845	1.5151163e-06
30788345	agmatine	spermidine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either  @TERM$1  or ornithine and gives rise to  @TERM$2  the precursor of spermine figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.9999951	4.868855e-06
30788345	arginine	cadaverine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from  @TERM$1  via either agmatine or ornithine and gives rise to spermidine the precursor of spermine figure s7a while  @TERM$2  is the product of lysine decarboxylation mccann 1982	0.9999932	6.782841e-06
30788345	arginine	spermidine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from  @TERM$1  via either agmatine or ornithine and gives rise to  @TERM$2  the precursor of spermine figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.99999857	1.4590033e-06
30788345	spermine	cadaverine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either agmatine or ornithine and gives rise to spermidine the precursor of  @TERM$1  figure s7a while  @TERM$2  is the product of lysine decarboxylation mccann 1982	0.9999981	1.9291354e-06
30788345	ornithine	cadaverine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either agmatine or  @TERM$1  and gives rise to spermidine the precursor of spermine figure s7a while  @TERM$2  is the product of lysine decarboxylation mccann 1982	0.9999988	1.1954568e-06
30788345	agmatine	spermine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either  @TERM$1  or ornithine and gives rise to spermidine the precursor of  @TERM$2  figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.9999982	1.809159e-06
30788345	agmatine	ornithine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either  @TERM$1  or  @TERM$2  and gives rise to spermidine the precursor of spermine figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.99999654	3.5163737e-06
30788345	arginine	spermine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from  @TERM$1  via either agmatine or ornithine and gives rise to spermidine the precursor of  @TERM$2  figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.98938507	0.0106149055
30788345	arginine	ornithine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from  @TERM$1  via either agmatine or  @TERM$2  and gives rise to spermidine the precursor of spermine figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.99999833	1.7192716e-06
30788345	cadaverine	lysine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either agmatine or ornithine and gives rise to spermidine the precursor of spermine figure s7a while  @TERM$1  is the product of  @TERM$2  decarboxylation mccann 1982	0.9999987	1.2741684e-06
30788345	ornithine	lysine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either agmatine or  @TERM$1  and gives rise to spermidine the precursor of spermine figure s7a while cadaverine is the product of  @TERM$2  decarboxylation mccann 1982	0.64209855	0.35790142
30788345	agmatine	lysine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either  @TERM$1  or ornithine and gives rise to spermidine the precursor of spermine figure s7a while cadaverine is the product of  @TERM$2  decarboxylation mccann 1982	0.99999607	3.898127e-06
30788345	arginine	agmatine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from  @TERM$1  via either  @TERM$2  or ornithine and gives rise to spermidine the precursor of spermine figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.9999968	3.2435041e-06
30788345	arginine	lysine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from  @TERM$1  via either agmatine or ornithine and gives rise to spermidine the precursor of spermine figure s7a while cadaverine is the product of  @TERM$2  decarboxylation mccann 1982	0.99999785	2.1642036e-06
30788345	putrescine	spermidine	30788345	197	208	@TERM$1	@TERM$2	 @TERM$1  is metabolized from arginine via either agmatine or ornithine and gives rise to  @TERM$2  the precursor of spermine figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.9999969	3.0736865e-06
30788345	ornithine	spermidine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either agmatine or  @TERM$1  and gives rise to  @TERM$2  the precursor of spermine figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.9999958	4.1510734e-06
30788345	putrescine	lysine	30788345	197	208	@TERM$1	@TERM$2	 @TERM$1  is metabolized from arginine via either agmatine or ornithine and gives rise to spermidine the precursor of spermine figure s7a while cadaverine is the product of  @TERM$2  decarboxylation mccann 1982	0.99999475	5.2715286e-06
30788345	putrescine	nacetylputrescine	30788345	194	92	@TERM$1	@TERM$2	ere is accumulation of polyamines with age namely  @TERM$1   @TERM$2  and cadaverin	0.99999297	6.9947264e-06
30788345	hypoxanthine	xanthurenic acid	30788345	190	242	@TERM$1	@TERM$2	contains degradation products of both nucleotides  @TERM$1  xanthosine and allantoin and amino acid metabolism betaine carnitine leucic acid pentothenate kynurenic acid and  @TERM$2  confirming a welldocumented imbalance in amino ac	0.9999888	1.1252737e-05
30788345	leucic acid	xanthurenic acid	30788345	190	160	@TERM$1	@TERM$2	ntoin and amino acid metabolism betaine carnitine  @TERM$1  pentothenate kynurenic acid and  @TERM$2  confirming a welldocumented imbalance in amino ac	0.999998	2.0204884e-06
30788345	betaine	carnitine	30788345	190	117	@TERM$1	@TERM$2	anthosine and allantoin and amino acid metabolism  @TERM$1   @TERM$2  leucic acid pentothenate kynurenic acid and xanth	0.99999595	4.0625473e-06
30788345	pentothenate	wan	30788345	190	232	@TERM$1	@TERM$2	ino acid metabolism betaine carnitine leucic acid  @TERM$1  kynurenic acid and xanthurenic acid confirming a welldocumented imbalance in amino acid and nucleotide metabolism with age copes et al 2015 gao et al 2017a  @TERM$2  et al 201	0.99999654	3.4493937e-06
30788345	carnitine	pentothenate	30788345	190	134	@TERM$1	@TERM$2	e and allantoin and amino acid metabolism betaine  @TERM$1  leucic acid  @TERM$2  kynurenic acid and xanthurenic acid confirming a 	0.99999845	1.5694777e-06
30788345	allantoin	betaine	30788345	190	145	@TERM$1	@TERM$2	s of both nucleotides hypoxanthine xanthosine and  @TERM$1  and amino acid metabolism  @TERM$2  carnitine leucic acid pentothenate kynurenic acid a	0.9999976	2.3674802e-06
30788345	xanthosine	carnitine	30788345	190	169	@TERM$1	@TERM$2	adation products of both nucleotides hypoxanthine  @TERM$1  and allantoin and amino acid metabolism betaine  @TERM$2  leucic acid pentothenate kynurenic acid and xanthu	0.9999945	5.505921e-06
30788345	hypoxanthine	pentothenate	30788345	190	206	@TERM$1	@TERM$2	contains degradation products of both nucleotides  @TERM$1  xanthosine and allantoin and amino acid metabolism betaine carnitine leucic acid  @TERM$2  kynurenic acid and xanthurenic acid confirming a 	0.99999	1.00490315e-05
30788345	carnitine	leucic acid	30788345	190	121	@TERM$1	@TERM$2	e and allantoin and amino acid metabolism betaine  @TERM$1   @TERM$2  pentothenate kynurenic acid and xanthurenic acid 	0.9999975	2.4618648e-06
30788345	leucic acid	pentothenate	30788345	190	124	@TERM$1	@TERM$2	ntoin and amino acid metabolism betaine carnitine  @TERM$1   @TERM$2  kynurenic acid and xanthurenic acid confirming a 	0.99999714	2.9145217e-06
30788345	gao	wan	30788345	190	79	@TERM$1	@TERM$2	d nucleotide metabolism with age copes et al 2015  @TERM$1  et al 2017a  @TERM$2  et al 201	0.9999964	3.5653093e-06
30788345	pentothenate	kynurenic acid	30788345	190	127	@TERM$1	@TERM$2	ino acid metabolism betaine carnitine leucic acid  @TERM$1   @TERM$2  and xanthurenic acid confirming a welldocumented 	0.99999833	1.6677584e-06
30788345	hypoxanthine	xanthosine	30788345	190	125	@TERM$1	@TERM$2	contains degradation products of both nucleotides  @TERM$1   @TERM$2  and allantoin and amino acid metabolism betaine car	0.99999833	1.7108596e-06
30788345	hypoxanthine	betaine	30788345	190	176	@TERM$1	@TERM$2	contains degradation products of both nucleotides  @TERM$1  xanthosine and allantoin and amino acid metabolism  @TERM$2  carnitine leucic acid pentothenate kynurenic acid and 	0.997593	0.0024069587
30788345	xanthosine	leucic acid	30788345	190	180	@TERM$1	@TERM$2	adation products of both nucleotides hypoxanthine  @TERM$1  and allantoin and amino acid metabolism betaine carnitine  @TERM$2  pentothenate kynurenic acid and xanthurenic acid 	0.9999925	7.5647076e-06
30788345	betaine	kynurenic acid	30788345	190	157	@TERM$1	@TERM$2	anthosine and allantoin and amino acid metabolism  @TERM$1  carnitine leucic acid pentothenate  @TERM$2  and xanthurenic acid confirming a welldocumented 	0.999998	2.0160844e-06
30788345	carnitine	xanthurenic acid	30788345	190	170	@TERM$1	@TERM$2	e and allantoin and amino acid metabolism betaine  @TERM$1  leucic acid pentothenate kynurenic acid and  @TERM$2  confirming a welldocumented imbalance in amino ac	0.9999732	2.6791347e-05
30788345	kynurenic acid	gao	30788345	190	219	@TERM$1	@TERM$2	bolism betaine carnitine leucic acid pentothenate  @TERM$1  and xanthurenic acid confirming a welldocumented imbalance in amino acid and nucleotide metabolism with age copes et al 2015  @TERM$2  et al 2017a wan et al 201	0.9999974	2.624543e-06
30788345	xanthosine	allantoin	30788345	190	125	@TERM$1	@TERM$2	adation products of both nucleotides hypoxanthine  @TERM$1  and  @TERM$2  and amino acid metabolism betaine carnitine leucic	0.9999982	1.8186264e-06
30788345	allantoin	pentothenate	30788345	190	178	@TERM$1	@TERM$2	s of both nucleotides hypoxanthine xanthosine and  @TERM$1  and amino acid metabolism betaine carnitine leucic acid  @TERM$2  kynurenic acid and xanthurenic acid confirming a 	0.9999981	1.8723106e-06
30788345	hypoxanthine	leucic acid	30788345	190	194	@TERM$1	@TERM$2	contains degradation products of both nucleotides  @TERM$1  xanthosine and allantoin and amino acid metabolism betaine carnitine  @TERM$2  pentothenate kynurenic acid and xanthurenic acid c	0.9999969	3.0576678e-06
30788345	xanthosine	kynurenic acid	30788345	190	208	@TERM$1	@TERM$2	adation products of both nucleotides hypoxanthine  @TERM$1  and allantoin and amino acid metabolism betaine carnitine leucic acid pentothenate  @TERM$2  and xanthurenic acid confirming a welldocumented 	0.999998	2.0697094e-06
30788345	putrescine	cadaverine	30788345	197	208	@TERM$1	@TERM$2	 @TERM$1  is metabolized from arginine via either agmatine or ornithine and gives rise to spermidine the precursor of spermine figure s7a while  @TERM$2  is the product of lysine decarboxylation mccann 1982	0.22055613	0.77944386
30788345	hydrophilichydrophobic	gao	30788345	191	237	@TERM$1	@TERM$2	the agerelated change in amino acids has been proposed to be driven by the ratio of  @TERM$1  surfaces that accompanies cell volume changes related to growth and not by either age copes et al 2015 or genotype  @TERM$2  et al 2017a	0.9999969	3.0832043e-06
30788345	putrescine	agmatine	30788345	197	208	@TERM$1	@TERM$2	 @TERM$1  is metabolized from arginine via either  @TERM$2  or ornithine and gives rise to spermidine the precursor of spermine figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.999998	1.996294e-06
30788345	putrescine	spermine	30788345	197	208	@TERM$1	@TERM$2	 @TERM$1  is metabolized from arginine via either agmatine or ornithine and gives rise to spermidine the precursor of  @TERM$2  figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.99995947	4.047567e-05
30788345	allantoin	kynurenic acid	30788345	190	193	@TERM$1	@TERM$2	s of both nucleotides hypoxanthine xanthosine and  @TERM$1  and amino acid metabolism betaine carnitine leucic acid pentothenate  @TERM$2  and xanthurenic acid confirming a welldocumented 	0.99999607	3.9921897e-06
30788345	tca	figure s8	30788345	203	190	@TERM$1	@TERM$2	overall there was a striking change in  @TERM$1  metabolites in 10day adults compared to day 5 or younger worms and some of the changes observed were in line with changes in idh1 mutants  @TERM$2 	0.9999224	7.762415e-05
30788345	tca	oxaloacetate	30788345	205	243	@TERM$1	@TERM$2	ysis indicated that most detected transcripts for  @TERM$1  enzymes show decreased levels with age figure s7b with the exception of citrate synthase which catalyzes the first step of the tca cycle condensing acetylcoa and  @TERM$2  to form citrat	0.99999607	3.89999e-06
30788345	citrate	acetylcoa	30788345	205	167	@TERM$1	@TERM$2	 levels with age figure s7b with the exception of  @TERM$1  synthase which catalyzes the first step of the tca cycle condensing  @TERM$2  and oxaloacetate to form citrat	0.018497026	0.981503
30788345	tca	citrate synthase	30788345	205	192	@TERM$1	@TERM$2	ysis indicated that most detected transcripts for  @TERM$1  enzymes show decreased levels with age figure s7b with the exception of  @TERM$2  which catalyzes the first step of the tca cycle c	0.080114625	0.9198854
30788345	synthase	acetylcoa	30788345	205	159	@TERM$1	@TERM$2	with age figure s7b with the exception of citrate  @TERM$1  which catalyzes the first step of the tca cycle condensing  @TERM$2  and oxaloacetate to form citrat	0.99998474	1.5217111e-05
30788345	synthase	oxaloacetate	30788345	205	159	@TERM$1	@TERM$2	with age figure s7b with the exception of citrate  @TERM$1  which catalyzes the first step of the tca cycle condensing acetylcoa and  @TERM$2  to form citrat	0.010276326	0.9897237
30788345	acetylcoa	oxaloacetate	30788345	205	91	@TERM$1	@TERM$2	alyzes the first step of the tca cycle condensing  @TERM$1  and  @TERM$2  to form citrat	0.9999957	4.30739e-06
30788345	citrate synthase	oxaloacetate	30788345	205	167	@TERM$1	@TERM$2	 levels with age figure s7b with the exception of  @TERM$1  which catalyzes the first step of the tca cycle condensing acetylcoa and  @TERM$2  to form citrat	0.999997	2.9311318e-06
30788345	tca	gem	30788345	202	242	@TERM$1	@TERM$2	an imbalance in the  @TERM$1  cycle in 10day old animals has been previously described wan et al 2017 and we observed in our metabolomics data a consistent change in both fem and  @TERM$2  with age indicating that changes were independent of the genotype	0.999992	7.942876e-06
30788345	tca	synthase	30788345	205	192	@TERM$1	@TERM$2	ysis indicated that most detected transcripts for  @TERM$1  enzymes show decreased levels with age figure s7b with the exception of citrate  @TERM$2  which catalyzes the first step of the tca cycle c	0.99999726	2.7817568e-06
30788345	tca	citrate	30788345	205	183	@TERM$1	@TERM$2	ysis indicated that most detected transcripts for  @TERM$1  enzymes show decreased levels with age figure s7b with the exception of  @TERM$2  synthase which catalyzes the first step of the tc	0.999997	2.9326054e-06
30788345	citrate	synthase	30788345	205	116	@TERM$1	@TERM$2	 levels with age figure s7b with the exception of  @TERM$1   @TERM$2  which catalyzes the first step of the tca cycle c	0.9993781	0.0006219127
30788345	citrate	oxaloacetate	30788345	205	167	@TERM$1	@TERM$2	 levels with age figure s7b with the exception of  @TERM$1  synthase which catalyzes the first step of the tca cycle condensing acetylcoa and  @TERM$2  to form citrat	0.999995	4.95307e-06
30788345	tca	acetylcoa	30788345	205	243	@TERM$1	@TERM$2	ysis indicated that most detected transcripts for  @TERM$1  enzymes show decreased levels with age figure s7b with the exception of citrate synthase which catalyzes the first step of the tca cycle condensing  @TERM$2  and oxaloacetate to form citrat	0.0030677011	0.99693227
30788345	fluxes	tca	30788345	207	88	@TERM$1	@TERM$2	ction was unable to recapitulate measured in vivo  @TERM$1  through the  @TERM$2  cycle figure s3	0.9999856	1.4426834e-05
30788345	flux	s9a	30788345	224	128	@TERM$1	@TERM$2	milarly ascertained the variability range for our  @TERM$1  predictions figure  @TERM$2  and confirm that the inclusion of the transcriptom	0.9999502	4.9788072e-05
30788345	tca	fluxes	30788345	230	148	@TERM$1	@TERM$2	first it predicts a peak in glycolysis during day 1 and in  @TERM$1  cycle during day 2 which is also evident in the heatmap of tca cycle  @TERM$2  figure 6d	0.9999975	2.460006e-06
30788345	citrate synthase	acetylcoa	30788345	205	167	@TERM$1	@TERM$2	 levels with age figure s7b with the exception of  @TERM$1  which catalyzes the first step of the tca cycle condensing  @TERM$2  and oxaloacetate to form citrat	0.99934214	0.00065781444
30788345	tca	wan	30788345	202	242	@TERM$1	@TERM$2	an imbalance in the  @TERM$1  cycle in 10day old animals has been previously described  @TERM$2  et al 2017 and we observed in our metabolomics data a consistent change in both fem and gem with age indicating that changes were independent of the genotype	0.9999987	1.3162696e-06
30788345	wan	gem	30788345	202	242	@TERM$1	@TERM$2	an imbalance in the tca cycle in 10day old animals has been previously described  @TERM$1  et al 2017 and we observed in our metabolomics data a consistent change in both fem and  @TERM$2  with age indicating that changes were independent of the genotype	0.9999976	2.3910009e-06
30788345	ornithine	spermine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either agmatine or  @TERM$1  and gives rise to spermidine the precursor of  @TERM$2  figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.99999714	2.8103038e-06
30788345	spermidine	lysine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either agmatine or ornithine and gives rise to  @TERM$1  the precursor of spermine figure s7a while cadaverine is the product of  @TERM$2  decarboxylation mccann 1982	0.99999595	4.0365026e-06
30788345	spermidine	spermine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either agmatine or ornithine and gives rise to  @TERM$1  the precursor of  @TERM$2  figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.99991083	8.920913e-05
30788345	spermine	lysine	30788345	197	208	@TERM$1	@TERM$2	putrescine is metabolized from arginine via either agmatine or ornithine and gives rise to spermidine the precursor of  @TERM$1  figure s7a while cadaverine is the product of  @TERM$2  decarboxylation mccann 1982	0.9921307	0.007869348
30788345	spermidine	synthase	30788345	199	227	@TERM$1	@TERM$2	as shown in figure s7a displaying the overlay of transcriptomics and metabolomics using pathview there is a significant agedependent upregulation in the levels of  @TERM$1   @TERM$2  see ec 25116 in figure s7a in day 10 animals	0.9999956	4.3729065e-06
30788345	synthase	25116	30788345	199	227	@TERM$1	@TERM$2	as shown in figure s7a displaying the overlay of transcriptomics and metabolomics using pathview there is a significant agedependent upregulation in the levels of spermidine  @TERM$1  see ec  @TERM$2  in figure s7a in day 10 animals	0.99999607	3.987073e-06
30788345	spermidine	25116	30788345	199	227	@TERM$1	@TERM$2	as shown in figure s7a displaying the overlay of transcriptomics and metabolomics using pathview there is a significant agedependent upregulation in the levels of  @TERM$1  synthase see ec  @TERM$2  in figure s7a in day 10 animals	0.994494	0.005505973
30788345	spermidine synthase	25116	30788345	199	227	@TERM$1	@TERM$2	as shown in figure s7a displaying the overlay of transcriptomics and metabolomics using pathview there is a significant agedependent upregulation in the levels of  @TERM$1  see ec  @TERM$2  in figure s7a in day 10 animals	0.9999968	3.21316e-06
30788345	sadenosylmethioninamine	putrescine	30788345	200	194	@TERM$1	@TERM$2	this enzyme catalyzes the transfer of a polyamine group from  @TERM$1  to  @TERM$2  in the biosynthesis of spermidine possibly reflecting an increased usage of spermidine with age	3.6033216e-05	0.999964
30788345	polyamine	sadenosylmethioninamine	30788345	200	194	@TERM$1	@TERM$2	this enzyme catalyzes the transfer of a  @TERM$1  group from  @TERM$2  to putrescine in the biosynthesis of spermidine possibly reflecting an increased usage of spermidine with age	0.9999913	8.67024e-06
30788345	putrescine	spermidine	30788345	200	194	@TERM$1	@TERM$2	this enzyme catalyzes the transfer of a polyamine group from sadenosylmethioninamine to  @TERM$1  in the biosynthesis of  @TERM$2  possibly reflecting an increased usage of spermidine with age	0.99999154	8.417155e-06
30788345	polyamine	spermidine	30788345	200	194	@TERM$1	@TERM$2	this enzyme catalyzes the transfer of a  @TERM$1  group from sadenosylmethioninamine to putrescine in the biosynthesis of  @TERM$2  possibly reflecting an increased usage of spermidine with age	0.999997	2.928765e-06
30788345	polyamine	putrescine	30788345	200	194	@TERM$1	@TERM$2	this enzyme catalyzes the transfer of a  @TERM$1  group from sadenosylmethioninamine to  @TERM$2  in the biosynthesis of spermidine possibly reflecting an increased usage of spermidine with age	0.99999785	2.1312296e-06
30788345	sadenosylmethioninamine	spermidine	30788345	200	194	@TERM$1	@TERM$2	this enzyme catalyzes the transfer of a polyamine group from  @TERM$1  to putrescine in the biosynthesis of  @TERM$2  possibly reflecting an increased usage of spermidine with age	0.99999726	2.685957e-06
30788345	tca	lactate	30788345	201	122	@TERM$1	@TERM$2	ved in central carbon metabolism particularly the  @TERM$1  cycle were significantly changed with age eg  @TERM$2  and oxaloacetat	0.99999225	7.796868e-06
30788345	polyamine	spermidine	30788345	201	74	@TERM$1	@TERM$2	the  @TERM$1   @TERM$2  has been associated with lifespan extension by ac	0.9999896	1.0319987e-05
30788345	putrescine	arginine	30788345	197	208	@TERM$1	@TERM$2	 @TERM$1  is metabolized from  @TERM$2  via either agmatine or ornithine and gives rise to spermidine the precursor of spermine figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.99999714	2.912274e-06
30788345	xanthurenic acid	gao	30788345	190	200	@TERM$1	@TERM$2	itine leucic acid pentothenate kynurenic acid and  @TERM$1  confirming a welldocumented imbalance in amino acid and nucleotide metabolism with age copes et al 2015  @TERM$2  et al 2017a wan et al 201	0.99999297	7.0156834e-06
30788345	xanthurenic acid	wan	30788345	190	200	@TERM$1	@TERM$2	itine leucic acid pentothenate kynurenic acid and  @TERM$1  confirming a welldocumented imbalance in amino acid and nucleotide metabolism with age copes et al 2015 gao et al 2017a  @TERM$2  et al 201	0.9999969	3.0881454e-06
30788345	peak	tca	30788345	230	148	@TERM$1	@TERM$2	first it predicts a  @TERM$1  in glycolysis during day 1 and in  @TERM$2  cycle during day 2 which is also evident in the heatmap of tca cycle fluxes figure 6d	0.99999845	1.4977533e-06
30788345	glutamateglutamic acid	guanosine	30788345	189	230	@TERM$1	@TERM$2	o acids including serine threonine leucine lysine  @TERM$1  methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides  @TERM$2  cytidine uridine gm	0.9999969	3.0447682e-06
30788345	homoserine	guanosine	30788345	189	127	@TERM$1	@TERM$2	nine and some byproducts of amino acid metabolism  @TERM$1  cystathionine as well as nucleotides  @TERM$2  cytidine uridine gm	0.9999963	3.6662188e-06
30788345	leucine	cystathionine	30788345	189	242	@TERM$1	@TERM$2	t measured amino acids including serine threonine  @TERM$1  lysine glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine  @TERM$2  as well as nucleotides guanosine cytidine uridine	0.99999607	3.9167444e-06
30788345	lysine	cytidine	30788345	189	237	@TERM$1	@TERM$2	ed amino acids including serine threonine leucine  @TERM$1  glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine  @TERM$2  uridine gm	0.99999785	2.1943322e-06
30788345	leucine	lysine	30788345	189	115	@TERM$1	@TERM$2	t measured amino acids including serine threonine  @TERM$1   @TERM$2  glutamateglutamic acid methionine tryptophan and a	0.99999833	1.626239e-06
30788345	arginine	cystathionine	30788345	189	178	@TERM$1	@TERM$2	 glutamateglutamic acid methionine tryptophan and  @TERM$1  and some byproducts of amino acid metabolism homoserine  @TERM$2  as well as nucleotides guanosine cytidine uridine	0.99999726	2.7200242e-06
30788345	guanosine	cytidine	30788345	189	79	@TERM$1	@TERM$2	m homoserine cystathionine as well as nucleotides  @TERM$1   @TERM$2  uridine gm	0.9999981	1.914318e-06
30788345	homoserine	cystathionine	30788345	189	124	@TERM$1	@TERM$2	nine and some byproducts of amino acid metabolism  @TERM$1   @TERM$2  as well as nucleotides guanosine cytidine uridine	0.9999753	2.4715811e-05
30788345	cytidine	uridine	30788345	189	69	@TERM$1	@TERM$2	ne cystathionine as well as nucleotides guanosine  @TERM$1   @TERM$2  gm	0.99999404	5.941887e-06
30788345	tryptophan	cytidine	30788345	189	196	@TERM$1	@TERM$2	 leucine lysine glutamateglutamic acid methionine  @TERM$1  and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine  @TERM$2  uridine gm	0.99999666	3.298609e-06
30788345	leucine	uridine	30788345	189	245	@TERM$1	@TERM$2	t measured amino acids including serine threonine  @TERM$1  lysine glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine cytidine  @TERM$2  gm	0.99999666	3.3037659e-06
30788345	threonine	glutamateglutamic acid	30788345	189	147	@TERM$1	@TERM$2	ntains most measured amino acids including serine  @TERM$1  leucine lysine  @TERM$2  methionine tryptophan and arginine and some bypro	0.99999654	3.4672494e-06
30788345	tryptophan	arginine	30788345	189	125	@TERM$1	@TERM$2	 leucine lysine glutamateglutamic acid methionine  @TERM$1  and  @TERM$2  and some byproducts of amino acid metabolism homose	0.9999963	3.7420743e-06
30788345	serine	threonine	30788345	189	116	@TERM$1	@TERM$2	time contains most measured amino acids including  @TERM$1   @TERM$2  leucine lysine glutamateglutamic acid methionine 	0.9999982	1.7807505e-06
30788345	glutamateglutamic acid	homoserine	30788345	189	225	@TERM$1	@TERM$2	o acids including serine threonine leucine lysine  @TERM$1  methionine tryptophan and arginine and some byproducts of amino acid metabolism  @TERM$2  cystathionine as well as nucleotides guanosine cytidine uridi	0.99999213	7.84695e-06
30788345	leucine	cytidine	30788345	189	245	@TERM$1	@TERM$2	t measured amino acids including serine threonine  @TERM$1  lysine glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine  @TERM$2  uridine gm	0.9999862	1.3838639e-05
30788345	leucine	tryptophan	30788345	189	159	@TERM$1	@TERM$2	t measured amino acids including serine threonine  @TERM$1  lysine glutamateglutamic acid methionine  @TERM$2  and arginine and some byproducts of amino acid me	0.99999845	1.5772335e-06
30788345	glutamateglutamic acid	cystathionine	30788345	189	230	@TERM$1	@TERM$2	o acids including serine threonine leucine lysine  @TERM$1  methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine  @TERM$2  as well as nucleotides guanosine cytidine uridine gm	0.99999845	1.5248603e-06
30788345	lysine	arginine	30788345	189	164	@TERM$1	@TERM$2	ed amino acids including serine threonine leucine  @TERM$1  glutamateglutamic acid methionine tryptophan and  @TERM$2  and some byproducts of amino acid metabolism homo	0.99999595	3.9979427e-06
30788345	leucine	glutamateglutamic acid	30788345	189	137	@TERM$1	@TERM$2	t measured amino acids including serine threonine  @TERM$1  lysine  @TERM$2  methionine tryptophan and arginine and some bypro	0.99999774	2.2130487e-06
30788345	serine	glutamateglutamic acid	30788345	189	154	@TERM$1	@TERM$2	time contains most measured amino acids including  @TERM$1  threonine leucine lysine  @TERM$2  methionine tryptophan and arginine and some bypro	0.99999857	1.4762255e-06
30788345	threonine	tryptophan	30788345	189	169	@TERM$1	@TERM$2	ntains most measured amino acids including serine  @TERM$1  leucine lysine glutamateglutamic acid methionine  @TERM$2  and arginine and some byproducts of amino acid me	0.999998	2.0556913e-06
30788345	glutamateglutamic acid	methionine	30788345	189	145	@TERM$1	@TERM$2	o acids including serine threonine leucine lysine  @TERM$1   @TERM$2  tryptophan and arginine and some byproducts of amino acid met	0.99999654	3.3981316e-06
30788345	lysine	glutamateglutamic acid	30788345	189	129	@TERM$1	@TERM$2	ed amino acids including serine threonine leucine  @TERM$1   @TERM$2  methionine tryptophan and arginine and some bypro	0.9999863	1.3723537e-05
30788345	serine	lysine	30788345	189	131	@TERM$1	@TERM$2	time contains most measured amino acids including  @TERM$1  threonine leucine  @TERM$2  glutamateglutamic acid methionine tryptophan and 	0.99999785	2.1587532e-06
30788345	leucine	homoserine	30788345	189	228	@TERM$1	@TERM$2	t measured amino acids including serine threonine  @TERM$1  lysine glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism  @TERM$2  cystathionine as well as nucleotides guanosine cy	0.99999785	2.1756407e-06
30788345	tryptophan	homoserine	30788345	189	179	@TERM$1	@TERM$2	 leucine lysine glutamateglutamic acid methionine  @TERM$1  and arginine and some byproducts of amino acid metabolism  @TERM$2  cystathionine as well as nucleotides guanosine cy	0.99999666	3.3252506e-06
30788345	glutamateglutamic acid	arginine	30788345	189	171	@TERM$1	@TERM$2	o acids including serine threonine leucine lysine  @TERM$1  methionine tryptophan and  @TERM$2  and some byproducts of amino acid metabolism homoserine cystath	0.99999785	2.146876e-06
30788345	methionine	guanosine	30788345	189	207	@TERM$1	@TERM$2	e threonine leucine lysine glutamateglutamic acid  @TERM$1  tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides  @TERM$2  cytidine uridine gm	0.9999982	1.765343e-06
30788345	threonine	homoserine	30788345	189	238	@TERM$1	@TERM$2	ntains most measured amino acids including serine  @TERM$1  leucine lysine glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism  @TERM$2  cystathionine as well as nucleotides guanosine cy	0.9999987	1.3040287e-06
30788345	methionine	homoserine	30788345	189	190	@TERM$1	@TERM$2	e threonine leucine lysine glutamateglutamic acid  @TERM$1  tryptophan and arginine and some byproducts of amino acid metabolism  @TERM$2  cystathionine as well as nucleotides guanosine cy	0.99999595	4.06216e-06
30788345	serine	homoserine	30788345	189	245	@TERM$1	@TERM$2	time contains most measured amino acids including  @TERM$1  threonine leucine lysine glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism  @TERM$2  cystathionine as well as nucleotides guanosine cy	0.99999535	4.707869e-06
30788345	glutamateglutamic acid	uridine	30788345	189	230	@TERM$1	@TERM$2	o acids including serine threonine leucine lysine  @TERM$1  methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine cytidine  @TERM$2  gm	0.99999714	2.8824106e-06
30788345	cystathionine	cytidine	30788345	189	116	@TERM$1	@TERM$2	me byproducts of amino acid metabolism homoserine  @TERM$1  as well as nucleotides guanosine  @TERM$2  uridine gm	0.99999607	3.958196e-06
30788345	tryptophan	cystathionine	30788345	189	193	@TERM$1	@TERM$2	 leucine lysine glutamateglutamic acid methionine  @TERM$1  and arginine and some byproducts of amino acid metabolism homoserine  @TERM$2  as well as nucleotides guanosine cytidine uridine	0.98692966	0.013070392
30788345	arginine	homoserine	30788345	189	164	@TERM$1	@TERM$2	 glutamateglutamic acid methionine tryptophan and  @TERM$1  and some byproducts of amino acid metabolism  @TERM$2  cystathionine as well as nucleotides guanosine cy	0.99999726	2.6942434e-06
30788345	methionine	cystathionine	30788345	189	204	@TERM$1	@TERM$2	e threonine leucine lysine glutamateglutamic acid  @TERM$1  tryptophan and arginine and some byproducts of amino acid metabolism homoserine  @TERM$2  as well as nucleotides guanosine cytidine uridine	0.9999976	2.3802713e-06
30788345	cystathionine	guanosine	30788345	189	116	@TERM$1	@TERM$2	me byproducts of amino acid metabolism homoserine  @TERM$1  as well as nucleotides  @TERM$2  cytidine uridine gm	0.9999982	1.7471589e-06
30788345	glutamateglutamic acid	tryptophan	30788345	189	156	@TERM$1	@TERM$2	o acids including serine threonine leucine lysine  @TERM$1  methionine  @TERM$2  and arginine and some byproducts of amino acid metabolism hom	0.99999774	2.2905392e-06
30788345	serine	tryptophan	30788345	189	176	@TERM$1	@TERM$2	time contains most measured amino acids including  @TERM$1  threonine leucine lysine glutamateglutamic acid methionine  @TERM$2  and arginine and some byproducts of amino acid me	0.9999453	5.4716547e-05
30788345	serine	arginine	30788345	189	189	@TERM$1	@TERM$2	time contains most measured amino acids including  @TERM$1  threonine leucine lysine glutamateglutamic acid methionine tryptophan and  @TERM$2  and some byproducts of amino acid metabolism homo	0.9999914	8.524758e-06
30788345	leucic acid	gao	30788345	190	244	@TERM$1	@TERM$2	ntoin and amino acid metabolism betaine carnitine  @TERM$1  pentothenate kynurenic acid and xanthurenic acid confirming a welldocumented imbalance in amino acid and nucleotide metabolism with age copes et al 2015  @TERM$2  et al 2017a wan et al 201	0.9999981	1.930466e-06
30788345	methionine	cytidine	30788345	189	207	@TERM$1	@TERM$2	e threonine leucine lysine glutamateglutamic acid  @TERM$1  tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine  @TERM$2  uridine gm	0.99999785	2.1856688e-06
30788345	leucine	methionine	30788345	189	148	@TERM$1	@TERM$2	t measured amino acids including serine threonine  @TERM$1  lysine glutamateglutamic acid  @TERM$2  tryptophan and arginine and some byproducts of am	0.9999981	1.9568051e-06
30788345	lysine	tryptophan	30788345	189	151	@TERM$1	@TERM$2	ed amino acids including serine threonine leucine  @TERM$1  glutamateglutamic acid methionine  @TERM$2  and arginine and some byproducts of amino acid me	0.9999981	1.9034354e-06
30788345	allantoin	leucic acid	30788345	190	165	@TERM$1	@TERM$2	s of both nucleotides hypoxanthine xanthosine and  @TERM$1  and amino acid metabolism betaine carnitine  @TERM$2  pentothenate kynurenic acid and xanthurenic acid 	0.9999924	7.5820335e-06
30788345	allantoin	xanthurenic acid	30788345	190	214	@TERM$1	@TERM$2	s of both nucleotides hypoxanthine xanthosine and  @TERM$1  and amino acid metabolism betaine carnitine leucic acid pentothenate kynurenic acid and  @TERM$2  confirming a welldocumented imbalance in amino ac	0.99998105	1.899306e-05
30788345	leucic acid	kynurenic acid	30788345	190	139	@TERM$1	@TERM$2	ntoin and amino acid metabolism betaine carnitine  @TERM$1  pentothenate  @TERM$2  and xanthurenic acid confirming a welldocumented 	0.99997914	2.0856374e-05
30788345	kynurenic acid	xanthurenic acid	30788345	190	135	@TERM$1	@TERM$2	bolism betaine carnitine leucic acid pentothenate  @TERM$1  and  @TERM$2  confirming a welldocumented imbalance in amino ac	0.9999888	1.1264935e-05
30788345	xanthosine	pentothenate	30788345	190	193	@TERM$1	@TERM$2	adation products of both nucleotides hypoxanthine  @TERM$1  and allantoin and amino acid metabolism betaine carnitine leucic acid  @TERM$2  kynurenic acid and xanthurenic acid confirming a 	0.99999774	2.2709894e-06
30788345	xanthosine	xanthurenic acid	30788345	190	229	@TERM$1	@TERM$2	adation products of both nucleotides hypoxanthine  @TERM$1  and allantoin and amino acid metabolism betaine carnitine leucic acid pentothenate kynurenic acid and  @TERM$2  confirming a welldocumented imbalance in amino ac	0.999998	2.0539787e-06
30788345	allantoin	carnitine	30788345	190	153	@TERM$1	@TERM$2	s of both nucleotides hypoxanthine xanthosine and  @TERM$1  and amino acid metabolism betaine  @TERM$2  leucic acid pentothenate kynurenic acid and xanth	0.99999857	1.4223649e-06
30788345	hypoxanthine	carnitine	30788345	190	184	@TERM$1	@TERM$2	contains degradation products of both nucleotides  @TERM$1  xanthosine and allantoin and amino acid metabolism betaine  @TERM$2  leucic acid pentothenate kynurenic acid and xanthure	0.99999714	2.811462e-06
30788345	homoserine	cytidine	30788345	189	127	@TERM$1	@TERM$2	nine and some byproducts of amino acid metabolism  @TERM$1  cystathionine as well as nucleotides guanosine  @TERM$2  uridine gm	0.9999939	6.0836646e-06
30788345	betaine	pentothenate	30788345	190	142	@TERM$1	@TERM$2	anthosine and allantoin and amino acid metabolism  @TERM$1  carnitine leucic acid  @TERM$2  kynurenic acid and xanthurenic acid confirming a 	0.9999969	3.1186469e-06
30788345	leucic acid	wan	30788345	190	244	@TERM$1	@TERM$2	ntoin and amino acid metabolism betaine carnitine  @TERM$1  pentothenate kynurenic acid and xanthurenic acid confirming a welldocumented imbalance in amino acid and nucleotide metabolism with age copes et al 2015 gao et al 2017a  @TERM$2  et al 201	0.999997	2.9958949e-06
30788345	pentothenate	xanthurenic acid	30788345	190	148	@TERM$1	@TERM$2	ino acid metabolism betaine carnitine leucic acid  @TERM$1  kynurenic acid and  @TERM$2  confirming a welldocumented imbalance in amino ac	0.9999974	2.5747322e-06
30788345	xanthosine	betaine	30788345	190	161	@TERM$1	@TERM$2	adation products of both nucleotides hypoxanthine  @TERM$1  and allantoin and amino acid metabolism  @TERM$2  carnitine leucic acid pentothenate kynurenic acid an	0.99999845	1.562344e-06
30788345	pentothenate	gao	30788345	190	232	@TERM$1	@TERM$2	ino acid metabolism betaine carnitine leucic acid  @TERM$1  kynurenic acid and xanthurenic acid confirming a welldocumented imbalance in amino acid and nucleotide metabolism with age copes et al 2015  @TERM$2  et al 2017a wan et al 201	0.99999547	4.5489846e-06
30788345	hypoxanthine	kynurenic acid	30788345	190	221	@TERM$1	@TERM$2	contains degradation products of both nucleotides  @TERM$1  xanthosine and allantoin and amino acid metabolism betaine carnitine leucic acid pentothenate  @TERM$2  and xanthurenic acid confirming a welldocumented 	0.9999875	1.2509794e-05
30788345	kynurenic acid	wan	30788345	190	219	@TERM$1	@TERM$2	bolism betaine carnitine leucic acid pentothenate  @TERM$1  and xanthurenic acid confirming a welldocumented imbalance in amino acid and nucleotide metabolism with age copes et al 2015 gao et al 2017a  @TERM$2  et al 201	0.9999981	1.860836e-06
30788345	hypoxanthine	allantoin	30788345	190	140	@TERM$1	@TERM$2	contains degradation products of both nucleotides  @TERM$1  xanthosine and  @TERM$2  and amino acid metabolism betaine carnitine leucic a	0.99999404	6.00164e-06
30788345	betaine	leucic acid	30788345	190	129	@TERM$1	@TERM$2	anthosine and allantoin and amino acid metabolism  @TERM$1  carnitine  @TERM$2  pentothenate kynurenic acid and xanthurenic acid 	0.9999975	2.5230165e-06
30788345	betaine	xanthurenic acid	30788345	190	178	@TERM$1	@TERM$2	anthosine and allantoin and amino acid metabolism  @TERM$1  carnitine leucic acid pentothenate kynurenic acid and  @TERM$2  confirming a welldocumented imbalance in amino ac	0.99999833	1.7049927e-06
30788345	carnitine	kynurenic acid	30788345	190	149	@TERM$1	@TERM$2	e and allantoin and amino acid metabolism betaine  @TERM$1  leucic acid pentothenate  @TERM$2  and xanthurenic acid confirming a welldocumented 	0.99998975	1.0300392e-05
30788345	homoserine	uridine	30788345	189	127	@TERM$1	@TERM$2	nine and some byproducts of amino acid metabolism  @TERM$1  cystathionine as well as nucleotides guanosine cytidine  @TERM$2  gm	0.999982	1.8006602e-05
30788345	lysine	cystathionine	30788345	189	234	@TERM$1	@TERM$2	ed amino acids including serine threonine leucine  @TERM$1  glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine  @TERM$2  as well as nucleotides guanosine cytidine uridine	0.9999713	2.873689e-05
30788345	methionine	uridine	30788345	189	207	@TERM$1	@TERM$2	e threonine leucine lysine glutamateglutamic acid  @TERM$1  tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine cytidine  @TERM$2  gm	0.99999785	2.1891567e-06
30788345	serine	leucine	30788345	189	124	@TERM$1	@TERM$2	time contains most measured amino acids including  @TERM$1  threonine  @TERM$2  lysine glutamateglutamic acid methionine tryptoph	0.9999958	4.19165e-06
30788345	arginine	guanosine	30788345	189	181	@TERM$1	@TERM$2	 glutamateglutamic acid methionine tryptophan and  @TERM$1  and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides  @TERM$2  cytidine uridine gm	0.9999958	4.187958e-06
30788345	arginine	uridine	30788345	189	181	@TERM$1	@TERM$2	 glutamateglutamic acid methionine tryptophan and  @TERM$1  and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine cytidine  @TERM$2  gm	0.9999683	3.1756517e-05
30788345	tryptophan	uridine	30788345	189	196	@TERM$1	@TERM$2	 leucine lysine glutamateglutamic acid methionine  @TERM$1  and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine cytidine  @TERM$2  gm	0.99998534	1.4698781e-05
30788345	methionine	tryptophan	30788345	189	121	@TERM$1	@TERM$2	e threonine leucine lysine glutamateglutamic acid  @TERM$1   @TERM$2  and arginine and some byproducts of amino acid me	0.9999982	1.8073999e-06
30788345	glutamateglutamic acid	cytidine	30788345	189	230	@TERM$1	@TERM$2	o acids including serine threonine leucine lysine  @TERM$1  methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine  @TERM$2  uridine gm	0.50457275	0.49542725
30788345	arginine	cytidine	30788345	189	181	@TERM$1	@TERM$2	 glutamateglutamic acid methionine tryptophan and  @TERM$1  and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine  @TERM$2  uridine gm	0.7946143	0.20538568
30788345	leucine	arginine	30788345	189	172	@TERM$1	@TERM$2	t measured amino acids including serine threonine  @TERM$1  lysine glutamateglutamic acid methionine tryptophan and  @TERM$2  and some byproducts of amino acid metabolism homo	0.99999833	1.6583359e-06
30788345	lysine	guanosine	30788345	189	237	@TERM$1	@TERM$2	ed amino acids including serine threonine leucine  @TERM$1  glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides  @TERM$2  cytidine uridine gm	0.99965036	0.00034959218
30788345	threonine	methionine	30788345	189	158	@TERM$1	@TERM$2	ntains most measured amino acids including serine  @TERM$1  leucine lysine glutamateglutamic acid  @TERM$2  tryptophan and arginine and some byproducts of am	0.99998975	1.02804315e-05
30788345	lysine	homoserine	30788345	189	220	@TERM$1	@TERM$2	ed amino acids including serine threonine leucine  @TERM$1  glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism  @TERM$2  cystathionine as well as nucleotides guanosine cy	0.99999845	1.5133444e-06
30788345	lysine	uridine	30788345	189	237	@TERM$1	@TERM$2	ed amino acids including serine threonine leucine  @TERM$1  glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides guanosine cytidine  @TERM$2  gm	0.99999785	2.1541177e-06
30788345	serine	methionine	30788345	189	165	@TERM$1	@TERM$2	time contains most measured amino acids including  @TERM$1  threonine leucine lysine glutamateglutamic acid  @TERM$2  tryptophan and arginine and some byproducts of am	0.95485204	0.045147974
30788345	threonine	arginine	30788345	189	183	@TERM$1	@TERM$2	ntains most measured amino acids including serine  @TERM$1  leucine lysine glutamateglutamic acid methionine tryptophan and  @TERM$2  and some byproducts of amino acid metabolism homos	0.9999362	6.378022e-05
30788345	methionine	arginine	30788345	189	136	@TERM$1	@TERM$2	e threonine leucine lysine glutamateglutamic acid  @TERM$1  tryptophan and  @TERM$2  and some byproducts of amino acid metabolism homose	0.99999285	7.1175923e-06
30788345	guanosine	uridine	30788345	189	79	@TERM$1	@TERM$2	m homoserine cystathionine as well as nucleotides  @TERM$1  cytidine  @TERM$2  gm	0.99999833	1.6926571e-06
30788345	threonine	leucine	30788345	189	119	@TERM$1	@TERM$2	ntains most measured amino acids including serine  @TERM$1   @TERM$2  lysine glutamateglutamic acid methionine tryptophan	0.999969	3.094762e-05
30788345	peak	fluxes	30788345	230	148	@TERM$1	@TERM$2	first it predicts a  @TERM$1  in glycolysis during day 1 and in tca cycle during day 2 which is also evident in the heatmap of tca cycle  @TERM$2  figure 6d	0.9999856	1.44657e-05
30788345	tryptophan	guanosine	30788345	189	196	@TERM$1	@TERM$2	 leucine lysine glutamateglutamic acid methionine  @TERM$1  and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides  @TERM$2  cytidine uridine gm	0.99999607	3.9044853e-06
30788345	aspartate	glutamate	30788345	271	130	@TERM$1	@TERM$2	because we did not directly measure  @TERM$1  we focused our analysis on  @TERM$2  which significantly decreased with age figure 4	0.99999845	1.5083748e-06
30788345	fluxes	tca	30788345	272	105	@TERM$1	@TERM$2	the  @TERM$1  through reactions that connect glutamate to the  @TERM$2  cycle are listed in supplementary table 11	0.9999963	3.7480174e-06
30788345	glutamate	tca	30788345	272	105	@TERM$1	@TERM$2	the fluxes through reactions that connect  @TERM$1  to the  @TERM$2  cycle are listed in supplementary table 11	0.99999785	2.1519434e-06
30788345	fluxes	glutamate	30788345	272	105	@TERM$1	@TERM$2	the  @TERM$1  through reactions that connect  @TERM$2  to the tca cycle are listed in supplementary table 11	0.9999969	3.113987e-06
30788345	fluxes	glutamate	30788345	273	207	@TERM$1	@TERM$2	 @TERM$1  predicted by standard fba are either inactive or unchanged from days 5 and 10 in fem animals figure 8 and therefore conventional fba modeling does not account for our in vivo measurements of  @TERM$2 	0.99999595	4.0787822e-06
30788345	fluxes	glutamate	30788345	274	160	@TERM$1	@TERM$2	when using the modified objective function metabfba predicts that several  @TERM$1  that connect tca metabolites with  @TERM$2  are substantially altered figure 8	0.9999989	1.1146975e-06
30788345	tca	glutamate	30788345	274	160	@TERM$1	@TERM$2	when using the modified objective function metabfba predicts that several fluxes that connect  @TERM$1  metabolites with  @TERM$2  are substantially altered figure 8	0.99999785	2.1606604e-06
30788345	fluxes	glutamate	30788345	275	217	@TERM$1	@TERM$2	first although  @TERM$1  that lead to  @TERM$2  production in the cytosol remain unchanged figure 8a all fluxes inside the mitochondria that contribute to production or consumption of glutamate were decreased figures 8bc	0.99999774	2.264268e-06
30788345	fluxes	glutamate	30788345	277	236	@TERM$1	@TERM$2	to specifically rule out that the optimized objective function is not biasing the results by forcing  @TERM$1  through  @TERM$2  we asked if the model arrives at a similar solution in the absence of direct prior information about glutamate	0.9999932	6.7992646e-06
30788345	fluxes	glutamate	30788345	278	188	@TERM$1	@TERM$2	in this in silico experiment  @TERM$1  were recalculated using a modified objective function that included all measured metabolites except for  @TERM$2  metabfbanoglu supplementary table 9	0.99999166	8.375102e-06
30788345	fluxes	tca	30788345	280	227	@TERM$1	@TERM$2	given that  @TERM$1  leading to catabolism of glutamate are predicted to sharply decrease with age a plausible hypothesis is that depletion of glutamate in old animals is caused by a failure of the  @TERM$2  cycle to replenish glutamate	0.99999595	4.099239e-06
30788345	glutamate	tca	30788345	280	227	@TERM$1	@TERM$2	given that fluxes leading to catabolism of  @TERM$1  are predicted to sharply decrease with age a plausible hypothesis is that depletion of glutamate in old animals is caused by a failure of the  @TERM$2  cycle to replenish glutamate	0.999998	2.013694e-06
30788345	fluxes	glutamate	30788345	280	227	@TERM$1	@TERM$2	given that  @TERM$1  leading to catabolism of  @TERM$2  are predicted to sharply decrease with age a plausible hypothesis is that depletion of glutamate in old animals is caused by a failure of the tca cycle to replenish glutamate	0.99809915	0.0019009076
30788345	glutamate	figure s8	30788345	285	144	@TERM$1	@TERM$2	 iv as well as in tcacycle defective idh1 mutants  @TERM$1  become depleted in worms  @TERM$2  connecting a malfunctioning tca cycle with cellul	0.99999774	2.25851e-06
30788345	fluxes	tca	30788345	274	160	@TERM$1	@TERM$2	when using the modified objective function metabfba predicts that several  @TERM$1  that connect  @TERM$2  metabolites with glutamate are substantially altered figure 8	0.999997	2.9382684e-06
30788345	tca	glutamate	30788345	269	194	@TERM$1	@TERM$2	 it is one of the drivers of the aging processthe  @TERM$1  cycle is a source of energy but it can also produce and consume amino acids such as  @TERM$2  and aspartate reactions 10 and 11 in figure s3	0.99940884	0.0005911858
30788345	tca	aspartate	30788345	269	194	@TERM$1	@TERM$2	 it is one of the drivers of the aging processthe  @TERM$1  cycle is a source of energy but it can also produce and consume amino acids such as glutamate and  @TERM$2  reactions 10 and 11 in figure s3	0.99999845	1.5279071e-06
30788345	glutamate	aspartate	30788345	269	106	@TERM$1	@TERM$2	 can also produce and consume amino acids such as  @TERM$1  and  @TERM$2  reactions 10 and 11 in figure s3	0.99999833	1.6927006e-06
30788345	malate	oxaloacetate	30788345	254	244	@TERM$1	@TERM$2	metabfba predicted that fluxes through the reaction mdhm which represents the conversion of  @TERM$1  to  @TERM$2  by malate dehydrogenase in the mitochondria was dramatically reduced from days 45 and days 510 in fem reaction 8 in figures 7bd	0.9999981	1.9573763e-06
30788345	malate	malate dehydrogenase	30788345	254	244	@TERM$1	@TERM$2	metabfba predicted that fluxes through the reaction mdhm which represents the conversion of  @TERM$1  to oxaloacetate by  @TERM$2  in the mitochondria was dramatically reduced from days 45 and days 510 in fem reaction 8 in figures 7bd	0.99992394	7.609718e-05
30788345	oxaloacetate	citrate	30788345	255	157	@TERM$1	@TERM$2	at the same time csm which represents the conversion of  @TERM$1  to  @TERM$2  in the mitochondria was also substantially reduced reaction 1 in figures 7bd	0.99999607	3.979574e-06
30788345	flux	oxaloacetate	30788345	260	209	@TERM$1	@TERM$2	one possibility is that this predicted  @TERM$1  is based solely on the direct measurements of  @TERM$2  and if so this may indicate that the inclusion of this information was disproportionately biasing the data	0.999997	3.031435e-06
30788345	fluxes	oxaloacetate	30788345	262	224	@TERM$1	@TERM$2	in this model figures 7cd we found that  @TERM$1  through mhdm reaction 1 in figure 7c remained the most depressed from days 45 to days 510 and net production of  @TERM$2  dropped by 25 from an 8 on days 45 to 6 on days 510	0.9998646	0.00013536683
30788345	oxaloacetate	fluxes	30788345	263	166	@TERM$1	@TERM$2	l still correctly predicted a substantial drop in  @TERM$1  productionthe striking difference in the  @TERM$2  within the tca cycle affecting oxaloacetate between day	0.9999944	5.5542973e-06
30788345	oxaloacetate	tca	30788345	263	184	@TERM$1	@TERM$2	l still correctly predicted a substantial drop in  @TERM$1  productionthe striking difference in the fluxes within the  @TERM$2  cycle affecting oxaloacetate between days 45 and 510 sugge	0.99999654	3.4243067e-06
30788345	fluxes	tca	30788345	263	124	@TERM$1	@TERM$2	oacetate productionthe striking difference in the  @TERM$1  within the  @TERM$2  cycle affecting oxaloacetate between days 45 and 510	0.9998932	0.00010676298
30788345	tca	oxaloacetate	30788345	267	211	@TERM$1	@TERM$2	ith this prediction while supplementation of most  @TERM$1  metabolites either does not affect lifespan or has only a small effect edwards et al 2013 2015  @TERM$2  extends lifespan by 25 and it depends on both amp	0.99999726	2.7353174e-06
30788345	ampk	insulin	30788345	267	95	@TERM$1	@TERM$2	nd it depends on both ampactivated protein kinase  @TERM$1  and  @TERM$2  signaling williams et al 200	0.999997	3.006551e-06
30788345	oxaloacetate	ampactivated protein kinase	30788345	267	182	@TERM$1	@TERM$2	r has only a small effect edwards et al 2013 2015  @TERM$1  extends lifespan by 25 and it depends on both  @TERM$2  ampk and insulin signaling williams et al 200	0.999997	2.9272962e-06
30788345	ampactivated protein kinase	insulin	30788345	267	123	@TERM$1	@TERM$2	ate extends lifespan by 25 and it depends on both  @TERM$1  ampk and  @TERM$2  signaling williams et al 200	0.99999	1.00434745e-05
30788345	oxaloacetate	insulin	30788345	267	182	@TERM$1	@TERM$2	r has only a small effect edwards et al 2013 2015  @TERM$1  extends lifespan by 25 and it depends on both ampactivated protein kinase ampk and  @TERM$2  signaling williams et al 200	0.9999883	1.1645972e-05
30788345	oxaloacetate	ampk	30788345	267	182	@TERM$1	@TERM$2	r has only a small effect edwards et al 2013 2015  @TERM$1  extends lifespan by 25 and it depends on both ampactivated protein kinase  @TERM$2  and insulin signaling williams et al 200	0.9999919	8.133152e-06
30788345	ampactivated protein kinase	ampk	30788345	267	123	@TERM$1	@TERM$2	ate extends lifespan by 25 and it depends on both  @TERM$1   @TERM$2  and insulin signaling williams et al 200	0.99998605	1.3996262e-05
30788345	aac	fluxes	30788345	285	136	@TERM$1	@TERM$2	nnecting a malfunctioning tca cycle with cellular  @TERM$1  contentpredicted exchange  @TERM$2  for glutamate inside the mitochondria and cytosol	0.9999964	3.5571616e-06
30788345	malate	dehydrogenase	30788345	254	244	@TERM$1	@TERM$2	metabfba predicted that fluxes through the reaction mdhm which represents the conversion of  @TERM$1  to oxaloacetate by malate  @TERM$2  in the mitochondria was dramatically reduced from days 45 and days 510 in fem reaction 8 in figures 7bd	0.9999938	6.197149e-06
30788345	tca	aac	30788345	285	127	@TERM$1	@TERM$2	ed in worms figure s8 connecting a malfunctioning  @TERM$1  cycle with cellular  @TERM$2  contentpredicted exchange fluxes for glutamate in	0.9403905	0.059609488
30788345	glutamate	fluxes	30788345	285	236	@TERM$1	@TERM$2	 iv as well as in tcacycle defective idh1 mutants  @TERM$1  become depleted in worms figure s8 connecting a malfunctioning tca cycle with cellular aac contentpredicted exchange  @TERM$2  for glutamate inside the mitochondria and cytosol by	0.9999962	3.833486e-06
30788345	ampk	weir	30788345	320	230	@TERM$1	@TERM$2	it is not known however what triggers the loss of functionality of the mitochondria in normal lived animals with age but it can be reversed by mutations in  @TERM$1  homolog aak2 a master regulator of energy homeostasis  @TERM$2  et al 2017	0.00055458135	0.9994454
30788345	ampk homolog	weir	30788345	320	230	@TERM$1	@TERM$2	it is not known however what triggers the loss of functionality of the mitochondria in normal lived animals with age but it can be reversed by mutations in  @TERM$1  aak2 a master regulator of energy homeostasis  @TERM$2  et al 2017	0.99999595	4.0064924e-06
30788345	reactive oxygen species	ros	30788345	323	184	@TERM$1	@TERM$2	free  @TERM$1   @TERM$2  can also have a healthy hormetic effect on mitochondria ristow and zarse 2010 so for this theory to be correct ros action has to be threshold dependent	0.99999833	1.7196668e-06
30788345	aconitate	aconitase	30788345	325	107	@TERM$1	@TERM$2	in support of this hypothesis we also observed a drop in  @TERM$1  levels which is synthesized by  @TERM$2 	0.9999981	1.9058875e-06
30788345	oxaloacetate	tca	30788345	327	143	@TERM$1	@TERM$2	interestingly we observed that aconitate levels drop earlier than  @TERM$1  levels suggesting that ros may precipitate  @TERM$2  cycle dysfunction	0.99999714	2.8332852e-06
30788345	aconitate	oxaloacetate	30788345	327	143	@TERM$1	@TERM$2	interestingly we observed that  @TERM$1  levels drop earlier than  @TERM$2  levels suggesting that ros may precipitate tca cycle dysfunction	0.9995103	0.00048972503
30788345	ros	tca	30788345	327	143	@TERM$1	@TERM$2	interestingly we observed that aconitate levels drop earlier than oxaloacetate levels suggesting that  @TERM$1  may precipitate  @TERM$2  cycle dysfunction	0.99999785	2.1753006e-06
30788345	aconitate	ros	30788345	327	143	@TERM$1	@TERM$2	interestingly we observed that  @TERM$1  levels drop earlier than oxaloacetate levels suggesting that  @TERM$2  may precipitate tca cycle dysfunction	0.9999914	8.527523e-06
30788345	aconitate	tca	30788345	327	143	@TERM$1	@TERM$2	interestingly we observed that  @TERM$1  levels drop earlier than oxaloacetate levels suggesting that ros may precipitate  @TERM$2  cycle dysfunction	0.99999344	6.5855074e-06
30788345	oxaloacetate	ros	30788345	327	143	@TERM$1	@TERM$2	interestingly we observed that aconitate levels drop earlier than  @TERM$1  levels suggesting that  @TERM$2  may precipitate tca cycle dysfunction	0.99999785	2.1251815e-06
30788345	oxaloacetate	sirtuins	30788345	333	136	@TERM$1	@TERM$2	 @TERM$1  supplementation elevates the levels of nad and restores redox balance acting through  @TERM$2  and ampk roth and ingram 2016	0.9999963	3.6394997e-06
30788345	oxaloacetate	nad	30788345	333	136	@TERM$1	@TERM$2	 @TERM$1  supplementation elevates the levels of  @TERM$2  and restores redox balance acting through sirtuins and ampk roth and ingram 2016	0.99999714	2.8343366e-06
30788345	nad	ampk	30788345	333	136	@TERM$1	@TERM$2	oxaloacetate supplementation elevates the levels of  @TERM$1  and restores redox balance acting through sirtuins and  @TERM$2  roth and ingram 2016	0.9999981	1.9352105e-06
30788345	oxaloacetate	ampk	30788345	333	136	@TERM$1	@TERM$2	 @TERM$1  supplementation elevates the levels of nad and restores redox balance acting through sirtuins and  @TERM$2  roth and ingram 2016	0.9999981	1.9100653e-06
30788345	sirtuins	ampk	30788345	333	136	@TERM$1	@TERM$2	oxaloacetate supplementation elevates the levels of nad and restores redox balance acting through  @TERM$1  and  @TERM$2  roth and ingram 2016	0.9999976	2.3638142e-06
30788345	tca	fluxes	30788345	337	108	@TERM$1	@TERM$2	our model also predicts that the  @TERM$1  cycle can have an impact on the  @TERM$2  of amino acids such as glutamate	0.9999976	2.4333551e-06
30788345	tca	glutamate	30788345	337	108	@TERM$1	@TERM$2	our model also predicts that the  @TERM$1  cycle can have an impact on the fluxes of amino acids such as  @TERM$2 	0.99999857	1.4248142e-06
30788345	fluxes	glutamate	30788345	337	108	@TERM$1	@TERM$2	our model also predicts that the tca cycle can have an impact on the  @TERM$1  of amino acids such as  @TERM$2 	0.9999951	4.861505e-06
30788345	erc	nih 1s10od02156201	30788345	344	217	@TERM$1	@TERM$2	this work has been supported by  @TERM$1  noisy aging 638426 and bbsrc bbseb000c0426 to oc mrc mrj0038081 to jh rutherford foundation fellowship to am and  @TERM$2  to nmrcthe supplementary material for this articl	0.9999981	1.9246625e-06
30788345	nad	sirtuins	30788345	333	136	@TERM$1	@TERM$2	oxaloacetate supplementation elevates the levels of  @TERM$1  and restores redox balance acting through  @TERM$2  and ampk roth and ingram 2016	0.99999845	1.5573813e-06
30788345	tca	gao	30788345	319	164	@TERM$1	@TERM$2	however our metabolomics data shows that  @TERM$1  intermediates are changed dramatically sometime after day 5 of adulthood and after day 7 as observed in  @TERM$2  et al 2017a	0.9999982	1.836512e-06
30788345	wormspecific	fatty	30788345	316	168	@TERM$1	@TERM$2	for example the annotation of  @TERM$1  metabolites is poor as is the annotation of pathways involving  @TERM$2  acids and lipidswe anticipate that other approaches to c	0.999998	1.9730965e-06
30788345	fluxes	tca	30788345	310	169	@TERM$1	@TERM$2	xample in figures 6ab the model predicts peaks in  @TERM$1  through carbohydrate metabolism at 49 h and through the  @TERM$2  cycle at 73 h the use of neighboring time points rat	0.999998	2.0051777e-06
30788345	tcacycle	aac	30788345	285	237	@TERM$1	@TERM$2	components of etc complexes i to iv as well as in  @TERM$1  defective idh1 mutants glutamate become depleted in worms figure s8 connecting a malfunctioning tca cycle with cellular  @TERM$2  contentpredicted exchange fluxes for glutamate inside 	0.99999845	1.5470281e-06
30788345	glutamate	tca	30788345	285	182	@TERM$1	@TERM$2	 iv as well as in  @TERM$2 cycle defective idh1 mutants  @TERM$1  become depleted in worms figure s8 connecting a malfunctioning tca cycle with cellular aac contentpredicted exchange fluxe	0.9999968	3.2443086e-06
30788345	tcacycle	glutamate	30788345	285	141	@TERM$1	@TERM$2	components of etc complexes i to iv as well as in  @TERM$1  defective idh1 mutants  @TERM$2  become depleted in worms figure s8 connecting a m	0.99222744	0.0077725668
30788345	glutamate	aac	30788345	285	206	@TERM$1	@TERM$2	 iv as well as in tcacycle defective idh1 mutants  @TERM$1  become depleted in worms figure s8 connecting a malfunctioning tca cycle with cellular  @TERM$2  contentpredicted exchange fluxes for glutamate inside t	0.99999714	2.9062837e-06
30788345	tcacycle	figure s8	30788345	285	176	@TERM$1	@TERM$2	components of etc complexes i to iv as well as in  @TERM$1  defective idh1 mutants glutamate become depleted in worms  @TERM$2  connecting a malfunctioning tca cycle with cellul	0.99999785	2.0898983e-06
30788345	tca	fluxes	30788345	285	160	@TERM$1	@TERM$2	ed in worms figure s8 connecting a malfunctioning  @TERM$1  cycle with cellular aac contentpredicted exchange  @TERM$2  for glutamate inside the mitochondria and cytosol	0.99999774	2.2192157e-06
30788345	figure s8	tca	30788345	285	147	@TERM$1	@TERM$2	e idh1 mutants glutamate become depleted in worms  @TERM$1  connecting a malfunctioning  @TERM$2  cycle with cellular aac contentpredicted exchange fluxe	0.99999607	3.875837e-06
30788345	tcacycle	tca	30788345	285	213	@TERM$1	@TERM$2	components of etc complexes i to iv as well as in  @TERM$1  defective idh1 mutants glutamate become depleted in worms figure s8 connecting a malfunctioning  @TERM$2  cycle with cellular aac contentpredicted exchange flux	0.9999975	2.5144413e-06
30788345	glutamate	tca	30788345	286	124	@TERM$1	@TERM$2	all comparisons refer to reactions that connect  @TERM$1  to the  @TERM$2  cycle in days 45 or days 510 fem samples using three di	0.9999969	3.073877e-06
30788345	fluxes	glutamate	30788345	288	191	@TERM$1	@TERM$2	b  @TERM$1  that produce  @TERM$2  within the mitochondria c fluxes that consume glutamate inside the mitochondria d difference between mitochondrial production and consumption per day per model	0.9999896	1.0315904e-05
30788345	spermidine	synthase	30788345	297	111	@TERM$1	@TERM$2	however as shown in figure s7  @TERM$1   @TERM$2  which catalyzes the biosynthesis of spermidine is upregulated	0.99997294	2.7048014e-05
30788345	spermidine synthase	spermidine	30788345	297	111	@TERM$1	@TERM$2	however as shown in figure s7  @TERM$1  which catalyzes the biosynthesis of  @TERM$2  is upregulated	0.9996495	0.000350476
30788345	putrescine	agmatine	30788345	298	146	@TERM$1	@TERM$2	supplementation of  @TERM$1  and  @TERM$2  increases lifespan in worms by 1020 edwards et al 2015 whilst the role of cadaverine remains unexplored	0.99999714	2.8634317e-06
30788345	putrescine	cadaverine	30788345	298	146	@TERM$1	@TERM$2	supplementation of  @TERM$1  and agmatine increases lifespan in worms by 1020 edwards et al 2015 whilst the role of  @TERM$2  remains unexplored	0.99954706	0.00045288945
30788345	agmatine	cadaverine	30788345	298	146	@TERM$1	@TERM$2	supplementation of putrescine and  @TERM$1  increases lifespan in worms by 1020 edwards et al 2015 whilst the role of  @TERM$2  remains unexplored	0.99991274	8.7307046e-05
30788345	3hydroxybutyric acid	3hba	30788345	301	105	@TERM$1	@TERM$2	it is interesting to note that the levels of  @TERM$1   @TERM$2  behave similarly to the polyamines	0.99999356	6.3989046e-06
30788345	3hba	ketone	30788345	302	161	@TERM$1	@TERM$2	 @TERM$1  is metabolized from ketogenic amino acids andor lipids and it is a component of  @TERM$2  bodies which supply energy during periods of fasting veech et al 2017	0.99997795	2.2027476e-05
30788345	spermidine	polyamine	30788345	304	232	@TERM$1	@TERM$2	at the same time we observe significantly increased levels of  @TERM$1  precursors thus  @TERM$2  synthesis may be enhanced in day 10 animals so as to stimulate autophagy when nutrient availability from food intake becomes limiting	0.9999685	3.1473835e-05
30788345	figure s8	fluxes	30788345	285	201	@TERM$1	@TERM$2	e idh1 mutants glutamate become depleted in worms  @TERM$1  connecting a malfunctioning tca cycle with cellular aac contentpredicted exchange  @TERM$2  for glutamate inside the mitochondria and cytosol by	0.9988142	0.0011858243
30788345	fluxes	malate dehydrogenase	30788345	254	244	@TERM$1	@TERM$2	metabfba predicted that  @TERM$1  through the reaction mdhm which represents the conversion of malate to oxaloacetate by  @TERM$2  in the mitochondria was dramatically reduced from days 45 and days 510 in fem reaction 8 in figures 7bd	0.99998033	1.9618763e-05
30788345	fluxes	red	30788345	248	161	@TERM$1	@TERM$2	the maps have been colo @TERM$2  in inkscape and colors represent the difference in the  @TERM$1  between the two time points where red is increased and blue is decreased	0.9999969	3.0582685e-06
30788345	fumarate	malate	30788345	251	158	@TERM$1	@TERM$2	qui oxidoreductase reaction 5 fumm mitochondrial  @TERM$1  hydratase reaction 6 mdhm mitochondrial  @TERM$2  dehydrogenase reaction 7 citlm citrate lyase react	0.99999785	2.1388694e-06
30788345	fumarate	hydratase	30788345	251	118	@TERM$1	@TERM$2	qui oxidoreductase reaction 5 fumm mitochondrial  @TERM$1   @TERM$2  reaction 6 mdhm mitochondrial malate dehydrogena	0.9999976	2.3526525e-06
30788345	oxidoreductase	malate	30788345	251	210	@TERM$1	@TERM$2	 dehydrogenase reaction 4 rm02164 succinateubiqui  @TERM$1  reaction 5 fumm mitochondrial fumarate hydratase reaction 6 mdhm mitochondrial  @TERM$2  dehydrogenase reaction 7 citlm citrate lyase reaction 8 	0.99999726	2.700525e-06
30788345	isocitrate	hydrolase	30788345	251	187	@TERM$1	@TERM$2	are illustrated in figure 2a as follows rrmc0001  @TERM$1  hydrolyase reaction 1 raconitatehydrrxnm aconitase  isocitrate  @TERM$2  reaction 1a rmc0001 cytosolic isocitrate hydrolase	0.99999833	1.611048e-06
30788345	aconitase	dehydrogenase	30788345	251	244	@TERM$1	@TERM$2	trate hydrolyase reaction 1 raconitatehydrrxnm  @TERM$1   isocitrate hydrolase reaction 1a rmc0001 cytosolic isocitrate hydrolase reaction 2  akgdhm mitochondrial 2oxoglutarate  @TERM$2  reaction 3 rxn9098m mitochondrial succinate deh	0.99999774	2.2821707e-06
30788345	2oxoglutarate dehydrogenase	dehydrogenase	30788345	251	141	@TERM$1	@TERM$2	trate hydrolase reaction 2  akgdhm mitochondrial  @TERM$1  reaction 3 rxn9098m mitochondrial succinate  @TERM$2  rea	0.9999981	1.8532367e-06
30788345	2oxoglutarate dehydrogenase	succinate	30788345	251	191	@TERM$1	@TERM$2	trate hydrolase reaction 2  akgdhm mitochondrial  @TERM$1  reaction 3 rxn9098m mitochondrial  @TERM$2  dehydrogenase reaction 4 rm02164 succinateubiqui oxidoreductase rea	0.99999785	2.1176452e-06
30788345	hydrolase	2oxoglutarate dehydrogenase	30788345	251	222	@TERM$1	@TERM$2	ion 1 raconitatehydrrxnm aconitase  isocitrate  @TERM$1  reaction 1a rmc0001 cytosolic isocitrate hydrolase reaction 2  akgdhm mitochondrial  @TERM$2  reaction 3 rxn9098m mitochondrial succinate deh	0.9999981	1.8764756e-06
30788345	2oxoglutarate	dehydrogenase	30788345	251	127	@TERM$1	@TERM$2	trate hydrolase reaction 2  akgdhm mitochondrial  @TERM$1   @TERM$2  reaction 3 rxn9098m mitochondrial succinate deh	0.9999974	2.566965e-06
30788345	hydratase	malate dehydrogenase	30788345	251	161	@TERM$1	@TERM$2	reductase reaction 5 fumm mitochondrial fumarate  @TERM$1  reaction 6 mdhm mitochondrial  @TERM$2  reaction 7 citlm citrate lyase reaction 8 isocit	0.99999833	1.7228398e-06
30788345	malate	citrate lyase	30788345	251	152	@TERM$1	@TERM$2	fumarate hydratase reaction 6 mdhm mitochondrial  @TERM$1  dehydrogenase reaction 7 citlm  @TERM$2  reaction 8 isocitdehrxnm mitochondrial isocitra	0.99999845	1.4992038e-06
30788345	hydratase	citrate lyase	30788345	251	193	@TERM$1	@TERM$2	reductase reaction 5 fumm mitochondrial fumarate  @TERM$1  reaction 6 mdhm mitochondrial malate dehydrogenase reaction 7 citlm  @TERM$2  reaction 8 isocitdehrxnm mitochondrial isocitra	0.99999094	9.008796e-06
30788345	fumarate	malate dehydrogenase	30788345	251	170	@TERM$1	@TERM$2	qui oxidoreductase reaction 5 fumm mitochondrial  @TERM$1  hydratase reaction 6 mdhm mitochondrial  @TERM$2  reaction 7 citlm citrate lyase reaction 8 isocit	0.9999974	2.5816657e-06
30788345	hydratase	isocitrate dehydrogenase	30788345	251	219	@TERM$1	@TERM$2	reductase reaction 5 fumm mitochondrial fumarate  @TERM$1  reaction 6 mdhm mitochondrial malate dehydrogenase reaction 7 citlm citrate lyase reaction 8 isocitdehrxnm mitochondrial  @TERM$2  reaction 	0.99999833	1.7241925e-06
30788345	hydrolase	2oxoglutarate	30788345	251	208	@TERM$1	@TERM$2	ion 1 raconitatehydrrxnm aconitase  isocitrate  @TERM$1  reaction 1a rmc0001 cytosolic isocitrate hydrolase reaction 2  akgdhm mitochondrial  @TERM$2  dehydrogenase reaction 3 rxn9098m mitochondrial	0.99999523	4.767685e-06
30788345	citrate	isocitrate dehydrogenase	30788345	251	139	@TERM$1	@TERM$2	ochondrial malate dehydrogenase reaction 7 citlm  @TERM$1  lyase reaction 8 isocitdehrxnm mitochondrial  @TERM$2  reaction 	0.99998367	1.634182e-05
30788345	aconitase	hydrolase	30788345	251	131	@TERM$1	@TERM$2	trate hydrolyase reaction 1 raconitatehydrrxnm  @TERM$1   isocitrate  @TERM$2  reaction 1a rmc0001 cytosolic isocitrate hydrolas	0.99999833	1.6761165e-06
30788345	fluxes	tca	30788345	246	244	@TERM$1	@TERM$2	these improved predictions should thus provide more confident grounds for hypotheses surrounding metabolites that were not measuredrepresentation of metabolic  @TERM$1  through the  @TERM$2  cycle in fem animals using three different objective functions	0.99999774	2.3003333e-06
30788345	fluxes	figure s8	30788345	245	234	@TERM$1	@TERM$2	when we included our metabolomics data as part of the objective function the model predicted a general decrease in  @TERM$1  through the tca cycle in agreement with the measured changes in metabolites supplementary table 10 and  @TERM$2 	0.99999833	1.631863e-06
30788345	tca	figure s8	30788345	245	234	@TERM$1	@TERM$2	when we included our metabolomics data as part of the objective function the model predicted a general decrease in fluxes through the  @TERM$1  cycle in agreement with the measured changes in metabolites supplementary table 10 and  @TERM$2 	0.99999774	2.2707036e-06
30788345	tca	flux	30788345	232	120	@TERM$1	@TERM$2	but not gem metabfba predicts a sharp decline in  @TERM$1  cycle total  @TERM$2  between days 4 and 5 subsequently referred to as 	0.99999833	1.6999238e-06
30788345	gem	flux	30788345	232	149	@TERM$1	@TERM$2	interestingly in fem animals but not  @TERM$1  metabfba predicts a sharp decline in tca cycle total  @TERM$2  between days 4 and 5 subsequently referred to as 	0.99999785	2.0898644e-06
30788345	gem	tca	30788345	232	132	@TERM$1	@TERM$2	interestingly in fem animals but not  @TERM$1  metabfba predicts a sharp decline in  @TERM$2  cycle total flux between days 4 and 5 subsequentl	0.9999975	2.5108181e-06
30788345	flux	tca	30788345	234	164	@TERM$1	@TERM$2	these plots show the magnitude of summed  @TERM$1  values at different timeframes per strain and pathway for the  @TERM$2  cycle a glycolysis b and oxidative phosphorylation c	0.99999845	1.5420994e-06
30788345	137	map	30788345	236	147	@TERM$1	@TERM$2	example the flux at  @TERM$1  h is the flux computed for the timeframe between 117 and 137 h d heat  @TERM$2  of the fluxes catalyzed by reactions related to t	0.99999833	1.7178146e-06
30788345	flux	fluxes	30788345	236	161	@TERM$1	@TERM$2	example the  @TERM$1  at 137 h is the flux computed for the timeframe between 117 and 137 h d heat map of the  @TERM$2  catalyzed by reactions related to the tca cycle i	0.9999981	1.9273534e-06
30788345	flux	map	30788345	236	148	@TERM$1	@TERM$2	example the  @TERM$1  at 137 h is the flux computed for the timeframe between 117 and 137 h d heat  @TERM$2  of the fluxes catalyzed by reactions related to th	0.9999981	1.9479796e-06
30788345	137	tca	30788345	236	203	@TERM$1	@TERM$2	example the flux at  @TERM$1  h is the flux computed for the timeframe between 117 and 137 h d heat map of the fluxes catalyzed by reactions related to the  @TERM$2  cycle in fem animals at day 1 41 and 49 h day 2 6	0.9999957	4.2925412e-06
30788345	map	fluxes	30788345	236	117	@TERM$1	@TERM$2	ed for the timeframe between 117 and 137 h d heat  @TERM$1  of the  @TERM$2  catalyzed by reactions related to the tca cycle i	0.9999981	1.9505078e-06
30788345	flux	tca	30788345	236	204	@TERM$1	@TERM$2	example the  @TERM$1  at 137 h is the flux computed for the timeframe between 117 and 137 h d heat map of the fluxes catalyzed by reactions related to the  @TERM$2  cycle in fem animals at day 1 41 and 49 h day 2 65	0.9999981	1.9077497e-06
30788345	fluxes	tca	30788345	236	151	@TERM$1	@TERM$2	timeframe between 117 and 137 h d heat map of the  @TERM$1  catalyzed by reactions related to the  @TERM$2  cycle in fem animals at day 1 41 and 49 h day 2 65 a	0.999998	1.994996e-06
30788345	flux	137	30788345	236	74	@TERM$1	@TERM$2	example the  @TERM$1  at  @TERM$2  h is the flux computed for the timeframe between 1	0.9999956	4.363708e-06
30788345	map	tca	30788345	236	159	@TERM$1	@TERM$2	ed for the timeframe between 117 and 137 h d heat  @TERM$1  of the fluxes catalyzed by reactions related to the  @TERM$2  cycle in fem animals at day 1 41 and 49 h day 2 6	0.99999845	1.545017e-06
30788345	137	fluxes	30788345	236	161	@TERM$1	@TERM$2	example the flux at  @TERM$1  h is the flux computed for the timeframe between 117 and 137 h d heat map of the  @TERM$2  catalyzed by reactions related to the tca cycle i	0.999998	2.0807763e-06
30788345	flux	red	30788345	238	54	@TERM$1	@TERM$2	greater  @TERM$1  values are indicated in  @TERM$2  lower in blue	0.9999975	2.4576143e-06
30788345	fluxes	flux	30788345	239	140	@TERM$1	@TERM$2	as the underlying model represents bidirectional reactions in some cases  @TERM$1  in the reverse direction are encoded by negative  @TERM$2  values	0.9999981	1.8535583e-06
30788345	map	fluxes	30788345	240	144	@TERM$1	@TERM$2	the heat  @TERM$1  here shows the absolute magnitude of the  @TERM$2  the direction of the fluxes and the reactions are given in supplementary tables 1 7	0.99999774	2.2926372e-06
30788345	fluxes	tca	30788345	243	192	@TERM$1	@TERM$2	does not accurately recapitulate in vivo measured  @TERM$1  figure s3b we observed that standard fba predicted that most fluxes across the  @TERM$2  cycle remained unchanged between days 5 and 10 figur	0.99999726	2.7395647e-06
30788345	tcarelated	figure s8	30788345	244	133	@TERM$1	@TERM$2	however we know this cannot be correct as we had demonstrated that many  @TERM$1  metabolites change with age figure 4 and  @TERM$2 	0.9999981	1.8751196e-06
30788345	fluxes	tca	30788345	245	234	@TERM$1	@TERM$2	when we included our metabolomics data as part of the objective function the model predicted a general decrease in  @TERM$1  through the  @TERM$2  cycle in agreement with the measured changes in metabolites supplementary table 10 and figure s8	0.2948383	0.7051617
30788345	lyase	isocitrate dehydrogenase	30788345	251	131	@TERM$1	@TERM$2	al malate dehydrogenase reaction 7 citlm citrate  @TERM$1  reaction 8 isocitdehrxnm mitochondrial  @TERM$2  reaction 	0.9999957	4.274135e-06
30788345	fluxes	oxaloacetate	30788345	254	244	@TERM$1	@TERM$2	metabfba predicted that  @TERM$1  through the reaction mdhm which represents the conversion of malate to  @TERM$2  by malate dehydrogenase in the mitochondria was dramatically reduced from days 45 and days 510 in fem reaction 8 in figures 7bd	0.9999974	2.6723644e-06
30788345	oxidoreductase	hydratase	30788345	251	169	@TERM$1	@TERM$2	 dehydrogenase reaction 4 rm02164 succinateubiqui  @TERM$1  reaction 5 fumm mitochondrial fumarate  @TERM$2  reaction 6 mdhm mitochondrial malate dehydrogenase re	0.9999963	3.7153902e-06
30788345	succinate	fumarate	30788345	251	214	@TERM$1	@TERM$2	dehydrogenase reaction 3 rxn9098m mitochondrial  @TERM$1  dehydrogenase reaction 4 rm02164 succinateubiqui oxidoreductase reaction 5 fumm mitochondrial  @TERM$2  hydratase reaction 6 mdhm mitochondrial malate de	0.9999976	2.4254132e-06
30788345	malate dehydrogenase	lyase	30788345	251	167	@TERM$1	@TERM$2	fumarate hydratase reaction 6 mdhm mitochondrial  @TERM$1  reaction 7 citlm citrate  @TERM$2  reaction 8 isocitdehrxnm mitochondrial isocitrate dehydrogenas	0.99999654	3.49048e-06
30788345	isocitrate	aconitase	30788345	251	165	@TERM$1	@TERM$2	are illustrated in figure 2a as follows rrmc0001  @TERM$1  hydrolyase reaction 1 raconitatehydrrxnm  @TERM$2   isocitrate hydrolase reaction 1a rmc0001 cytosoli	0.9999975	2.4854128e-06
30788345	hydratase	lyase	30788345	251	197	@TERM$1	@TERM$2	reductase reaction 5 fumm mitochondrial fumarate  @TERM$1  reaction 6 mdhm mitochondrial malate dehydrogenase reaction 7 citlm citrate  @TERM$2  reaction 8 isocitdehrxnm mitochondrial isocitrate d	0.9999982	1.812281e-06
30788345	dehydrogenase	oxidoreductase	30788345	251	223	@TERM$1	@TERM$2	e reaction 2  akgdhm mitochondrial 2oxoglutarate  @TERM$1  reaction 3 rxn9098m mitochondrial succinate dehydrogenase reaction 4 rm02164 succinateubiqui  @TERM$2  reaction 5 fumm mitochondrial fumarate hydratase	0.9999976	2.3355244e-06
30788345	fumarate	lyase	30788345	251	205	@TERM$1	@TERM$2	qui oxidoreductase reaction 5 fumm mitochondrial  @TERM$1  hydratase reaction 6 mdhm mitochondrial malate dehydrogenase reaction 7 citlm citrate  @TERM$2  reaction 8 isocitdehrxnm mitochondrial isocitrate 	0.99999774	2.2696925e-06
30788345	malate dehydrogenase	citrate	30788345	251	159	@TERM$1	@TERM$2	fumarate hydratase reaction 6 mdhm mitochondrial  @TERM$1  reaction 7 citlm  @TERM$2  lyase reaction 8 isocitdehrxnm mitochondrial isocitrate dehy	0.9999956	4.403166e-06
30788345	hydratase	citrate	30788345	251	189	@TERM$1	@TERM$2	reductase reaction 5 fumm mitochondrial fumarate  @TERM$1  reaction 6 mdhm mitochondrial malate dehydrogenase reaction 7 citlm  @TERM$2  lyase reaction 8 isocitdehrxnm mitochondrial isoc	0.9999968	3.212541e-06
30788345	oxidoreductase	malate dehydrogenase	30788345	251	216	@TERM$1	@TERM$2	 dehydrogenase reaction 4 rm02164 succinateubiqui  @TERM$1  reaction 5 fumm mitochondrial fumarate hydratase reaction 6 mdhm mitochondrial  @TERM$2  reaction 7 citlm citrate lyase reaction 8 isocit	0.99999845	1.5444263e-06
30788345	succinate	oxidoreductase	30788345	251	173	@TERM$1	@TERM$2	dehydrogenase reaction 3 rxn9098m mitochondrial  @TERM$1  dehydrogenase reaction 4 rm02164 succinateubiqui  @TERM$2  reaction 5 fumm mitochondrial fumarate hydratase	0.99999774	2.2671895e-06
30788345	succinate	hydratase	30788345	251	223	@TERM$1	@TERM$2	dehydrogenase reaction 3 rxn9098m mitochondrial  @TERM$1  dehydrogenase reaction 4 rm02164 succinateubiqui oxidoreductase reaction 5 fumm mitochondrial fumarate  @TERM$2  reaction 6 mdhm mitochondrial malate dehydrogena	0.99999726	2.7322642e-06
30788345	oxaloacetate	dehydrogenase	30788345	254	244	@TERM$1	@TERM$2	metabfba predicted that fluxes through the reaction mdhm which represents the conversion of malate to  @TERM$1  by malate  @TERM$2  in the mitochondria was dramatically reduced from days 45 and days 510 in fem reaction 8 in figures 7bd	0.99999833	1.701549e-06
30788345	oxaloacetate	malate dehydrogenase	30788345	254	244	@TERM$1	@TERM$2	metabfba predicted that fluxes through the reaction mdhm which represents the conversion of malate to  @TERM$1  by  @TERM$2  in the mitochondria was dramatically reduced from days 45 and days 510 in fem reaction 8 in figures 7bd	0.99999833	1.6126359e-06
30788345	fluxes	malate	30788345	254	244	@TERM$1	@TERM$2	metabfba predicted that  @TERM$1  through the reaction mdhm which represents the conversion of  @TERM$2  to oxaloacetate by malate dehydrogenase in the mitochondria was dramatically reduced from days 45 and days 510 in fem reaction 8 in figures 7bd	0.9999968	3.1845996e-06
30788345	fluxes	dehydrogenase	30788345	254	244	@TERM$1	@TERM$2	metabfba predicted that  @TERM$1  through the reaction mdhm which represents the conversion of malate to oxaloacetate by malate  @TERM$2  in the mitochondria was dramatically reduced from days 45 and days 510 in fem reaction 8 in figures 7bd	0.99999857	1.4449486e-06
30788345	oxaloacetate	fluxes	30788345	253	213	@TERM$1	@TERM$2	all other reactions and metabolite identifiers are listed in supplementary table 10we looked into  @TERM$1  in more detail because  @TERM$2  through this metabolite were predicted to be the most depressed with age	0.99999547	4.5278634e-06
30788345	fumarate	citrate lyase	30788345	251	202	@TERM$1	@TERM$2	qui oxidoreductase reaction 5 fumm mitochondrial  @TERM$1  hydratase reaction 6 mdhm mitochondrial malate dehydrogenase reaction 7 citlm  @TERM$2  reaction 8 isocitdehrxnm mitochondrial isocitra	0.9999981	1.8963998e-06
30788345	oxidoreductase	citrate lyase	30788345	251	249	@TERM$1	@TERM$2	 dehydrogenase reaction 4 rm02164 succinateubiqui  @TERM$1  reaction 5 fumm mitochondrial fumarate hydratase reaction 6 mdhm mitochondrial malate dehydrogenase reaction 7 citlm  @TERM$2  reaction 8 isocitdehrxnm mitochondrial isocitrat	0.9999974	2.6505868e-06
30788345	malate	citrate	30788345	251	146	@TERM$1	@TERM$2	fumarate hydratase reaction 6 mdhm mitochondrial  @TERM$1  dehydrogenase reaction 7 citlm  @TERM$2  lyase reaction 8 isocitdehrxnm mitochondrial is	0.9999976	2.4170452e-06
30788345	dehydrogenase	succinate	30788345	251	163	@TERM$1	@TERM$2	e reaction 2  akgdhm mitochondrial 2oxoglutarate  @TERM$1  reaction 3 rxn9098m mitochondrial  @TERM$2  dehydrogenase reaction 4 rm02164 succinateubiqui oxid	0.999998	2.021961e-06
30788345	2oxoglutarate dehydrogenase	oxidoreductase	30788345	251	250	@TERM$1	@TERM$2	trate hydrolase reaction 2  akgdhm mitochondrial  @TERM$1  reaction 3 rxn9098m mitochondrial succinate dehydrogenase reaction 4 rm02164 succinateubiqui  @TERM$2  reaction 5 fumm mitochondrial fumarate hydratase reaction 6 m	0.99999833	1.6546599e-06
30788345	malate	isocitrate dehydrogenase	30788345	251	178	@TERM$1	@TERM$2	fumarate hydratase reaction 6 mdhm mitochondrial  @TERM$1  dehydrogenase reaction 7 citlm citrate lyase reaction 8 isocitdehrxnm mitochondrial  @TERM$2  reaction 	0.9999981	1.8989425e-06
30788345	malate dehydrogenase	citrate lyase	30788345	251	159	@TERM$1	@TERM$2	fumarate hydratase reaction 6 mdhm mitochondrial  @TERM$1  reaction 7 citlm  @TERM$2  reaction 8 isocitdehrxnm mitochondrial isocitrate dehy	0.99999774	2.2374106e-06
30788345	isocitrate hydrolyase	aconitase	30788345	251	176	@TERM$1	@TERM$2	are illustrated in figure 2a as follows rrmc0001  @TERM$1  reaction 1 raconitatehydrrxnm  @TERM$2   isocitrate hydrolase reaction 1a rmc0001 cytosolic isocitrat	0.9999949	5.1301413e-06
30788345	hydrolase	dehydrogenase	30788345	251	222	@TERM$1	@TERM$2	ion 1 raconitatehydrrxnm aconitase  isocitrate  @TERM$1  reaction 1a rmc0001 cytosolic isocitrate hydrolase reaction 2  akgdhm mitochondrial 2oxoglutarate  @TERM$2  reaction 3 rxn9098m mitochondrial succinate deh	0.99999726	2.7804756e-06
30788345	2oxoglutarate	succinate	30788345	251	177	@TERM$1	@TERM$2	trate hydrolase reaction 2  akgdhm mitochondrial  @TERM$1  dehydrogenase reaction 3 rxn9098m mitochondrial  @TERM$2  dehydrogenase reaction 4 rm02164 succinateubiqui oxid	0.99999774	2.3141845e-06
30788345	fumarate	isocitrate dehydrogenase	30788345	251	228	@TERM$1	@TERM$2	qui oxidoreductase reaction 5 fumm mitochondrial  @TERM$1  hydratase reaction 6 mdhm mitochondrial malate dehydrogenase reaction 7 citlm citrate lyase reaction 8 isocitdehrxnm mitochondrial  @TERM$2  reaction 	0.99999774	2.2526633e-06
30788345	aconitase	2oxoglutarate dehydrogenase	30788345	251	244	@TERM$1	@TERM$2	trate hydrolyase reaction 1 raconitatehydrrxnm  @TERM$1   isocitrate hydrolase reaction 1a rmc0001 cytosolic isocitrate hydrolase reaction 2  akgdhm mitochondrial  @TERM$2  reaction 3 rxn9098m mitochondrial succinate deh	0.9999969	3.051556e-06
30788345	oxidoreductase	fumarate	30788345	251	160	@TERM$1	@TERM$2	 dehydrogenase reaction 4 rm02164 succinateubiqui  @TERM$1  reaction 5 fumm mitochondrial  @TERM$2  hydratase reaction 6 mdhm mitochondrial malate dehydro	0.99999774	2.3127461e-06
30788345	malate dehydrogenase	isocitrate dehydrogenase	30788345	251	178	@TERM$1	@TERM$2	fumarate hydratase reaction 6 mdhm mitochondrial  @TERM$1  reaction 7 citlm citrate lyase reaction 8 isocitdehrxnm mitochondrial  @TERM$2  reaction 	0.9999932	6.753897e-06
30788345	isocitrate hydrolyase	hydrolase	30788345	251	198	@TERM$1	@TERM$2	are illustrated in figure 2a as follows rrmc0001  @TERM$1  reaction 1 raconitatehydrrxnm aconitase  isocitrate  @TERM$2  reaction 1a rmc0001 cytosolic isocitrate hydrolase reaction 2	0.9999951	4.8390066e-06
30788345	fumarate	citrate	30788345	251	197	@TERM$1	@TERM$2	qui oxidoreductase reaction 5 fumm mitochondrial  @TERM$1  hydratase reaction 6 mdhm mitochondrial malate dehydrogenase reaction 7 citlm  @TERM$2  lyase reaction 8 isocitdehrxnm mitochondrial iso	0.9999937	6.271723e-06
30788345	citrate	lyase	30788345	251	115	@TERM$1	@TERM$2	ochondrial malate dehydrogenase reaction 7 citlm  @TERM$1   @TERM$2  reaction 8 isocitdehrxnm mitochondrial isocitrate	0.999997	3.0154467e-06
30788345	malate	lyase	30788345	251	153	@TERM$1	@TERM$2	fumarate hydratase reaction 6 mdhm mitochondrial  @TERM$1  dehydrogenase reaction 7 citlm citrate  @TERM$2  reaction 8 isocitdehrxnm mitochondrial isocitrat	0.99999416	5.8844244e-06
30788345	aconitase	2oxoglutarate	30788345	251	230	@TERM$1	@TERM$2	trate hydrolyase reaction 1 raconitatehydrrxnm  @TERM$1   isocitrate hydrolase reaction 1a rmc0001 cytosolic isocitrate hydrolase reaction 2  akgdhm mitochondrial  @TERM$2  dehydrogenase reaction 3 rxn9098m mitochondrial	0.9999888	1.1177399e-05
30788345	citrate lyase	isocitrate dehydrogenase	30788345	251	139	@TERM$1	@TERM$2	ochondrial malate dehydrogenase reaction 7 citlm  @TERM$1  reaction 8 isocitdehrxnm mitochondrial  @TERM$2  reaction 	0.999997	2.977969e-06
30788345	2oxoglutarate	oxidoreductase	30788345	251	237	@TERM$1	@TERM$2	trate hydrolase reaction 2  akgdhm mitochondrial  @TERM$1  dehydrogenase reaction 3 rxn9098m mitochondrial succinate dehydrogenase reaction 4 rm02164 succinateubiqui  @TERM$2  reaction 5 fumm mitochondrial fumarate hydratase	0.9999982	1.839734e-06
30788345	hydratase	malate	30788345	251	150	@TERM$1	@TERM$2	reductase reaction 5 fumm mitochondrial fumarate  @TERM$1  reaction 6 mdhm mitochondrial  @TERM$2  dehydrogenase reaction 7 citlm citrate lyase reacti	0.9999982	1.7475638e-06
30788345	oxidoreductase	citrate	30788345	251	249	@TERM$1	@TERM$2	 dehydrogenase reaction 4 rm02164 succinateubiqui  @TERM$1  reaction 5 fumm mitochondrial fumarate hydratase reaction 6 mdhm mitochondrial malate dehydrogenase reaction 7 citlm  @TERM$2  lyase reaction 8 isocitdehrxnm mitochondrial isocitrat	0.9999982	1.8402025e-06
30788345	leucine	guanosine	30788345	189	245	@TERM$1	@TERM$2	t measured amino acids including serine threonine  @TERM$1  lysine glutamateglutamic acid methionine tryptophan and arginine and some byproducts of amino acid metabolism homoserine cystathionine as well as nucleotides  @TERM$2  cytidine uridine gm	0.99999654	3.4549441e-06
30788345	putrescine	ornithine	30788345	197	208	@TERM$1	@TERM$2	 @TERM$1  is metabolized from arginine via either agmatine or  @TERM$2  and gives rise to spermidine the precursor of spermine figure s7a while cadaverine is the product of lysine decarboxylation mccann 1982	0.99999523	4.7964436e-06
30788345	threonine	lysine	30788345	189	127	@TERM$1	@TERM$2	ntains most measured amino acids including serine  @TERM$1  leucine  @TERM$2  glutamateglutamic acid methionine tryptophan and arg	0.999997	2.9865098e-06
30788345	ammonium	acetate	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93 acetonitrile 5 water 2 methanol 02 acetic acid and 10 mm  @TERM$1   @TERM$2 	0.99999475	5.2530954e-06
30788345	acetonitrile	acetate	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93  @TERM$1  5 water 2 methanol 02 acetic acid and 10 mm ammonium  @TERM$2 	0.9760583	0.023941725
30788345	acetic acid	acetate	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93 acetonitrile 5 water 2 methanol 02  @TERM$1  and 10 mm ammonium  @TERM$2 	0.9999918	8.239064e-06
30788345	acetonitrile	methanol	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93  @TERM$1  5 water 2  @TERM$2  02 acetic acid and 10 mm ammonium acetate	0.99999475	5.2963974e-06
30788345	methanol	acetate	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93 acetonitrile 5 water 2  @TERM$1  02 acetic acid and 10 mm ammonium  @TERM$2 	0.99999034	9.624964e-06
30788345	acetic acid	ammonium	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93 acetonitrile 5 water 2 methanol 02  @TERM$1  and 10 mm  @TERM$2  acetate	0.99999607	3.8915264e-06
30788345	acetic acid	ammonium acetate	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93 acetonitrile 5 water 2 methanol 02  @TERM$1  and 10 mm  @TERM$2 	0.99984646	0.00015355158
30788345	methanol	ammonium	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93 acetonitrile 5 water 2  @TERM$1  02 acetic acid and 10 mm  @TERM$2  acetate	0.99999774	2.2998813e-06
30788345	acetonitrile	acetic acid	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93  @TERM$1  5 water 2 methanol 02  @TERM$2  and 10 mm ammonium acetate	0.99999297	6.9884254e-06
30788345	methanol	ammonium acetate	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93 acetonitrile 5 water 2  @TERM$1  02 acetic acid and 10 mm  @TERM$2 	0.99999666	3.3285758e-06
30788345	methanol	acetic acid	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93 acetonitrile 5 water 2  @TERM$1  02  @TERM$2  and 10 mm ammonium acetate	0.9999956	4.3920227e-06
30788345	hilic	acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a  @TERM$1  regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid vvvv 10 mm ammonium  @TERM$2  ph 42	0.9999963	3.72193e-06
30788345	acetonitrile	ammonium acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3  @TERM$1  2 methanol 02 acetic acid vvvv 10 mm  @TERM$2  ph 42	0.9999982	1.7484606e-06
30788345	ammonium	acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid vvvv 10 mm  @TERM$1   @TERM$2  ph 42	0.9999974	2.62406e-06
30788345	acetonitrile	acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3  @TERM$1  2 methanol 02 acetic acid vvvv 10 mm ammonium  @TERM$2  ph 42	0.9999958	4.144697e-06
30788345	acetic acid	acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02  @TERM$1  vvvv 10 mm ammonium  @TERM$2  ph 42	0.9999962	3.8675084e-06
30788345	methanol	acetic acid	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2  @TERM$1  02  @TERM$2  vvvv 10 mm ammonium acetate ph 42	0.9999958	4.227266e-06
30788345	hilic	methanol	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a  @TERM$1  regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2  @TERM$2  02 acetic acid vvvv 10 mm ammonium acetate ph 42	0.9999949	5.18397e-06
30788345	beh	acetic acid	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge  @TERM$1  amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02  @TERM$2  vvvv 10 mm ammonium acetate ph 42	0.99999785	2.1760227e-06
30788345	beh	methanol	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge  @TERM$1  amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2  @TERM$2  02 acetic acid vvvv 10 mm ammonium acetate ph 42	0.99999654	3.4350414e-06
30788345	acetic acid	vvvv	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02  @TERM$1   @TERM$2  10 mm ammonium acetate ph 42	0.9999975	2.5489574e-06
30788345	acetonitrile	ammonium	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93  @TERM$1  5 water 2 methanol 02 acetic acid and 10 mm  @TERM$2  acetate	0.99999714	2.8973786e-06
30788345	acetic acid	ammonium	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02  @TERM$1  vvvv 10 mm  @TERM$2  acetate ph 42	0.9999982	1.8031028e-06
30788345	acetonitrile	ammonium acetate	30788345	67	99	@TERM$1	@TERM$2	solvent b consisted of 93  @TERM$1  5 water 2 methanol 02 acetic acid and 10 mm  @TERM$2 	0.9999981	1.9042052e-06
30788345	collagens	glycogens	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans phospholipids  @TERM$1  dna rna free fatty acids  @TERM$2  proteins triacylglycerols and trehalose	0.99999845	1.596806e-06
30788345	phospholipids	glycogens	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans  @TERM$1  collagens dna rna free fatty acids  @TERM$2  proteins triacylglycerols and trehalose	0.99999774	2.2562303e-06
30788345	mg2	mn2	30788345	91	246	@TERM$1	@TERM$2	all sources of input uptake were constrained to zero except oxygen maximum of 100 units allowed uptake bacterial input as food source maximum of 10 units allowed uptake and trace minerals and ions ca2 cu2 k  @TERM$1   @TERM$2  na zn2 arbitrary allowed uptake	0.99999833	1.6836702e-06
30788345	ca2	mn2	30788345	91	246	@TERM$1	@TERM$2	all sources of input uptake were constrained to zero except oxygen maximum of 100 units allowed uptake bacterial input as food source maximum of 10 units allowed uptake and trace minerals and ions  @TERM$1  cu2 k mg2  @TERM$2  na zn2 arbitrary allowed uptake	0.9999976	2.4098824e-06
30788345	cu2	mn2	30788345	91	246	@TERM$1	@TERM$2	all sources of input uptake were constrained to zero except oxygen maximum of 100 units allowed uptake bacterial input as food source maximum of 10 units allowed uptake and trace minerals and ions ca2  @TERM$1  k mg2  @TERM$2  na zn2 arbitrary allowed uptake	0.99999774	2.2384993e-06
30788345	cu2	zn2	30788345	91	246	@TERM$1	@TERM$2	all sources of input uptake were constrained to zero except oxygen maximum of 100 units allowed uptake bacterial input as food source maximum of 10 units allowed uptake and trace minerals and ions ca2  @TERM$1  k mg2 mn2 na  @TERM$2  arbitrary allowed uptake	0.99999857	1.4856287e-06
30788345	cu2	mg2	30788345	91	246	@TERM$1	@TERM$2	all sources of input uptake were constrained to zero except oxygen maximum of 100 units allowed uptake bacterial input as food source maximum of 10 units allowed uptake and trace minerals and ions ca2  @TERM$1  k  @TERM$2  mn2 na zn2 arbitrary allowed uptake	0.999998	2.0813716e-06
30788345	ca2	cu2	30788345	91	246	@TERM$1	@TERM$2	all sources of input uptake were constrained to zero except oxygen maximum of 100 units allowed uptake bacterial input as food source maximum of 10 units allowed uptake and trace minerals and ions  @TERM$1   @TERM$2  k mg2 mn2 na zn2 arbitrary allowed uptake	0.9999982	1.7587993e-06
30788345	mg2	zn2	30788345	91	246	@TERM$1	@TERM$2	all sources of input uptake were constrained to zero except oxygen maximum of 100 units allowed uptake bacterial input as food source maximum of 10 units allowed uptake and trace minerals and ions ca2 cu2 k  @TERM$1  mn2 na  @TERM$2  arbitrary allowed uptake	0.9999981	1.9459112e-06
30788345	ca2	zn2	30788345	91	246	@TERM$1	@TERM$2	all sources of input uptake were constrained to zero except oxygen maximum of 100 units allowed uptake bacterial input as food source maximum of 10 units allowed uptake and trace minerals and ions  @TERM$1  cu2 k mg2 mn2 na  @TERM$2  arbitrary allowed uptake	0.99999833	1.6175277e-06
30788345	ca2	mg2	30788345	91	246	@TERM$1	@TERM$2	all sources of input uptake were constrained to zero except oxygen maximum of 100 units allowed uptake bacterial input as food source maximum of 10 units allowed uptake and trace minerals and ions  @TERM$1  cu2 k  @TERM$2  mn2 na zn2 arbitrary allowed uptake	0.9999969	3.0473682e-06
30788345	mn2	zn2	30788345	91	246	@TERM$1	@TERM$2	all sources of input uptake were constrained to zero except oxygen maximum of 100 units allowed uptake bacterial input as food source maximum of 10 units allowed uptake and trace minerals and ions ca2 cu2 k mg2  @TERM$1  na  @TERM$2  arbitrary allowed uptake	0.9999982	1.8042311e-06
30788345	omnibus	geo	30788345	83	115	@TERM$1	@TERM$2	ing dataset is available from the gene expression  @TERM$1   @TERM$2  database with accession gse124994 httpwwwncbinlmnihgo	0.9999974	2.6286511e-06
30788345	ammonium acetate	sigma	30788345	68	117	@TERM$1	@TERM$2	organic solvents and acetic acid were optima grade from fisher scientific usa  @TERM$1  was from  @TERM$2  aldrich	0.99999857	1.3810312e-06
30788345	ammonium	acetate	30788345	68	117	@TERM$1	@TERM$2	organic solvents and acetic acid were optima grade from fisher scientific usa  @TERM$1   @TERM$2  was from sigma aldrich	0.99999595	4.0906093e-06
30788345	acetic acid	acetate	30788345	68	117	@TERM$1	@TERM$2	organic solvents and  @TERM$1  were optima grade from fisher scientific usa ammonium  @TERM$2  was from sigma aldrich	0.9999974	2.5731242e-06
30788345	acetic acid	ammonium	30788345	68	117	@TERM$1	@TERM$2	organic solvents and  @TERM$1  were optima grade from fisher scientific usa  @TERM$2  acetate was from sigma aldrich	0.99999714	2.9181263e-06
30788345	acetic acid	ammonium acetate	30788345	68	117	@TERM$1	@TERM$2	organic solvents and  @TERM$1  were optima grade from fisher scientific usa  @TERM$2  was from sigma aldrich	0.99999833	1.7081012e-06
30788345	acetate	sigma	30788345	68	117	@TERM$1	@TERM$2	organic solvents and acetic acid were optima grade from fisher scientific usa ammonium  @TERM$1  was from  @TERM$2  aldrich	0.99999654	3.5099476e-06
30788345	ammonium	sigma	30788345	68	117	@TERM$1	@TERM$2	organic solvents and acetic acid were optima grade from fisher scientific usa  @TERM$1  acetate was from  @TERM$2  aldrich	0.999998	1.987654e-06
30788345	acetic acid	sigma	30788345	68	117	@TERM$1	@TERM$2	organic solvents and  @TERM$1  were optima grade from fisher scientific usa ammonium acetate was from  @TERM$2  aldrich	0.9999739	2.6120726e-05
30788345	fatty	glycogens	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans phospholipids collagens dna rna free  @TERM$1  acids  @TERM$2  proteins triacylglycerols and trehalose	0.99999726	2.724609e-06
30788345	hilic	vvvv	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a  @TERM$1  regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid  @TERM$2  10 mm ammonium acetate ph 42	0.99999166	8.298721e-06
30788345	beh	vvvv	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge  @TERM$1  amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid  @TERM$2  10 mm ammonium acetate ph 42	0.9999931	6.914647e-06
30788345	sodium hypochlorite	potassium	30788345	44	195	@TERM$1	@TERM$2	synchronized experimental populations were prepared by washing gravid adults and eggs from plates and bleaching in a freshly prepared solution of 1  @TERM$1  and 1 m  @TERM$2  hydroxide	0.99999785	2.0904345e-06
30788345	sodium	potassium	30788345	44	195	@TERM$1	@TERM$2	synchronized experimental populations were prepared by washing gravid adults and eggs from plates and bleaching in a freshly prepared solution of 1  @TERM$1  hypochlorite and 1 m  @TERM$2  hydroxide	0.9999982	1.7366965e-06
30788345	gift	mg2	30788345	40	131	@TERM$1	@TERM$2	ej1171 was a kind  @TERM$1  from eric lambies lab kemp et al 2009 stocks were grown at 16c in  @TERM$2  containing plates and thawed regularly	0.9999931	6.970096e-06
30788345	n2 7 timesej1171	ivmoc91	30788345	38	165	@TERM$1	@TERM$2	10pgfppest ttx1pgfp ivmoc001 gr1395 outcrossed to  @TERM$1  gon2q388 gem1bc364jk816 fem3q20  @TERM$2  gon2q388 gem1bc364 mgis49mlt10pgfppest ttx1pgfp ivgr1395 w	0.99999785	2.1748297e-06
30788345	glutamate	tca	30788345	37	128	@TERM$1	@TERM$2	the model also provides a mechanistic explanation that links the decreased production of  @TERM$1  to a malfunctioning  @TERM$2  cycle	0.9999981	1.9625259e-06
30788345	fluxes	oxaloacetate	30788345	36	233	@TERM$1	@TERM$2	this optimized method correctly predicts that the most decreased  @TERM$1  within the tca metabolic shift are through  @TERM$2  in line with experiments that show that it becomes the most limiting tcarelated metabolite in old animals	0.9999982	1.7316605e-06
30788345	tca	tcarelated	30788345	36	233	@TERM$1	@TERM$2	this optimized method correctly predicts that the most decreased fluxes within the  @TERM$1  metabolic shift are through oxaloacetate in line with experiments that show that it becomes the most limiting  @TERM$2  metabolite in old animals	0.9999982	1.7748639e-06
30788345	fluxes	tcarelated	30788345	36	233	@TERM$1	@TERM$2	this optimized method correctly predicts that the most decreased  @TERM$1  within the tca metabolic shift are through oxaloacetate in line with experiments that show that it becomes the most limiting  @TERM$2  metabolite in old animals	0.9999982	1.8166398e-06
30788345	fluxes	tca	30788345	36	233	@TERM$1	@TERM$2	this optimized method correctly predicts that the most decreased  @TERM$1  within the  @TERM$2  metabolic shift are through oxaloacetate in line with experiments that show that it becomes the most limiting tcarelated metabolite in old animals	0.9882032	0.0117968
30788345	oxaloacetate	tcarelated	30788345	36	233	@TERM$1	@TERM$2	this optimized method correctly predicts that the most decreased fluxes within the tca metabolic shift are through  @TERM$1  in line with experiments that show that it becomes the most limiting  @TERM$2  metabolite in old animals	0.999997	2.999131e-06
30788345	tca	oxaloacetate	30788345	36	233	@TERM$1	@TERM$2	this optimized method correctly predicts that the most decreased fluxes within the  @TERM$1  metabolic shift are through  @TERM$2  in line with experiments that show that it becomes the most limiting tcarelated metabolite in old animals	0.9999043	9.5682146e-05
30788345	aminoacids	polyamine	30788345	29	155	@TERM$1	@TERM$2	the data shows metabolic shifts during the course of aging with a prominent decrease in the levels of  @TERM$1  while their  @TERM$2  derivatives increase	0.9999982	1.7736303e-06
30788345	fluxes	flux	30788345	23	156	@TERM$1	@TERM$2	n be used to predict intracellular turnover rates  @TERM$1  for metabolic reactions using for instance  @TERM$2  balance analysis fba a mathematical method that use	0.9999982	1.7352644e-06
30788345	5fluoro2deoxyuridine	fudr	30788345	18	102	@TERM$1	@TERM$2	the use of  @TERM$1   @TERM$2  can circumvent this problem because it decreases progeny producti	0.9999975	2.4552576e-06
30788345	gao	wan	30788345	16	80	@TERM$1	@TERM$2	s as one layer copes et al 2015 davies et al 2015  @TERM$1  et al 2017ab  @TERM$2  et al 201	0.99999666	3.3620581e-06
30788345	alphaketoglutarate	nacylethanolamine	30788345	15	157	@TERM$1	@TERM$2	ging in worms eg oxaloacetate williams et al 2009  @TERM$1  chin et al 2014 and  @TERM$2  lucanic et al 2011omics techniques can provide a g	0.999997	2.9865469e-06
30788345	oxaloacetate	alphaketoglutarate	30788345	15	151	@TERM$1	@TERM$2	abolites that are able to delay aging in worms eg  @TERM$1  williams et al 2009  @TERM$2  chin et al 2014 and nacylethanolamine lucanic et 	0.9999982	1.8213584e-06
30788345	oxaloacetate	nacylethanolamine	30788345	15	189	@TERM$1	@TERM$2	abolites that are able to delay aging in worms eg  @TERM$1  williams et al 2009 alphaketoglutarate chin et al 2014 and  @TERM$2  lucanic et al 2011omics techniques can provide a 	0.99999785	2.161854e-06
30788345	fluxes	citric acid	30788345	4	156	@TERM$1	@TERM$2	we find that standard flux balance analysis does not accurately predict in vivo measured  @TERM$1  nor agerelated changes associated with the  @TERM$2  cycle	0.9999951	4.931841e-06
30788345	flux	citric acid	30788345	4	156	@TERM$1	@TERM$2	we find that standard  @TERM$1  balance analysis does not accurately predict in vivo measured fluxes nor agerelated changes associated with the  @TERM$2  cycle	0.99999726	2.776231e-06
30788345	flux	fluxes	30788345	4	156	@TERM$1	@TERM$2	we find that standard  @TERM$1  balance analysis does not accurately predict in vivo measured  @TERM$2  nor agerelated changes associated with the citric acid cycle	0.99998033	1.9631545e-05
30788345	statesreviewed	des	30788345	0	244	@TERM$1	@TERM$2	d by arthur s edison university of georgia united  @TERM$1  by timothy garrett university of florida united states benedicte elenaherrmann inserm u1209 institut pour lavance  @TERM$2  biosciences iab france hunter n b moseley university of kent	0.99999833	1.619695e-06
30788345	lysine	methionine	30788345	189	140	@TERM$1	@TERM$2	ed amino acids including serine threonine leucine  @TERM$1  glutamateglutamic acid  @TERM$2  tryptophan and arginine and some byproducts of am	0.99999547	4.50339e-06
30788345	sodium	1 m potassium hydroxide	30788345	44	195	@TERM$1	@TERM$2	synchronized experimental populations were prepared by washing gravid adults and eggs from plates and bleaching in a freshly prepared solution of 1  @TERM$1  hypochlorite and  @TERM$2 	0.99999523	4.71307e-06
30788345	acetonitrile	acetic acid	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3  @TERM$1  2 methanol 02  @TERM$2  vvvv 10 mm ammonium acetate ph 42	0.99999523	4.739754e-06
30788345	beh	hilic	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge  @TERM$1  amide column 25 um 130 angstroms 21 x 150 mm operated in a  @TERM$2  regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid vvvv 10 mm ammonium acetate ph 42	0.999987	1.2977219e-05
30788345	acetonitrile	methanol	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3  @TERM$1  2  @TERM$2  02 acetic acid vvvv 10 mm ammonium acetate ph 42	0.9999865	1.3499701e-05
30788345	methanol	vvvv	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2  @TERM$1  02 acetic acid  @TERM$2  10 mm ammonium acetate ph 42	0.99999547	4.5236075e-06
30788345	acetic acid	ammonium acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02  @TERM$1  vvvv 10 mm  @TERM$2  ph 42	0.9999951	4.9033974e-06
30788345	methanol	ammonium	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2  @TERM$1  02 acetic acid vvvv 10 mm  @TERM$2  acetate ph 42	0.99998844	1.1570959e-05
30788345	beh	ammonium	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge  @TERM$1  amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid vvvv 10 mm  @TERM$2  acetate ph 42	0.99999166	8.328476e-06
30788345	beh	acetonitrile	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge  @TERM$1  amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3  @TERM$2  2 methanol 02 acetic acid vvvv 10 mm ammonium acetate ph 42	0.9974343	0.0025657085
30788345	acetonitrile	vvvv	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3  @TERM$1  2 methanol 02 acetic acid  @TERM$2  10 mm ammonium acetate ph 42	0.999985	1.4999322e-05
30788345	hilic	acetonitrile	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a  @TERM$1  regime at 40 c solvent a consisted of 95 water 3  @TERM$2  2 methanol 02 acetic acid vvvv 10 mm ammonium acetate ph 42	0.999998	2.02318e-06
30788345	methanol	ammonium acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2  @TERM$1  02 acetic acid vvvv 10 mm  @TERM$2  ph 42	0.9999969	3.1513578e-06
30788345	vvvv	ammonium	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid  @TERM$1  10 mm  @TERM$2  acetate ph 42	0.99999845	1.4911374e-06
30788345	hilic	ammonium	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a  @TERM$1  regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid vvvv 10 mm  @TERM$2  acetate ph 42	0.9999968	3.1980153e-06
30788345	acetonitrile	ammonium	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3  @TERM$1  2 methanol 02 acetic acid vvvv 10 mm  @TERM$2  acetate ph 42	0.999998	2.0497207e-06
30788345	beh	ammonium acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge  @TERM$1  amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid vvvv 10 mm  @TERM$2  ph 42	0.99999785	2.1271503e-06
30788345	methanol	acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2  @TERM$1  02 acetic acid vvvv 10 mm ammonium  @TERM$2  ph 42	0.9999974	2.6585715e-06
30788345	beh	acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge  @TERM$1  amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid vvvv 10 mm ammonium  @TERM$2  ph 42	0.9999585	4.153827e-05
30788345	vvvv	ammonium acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid  @TERM$1  10 mm  @TERM$2  ph 42	0.9999981	1.9472516e-06
30788345	hilic	ammonium acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a  @TERM$1  regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid vvvv 10 mm  @TERM$2  ph 42	0.9999826	1.7356255e-05
30788345	vvvv	acetate	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a hilic regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02 acetic acid  @TERM$1  10 mm ammonium  @TERM$2  ph 42	0.99999785	2.1289422e-06
30788345	carbenicillin	iptg	30788345	47	205	@TERM$1	@TERM$2	experimental populations were placed at 25c on ht115 e coli containing the empty vector plasmid l4440 on standard ngm plates containing 50 gml  @TERM$1  1 mm  @TERM$2  and 10 gml nystatin until harvesting	0.99999833	1.6357365e-06
30788345	carbenicillin	nystatin	30788345	47	205	@TERM$1	@TERM$2	experimental populations were placed at 25c on ht115 e coli containing the empty vector plasmid l4440 on standard ngm plates containing 50 gml  @TERM$1  1 mm iptg and 10 gml  @TERM$2  until harvesting	0.9999969	3.124586e-06
30788345	iptg	nystatin	30788345	47	205	@TERM$1	@TERM$2	experimental populations were placed at 25c on ht115 e coli containing the empty vector plasmid l4440 on standard ngm plates containing 50 gml carbenicillin 1 mm  @TERM$1  and 10 gml  @TERM$2  until harvesting	0.99999714	2.8302147e-06
30788345	nacl	mgso4	30788345	45	154	@TERM$1	@TERM$2	eggs were allowed to hatch overnight at 25c in m9 solution 22 mm kh2p04 42 mm na2hp04 86 mm  @TERM$1  1 mm  @TERM$2  to ensure all animals arrested at the l1 stage	0.99999547	4.496433e-06
30788345	sodium hypochlorite	1 m potassium hydroxide	30788345	44	195	@TERM$1	@TERM$2	synchronized experimental populations were prepared by washing gravid adults and eggs from plates and bleaching in a freshly prepared solution of 1  @TERM$1  and  @TERM$2 	0.99998	2.0057012e-05
30788345	collagens	triacylglycerols	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans phospholipids  @TERM$1  dna rna free fatty acids glycogens proteins  @TERM$2  and trehalose	0.9999355	6.4440115e-05
30788345	hilic	acetic acid	30788345	66	237	@TERM$1	@TERM$2	the samples were separated on a waters xbridge beh amide column 25 um 130 angstroms 21 x 150 mm operated in a  @TERM$1  regime at 40 c solvent a consisted of 95 water 3 acetonitrile 2 methanol 02  @TERM$2  vvvv 10 mm ammonium acetate ph 42	0.999998	2.043623e-06
30788345	fatty	triacylglycerols	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans phospholipids collagens dna rna free  @TERM$1  acids glycogens proteins  @TERM$2  and trehalose	0.9999944	5.6002204e-06
30788345	flux	glutamate	30788345	146	219	@TERM$1	@TERM$2	in addition in silico lack of alphaketoglutarate concurred to some extent with in vivo metabolic  @TERM$1  experiments causing a reduction in the fluxes that lead to  @TERM$2  production and an increase in citrate production	0.9999969	3.053192e-06
30788345	fluxes	alphaketoglutarate	30788345	145	184	@TERM$1	@TERM$2	we observed that as expected the loss of idh activity eliminated  @TERM$1  through the reaction it catalyzes making  @TERM$2  from isocitrate supplementary table 3 and figure s3b	0.99999726	2.739698e-06
30788345	idh	fluxes	30788345	145	184	@TERM$1	@TERM$2	we observed that as expected the loss of  @TERM$1  activity eliminated  @TERM$2  through the reaction it catalyzes making alphaketoglutarate from isocitrate supplementary table 3 and figure s3b	0.9999981	1.9098795e-06
30788345	idh	isocitrate	30788345	145	184	@TERM$1	@TERM$2	we observed that as expected the loss of  @TERM$1  activity eliminated fluxes through the reaction it catalyzes making alphaketoglutarate from  @TERM$2  supplementary table 3 and figure s3b	0.99999154	8.42824e-06
30788345	fluxes	isocitrate	30788345	145	184	@TERM$1	@TERM$2	we observed that as expected the loss of idh activity eliminated  @TERM$1  through the reaction it catalyzes making alphaketoglutarate from  @TERM$2  supplementary table 3 and figure s3b	0.99999726	2.7758235e-06
30788345	idh	alphaketoglutarate	30788345	145	184	@TERM$1	@TERM$2	we observed that as expected the loss of  @TERM$1  activity eliminated fluxes through the reaction it catalyzes making  @TERM$2  from isocitrate supplementary table 3 and figure s3b	0.9999982	1.7890777e-06
30788345	fluxes	malate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in  @TERM$1  were identified that led to the accumulation of lactate fumarate succinate  @TERM$2  and in the depletion of glutamate and aspartate	0.9999982	1.7792074e-06
30788345	glutamate	aspartate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of lactate fumarate succinate malate and in the depletion of  @TERM$1  and  @TERM$2 	0.99999714	2.8995732e-06
30788345	lactate	fumarate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of  @TERM$1   @TERM$2  succinate malate and in the depletion of glutamate and aspartate	0.9999975	2.452999e-06
30788345	succinate	glutamate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of lactate fumarate  @TERM$1  malate and in the depletion of  @TERM$2  and aspartate	0.9999976	2.392075e-06
30788345	succinate	aspartate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of lactate fumarate  @TERM$1  malate and in the depletion of glutamate and  @TERM$2 	0.9999982	1.7988879e-06
30788345	malate	glutamate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of lactate fumarate succinate  @TERM$1  and in the depletion of  @TERM$2  and aspartate	0.99999845	1.6000284e-06
30788345	malate	aspartate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of lactate fumarate succinate  @TERM$1  and in the depletion of glutamate and  @TERM$2 	0.99999845	1.5054187e-06
30788345	fluxes	lactate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in  @TERM$1  were identified that led to the accumulation of  @TERM$2  fumarate succinate malate and in the depletion of glutamate and aspartate	0.99999845	1.5493137e-06
30788345	lactate	succinate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of  @TERM$1  fumarate  @TERM$2  malate and in the depletion of glutamate and aspartate	0.99999714	2.89465e-06
30788345	fluxes	fumarate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in  @TERM$1  were identified that led to the accumulation of lactate  @TERM$2  succinate malate and in the depletion of glutamate and aspartate	0.99999726	2.6854652e-06
30788345	lactate	malate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of  @TERM$1  fumarate succinate  @TERM$2  and in the depletion of glutamate and aspartate	0.9999956	4.4050685e-06
30788345	fumarate	glutamate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of lactate  @TERM$1  succinate malate and in the depletion of  @TERM$2  and aspartate	0.99999774	2.2507093e-06
30788345	fluxes	aspartate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in  @TERM$1  were identified that led to the accumulation of lactate fumarate succinate malate and in the depletion of glutamate and  @TERM$2 	0.9999982	1.7419264e-06
30788345	fumarate	succinate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of lactate  @TERM$1   @TERM$2  malate and in the depletion of glutamate and aspartate	0.99999	1.0016291e-05
30788345	lactate	glutamate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of  @TERM$1  fumarate succinate malate and in the depletion of  @TERM$2  and aspartate	0.99999714	2.858886e-06
30788345	lactate	aspartate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of  @TERM$1  fumarate succinate malate and in the depletion of glutamate and  @TERM$2 	0.9999939	6.091177e-06
30788345	fluxes	glutamate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in  @TERM$1  were identified that led to the accumulation of lactate fumarate succinate malate and in the depletion of  @TERM$2  and aspartate	0.9999943	5.7260418e-06
30788345	alphaketoglutarate	citrate	30788345	146	219	@TERM$1	@TERM$2	in addition in silico lack of  @TERM$1  concurred to some extent with in vivo metabolic flux experiments causing a reduction in the fluxes that lead to glutamate production and an increase in  @TERM$2  production	0.99999714	2.8164266e-06
30788345	flux	fluxes	30788345	146	219	@TERM$1	@TERM$2	in addition in silico lack of alphaketoglutarate concurred to some extent with in vivo metabolic  @TERM$1  experiments causing a reduction in the  @TERM$2  that lead to glutamate production and an increase in citrate production	0.999997	3.0388596e-06
30788345	flux	citrate	30788345	146	219	@TERM$1	@TERM$2	in addition in silico lack of alphaketoglutarate concurred to some extent with in vivo metabolic  @TERM$1  experiments causing a reduction in the fluxes that lead to glutamate production and an increase in  @TERM$2  production	0.9999975	2.5142638e-06
30788345	fluxes	glutamate	30788345	146	219	@TERM$1	@TERM$2	in addition in silico lack of alphaketoglutarate concurred to some extent with in vivo metabolic flux experiments causing a reduction in the  @TERM$1  that lead to  @TERM$2  production and an increase in citrate production	0.9999969	3.1373058e-06
30788345	cystathionine	uridine	30788345	189	116	@TERM$1	@TERM$2	me byproducts of amino acid metabolism homoserine  @TERM$1  as well as nucleotides guanosine cytidine  @TERM$2  gm	0.9999975	2.5405216e-06
30788345	phospholipids	triacylglycerols	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans  @TERM$1  collagens dna rna free fatty acids glycogens proteins  @TERM$2  and trehalose	0.999998	2.0540726e-06
30788345	gao	wan	30788345	188	119	@TERM$1	@TERM$2	erally agrees with other studies copes et al 2015  @TERM$1  et al 2017a  @TERM$2  et al 2017 and a crosscomparison can be found in 	0.9999969	3.1368004e-06
30788345	red	wan	30788345	188	220	@TERM$1	@TERM$2	etermined to be increasing or decreasing with age  @TERM$1  for increasing blue for decreasingour study generally agrees with other studies copes et al 2015 gao et al 2017a  @TERM$2  et al 2017 and a crosscomparison can be found in 	0.99999523	4.7100775e-06
30788345	red	gao	30788345	188	204	@TERM$1	@TERM$2	etermined to be increasing or decreasing with age  @TERM$1  for increasing blue for decreasingour study generally agrees with other studies copes et al 2015  @TERM$2  et al 2017a wan et al 2017 and a crosscomparison 	0.9999974	2.6002274e-06
30788345	137	map	30788345	183	184	@TERM$1	@TERM$2	for example the levels of several amino acids drop at day 1 of aging between 41 and 49 h and then again sometime after day 5  @TERM$1  hclustered heat  @TERM$2  showing metabolite levels over time	0.999998	2.0272478e-06
30788345	linoleic acid	hypoxanthine	30788345	182	177	@TERM$1	@TERM$2	some metabolites drift with age a gradually change for  @TERM$1   @TERM$2  and malate whereas others show abrupt shifts at specific time points during early or late aging	0.99999833	1.6822402e-06
30788345	linoleic acid	malate	30788345	182	177	@TERM$1	@TERM$2	some metabolites drift with age a gradually change for  @TERM$1  hypoxanthine and  @TERM$2  whereas others show abrupt shifts at specific time points during early or late aging	0.99999833	1.7208085e-06
30788345	hypoxanthine	malate	30788345	182	177	@TERM$1	@TERM$2	some metabolites drift with age a gradually change for linoleic acid  @TERM$1  and  @TERM$2  whereas others show abrupt shifts at specific time points during early or late aging	0.9999981	1.8799182e-06
30788345	s3a	malate	30788345	147	167	@TERM$1	@TERM$2	any of the altered fluxes measured in vivo figure  @TERM$1  including those leading to accumulation of succinate and  @TERM$2  were not accurately reproduced by the in silico k	0.9999981	1.8539879e-06
30788345	fumarate	malate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of lactate  @TERM$1  succinate  @TERM$2  and in the depletion of glutamate and aspartate	0.999998	2.0371433e-06
30788345	fluxes	malate	30788345	147	176	@TERM$1	@TERM$2	however many of the altered  @TERM$1  measured in vivo figure s3a including those leading to accumulation of succinate and  @TERM$2  were not accurately reproduced by the in silico k	0.999998	2.0061304e-06
30788345	s3a	succinate	30788345	147	156	@TERM$1	@TERM$2	any of the altered fluxes measured in vivo figure  @TERM$1  including those leading to accumulation of  @TERM$2  and malate were not accurately reproduced by the 	0.9999896	1.0358689e-05
30788345	isocitrate	dehydrogenase	30788345	147	124	@TERM$1	@TERM$2	sured in wild type n2 young adult animals lacking  @TERM$1   @TERM$2  activity and the in silico experiment was perform	0.0019378876	0.9980621
30788345	succinate	malate	30788345	147	123	@TERM$1	@TERM$2	re s3a including those leading to accumulation of  @TERM$1  and  @TERM$2  were not accurately reproduced by the in silico knoc	0.9999926	7.446505e-06
30788345	fluxes	succinate	30788345	147	165	@TERM$1	@TERM$2	however many of the altered  @TERM$1  measured in vivo figure s3a including those leading to accumulation of  @TERM$2  and malate were not accurately reproduced by the 	0.9999701	2.992141e-05
30788345	alphaketoglutarate	glutamate	30788345	146	219	@TERM$1	@TERM$2	in addition in silico lack of  @TERM$1  concurred to some extent with in vivo metabolic flux experiments causing a reduction in the fluxes that lead to  @TERM$2  production and an increase in citrate production	0.99999714	2.8492316e-06
30788345	alphaketoglutarate	fluxes	30788345	146	219	@TERM$1	@TERM$2	in addition in silico lack of  @TERM$1  concurred to some extent with in vivo metabolic flux experiments causing a reduction in the  @TERM$2  that lead to glutamate production and an increase in citrate production	0.9999485	5.146802e-05
30788345	alphaketoglutarate	flux	30788345	146	219	@TERM$1	@TERM$2	in addition in silico lack of  @TERM$1  concurred to some extent with in vivo metabolic  @TERM$2  experiments causing a reduction in the fluxes that lead to glutamate production and an increase in citrate production	0.99999285	7.1881054e-06
30788345	glutamate	citrate	30788345	146	219	@TERM$1	@TERM$2	in addition in silico lack of alphaketoglutarate concurred to some extent with in vivo metabolic flux experiments causing a reduction in the fluxes that lead to  @TERM$1  production and an increase in  @TERM$2  production	0.99999666	3.2941575e-06
30788345	fluxes	citrate	30788345	146	219	@TERM$1	@TERM$2	in addition in silico lack of alphaketoglutarate concurred to some extent with in vivo metabolic flux experiments causing a reduction in the  @TERM$1  that lead to glutamate production and an increase in  @TERM$2  production	0.99999535	4.6330724e-06
30788345	fluxes	s3a	30788345	147	115	@TERM$1	@TERM$2	however many of the altered  @TERM$1  measured in vivo figure  @TERM$2  including those leading to accumulation of succinate	0.99997103	2.894515e-05
30788345	succinate	malate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of lactate fumarate  @TERM$1   @TERM$2  and in the depletion of glutamate and aspartate	0.9999118	8.822321e-05
30788345	alphaketoglutarate	isocitrate	30788345	145	184	@TERM$1	@TERM$2	we observed that as expected the loss of idh activity eliminated fluxes through the reaction it catalyzes making  @TERM$1  from  @TERM$2  supplementary table 3 and figure s3b	0.99999607	3.902728e-06
30788345	phospholipids	trehalose	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans  @TERM$1  collagens dna rna free fatty acids glycogens proteins triacylglycerols and  @TERM$2 	0.9999949	5.1831694e-06
30788345	glucose	tca	30788345	139	239	@TERM$1	@TERM$2	here we took advantage of a previous study where mass spectrometry was used to quantify fluxes using the relationship between a labeled precursor  @TERM$1  provided in the food and several products of the  @TERM$2  cycle schrier vergano et al 2014	0.9999901	9.940013e-06
30788345	fluxes	tca	30788345	139	239	@TERM$1	@TERM$2	here we took advantage of a previous study where mass spectrometry was used to quantify  @TERM$1  using the relationship between a labeled precursor glucose provided in the food and several products of the  @TERM$2  cycle schrier vergano et al 2014	0.999956	4.4015454e-05
30788345	fluxes	glucose	30788345	139	239	@TERM$1	@TERM$2	here we took advantage of a previous study where mass spectrometry was used to quantify  @TERM$1  using the relationship between a labeled precursor  @TERM$2  provided in the food and several products of the tca cycle schrier vergano et al 2014	0.9998921	0.000107855616
30788345	glutathione	tca	30788345	137	223	@TERM$1	@TERM$2	we found that the most enriched include fluxes through pathways that are expected to change with age such as purine and pyrimidine and amino acid metabolism oxidative phosphorylation  @TERM$1  metabolism and the  @TERM$2  cycle	0.999998	2.0126304e-06
30788345	fluxes	glutathione	30788345	137	223	@TERM$1	@TERM$2	we found that the most enriched include  @TERM$1  through pathways that are expected to change with age such as purine and pyrimidine and amino acid metabolism oxidative phosphorylation  @TERM$2  metabolism and the tca cycle	0.9999956	4.426584e-06
30788345	fluxes	tca	30788345	137	223	@TERM$1	@TERM$2	we found that the most enriched include  @TERM$1  through pathways that are expected to change with age such as purine and pyrimidine and amino acid metabolism oxidative phosphorylation glutathione metabolism and the  @TERM$2  cycle	0.9999639	3.6119603e-05
30788345	s3c	supplementary table 2	30788345	136	173	@TERM$1	@TERM$2	we first performed fluxbased pathway analysis to detect pathways that were significantly changed in day 10 compared to day 5 fem animals figure  @TERM$1  and  @TERM$2 	0.9999852	1.4753115e-05
30788345	solute	carrier	30788345	118	202	@TERM$1	@TERM$2	at restrictive temperature the gon2q388ts mutation is enhanced by mutation of the  @TERM$1   @TERM$2  gem1 kemp et al 2009 but remains incompletely penetrant resulting in delayed and degenerate gonadogenesis	0.99999166	8.397032e-06
30788345	gon2q388ts	solute	30788345	118	202	@TERM$1	@TERM$2	at restrictive temperature the  @TERM$1  mutation is enhanced by mutation of the  @TERM$2  carrier gem1 kemp et al 2009 but remains incompletely penetrant resulting in delayed and degenerate gonadogenesis	0.9999963	3.6533888e-06
30788345	gon2q388ts	gem	30788345	116	137	@TERM$1	@TERM$2	to avoid this confounding factor we used two conditionally sterile strains  @TERM$1   @TERM$2 1bc364 gem hereafter and fem3q20ts fem hereafter	0.9999535	4.6494613e-05
30788345	xmi	tru are flux	30788345	107	204	@TERM$1	@TERM$2	red metabolites that could be mapped to the model  @TERM$1  is a metabolite level for a particular metabolite m at a given time point i and trl and  @TERM$2  lower and upper constraints set from the transcri	0.9998816	0.000118399636
30788345	fluxes	xmi	30788345	107	188	@TERM$1	@TERM$2	for all reactions in the model v is the vector of  @TERM$1  m is the set of all measured metabolites that could be mapped to the model  @TERM$2  is a metabolite level for a particular metabolite m 	0.999998	2.0758052e-06
30788345	xmi	flux	30788345	107	204	@TERM$1	@TERM$2	red metabolites that could be mapped to the model  @TERM$1  is a metabolite level for a particular metabolite m at a given time point i and trl and tru are  @TERM$2  lower and upper constraints set from the transcri	0.9999932	6.8263453e-06
30788345	glycogens	trehalose	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans phospholipids collagens dna rna free fatty acids  @TERM$1  proteins triacylglycerols and  @TERM$2 	0.99999547	4.514187e-06
30788345	collagens	fatty	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans phospholipids  @TERM$1  dna rna free  @TERM$2  acids glycogens proteins triacylglycerols and trehalose	0.9999951	4.890904e-06
30788345	glycogens	triacylglycerols	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans phospholipids collagens dna rna free fatty acids  @TERM$1  proteins  @TERM$2  and trehalose	0.9999963	3.6991762e-06
30788345	phospholipids	fatty	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans  @TERM$1  collagens dna rna free  @TERM$2  acids glycogens proteins triacylglycerols and trehalose	0.99999356	6.490629e-06
30788345	phospholipids	collagens	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans  @TERM$1   @TERM$2  dna rna free fatty acids glycogens proteins triacylglycerols and trehalose	0.9999896	1.0357346e-05
30788345	fatty	trehalose	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans phospholipids collagens dna rna free  @TERM$1  acids glycogens proteins triacylglycerols and  @TERM$2 	0.9999931	6.9405123e-06
30788345	fumarate	aspartate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in fluxes were identified that led to the accumulation of lactate  @TERM$1  succinate malate and in the depletion of glutamate and  @TERM$2 	0.99999344	6.509212e-06
30788345	collagens	trehalose	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans phospholipids  @TERM$1  dna rna free fatty acids glycogens proteins triacylglycerols and  @TERM$2 	0.9999957	4.2831202e-06
30788345	triacylglycerols	trehalose	30788345	92	175	@TERM$1	@TERM$2	the biomass reaction used as the default objective function included glycans phospholipids collagens dna rna free fatty acids glycogens proteins  @TERM$1  and  @TERM$2 	0.99999404	5.945152e-06
30788345	tca	s3a	30788345	140	149	@TERM$1	@TERM$2	the  @TERM$1  cycle is composed of a series of enzymatic reactions that include the core of aerobic respiration in the mitochondria a diagram in figure  @TERM$2 	0.9998822	0.000117791424
30788345	isocitrate dehydrogenase	alphaketoglutarate	30788345	141	179	@TERM$1	@TERM$2	ycle in wild type worms as well as in mutants for  @TERM$1  idh1 the enzyme that produces  @TERM$2  from isocitrate figure s3a reaction 3 schrier vergano e	0.9999987	1.3092125e-06
30788345	gon2q388ts	carrier	30788345	118	202	@TERM$1	@TERM$2	at restrictive temperature the  @TERM$1  mutation is enhanced by mutation of the solute  @TERM$2  gem1 kemp et al 2009 but remains incompletely penetrant resulting in delayed and degenerate gonadogenesis	0.99999774	2.2349113e-06
30788345	tca	alphaketoglutarate	30788345	141	228	@TERM$1	@TERM$2	ux profiling directly measured fluxes through the  @TERM$1  cycle in wild type worms as well as in mutants for isocitrate dehydrogenase idh1 the enzyme that produces  @TERM$2  from isocitrate figure s3a reaction 3 schrier ver	0.99999607	3.945872e-06
30788345	fluxes	succinate	30788345	142	198	@TERM$1	@TERM$2	in the absence of this upstream enzyme significant changes in  @TERM$1  were identified that led to the accumulation of lactate fumarate  @TERM$2  malate and in the depletion of glutamate and aspartate	0.99996126	3.8700535e-05
30788345	alphaketoglutarate	s3a	30788345	141	132	@TERM$1	@TERM$2	trate dehydrogenase idh1 the enzyme that produces  @TERM$1  from isocitrate figure  @TERM$2  reaction 3 schrier vergano et al 201	0.99999464	5.3205754e-06
30788345	fluxes	isocitrate	30788345	141	184	@TERM$1	@TERM$2	evious metabolic flux profiling directly measured  @TERM$1  through the tca cycle in wild type worms as well as in mutants for  @TERM$2  dehydrogenase idh1 the enzyme that produces alpha	0.99999857	1.4504574e-06
30788345	fluxes	tca	30788345	141	125	@TERM$1	@TERM$2	evious metabolic flux profiling directly measured  @TERM$1  through the  @TERM$2  cycle in wild type worms as well as in mutants for i	0.999992	7.98656e-06
30788345	fluxes	dehydrogenase	30788345	141	198	@TERM$1	@TERM$2	evious metabolic flux profiling directly measured  @TERM$1  through the tca cycle in wild type worms as well as in mutants for isocitrate  @TERM$2  idh1 the enzyme that produces alphaketoglutarate 	0.99999475	5.2457367e-06
30788345	flux	isocitrate	30788345	141	190	@TERM$1	@TERM$2	the previous metabolic  @TERM$1  profiling directly measured fluxes through the tca cycle in wild type worms as well as in mutants for  @TERM$2  dehydrogenase idh1 the enzyme that produces alpha	0.9999981	1.8499716e-06
30788345	fluxes	alphaketoglutarate	30788345	141	247	@TERM$1	@TERM$2	evious metabolic flux profiling directly measured  @TERM$1  through the tca cycle in wild type worms as well as in mutants for isocitrate dehydrogenase idh1 the enzyme that produces  @TERM$2  from isocitrate figure s3a reaction 3 schrier ver	0.9999932	6.79719e-06
30788345	flux	tca	30788345	141	129	@TERM$1	@TERM$2	the previous metabolic  @TERM$1  profiling directly measured fluxes through the  @TERM$2  cycle in wild type worms as well as in mutants for	0.99999094	9.046298e-06
30788345	flux	isocitrate dehydrogenase	30788345	141	204	@TERM$1	@TERM$2	the previous metabolic  @TERM$1  profiling directly measured fluxes through the tca cycle in wild type worms as well as in mutants for  @TERM$2  idh1 the enzyme that produces alphaketoglutarate 	0.9999658	3.416427e-05
30788345	tca	isocitrate dehydrogenase	30788345	141	179	@TERM$1	@TERM$2	ux profiling directly measured fluxes through the  @TERM$1  cycle in wild type worms as well as in mutants for  @TERM$2  idh1 the enzyme that produces alphaketoglutarate 	0.99999106	8.9719215e-06
30788345	isocitrate dehydrogenase	s3a	30788345	141	187	@TERM$1	@TERM$2	ycle in wild type worms as well as in mutants for  @TERM$1  idh1 the enzyme that produces alphaketoglutarate from isocitrate figure  @TERM$2  reaction 3 schrier vergano et al 201	0.9999975	2.5471859e-06
30788345	isocitrate	dehydrogenase	30788345	141	124	@TERM$1	@TERM$2	ycle in wild type worms as well as in mutants for  @TERM$1   @TERM$2  idh1 the enzyme that produces alphaketoglutarate 	0.99999785	2.1825485e-06
30788345	flux	dehydrogenase	30788345	141	204	@TERM$1	@TERM$2	the previous metabolic  @TERM$1  profiling directly measured fluxes through the tca cycle in wild type worms as well as in mutants for isocitrate  @TERM$2  idh1 the enzyme that produces alphaketoglutarate 	0.99999833	1.6490296e-06
30788345	fluxes	isocitrate dehydrogenase	30788345	141	198	@TERM$1	@TERM$2	evious metabolic flux profiling directly measured  @TERM$1  through the tca cycle in wild type worms as well as in mutants for  @TERM$2  idh1 the enzyme that produces alphaketoglutarate 	0.99999666	3.2964454e-06
30788345	flux	fluxes	30788345	141	112	@TERM$1	@TERM$2	the previous metabolic  @TERM$1  profiling directly measured  @TERM$2  through the tca cycle in wild type worms as well 	0.99999726	2.705214e-06
30788345	tca	s3a	30788345	141	242	@TERM$1	@TERM$2	ux profiling directly measured fluxes through the  @TERM$1  cycle in wild type worms as well as in mutants for isocitrate dehydrogenase idh1 the enzyme that produces alphaketoglutarate from isocitrate figure  @TERM$2  reaction 3 schrier vergano et al 201	0.9999969	3.0446085e-06
30788345	isocitrate	s3a	30788345	141	187	@TERM$1	@TERM$2	ycle in wild type worms as well as in mutants for  @TERM$1  dehydrogenase idh1 the enzyme that produces alphaketoglutarate from isocitrate figure  @TERM$2  reaction 3 schrier vergano et al 201	0.99999785	2.2021118e-06
30788345	dehydrogenase	s3a	30788345	141	176	@TERM$1	@TERM$2	d type worms as well as in mutants for isocitrate  @TERM$1  idh1 the enzyme that produces alphaketoglutarate from isocitrate figure  @TERM$2  reaction 3 schrier vergano et al 201	0.99999833	1.6235504e-06
30788345	dehydrogenase	alphaketoglutarate	30788345	141	162	@TERM$1	@TERM$2	d type worms as well as in mutants for isocitrate  @TERM$1  idh1 the enzyme that produces  @TERM$2  from isocitrate figure s3a reaction 3 schrier ver	0.9999981	1.9427514e-06
30788345	tca	isocitrate	30788345	141	165	@TERM$1	@TERM$2	ux profiling directly measured fluxes through the  @TERM$1  cycle in wild type worms as well as in mutants for  @TERM$2  dehydrogenase idh1 the enzyme that produces alpha	0.99996567	3.4389686e-05
30788345	tca	dehydrogenase	30788345	141	179	@TERM$1	@TERM$2	ux profiling directly measured fluxes through the  @TERM$1  cycle in wild type worms as well as in mutants for isocitrate  @TERM$2  idh1 the enzyme that produces alphaketoglutarate 	0.9999964	3.5415603e-06
30788345	isocitrate	alphaketoglutarate	30788345	141	173	@TERM$1	@TERM$2	ycle in wild type worms as well as in mutants for  @TERM$1  dehydrogenase idh1 the enzyme that produces  @TERM$2  from isocitrate figure s3a reaction 3 schrier ver	0.9999987	1.3632286e-06
30796049	pde	akt	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of  @TERM$1  inhibitors since the pde3 inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of  @TERM$2  appendixfig s4d	0.999998	2.0768746e-06
30796049	pde3	cilostazol	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde inhibitors since the  @TERM$1  inhibitor  @TERM$2  enhanced pka activity without altering the phosphorylation status of akt appendixfig s4d	0.9999981	1.8599135e-06
30796049	pka	s4d	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde inhibitors since the pde3 inhibitor cilostazol enhanced  @TERM$1  activity without altering the phosphorylation status of akt appendixfig  @TERM$2 	0.99998224	1.773016e-05
30796049	iis	inhibitor	30796049	203	187	@TERM$1	@TERM$2	this effect on  @TERM$1  was not a common feature of pde  @TERM$2 s since the pde3 inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of akt appendixfig s4d	0.99999416	5.844058e-06
30796049	pde	pde3	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of  @TERM$1  inhibitors since the  @TERM$2  inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of akt appendixfig s4d	0.9999882	1.1795494e-05
30796049	iis	pde3	30796049	203	187	@TERM$1	@TERM$2	this effect on  @TERM$1  was not a common feature of pde inhibitors since the  @TERM$2  inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of akt appendixfig s4d	0.99998987	1.0102447e-05
30796049	cilostazol	akt	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde inhibitors since the pde3 inhibitor  @TERM$1  enhanced pka activity without altering the phosphorylation status of  @TERM$2  appendixfig s4d	0.99999714	2.863268e-06
30796049	iis	cilostazol	30796049	203	187	@TERM$1	@TERM$2	this effect on  @TERM$1  was not a common feature of pde inhibitors since the pde3 inhibitor  @TERM$2  enhanced pka activity without altering the phosphorylation status of akt appendixfig s4d	0.99999774	2.3029145e-06
30796049	pde	inhibitor	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of  @TERM$1   @TERM$2 s since the pde3 inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of akt appendixfig s4d	0.999998	2.0237321e-06
30796049	inhibitor	cilostazol	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde  @TERM$1 s since the pde3 inhibitor  @TERM$2  enhanced pka activity without altering the phosphorylation status of akt appendixfig s4d	0.999997	2.9371313e-06
30796049	pde3	pka	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde inhibitors since the  @TERM$1  inhibitor cilostazol enhanced  @TERM$2  activity without altering the phosphorylation status of akt appendixfig s4d	0.99999404	5.9510685e-06
30796049	pde3	s4d	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde inhibitors since the  @TERM$1  inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of akt appendixfig  @TERM$2 	0.99978584	0.0002141661
30796049	iis	akt	30796049	203	187	@TERM$1	@TERM$2	this effect on  @TERM$1  was not a common feature of pde inhibitors since the pde3 inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of  @TERM$2  appendixfig s4d	0.999995	4.9906225e-06
30796049	pde3	inhibitor	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde  @TERM$2 s since the  @TERM$1  inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of akt appendixfig s4d	0.99999154	8.4275325e-06
30796049	pde3	akt	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde inhibitors since the  @TERM$1  inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of  @TERM$2  appendixfig s4d	0.9999969	3.060054e-06
30796049	pde	pka	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of  @TERM$1  inhibitors since the pde3 inhibitor cilostazol enhanced  @TERM$2  activity without altering the phosphorylation status of akt appendixfig s4d	0.99999607	3.919192e-06
30796049	iis	pka	30796049	203	187	@TERM$1	@TERM$2	this effect on  @TERM$1  was not a common feature of pde inhibitors since the pde3 inhibitor cilostazol enhanced  @TERM$2  activity without altering the phosphorylation status of akt appendixfig s4d	0.99999607	3.8897306e-06
30796049	pde	s4d	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of  @TERM$1  inhibitors since the pde3 inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of akt appendixfig  @TERM$2 	0.99999666	3.3519448e-06
30796049	cilostazol	pka	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde inhibitors since the pde3 inhibitor  @TERM$1  enhanced  @TERM$2  activity without altering the phosphorylation status of akt appendixfig s4d	0.9999951	4.838508e-06
30796049	inhibitor	pka	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde  @TERM$1 s since the pde3 inhibitor cilostazol enhanced  @TERM$2  activity without altering the phosphorylation status of akt appendixfig s4d	0.99999666	3.3082235e-06
30796049	inhibitor	s4d	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde  @TERM$1 s since the pde3 inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of akt appendixfig  @TERM$2 	0.99999225	7.780178e-06
30796049	cilostazol	s4d	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde inhibitors since the pde3 inhibitor  @TERM$1  enhanced pka activity without altering the phosphorylation status of akt appendixfig  @TERM$2 	0.99999654	3.4708755e-06
30796049	pde	cilostazol	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of  @TERM$1  inhibitors since the pde3 inhibitor  @TERM$2  enhanced pka activity without altering the phosphorylation status of akt appendixfig s4d	0.9999565	4.352409e-05
30796049	inhibitor	akt	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde  @TERM$1 s since the pde3 inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of  @TERM$2  appendixfig s4d	0.9999924	7.605519e-06
30796049	methylxanthines	akt	30796049	202	137	@TERM$1	@TERM$2	all three  @TERM$1  partially attenuated the phosphorylation status of  @TERM$2  and mtor targets fig4f and enhanced pka activity fig4g	0.99999654	3.4994393e-06
30796049	akt	pka	30796049	202	137	@TERM$1	@TERM$2	all three methylxanthines partially attenuated the phosphorylation status of  @TERM$1  and mtor targets fig4f and enhanced  @TERM$2  activity fig4g	0.9999975	2.4859817e-06
30796049	akt	s4d	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde inhibitors since the pde3 inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of  @TERM$1  appendixfig  @TERM$2 	0.9999989	1.0623239e-06
30796049	aminophylline	pentoxifylline	30796049	201	154	@TERM$1	@TERM$2	lity of xanthine in aqueous solutions we employed  @TERM$1  amp enprofylline enpf and  @TERM$2  ptx fig4e which are three widely used methylxant	0.9998381	0.00016186327
30796049	ptx	phosphodiesterase	30796049	201	216	@TERM$1	@TERM$2	phylline amp enprofylline enpf and pentoxifylline  @TERM$1  fig4e which are three widely used methylxanthines generally known as competitive nonselective  @TERM$2  inhibitors pdes and adenosine receptor antagonist	0.9999974	2.5927789e-06
30796049	methylxanthines	adenosine	30796049	201	213	@TERM$1	@TERM$2	oxifylline ptx fig4e which are three widely used  @TERM$1  generally known as competitive nonselective phosphodiesterase inhibitors pdes and  @TERM$2  receptor antagonists snyder etal 1981 monteiro etal 2	0.99999607	3.9868637e-06
30796049	xanthine	ptx	30796049	201	183	@TERM$1	@TERM$2	given the low solubility of  @TERM$1  in aqueous solutions we employed aminophylline amp enprofylline enpf and pentoxifylline  @TERM$2  fig4e which are three widely used methylxanthines gen	0.9999924	7.633896e-06
30796049	ptx	adenosine	30796049	201	246	@TERM$1	@TERM$2	phylline amp enprofylline enpf and pentoxifylline  @TERM$1  fig4e which are three widely used methylxanthines generally known as competitive nonselective phosphodiesterase inhibitors pdes and  @TERM$2  receptor antagonists snyder etal 1981 monteiro e	0.9999982	1.823025e-06
30796049	phosphodiesterase	adenosine receptor antagonists	30796049	201	155	@TERM$1	@TERM$2	hines generally known as competitive nonselective  @TERM$1  inhibitors pdes and  @TERM$2  snyder etal 1981 monteiro etal 201	0.99999833	1.6547372e-06
30796049	xanthine	methylxanthines	30796049	201	229	@TERM$1	@TERM$2	given the low solubility of  @TERM$1  in aqueous solutions we employed aminophylline amp enprofylline enpf and pentoxifylline ptx fig4e which are three widely used  @TERM$2  generally known as competitive nonselective phosp	0.99999225	7.793589e-06
30796049	methylxanthines	phosphodiesterase	30796049	201	177	@TERM$1	@TERM$2	oxifylline ptx fig4e which are three widely used  @TERM$1  generally known as competitive nonselective  @TERM$2  inhibitors pdes and adenosine receptor antagonist	0.9999976	2.3282923e-06
30796049	xanthine	amp	30796049	201	142	@TERM$1	@TERM$2	given the low solubility of  @TERM$1  in aqueous solutions we employed aminophylline  @TERM$2  enprofylline enpf and pentoxifylline ptx fig4e which 	0.9999982	1.8348192e-06
30796049	enprofylline	methylxanthines	30796049	201	191	@TERM$1	@TERM$2	n aqueous solutions we employed aminophylline amp  @TERM$1  enpf and pentoxifylline ptx fig4e which are three widely used  @TERM$2  generally known as competitive nonselective phosp	0.9999976	2.3356267e-06
30796049	xanthine	aminophylline	30796049	201	133	@TERM$1	@TERM$2	given the low solubility of  @TERM$1  in aqueous solutions we employed  @TERM$2  amp enprofylline enpf and pentoxifylline ptx fig	0.9999987	1.3444585e-06
30796049	pentoxifylline	ptx	30796049	201	129	@TERM$1	@TERM$2	 employed aminophylline amp enprofylline enpf and  @TERM$1   @TERM$2  fig4e which are three widely used methylxanthines generally	0.9999981	1.8922483e-06
30796049	enprofylline	ptx	30796049	201	149	@TERM$1	@TERM$2	n aqueous solutions we employed aminophylline amp  @TERM$1  enpf and pentoxifylline  @TERM$2  fig4e which are three widely used methylxanthines general	0.99999833	1.6124129e-06
30796049	amp	enprofylline	30796049	201	116	@TERM$1	@TERM$2	ne in aqueous solutions we employed aminophylline  @TERM$1   @TERM$2  enpf and pentoxifylline ptx fig4e which are thre	0.99999833	1.7248373e-06
30796049	phosphodiesterase	adenosine receptor	30796049	201	155	@TERM$1	@TERM$2	hines generally known as competitive nonselective  @TERM$1  inhibitors pdes and  @TERM$2  antagonists snyder etal 1981 monteiro etal 201	0.99999833	1.7275602e-06
30796049	aminophylline	enprofylline	30796049	201	131	@TERM$1	@TERM$2	lity of xanthine in aqueous solutions we employed  @TERM$1  amp  @TERM$2  enpf and pentoxifylline ptx fig4e which are three	0.9999988	1.1550974e-06
30796049	methylxanthines	adenosine receptor antagonists	30796049	201	215	@TERM$1	@TERM$2	oxifylline ptx fig4e which are three widely used  @TERM$1  generally known as competitive nonselective phosphodiesterase inhibitors pdes and  @TERM$2  snyder etal 1981 monteiro etal 201	0.99998057	1.9402965e-05
30796049	enprofylline	pentoxifylline	30796049	201	136	@TERM$1	@TERM$2	n aqueous solutions we employed aminophylline amp  @TERM$1  enpf and  @TERM$2  ptx fig4e which are three widely used methylxant	0.99999833	1.7215489e-06
30796049	akt	mtor	30796049	202	137	@TERM$1	@TERM$2	all three methylxanthines partially attenuated the phosphorylation status of  @TERM$1  and  @TERM$2  targets fig4f and enhanced pka activity fig4g	0.99999595	4.038189e-06
30796049	methylxanthines	mtor	30796049	202	137	@TERM$1	@TERM$2	all three  @TERM$1  partially attenuated the phosphorylation status of akt and  @TERM$2  targets fig4f and enhanced pka activity fig4g	0.9999981	1.9194183e-06
30796049	mtor	pka	30796049	202	137	@TERM$1	@TERM$2	all three methylxanthines partially attenuated the phosphorylation status of akt and  @TERM$1  targets fig4f and enhanced  @TERM$2  activity fig4g	0.99999785	2.1329743e-06
30796049	methylxanthines	pka	30796049	202	137	@TERM$1	@TERM$2	all three  @TERM$1  partially attenuated the phosphorylation status of akt and mtor targets fig4f and enhanced  @TERM$2  activity fig4g	0.99999774	2.324328e-06
30796049	pride	pxd011859	30796049	387	221	@TERM$1	@TERM$2	posited to the proteomexchange consortium via the  @TERM$1  partner repository with the dataset identifier pxd011851 httpswwwebiacukpridearchiveprojectspxd011851 and  @TERM$2  httpswwwebiacukpridearchiveprojectspxd011859 resp	0.9999989	1.1207488e-06
30796049	ipa	geo	30796049	385	179	@TERM$1	@TERM$2	of thenematode genes with human homologs for the  @TERM$1  of the transcriptomicdatarna sequencing has been deposited to the ncbi  @TERM$2  database under the accession number gse122902 htt	0.9999987	1.3547655e-06
30796049	pyruvate	glucose	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm sodium  @TERM$1  10mm  @TERM$2  and 2mm lglutamine ph 74	0.99999666	3.281274e-06
30796049	dmso	glucose	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with  @TERM$1  vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm sodium pyruvate 10mm  @TERM$2  and 2mm lglutamine ph 74	0.9999927	7.2282846e-06
30796049	dmso	sodium	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with  @TERM$1  vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm  @TERM$2  pyruvate 10mm glucose and 2mm lglutamine ph 74	0.99999046	9.576156e-06
30796049	sodium	lglutamine	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm  @TERM$1  pyruvate 10mm glucose and 2mm  @TERM$2  ph 74	0.99999774	2.2539314e-06
30796049	methylxanthines	sodium pyruvate	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or  @TERM$1  for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm  @TERM$2  10mm glucose and 2mm lglutamine ph 74	0.99999857	1.4760861e-06
30796049	sodium	pyruvate	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm  @TERM$1   @TERM$2  10mm glucose and 2mm lglutamine ph 74	0.9999957	4.2663323e-06
30796049	methylxanthines	glucose	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or  @TERM$1  for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm sodium pyruvate 10mm  @TERM$2  and 2mm lglutamine ph 74	0.99999857	1.4025211e-06
30796049	dmso	pyruvate	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with  @TERM$1  vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm sodium  @TERM$2  10mm glucose and 2mm lglutamine ph 74	0.9999988	1.1547229e-06
30796049	pyruvate	lglutamine	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm sodium  @TERM$1  10mm glucose and 2mm  @TERM$2  ph 74	0.9999974	2.6587743e-06
30796049	dmso	methylxanthines	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with  @TERM$1  vehicle or  @TERM$2  for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm sodium pyruvate 10mm glucose and 2mm lglutamine ph 74	0.999998	2.0594393e-06
30796049	dmso	lglutamine	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with  @TERM$1  vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm sodium pyruvate 10mm glucose and 2mm  @TERM$2  ph 74	0.99999857	1.3914871e-06
30796049	sodium pyruvate	glucose	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm  @TERM$1  10mm  @TERM$2  and 2mm lglutamine ph 74	0.99999845	1.5312665e-06
30796049	methylxanthines	sodium	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or  @TERM$1  for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm  @TERM$2  pyruvate 10mm glucose and 2mm lglutamine ph 74	0.9999982	1.8248444e-06
30796049	methylxanthines	pyruvate	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or  @TERM$1  for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm sodium  @TERM$2  10mm glucose and 2mm lglutamine ph 74	0.99999774	2.3175173e-06
30796049	glucose	lglutamine	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm sodium pyruvate 10mm  @TERM$1  and 2mm  @TERM$2  ph 74	0.999997	2.9519438e-06
30796049	dmso	sodium pyruvate	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with  @TERM$1  vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm  @TERM$2  10mm glucose and 2mm lglutamine ph 74	0.9999969	3.129447e-06
30796049	sodium pyruvate	lglutamine	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm  @TERM$1  10mm glucose and 2mm  @TERM$2  ph 74	0.9999974	2.5876284e-06
30796049	sodium	glucose	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or methylxanthines for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm  @TERM$1  pyruvate 10mm  @TERM$2  and 2mm lglutamine ph 74	0.9999988	1.2020886e-06
30796049	sodium	azide	30796049	334	49	@TERM$1	@TERM$2	the final concentration of  @TERM$1   @TERM$2  was 20mm	0.99993336	6.669305e-05
30796049	pentoxifylline	phosphodiesterase	30796049	201	231	@TERM$1	@TERM$2	 employed aminophylline amp enprofylline enpf and  @TERM$1  ptx fig4e which are three widely used methylxanthines generally known as competitive nonselective  @TERM$2  inhibitors pdes and adenosine receptor antagonist	0.9999764	2.3563087e-05
30796049	frap	gas1	30796049	324	194	@TERM$1	@TERM$2	 @TERM$1  experiments were conducted blind to the respective condition genotype treatment or rnai of the nematodeswe used five biological replicates of wt  @TERM$2  and age1 gas1 worms for transcriptomics	0.9999975	2.4607427e-06
30796049	methylxanthines	lglutamine	30796049	337	232	@TERM$1	@TERM$2	the next morning cells were treated with dmso vehicle or  @TERM$1  for 24h after treatment growth medium was replaced with seahorse xf base medium supplemented with 1mm sodium pyruvate 10mm glucose and 2mm  @TERM$2  ph 74	0.9999894	1.0584786e-05
30796049	geo	gse122902	30796049	385	146	@TERM$1	@TERM$2	datarna sequencing has been deposited to the ncbi  @TERM$1  database under the accession number  @TERM$2  httpswwwncbinlmnihgovgeoqueryacccgiaccgse12290	0.9999981	1.8573822e-06
30796049	fccp	rotenoneantimycin	30796049	339	100	@TERM$1	@TERM$2	the final concentrations of oligomycin  @TERM$1  and  @TERM$2  were 1 0125 and 05m respectively	0.9999981	1.8750517e-06
30796049	oligomycin	rotenoneantimycin	30796049	339	100	@TERM$1	@TERM$2	the final concentrations of  @TERM$1  fccp and  @TERM$2  were 1 0125 and 05m respectively	0.9999876	1.242559e-05
30796049	ipa	gse122902	30796049	385	222	@TERM$1	@TERM$2	of thenematode genes with human homologs for the  @TERM$1  of the transcriptomicdatarna sequencing has been deposited to the ncbi geo database under the accession number  @TERM$2  httpswwwncbinlmnihgovgeoqueryacccgiaccgse12290	0.999726	0.0002740358
30796049	appendixclick	fileclick	30796049	379	171	@TERM$1	@TERM$2	lick here for additional data filesource data for  @TERM$1  here for additional data filereview process  @TERM$2  here for additional data filesource data for figure3	0.9999976	2.4280168e-06
30796049	xanthine	oxidase	30796049	377	96	@TERM$1	@TERM$2	 @TERM$1   @TERM$2  activity was measured in the supernatants as per the manufacturers instructions	0.9999974	2.6728233e-06
30796049	xanthine	oxidase	30796049	376	143	@TERM$1	@TERM$2	the pellets were disrupted in  @TERM$1   @TERM$2  assay buffer with a sonicator and spun down in a chilled microcentrifuge at 14000rpm for 10min	0.99999845	1.6000681e-06
30796049	oxidase	xanthine oxidase	30796049	374	159	@TERM$1	@TERM$2	immunoblots were visualized with a chemidoc imaging system bioradxanthine  @TERM$1  activity was measured with a  @TERM$2  activity assay kit sigma mak078	0.9999988	1.1474656e-06
30796049	xanthine oxidase	xanthine	30796049	374	159	@TERM$1	@TERM$2	immunoblots were visualized with a chemidoc imaging system biorad @TERM$1  activity was measured with a  @TERM$2  oxidase activity assay kit sigma mak078	0.999984	1.6033238e-05
30796049	oxidase	xanthine	30796049	374	159	@TERM$1	@TERM$2	immunoblots were visualized with a chemidoc imaging system biorad @TERM$2   @TERM$1  activity was measured with a xanthine oxidase activity assay kit sigma mak078	0.999995	5.007509e-06
30796049	oligomycin	fccp	30796049	339	100	@TERM$1	@TERM$2	the final concentrations of  @TERM$1   @TERM$2  and rotenoneantimycin were 1 0125 and 05m respectively	0.99998164	1.8343768e-05
30796049	xanthine oxidase	sigma	30796049	374	159	@TERM$1	@TERM$2	immunoblots were visualized with a chemidoc imaging system biorad @TERM$1  activity was measured with a xanthine oxidase activity assay kit  @TERM$2  mak078	0.99996376	3.6254365e-05
30796049	xanthine	sigma	30796049	374	159	@TERM$1	@TERM$2	immunoblots were visualized with a chemidoc imaging system biorad @TERM$1  oxidase activity was measured with a xanthine oxidase activity assay kit  @TERM$2  mak078	0.99996746	3.2505573e-05
30796049	sigma	phosphatase	30796049	369	201	@TERM$1	@TERM$2	the volcano plot of the tmtitraq scan data was generated in r 313nematode and cell pellets were disrupted via sonication in ripa buffer  @TERM$1  supplemented with protease and  @TERM$2  inhibitors roche	0.99999857	1.4230013e-06
30796049	tmtitraq	protease	30796049	369	201	@TERM$1	@TERM$2	the volcano plot of the  @TERM$1  scan data was generated in r 313nematode and cell pellets were disrupted via sonication in ripa buffer sigma supplemented with  @TERM$2  and phosphatase inhibitors roche	0.9999988	1.2510621e-06
30796049	sigma	protease	30796049	369	201	@TERM$1	@TERM$2	the volcano plot of the tmtitraq scan data was generated in r 313nematode and cell pellets were disrupted via sonication in ripa buffer  @TERM$1  supplemented with  @TERM$2  and phosphatase inhibitors roche	0.9999987	1.2522557e-06
30796049	tmtitraq	sigma	30796049	369	201	@TERM$1	@TERM$2	the volcano plot of the  @TERM$1  scan data was generated in r 313nematode and cell pellets were disrupted via sonication in ripa buffer  @TERM$2  supplemented with protease and phosphatase inhibitors roche	0.999992	8.01483e-06
30796049	tmtitraq	phosphatase	30796049	369	201	@TERM$1	@TERM$2	the volcano plot of the  @TERM$1  scan data was generated in r 313nematode and cell pellets were disrupted via sonication in ripa buffer sigma supplemented with protease and  @TERM$2  inhibitors roche	0.9999877	1.2251981e-05
30796049	protease	phosphatase	30796049	369	201	@TERM$1	@TERM$2	the volcano plot of the tmtitraq scan data was generated in r 313nematode and cell pellets were disrupted via sonication in ripa buffer sigma supplemented with  @TERM$1  and  @TERM$2  inhibitors roche	0.99999213	7.854025e-06
30796049	tmt	tag	30796049	365	198	@TERM$1	@TERM$2	dc biosciences ltd scotland uk lysed the samples with bead beating and protein was precipitated with methanolchloroform digested and labeled with a thermo fisher scientific  @TERM$1  mass  @TERM$2  labeling kit	0.99999714	2.8794077e-06
30796049	gas1	age1	30796049	360	131	@TERM$1	@TERM$2	chenomx inc canada performed an nmr1d analysis to determine the metabolites present in wildtype  @TERM$1  and  @TERM$2  gas1 mutant nematodes	0.999997	2.9298155e-06
30796049	gas1	ipa	30796049	347	171	@TERM$1	@TERM$2	only proteins dysregulated in  @TERM$1  versus wt with fdr20 and an absolute fold change 5 most extreme control ratios ie 0345 were used in the subsequent  @TERM$2  see also below	0.99998844	1.1614296e-05
30796049	tmt	tag	30796049	343	194	@TERM$1	@TERM$2	dc biosciences ltd scotland uk lysed the samples with bead beating protein was precipitated with methanolchloroform digested and labeled with a thermo fisher scientific  @TERM$1  mass  @TERM$2  labeling kit	0.99999654	3.4517432e-06
30796049	oxidase	sigma	30796049	374	159	@TERM$1	@TERM$2	immunoblots were visualized with a chemidoc imaging system bioradxanthine  @TERM$1  activity was measured with a xanthine oxidase activity assay kit  @TERM$2  mak078	0.99999857	1.4571901e-06
30796049	xanthine	enprofylline	30796049	201	150	@TERM$1	@TERM$2	given the low solubility of  @TERM$1  in aqueous solutions we employed aminophylline amp  @TERM$2  enpf and pentoxifylline ptx fig4e which are thre	0.99999547	4.498801e-06
30796049	amp	actin	30796049	183	148	@TERM$1	@TERM$2	and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$1  2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.99999726	2.7445387e-06
30796049	amp	pentoxifylline	30796049	201	140	@TERM$1	@TERM$2	ne in aqueous solutions we employed aminophylline  @TERM$1  enprofylline enpf and  @TERM$2  ptx fig4e which are three widely used methylxant	0.9999789	2.1148757e-05
30796049	xanthine	oxidase	30796049	193	66	@TERM$1	@TERM$2	right  @TERM$1   @TERM$2  activity levels normalized to animal number	0.99999356	6.3824614e-06
30796049	akt	ndufa9	30796049	194	156	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40 t246 and total pras40 in wt and  @TERM$2  ko hap1 cells treated with 02 dmso  or amp 2m e	0.9999976	2.4280168e-06
30796049	pras40	dmso	30796049	194	160	@TERM$1	@TERM$2	sphoakt s473 pan akt phospho @TERM$1  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$2   or amp 2m enpf 2m and ptx 36m  for 24h acti	0.99999905	1.0082996e-06
30796049	akt	t246	30796049	194	122	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40  @TERM$2  and total pras40 in wt and ndufa9 ko hap1 cells t	0.99999857	1.3791295e-06
30796049	pan	ptx	30796049	194	226	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot a	0.9999974	2.5932043e-06
30796049	xanthine	t246	30796049	194	220	@TERM$1	@TERM$2	ant mannwhitney utestschematic representations of  @TERM$1  and the methylxanthines used in this studyimmunoblot analysis of phosphoakt s473 pan akt phosphopras40  @TERM$2  and total pras40 in wt and ndufa9 ko hap1 cells treat	0.9999975	2.4771023e-06
30796049	xanthine	pras40	30796049	194	235	@TERM$1	@TERM$2	ant mannwhitney utestschematic representations of  @TERM$1  and the methylxanthines used in this studyimmunoblot analysis of phosphoakt s473 pan akt phospho @TERM$2  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso	0.99999726	2.7372796e-06
30796049	akt	dmso	30796049	194	191	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$2   or amp 2m enpf 2m and ptx 36m  for 24h ac	0.9999975	2.4630156e-06
30796049	amp	ptx	30796049	194	126	@TERM$1	@TERM$2	and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$1  2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot a	0.9999633	3.670879e-05
30796049	akt	amp	30796049	194	199	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin load	0.9999987	1.3001023e-06
30796049	ndufa9	dmso	30796049	194	143	@TERM$1	@TERM$2	akt phosphopras40 t246 and total pras40 in wt and  @TERM$1  ko hap1 cells treated with 02  @TERM$2   or amp 2m enpf 2m and ptx 36m  for 24h acti	0.9999988	1.2340223e-06
30796049	pan	actin	30796049	194	248	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.99999845	1.5895115e-06
30796049	pan	ndufa9	30796049	194	160	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and  @TERM$2  ko hap1 cells treated with 02 dmso  or amp 2m e	0.9999987	1.352616e-06
30796049	methylxanthines	akt	30796049	194	192	@TERM$1	@TERM$2	testschematic representations of xanthine and the  @TERM$1  used in this studyimmunoblot analysis of phospho @TERM$2  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 	0.9999988	1.2020886e-06
30796049	t246	dmso	30796049	194	173	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phosphopras40  @TERM$1  and total pras40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$2   or amp 2m enpf 2m and ptx 36m  for 24h ac	0.99902225	0.0009777574
30796049	sem	pan	30796049	194	228	@TERM$1	@TERM$2	bars mean @TERM$1  n2 nsnonsignificant mannwhitney utestschematic representations of xanthine and the methylxanthines used in this studyimmunoblot analysis of phosphoakt s473  @TERM$2  akt phosphopras40 t246 and total pras40 in wt and	0.99999857	1.4025211e-06
30796049	t246	pras40	30796049	194	121	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phospho @TERM$2   @TERM$1  and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dm	0.9999982	1.823025e-06
30796049	akt	ptx	30796049	194	222	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot a	0.9999974	2.6587743e-06
30796049	sem	methylxanthines	30796049	194	167	@TERM$1	@TERM$2	bars mean @TERM$1  n2 nsnonsignificant mannwhitney utestschematic representations of xanthine and the  @TERM$2  used in this studyimmunoblot analysis of phosphoa	0.9999968	3.2436465e-06
30796049	pras40	actin	30796049	194	212	@TERM$1	@TERM$2	sphoakt s473 pan akt phospho @TERM$1  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka s	0.999998	2.0594393e-06
30796049	pras40	ndufa9	30796049	194	123	@TERM$1	@TERM$2	sphoakt s473 pan akt phospho @TERM$1  t246 and total pras40 in wt and  @TERM$2  ko hap1 cells treated with 02 dmso  or amp 2m e	0.99999857	1.3914871e-06
30796049	gas1	xanthine	30796049	189	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in age1  @TERM$1  mutants and the consequent  @TERM$2  accumulation	0.99999845	1.5312665e-06
30796049	sem	xanthine	30796049	189	226	@TERM$1	@TERM$2	bar mean @TERM$1  n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in age1 gas1 mutants and the consequent  @TERM$2  accumulation	0.9999982	1.8248444e-06
30796049	sem	map	30796049	189	226	@TERM$1	@TERM$2	bar mean @TERM$1  n7schematic representation of purine degradation pathway with overlaid molecule activity predictor  @TERM$2  analysis showing increased purine degradation in age1 gas1 mutants and the consequent xanthine accumulation	0.99999774	2.3175173e-06
30796049	sem	gas1	30796049	189	226	@TERM$1	@TERM$2	bar mean @TERM$1  n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in age1  @TERM$2  mutants and the consequent xanthine accumulation	0.999997	2.9519438e-06
30796049	pan	t246	30796049	183	126	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40  @TERM$2  and total pras40 in wt and ndufa9 ko hap1 cells t	0.9999974	2.5876284e-06
30796049	t246	ptx	30796049	183	205	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phosphopras40  @TERM$1  and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot an	0.9999957	4.2663323e-06
30796049	gas1	age1	30796049	324	194	@TERM$1	@TERM$2	frap experiments were conducted blind to the respective condition genotype treatment or rnai of the nematodeswe used five biological replicates of wt  @TERM$1  and  @TERM$2  gas1 worms for transcriptomics	0.9999944	5.6198337e-06
30796049	methylxanthines	ndufa9	30796049	183	242	@TERM$1	@TERM$2	testschematic representations of xanthine and the  @TERM$1  used in this studyimmunoblot analysis of phosphoakt s473 pan akt phosphopras40 t246 and total pras40 in wt and  @TERM$2  ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m 	0.99999726	2.7568205e-06
30796049	ndufa9	amp	30796049	183	152	@TERM$1	@TERM$2	akt phosphopras40 t246 and total pras40 in wt and  @TERM$1  ko hap1 cells treated with 02 dmso  or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin loading	0.9999981	1.9013055e-06
30796049	methylxanthines	t246	30796049	183	210	@TERM$1	@TERM$2	testschematic representations of xanthine and the  @TERM$1  used in this studyimmunoblot analysis of phosphoakt s473 pan akt phosphopras40  @TERM$2  and total pras40 in wt and ndufa9 ko hap1 cells treated with	0.999998	2.0539906e-06
30796049	t246	amp	30796049	183	182	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phosphopras40  @TERM$1  and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin loadi	0.9999962	3.8051849e-06
30796049	akt	actin	30796049	183	244	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.9999987	1.3435741e-06
30796049	akt	pras40	30796049	183	139	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phospho @TERM$2  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dm	0.999997	2.9522027e-06
30796049	pan	dmso	30796049	183	195	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$2   or amp 2m enpf 2m and ptx 36m  for 24h ac	0.999998	2.025858e-06
30796049	xanthine	akt	30796049	183	202	@TERM$1	@TERM$2	ant mannwhitney utestschematic representations of  @TERM$1  and the methylxanthines used in this studyimmunoblot analysis of phospho @TERM$2  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 k	0.9999486	5.135712e-05
30796049	methylxanthines	pan	30796049	194	188	@TERM$1	@TERM$2	testschematic representations of xanthine and the  @TERM$1  used in this studyimmunoblot analysis of phosphoakt s473  @TERM$2  akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko h	0.9999918	8.204283e-06
30796049	ptx	actin	30796049	183	125	@TERM$1	@TERM$2	s treated with 02 dmso  or amp 2m enpf 2m and  @TERM$1  36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.99998665	1.3377566e-05
30796049	dmso	amp	30796049	183	113	@TERM$1	@TERM$2	40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$1   or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin loadi	0.9999974	2.5826903e-06
30796049	gas1	age1	30796049	185	68	@TERM$1	@TERM$2	volcano plot of lipidomic profiling in  @TERM$1  versus  @TERM$2  gas1 mutants	0.99999475	5.243091e-06
30796049	age1	gas1	30796049	186	148	@TERM$1	@TERM$2	red stars significantly altered lipids in  @TERM$1   @TERM$2  versus gas1 5 fdr n5nmr1d targeted metabolic profiling in age1 gas1 mutants normalized to gas1	0.9999937	6.295832e-06
30796049	red	age1	30796049	186	148	@TERM$1	@TERM$2	 @TERM$1  stars significantly altered lipids in  @TERM$2  gas1 versus gas1 5 fdr n5nmr1d targeted metabolic profiling in age1 gas1 mutants normalized to gas1	0.99999607	3.9174874e-06
30796049	red	gas1	30796049	186	148	@TERM$1	@TERM$2	 @TERM$1  stars significantly altered lipids in age1  @TERM$2  versus gas1 5 fdr n5nmr1d targeted metabolic profiling in age1 gas1 mutants normalized to gas1	0.99999344	6.572313e-06
30796049	map	age1	30796049	189	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor  @TERM$1  analysis showing increased purine degradation in  @TERM$2  gas1 mutants and the consequent xanthine accumulation	0.99999845	1.5641881e-06
30796049	map	xanthine	30796049	189	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor  @TERM$1  analysis showing increased purine degradation in age1 gas1 mutants and the consequent  @TERM$2  accumulation	0.999998	2.0249174e-06
30796049	sem	age1	30796049	189	226	@TERM$1	@TERM$2	bar mean @TERM$1  n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in  @TERM$2  gas1 mutants and the consequent xanthine accumulation	0.99999833	1.6184721e-06
30796049	map	gas1	30796049	189	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor  @TERM$1  analysis showing increased purine degradation in age1  @TERM$2  mutants and the consequent xanthine accumulation	0.9999982	1.8283074e-06
30796049	age1	xanthine	30796049	189	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in  @TERM$1  gas1 mutants and the consequent  @TERM$2  accumulation	0.99999416	5.88296e-06
30796049	age1	gas1	30796049	189	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in  @TERM$1   @TERM$2  mutants and the consequent xanthine accumulation	0.999997	3.0263368e-06
30796049	ndufa9	ptx	30796049	183	175	@TERM$1	@TERM$2	akt phosphopras40 t246 and total pras40 in wt and  @TERM$1  ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot anal	0.99999535	4.609617e-06
30796049	pan	amp	30796049	194	203	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin load	0.9998173	0.0001827229
30796049	ndufa9	actin	30796049	194	195	@TERM$1	@TERM$2	akt phosphopras40 t246 and total pras40 in wt and  @TERM$1  ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka s	0.99999726	2.6933135e-06
30796049	pan	pras40	30796049	194	143	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phospho @TERM$2  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dm	0.9999956	4.4364056e-06
30796049	xanthine	ndufs4	30796049	199	201	@TERM$1	@TERM$2	to investigate the effect of  @TERM$1  derivatives on mitochondrial mutant cells we used genetically modified hap1 cells lacking mitochondrial complex i subunits ndufs2  @TERM$2  or ndufa9 appendixfig s4a	0.99999774	2.2798713e-06
30796049	ndufs2	ndufs4	30796049	199	201	@TERM$1	@TERM$2	to investigate the effect of xanthine derivatives on mitochondrial mutant cells we used genetically modified hap1 cells lacking mitochondrial complex i subunits  @TERM$1   @TERM$2  or ndufa9 appendixfig s4a	0.9999913	8.697321e-06
30796049	xanthine	ndufa9	30796049	199	201	@TERM$1	@TERM$2	to investigate the effect of  @TERM$1  derivatives on mitochondrial mutant cells we used genetically modified hap1 cells lacking mitochondrial complex i subunits ndufs2 ndufs4 or  @TERM$2  appendixfig s4a	0.9999987	1.3314894e-06
30796049	ndufs2	ndufa9	30796049	199	201	@TERM$1	@TERM$2	to investigate the effect of xanthine derivatives on mitochondrial mutant cells we used genetically modified hap1 cells lacking mitochondrial complex i subunits  @TERM$1  ndufs4 or  @TERM$2  appendixfig s4a	0.9999893	1.07224105e-05
30796049	mtor	paktser473	30796049	200	230	@TERM$1	@TERM$2	these tumorigenic cells showed impaired mitochondrial respiration appendixfig s4b and enhanced iis as revealed by the increased phosphorylation of  @TERM$1  and akt targets ie  @TERM$2  and ppras40thr246 respectively appendixfig s4c	0.9999957	4.3481386e-06
30796049	mtor	akt	30796049	200	230	@TERM$1	@TERM$2	these tumorigenic cells showed impaired mitochondrial respiration appendixfig s4b and enhanced iis as revealed by the increased phosphorylation of  @TERM$1  and  @TERM$2  targets ie paktser473 and ppras40thr246 respectively appendixfig s4c	0.99998057	1.9379073e-05
30796049	akt	paktser473	30796049	200	230	@TERM$1	@TERM$2	these tumorigenic cells showed impaired mitochondrial respiration appendixfig s4b and enhanced iis as revealed by the increased phosphorylation of mtor and  @TERM$1  targets ie  @TERM$2  and ppras40thr246 respectively appendixfig s4c	0.99999845	1.6048944e-06
30796049	mtor	s4c	30796049	200	230	@TERM$1	@TERM$2	these tumorigenic cells showed impaired mitochondrial respiration appendixfig s4b and enhanced iis as revealed by the increased phosphorylation of  @TERM$1  and akt targets ie paktser473 and ppras40thr246 respectively appendixfig  @TERM$2 	0.9999976	2.4284684e-06
30796049	akt	s4c	30796049	200	230	@TERM$1	@TERM$2	these tumorigenic cells showed impaired mitochondrial respiration appendixfig s4b and enhanced iis as revealed by the increased phosphorylation of mtor and  @TERM$1  targets ie paktser473 and ppras40thr246 respectively appendixfig  @TERM$2 	0.99999833	1.7219709e-06
30796049	iis	paktser473	30796049	200	230	@TERM$1	@TERM$2	these tumorigenic cells showed impaired mitochondrial respiration appendixfig s4b and enhanced  @TERM$1  as revealed by the increased phosphorylation of mtor and akt targets ie  @TERM$2  and ppras40thr246 respectively appendixfig s4c	0.9999981	1.8810695e-06
30796049	iis	mtor	30796049	200	230	@TERM$1	@TERM$2	these tumorigenic cells showed impaired mitochondrial respiration appendixfig s4b and enhanced  @TERM$1  as revealed by the increased phosphorylation of  @TERM$2  and akt targets ie paktser473 and ppras40thr246 respectively appendixfig s4c	0.99999344	6.5900813e-06
30796049	ndufs4	ndufa9	30796049	199	201	@TERM$1	@TERM$2	to investigate the effect of xanthine derivatives on mitochondrial mutant cells we used genetically modified hap1 cells lacking mitochondrial complex i subunits ndufs2  @TERM$1  or  @TERM$2  appendixfig s4a	0.999997	2.995615e-06
30796049	iis	s4c	30796049	200	230	@TERM$1	@TERM$2	these tumorigenic cells showed impaired mitochondrial respiration appendixfig s4b and enhanced  @TERM$1  as revealed by the increased phosphorylation of mtor and akt targets ie paktser473 and ppras40thr246 respectively appendixfig  @TERM$2 	0.99999523	4.7669755e-06
30796049	paktser473	s4c	30796049	200	230	@TERM$1	@TERM$2	these tumorigenic cells showed impaired mitochondrial respiration appendixfig s4b and enhanced iis as revealed by the increased phosphorylation of mtor and akt targets ie  @TERM$1  and ppras40thr246 respectively appendixfig  @TERM$2 	0.9998173	0.0001827229
30796049	aminophylline	amp	30796049	201	127	@TERM$1	@TERM$2	lity of xanthine in aqueous solutions we employed  @TERM$1   @TERM$2  enprofylline enpf and pentoxifylline ptx fig4e which are t	0.99999714	2.83388e-06
30796049	amp	methylxanthines	30796049	201	195	@TERM$1	@TERM$2	ne in aqueous solutions we employed aminophylline  @TERM$1  enprofylline enpf and pentoxifylline ptx fig4e which are three widely used  @TERM$2  generally known as competitive nonselective phosp	0.999997	2.9627006e-06
30796049	phosphodiesterase	adenosine	30796049	201	155	@TERM$1	@TERM$2	hines generally known as competitive nonselective  @TERM$1  inhibitors pdes and  @TERM$2  receptor antagonists snyder etal 1981 monteiro etal 201	0.9999951	4.8285606e-06
30796049	ptx	methylxanthines	30796049	201	154	@TERM$1	@TERM$2	phylline amp enprofylline enpf and pentoxifylline  @TERM$1  fig4e which are three widely used  @TERM$2  generally known as competitive nonselective phosp	0.22366267	0.7763373
30796049	aminophylline	methylxanthines	30796049	201	209	@TERM$1	@TERM$2	lity of xanthine in aqueous solutions we employed  @TERM$1  amp enprofylline enpf and pentoxifylline ptx fig4e which are three widely used  @TERM$2  generally known as competitive nonselective phosp	0.99999654	3.498832e-06
30796049	amp	ptx	30796049	201	144	@TERM$1	@TERM$2	ne in aqueous solutions we employed aminophylline  @TERM$1  enprofylline enpf and pentoxifylline  @TERM$2  fig4e which are three widely used methylxanthine	0.9999938	6.247708e-06
30796049	methylxanthines	adenosine receptor	30796049	201	215	@TERM$1	@TERM$2	oxifylline ptx fig4e which are three widely used  @TERM$1  generally known as competitive nonselective phosphodiesterase inhibitors pdes and  @TERM$2  antagonists snyder etal 1981 monteiro etal 201	0.9999974	2.5896602e-06
30796049	aminophylline	ptx	30796049	201	168	@TERM$1	@TERM$2	lity of xanthine in aqueous solutions we employed  @TERM$1  amp enprofylline enpf and pentoxifylline  @TERM$2  fig4e which are three widely used methylxanthines generall	0.999998	2.0025464e-06
30796049	pentoxifylline	methylxanthines	30796049	201	169	@TERM$1	@TERM$2	 employed aminophylline amp enprofylline enpf and  @TERM$1  ptx fig4e which are three widely used  @TERM$2  generally known as competitive nonselective phosp	0.96847	0.031529985
30796049	iis	akt	30796049	200	230	@TERM$1	@TERM$2	these tumorigenic cells showed impaired mitochondrial respiration appendixfig s4b and enhanced  @TERM$1  as revealed by the increased phosphorylation of mtor and  @TERM$2  targets ie paktser473 and ppras40thr246 respectively appendixfig s4c	0.99999714	2.8325721e-06
30796049	xanthine	pentoxifylline	30796049	201	174	@TERM$1	@TERM$2	given the low solubility of  @TERM$1  in aqueous solutions we employed aminophylline amp enprofylline enpf and  @TERM$2  ptx fig4e which are three widely used methylxant	0.9999883	1.17006775e-05
30796049	xanthine	ndufs2	30796049	199	201	@TERM$1	@TERM$2	to investigate the effect of  @TERM$1  derivatives on mitochondrial mutant cells we used genetically modified hap1 cells lacking mitochondrial complex i subunits  @TERM$2  ndufs4 or ndufa9 appendixfig s4a	0.9999764	2.3553494e-05
30796049	ndufa9	ptx	30796049	194	175	@TERM$1	@TERM$2	akt phosphopras40 t246 and total pras40 in wt and  @TERM$1  ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot anal	0.999856	0.0001439688
30796049	dmso	ptx	30796049	194	136	@TERM$1	@TERM$2	40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$1   or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot an	0.999997	2.9627006e-06
30796049	t246	actin	30796049	194	226	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phosphopras40  @TERM$1  and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.9999933	6.7254246e-06
30796049	t246	ndufa9	30796049	194	138	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phosphopras40  @TERM$1  and total pras40 in wt and  @TERM$2  ko hap1 cells treated with 02 dmso  or amp 2m e	0.22366267	0.7763373
30796049	methylxanthines	pras40	30796049	194	225	@TERM$1	@TERM$2	testschematic representations of xanthine and the  @TERM$1  used in this studyimmunoblot analysis of phosphoakt s473 pan akt phospho @TERM$2  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or am	0.9999938	6.247708e-06
30796049	xanthine	pan	30796049	194	198	@TERM$1	@TERM$2	ant mannwhitney utestschematic representations of  @TERM$1  and the methylxanthines used in this studyimmunoblot analysis of phosphoakt s473  @TERM$2  akt phosphopras40 t246 and total pras40 in wt and nduf	0.9999827	1.7293902e-05
30796049	sem	akt	30796049	194	232	@TERM$1	@TERM$2	bars mean @TERM$1  n2 nsnonsignificant mannwhitney utestschematic representations of xanthine and the methylxanthines used in this studyimmunoblot analysis of phospho @TERM$2  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndu	0.9999919	8.102811e-06
30796049	xanthine	methylxanthines	30796049	194	132	@TERM$1	@TERM$2	ant mannwhitney utestschematic representations of  @TERM$1  and the  @TERM$2  used in this studyimmunoblot analysis of phosphoa	0.99999595	4.028373e-06
30796049	pras40	ptx	30796049	194	192	@TERM$1	@TERM$2	sphoakt s473 pan akt phospho @TERM$1  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot anal	0.99999607	3.894868e-06
30796049	pras40	amp	30796049	194	169	@TERM$1	@TERM$2	sphoakt s473 pan akt phospho @TERM$1  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin loading	0.9999933	6.636949e-06
30796049	pan	akt	30796049	194	107	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phospho @TERM$2  s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and ndu	0.99999774	2.3065104e-06
30796049	dmso	actin	30796049	194	157	@TERM$1	@TERM$2	40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$1   or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.9999423	5.7736215e-05
30796049	dmso	amp	30796049	194	113	@TERM$1	@TERM$2	40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$1   or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin loadi	0.9999962	3.820016e-06
30796049	sem	xanthine	30796049	194	143	@TERM$1	@TERM$2	bars mean @TERM$1  n2 nsnonsignificant mannwhitney utestschematic representations of  @TERM$2  and the methylxanthines used in this studyimmunob	0.99961215	0.00038790287
30796049	t246	ptx	30796049	194	205	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phosphopras40  @TERM$1  and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot an	0.99999774	2.2367344e-06
30796049	amp	actin	30796049	194	148	@TERM$1	@TERM$2	and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$1  2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.9999975	2.5217632e-06
30796049	methylxanthines	ndufa9	30796049	194	242	@TERM$1	@TERM$2	testschematic representations of xanthine and the  @TERM$1  used in this studyimmunoblot analysis of phosphoakt s473 pan akt phosphopras40 t246 and total pras40 in wt and  @TERM$2  ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m 	0.9999975	2.5384993e-06
30796049	ndufa9	amp	30796049	194	152	@TERM$1	@TERM$2	akt phosphopras40 t246 and total pras40 in wt and  @TERM$1  ko hap1 cells treated with 02 dmso  or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin loading	0.9999443	5.5627526e-05
30796049	methylxanthines	t246	30796049	194	210	@TERM$1	@TERM$2	testschematic representations of xanthine and the  @TERM$1  used in this studyimmunoblot analysis of phosphoakt s473 pan akt phosphopras40  @TERM$2  and total pras40 in wt and ndufa9 ko hap1 cells treated with	0.80851954	0.1914804
30796049	t246	amp	30796049	194	182	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phosphopras40  @TERM$1  and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin loadi	0.99999404	5.907906e-06
30796049	akt	actin	30796049	194	244	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.999998	2.02753e-06
30796049	akt	pras40	30796049	194	139	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phospho @TERM$2  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dm	0.99999774	2.2157392e-06
30796049	pan	dmso	30796049	194	195	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$2   or amp 2m enpf 2m and ptx 36m  for 24h ac	0.9999969	3.102036e-06
30796049	xanthine	akt	30796049	194	202	@TERM$1	@TERM$2	ant mannwhitney utestschematic representations of  @TERM$1  and the methylxanthines used in this studyimmunoblot analysis of phospho @TERM$2  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 k	0.99999714	2.8838047e-06
30796049	ptx	actin	30796049	194	125	@TERM$1	@TERM$2	s treated with 02 dmso  or amp 2m enpf 2m and  @TERM$1  36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.9999974	2.625389e-06
30796049	pan	t246	30796049	194	126	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40  @TERM$2  and total pras40 in wt and ndufa9 ko hap1 cells t	0.99902225	0.0009777574
30796049	frap	age1	30796049	324	194	@TERM$1	@TERM$2	 @TERM$1  experiments were conducted blind to the respective condition genotype treatment or rnai of the nematodeswe used five biological replicates of wt gas1 and  @TERM$2  gas1 worms for transcriptomics	0.999998	2.029627e-06
30796049	post	gas1	30796049	217	139	@TERM$1	@TERM$2	bars meansem pvalue001 pvalue0001 oneway anova dunnetts  @TERM$1  hoc correctionceffect of methylxanthines on the survival of  @TERM$2  mutants	0.99999833	1.7247615e-06
30796049	levamisole	applichem	30796049	323	161	@TERM$1	@TERM$2	in all the experiments nematodes were paralyzed with 25mm  @TERM$1   @TERM$2  in m9 buffer mounted on 2 agarose pads on glass slides and closed with coverslips	0.99957174	0.00042821618
30796049	sem	post	30796049	231	138	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue001 pvalue0001 oneway anova dunnetts  @TERM$2  hoc correctioneffect of methylxanthines on the survival of gas1 mutants	0.9999951	4.838033e-06
30796049	methylxanthines	gas1	30796049	231	138	@TERM$1	@TERM$2	bars meansem pvalue001 pvalue0001 oneway anova dunnetts post hoc correctioneffect of  @TERM$1  on the survival of  @TERM$2  mutants	0.9999974	2.5896602e-06
30796049	sem	methylxanthines	30796049	231	138	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue001 pvalue0001 oneway anova dunnetts post hoc correctioneffect of  @TERM$2  on the survival of gas1 mutants	0.999998	2.0025464e-06
30796049	post	gas1	30796049	231	138	@TERM$1	@TERM$2	bars meansem pvalue001 pvalue0001 oneway anova dunnetts  @TERM$1  hoc correctioneffect of methylxanthines on the survival of  @TERM$2  mutants	0.99999595	4.0841305e-06
30796049	sem	gas1	30796049	231	138	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue001 pvalue0001 oneway anova dunnetts post hoc correctioneffect of methylxanthines on the survival of  @TERM$2  mutants	0.96847	0.031529985
30796049	gas1	methylxanthines	30796049	232	188	@TERM$1	@TERM$2	average median lifespanssem from all replicates indicated beneath representative curvespharyngeal pumpsminute in young adult  @TERM$1  mutant nematodes treated with vehicle or  @TERM$2 	0.99999714	2.8325721e-06
30796049	sem	gas1	30796049	232	188	@TERM$1	@TERM$2	average median lifespans @TERM$1  from all replicates indicated beneath representative curvespharyngeal pumpsminute in young adult  @TERM$2  mutant nematodes treated with vehicle or methylxanthines	0.99994814	5.1813233e-05
30796049	sem	methylxanthines	30796049	232	188	@TERM$1	@TERM$2	average median lifespans @TERM$1  from all replicates indicated beneath representative curvespharyngeal pumpsminute in young adult gas1 mutant nematodes treated with vehicle or  @TERM$2 	0.99999166	8.310561e-06
30796049	actin	frap	30796049	234	123	@TERM$1	@TERM$2	odes treated with vehicle dmso or methylxanthines  @TERM$1  loading controlleft panel  @TERM$2  in vehicle or ptxtreated gas1 animal	0.99999774	2.2896743e-06
30796049	methylxanthines	actin	30796049	234	131	@TERM$1	@TERM$2	as1 mutant nematodes treated with vehicle dmso or  @TERM$1   @TERM$2  loading controlleft panel frap in vehicle or ptxtreated gas	0.9999845	1.5480935e-05
30796049	gas1	dmso	30796049	234	147	@TERM$1	@TERM$2	hosphosubstrates and f phosphoaak2 in young adult  @TERM$1  mutant nematodes treated with vehicle  @TERM$2  or methylxanthines actin loading controlleft pane	0.9999957	4.300125e-06
30796049	gas1	methylxanthines	30796049	234	166	@TERM$1	@TERM$2	hosphosubstrates and f phosphoaak2 in young adult  @TERM$1  mutant nematodes treated with vehicle dmso or  @TERM$2  actin loading controlleft panel frap in vehicle o	0.99999774	2.2092488e-06
30796049	gas1	frap	30796049	234	190	@TERM$1	@TERM$2	hosphosubstrates and f phosphoaak2 in young adult  @TERM$1  mutant nematodes treated with vehicle dmso or methylxanthines actin loading controlleft panel  @TERM$2  in vehicle or ptxtreated gas1 animal	0.99999654	3.498832e-06
30796049	dmso	actin	30796049	234	129	@TERM$1	@TERM$2	 adult gas1 mutant nematodes treated with vehicle  @TERM$1  or methylxanthines  @TERM$2  loading controlleft panel frap in vehicle or ptxt	0.99999523	4.7844833e-06
30796049	post	gas1	30796049	234	190	@TERM$1	@TERM$2	pvalue00001 oneway anova dunnetts  @TERM$1  hoc correctionimmunoblot analysis of e kin1 phosphosubstrates and f phosphoaak2 in young adult  @TERM$2  mutant nematodes treated with vehicle dmso or met	0.9999963	3.6660092e-06
30796049	dmso	frap	30796049	234	147	@TERM$1	@TERM$2	 adult gas1 mutant nematodes treated with vehicle  @TERM$1  or methylxanthines actin loading controlleft panel  @TERM$2  in vehicle or ptxtreated gas1 animal	0.99999845	1.6069282e-06
30796049	dmso	methylxanthines	30796049	234	123	@TERM$1	@TERM$2	 adult gas1 mutant nematodes treated with vehicle  @TERM$1  or  @TERM$2  actin loading controlleft panel frap in vehicle o	0.99999726	2.7322487e-06
30796049	methylxanthines	frap	30796049	234	139	@TERM$1	@TERM$2	as1 mutant nematodes treated with vehicle dmso or  @TERM$1  actin loading controlleft panel  @TERM$2  in vehicle or ptxtreated gas1 animal	0.9999871	1.28738975e-05
30796049	post	dmso	30796049	234	233	@TERM$1	@TERM$2	pvalue00001 oneway anova dunnetts  @TERM$1  hoc correctionimmunoblot analysis of e kin1 phosphosubstrates and f phosphoaak2 in young adult gas1 mutant nematodes treated with vehicle  @TERM$2  or methylxanthines actin loading controlleft pane	0.99999666	3.3633955e-06
30796049	gas1	actin	30796049	234	172	@TERM$1	@TERM$2	hosphosubstrates and f phosphoaak2 in young adult  @TERM$1  mutant nematodes treated with vehicle dmso or methylxanthines  @TERM$2  loading controlleft panel frap in vehicle or ptxt	0.9999913	8.741693e-06
30796049	age1	gas1	30796049	238	75	@TERM$1	@TERM$2	al processes underlying the lifespan extension of  @TERM$1   @TERM$2  mutant nematode	0.9999957	4.285641e-06
30796049	sem	gas1	30796049	238	208	@TERM$1	@TERM$2	span curves the legend shows meanmedian lifespan @TERM$1  across all biological replicatesschematic drawing showing the critical biological processes underlying the lifespan extension of age1  @TERM$2  mutant nematode	0.999998	2.0478683e-06
30796049	sem	age1	30796049	238	208	@TERM$1	@TERM$2	span curves the legend shows meanmedian lifespan @TERM$1  across all biological replicatesschematic drawing showing the critical biological processes underlying the lifespan extension of  @TERM$2  gas1 mutant nematode	0.9999918	8.220167e-06
30796049	post	methylxanthines	30796049	231	138	@TERM$1	@TERM$2	bars meansem pvalue001 pvalue0001 oneway anova dunnetts  @TERM$1  hoc correctioneffect of  @TERM$2  on the survival of gas1 mutants	0.9999933	6.656707e-06
30796049	sem	gas1	30796049	229	185	@TERM$1	@TERM$2	average median lifespans @TERM$1  from all replicates indicated beneath representative curvelocomotor activity of 10dayold  @TERM$2  mutant nematodes treated with vehicle dmso or methylxanthines	0.99999344	6.537425e-06
30796049	dmso	methylxanthines	30796049	229	185	@TERM$1	@TERM$2	average median lifespanssem from all replicates indicated beneath representative curvelocomotor activity of 10dayold gas1 mutant nematodes treated with vehicle  @TERM$1  or  @TERM$2 	0.9999951	4.869222e-06
30796049	sem	methylxanthines	30796049	229	185	@TERM$1	@TERM$2	average median lifespans @TERM$1  from all replicates indicated beneath representative curvelocomotor activity of 10dayold gas1 mutant nematodes treated with vehicle dmso or  @TERM$2 	0.99999464	5.421185e-06
30796049	gas1	methylxanthines	30796049	220	166	@TERM$1	@TERM$2	hosphosubstrates and f phosphoaak2 in young adult  @TERM$1  mutant nematodes treated with vehicle dmso or  @TERM$2  actin loading controlgleft panel frap in vehicle 	0.9999974	2.5642441e-06
30796049	gas1	frap	30796049	220	191	@TERM$1	@TERM$2	hosphosubstrates and f phosphoaak2 in young adult  @TERM$1  mutant nematodes treated with vehicle dmso or methylxanthines actin loading controlgleft panel  @TERM$2  in vehicle or ptxtreated gas1 animal	0.99998534	1.4707895e-05
30796049	dmso	actin	30796049	220	129	@TERM$1	@TERM$2	 adult gas1 mutant nematodes treated with vehicle  @TERM$1  or methylxanthines  @TERM$2  loading controlgleft panel frap in vehicle or ptx	0.9999982	1.8069794e-06
30796049	post	gas1	30796049	220	193	@TERM$1	@TERM$2	pvalue00001 oneway anova dunnetts  @TERM$1  hoc correctione fimmunoblot analysis of e kin1 phosphosubstrates and f phosphoaak2 in young adult  @TERM$2  mutant nematodes treated with vehicle dmso or met	0.9999976	2.3528387e-06
30796049	dmso	frap	30796049	220	148	@TERM$1	@TERM$2	 adult gas1 mutant nematodes treated with vehicle  @TERM$1  or methylxanthines actin loading controlgleft panel  @TERM$2  in vehicle or ptxtreated gas1 animal	0.99999464	5.3956946e-06
30796049	dmso	methylxanthines	30796049	220	123	@TERM$1	@TERM$2	 adult gas1 mutant nematodes treated with vehicle  @TERM$1  or  @TERM$2  actin loading controlgleft panel frap in vehicle 	0.99594504	0.00405502
30796049	methylxanthines	frap	30796049	220	140	@TERM$1	@TERM$2	as1 mutant nematodes treated with vehicle dmso or  @TERM$1  actin loading controlgleft panel  @TERM$2  in vehicle or ptxtreated gas1 animal	0.52624166	0.47375837
30796049	post	dmso	30796049	220	236	@TERM$1	@TERM$2	pvalue00001 oneway anova dunnetts  @TERM$1  hoc correctione fimmunoblot analysis of e kin1 phosphosubstrates and f phosphoaak2 in young adult gas1 mutant nematodes treated with vehicle  @TERM$2  or methylxanthines actin loading controlgleft pan	0.99999857	1.4336821e-06
30796049	gas1	actin	30796049	220	172	@TERM$1	@TERM$2	hosphosubstrates and f phosphoaak2 in young adult  @TERM$1  mutant nematodes treated with vehicle dmso or methylxanthines  @TERM$2  loading controlgleft panel frap in vehicle or ptx	0.99999666	3.329944e-06
30796049	age1	gas1	30796049	224	75	@TERM$1	@TERM$2	al processes underlying the lifespan extension of  @TERM$1   @TERM$2  mutant nematode	0.12362973	0.8763703
30796049	sem	gas1	30796049	224	209	@TERM$1	@TERM$2	span curves the legend shows meanmedian lifespan @TERM$1  across all biological replicateshschematic drawing showing the critical biological processes underlying the lifespan extension of age1  @TERM$2  mutant nematode	0.999997	2.9857324e-06
30796049	atp	iis	30796049	239	182	@TERM$1	@TERM$2	oxphosdeficient nematodes display decreased lifespan diminished  @TERM$1  production fragmented mitochondrial network and a phosphoproteome signature associated with enhanced  @TERM$2  signaling	0.9999943	5.7342827e-06
30796049	sem	age1	30796049	224	209	@TERM$1	@TERM$2	span curves the legend shows meanmedian lifespan @TERM$1  across all biological replicateshschematic drawing showing the critical biological processes underlying the lifespan extension of  @TERM$2  gas1 mutant nematode	0.9999497	5.0285227e-05
30796049	signature	iis	30796049	225	182	@TERM$1	@TERM$2	oxphosdeficient nematodes display decreased lifespan diminished atp production fragmented mitochondrial network and a phosphoproteome  @TERM$1  associated with enhanced  @TERM$2  signaling	0.9999199	8.0159065e-05
30796049	atp	signature	30796049	225	182	@TERM$1	@TERM$2	oxphosdeficient nematodes display decreased lifespan diminished  @TERM$1  production fragmented mitochondrial network and a phosphoproteome  @TERM$2  associated with enhanced iis signaling	0.99969566	0.0003044246
30796049	pka	oxphos	30796049	226	133	@TERM$1	@TERM$2	as a result of iis inhibition ampk and  @TERM$1  drive a catabolic shift underlying lifespan extension of nematodes carrying  @TERM$2  defects	0.96909755	0.030902453
30796049	ampk	pka	30796049	226	133	@TERM$1	@TERM$2	as a result of iis inhibition  @TERM$1  and  @TERM$2  drive a catabolic shift underlying lifespan extension of nematodes carrying oxphos defects	0.99995184	4.811856e-05
30796049	iis	pka	30796049	226	133	@TERM$1	@TERM$2	as a result of  @TERM$1  inhibition ampk and  @TERM$2  drive a catabolic shift underlying lifespan extension of nematodes carrying oxphos defects	0.55630064	0.44369927
30796049	ampk	oxphos	30796049	226	133	@TERM$1	@TERM$2	as a result of iis inhibition  @TERM$1  and pka drive a catabolic shift underlying lifespan extension of nematodes carrying  @TERM$2  defects	0.9999982	1.8148269e-06
30796049	iis	ampk	30796049	226	133	@TERM$1	@TERM$2	as a result of  @TERM$1  inhibition  @TERM$2  and pka drive a catabolic shift underlying lifespan extension of nematodes carrying oxphos defects	0.99999857	1.4278448e-06
30796049	iis	oxphos	30796049	226	133	@TERM$1	@TERM$2	as a result of  @TERM$1  inhibition ampk and pka drive a catabolic shift underlying lifespan extension of nematodes carrying  @TERM$2  defects	0.99999857	1.3882955e-06
30796049	sem	dmso	30796049	229	185	@TERM$1	@TERM$2	average median lifespans @TERM$1  from all replicates indicated beneath representative curvelocomotor activity of 10dayold gas1 mutant nematodes treated with vehicle  @TERM$2  or methylxanthines	0.99999857	1.4444513e-06
30796049	gas1	dmso	30796049	229	185	@TERM$1	@TERM$2	average median lifespanssem from all replicates indicated beneath representative curvelocomotor activity of 10dayold  @TERM$1  mutant nematodes treated with vehicle  @TERM$2  or methylxanthines	0.99999845	1.5421568e-06
30796049	gas1	methylxanthines	30796049	229	185	@TERM$1	@TERM$2	average median lifespanssem from all replicates indicated beneath representative curvelocomotor activity of 10dayold  @TERM$1  mutant nematodes treated with vehicle dmso or  @TERM$2 	0.9999981	1.9569954e-06
30796049	atp	iis	30796049	225	182	@TERM$1	@TERM$2	oxphosdeficient nematodes display decreased lifespan diminished  @TERM$1  production fragmented mitochondrial network and a phosphoproteome signature associated with enhanced  @TERM$2  signaling	0.99999726	2.6999792e-06
30796049	gas1	dmso	30796049	220	147	@TERM$1	@TERM$2	hosphosubstrates and f phosphoaak2 in young adult  @TERM$1  mutant nematodes treated with vehicle  @TERM$2  or methylxanthines actin loading controlgleft pan	0.999997	2.9545997e-06
30796049	signature	iis	30796049	239	182	@TERM$1	@TERM$2	oxphosdeficient nematodes display decreased lifespan diminished atp production fragmented mitochondrial network and a phosphoproteome  @TERM$1  associated with enhanced  @TERM$2  signaling	0.9999864	1.3607136e-05
30796049	pka	oxphos	30796049	240	133	@TERM$1	@TERM$2	as a result of iis inhibition ampk and  @TERM$1  drive a catabolic shift underlying lifespan extension of nematodes carrying  @TERM$2  defects	0.99999714	2.8236664e-06
30796049	iis	pka	30796049	266	189	@TERM$1	@TERM$2	in line with this argument the lifespanextending effect of  @TERM$1  inhibition critically depends on ampk and  @TERM$2  since their downregulation drastically affects the survival of age1 gas1 mutants	0.99999857	1.3945746e-06
30796049	age1	gas1	30796049	266	189	@TERM$1	@TERM$2	in line with this argument the lifespanextending effect of iis inhibition critically depends on ampk and pka since their downregulation drastically affects the survival of  @TERM$1   @TERM$2  mutants	0.99999833	1.6659415e-06
30796049	iis	gas1	30796049	266	189	@TERM$1	@TERM$2	in line with this argument the lifespanextending effect of  @TERM$1  inhibition critically depends on ampk and pka since their downregulation drastically affects the survival of age1  @TERM$2  mutants	0.99999833	1.7128285e-06
30796049	ampk	age1	30796049	266	189	@TERM$1	@TERM$2	in line with this argument the lifespanextending effect of iis inhibition critically depends on  @TERM$1  and pka since their downregulation drastically affects the survival of  @TERM$2  gas1 mutants	0.9999968	3.1737757e-06
30796049	iis	age1	30796049	266	189	@TERM$1	@TERM$2	in line with this argument the lifespanextending effect of  @TERM$1  inhibition critically depends on ampk and pka since their downregulation drastically affects the survival of  @TERM$2  gas1 mutants	0.99999785	2.1775859e-06
30796049	ampk	gas1	30796049	266	189	@TERM$1	@TERM$2	in line with this argument the lifespanextending effect of iis inhibition critically depends on  @TERM$1  and pka since their downregulation drastically affects the survival of age1  @TERM$2  mutants	0.99999297	7.048646e-06
30796049	iis	ampk	30796049	266	189	@TERM$1	@TERM$2	in line with this argument the lifespanextending effect of  @TERM$1  inhibition critically depends on  @TERM$2  and pka since their downregulation drastically affects the survival of age1 gas1 mutants	0.9999963	3.6611527e-06
30796049	pka	age1	30796049	266	189	@TERM$1	@TERM$2	in line with this argument the lifespanextending effect of iis inhibition critically depends on ampk and  @TERM$1  since their downregulation drastically affects the survival of  @TERM$2  gas1 mutants	0.99999785	2.1795513e-06
30796049	ipa	module	30796049	267	204	@TERM$1	@TERM$2	based on a statistical analysis performed by  @TERM$1  it seems that these two pleiotropic kinases form a signaling  @TERM$2  upstream of the route associated with metabolic flexibility and shift toward catabolism	0.9999968	3.265821e-06
30796049	ampk	pka	30796049	268	83	@TERM$1	@TERM$2	while we focused on  @TERM$1  and  @TERM$2  and confirmed that they are two critical regulator	0.9999976	2.4072226e-06
30796049	xanthine	iis	30796049	268	159	@TERM$1	@TERM$2	ed enhanced purine degradation and the subsequent  @TERM$1  buildup as a main downstream event that occurs in mitochondriadeficient nematodes upon  @TERM$2  inhibitio	0.99999845	1.5651893e-06
30796049	iis	pka	30796049	269	162	@TERM$1	@TERM$2	we provide evidence that xanthine derivatives have pleiotropic effects in complex ideficient cells since they attenuate hyperactive  @TERM$1  and stimulate  @TERM$2  activity	0.99999714	2.8179634e-06
30796049	xanthine	pka	30796049	269	162	@TERM$1	@TERM$2	we provide evidence that  @TERM$1  derivatives have pleiotropic effects in complex ideficient cells since they attenuate hyperactive iis and stimulate  @TERM$2  activity	0.99999833	1.6203717e-06
30796049	xanthine	iis	30796049	269	162	@TERM$1	@TERM$2	we provide evidence that  @TERM$1  derivatives have pleiotropic effects in complex ideficient cells since they attenuate hyperactive  @TERM$2  and stimulate pka activity	0.999998	2.016392e-06
30796049	xanthine	iis	30796049	270	79	@TERM$1	@TERM$2	this is not the first study to connect  @TERM$1  and  @TERM$2  inhibition in celegans	0.99999785	2.1588912e-06
30796049	adenine	gao	30796049	271	184	@TERM$1	@TERM$2	previously xanthine along with  @TERM$1  has been found to be slightly yet significantly reduced in iisdeficient nematodes within a larger context of metabolic flexibility  @TERM$2  etal 2018	0.99999833	1.6699832e-06
30796049	xanthine	adenine	30796049	271	184	@TERM$1	@TERM$2	previously  @TERM$1  along with  @TERM$2  has been found to be slightly yet significantly reduced in iisdeficient nematodes within a larger context of metabolic flexibility gao etal 2018	0.999998	1.996075e-06
30796049	xanthine	gao	30796049	271	184	@TERM$1	@TERM$2	previously  @TERM$1  along with adenine has been found to be slightly yet significantly reduced in iisdeficient nematodes within a larger context of metabolic flexibility  @TERM$2  etal 2018	0.99999833	1.7051585e-06
30796049	methylxanthines	xanthine	30796049	273	214	@TERM$1	@TERM$2	lthough our work leaves open the possibility that  @TERM$1  may have additional targets in nematodes we clearly show that treatment with these  @TERM$2  derivatives is enough to significantly promote survival 	0.9999964	3.6089875e-06
30796049	xanthine	gas1	30796049	273	195	@TERM$1	@TERM$2	matodes we clearly show that treatment with these  @TERM$1  derivatives is enough to significantly promote survival of complex ideficient  @TERM$2  mutants despite being a much milder effect than a hyp	0.9999958	4.1903872e-06
30796049	sem	xanthine	30796049	183	143	@TERM$1	@TERM$2	bars mean @TERM$1  n2 nsnonsignificant mannwhitney utestschematic representations of  @TERM$2  and the methylxanthines used in this studyimmunob	0.99999785	2.170783e-06
30796049	pka	gas1	30796049	266	189	@TERM$1	@TERM$2	in line with this argument the lifespanextending effect of iis inhibition critically depends on ampk and  @TERM$1  since their downregulation drastically affects the survival of age1  @TERM$2  mutants	0.78599656	0.2140034
30796049	ampk	pka	30796049	266	189	@TERM$1	@TERM$2	in line with this argument the lifespanextending effect of iis inhibition critically depends on  @TERM$1  and  @TERM$2  since their downregulation drastically affects the survival of age1 gas1 mutants	0.99999833	1.6293111e-06
30796049	age1	gas1	30796049	263	103	@TERM$1	@TERM$2	what was perhaps most surprising was the degree of the lifespan extension observed in  @TERM$1   @TERM$2  mutants	0.9999851	1.4861665e-05
30796049	gas1	iis	30796049	262	223	@TERM$1	@TERM$2	in fact there were very few differentially phosphorylated proteins between wt and age1  @TERM$1  mutants data not shown which further strengthened the hypothesis that the inhibition of  @TERM$2  may counteract mitochondrial deficiency	0.99999547	4.474186e-06
30796049	ampk	pka	30796049	240	133	@TERM$1	@TERM$2	as a result of iis inhibition  @TERM$1  and  @TERM$2  drive a catabolic shift underlying lifespan extension of nematodes carrying oxphos defects	0.99999523	4.7306094e-06
30796049	iis	pka	30796049	240	133	@TERM$1	@TERM$2	as a result of  @TERM$1  inhibition ampk and  @TERM$2  drive a catabolic shift underlying lifespan extension of nematodes carrying oxphos defects	0.99999785	2.2022043e-06
30796049	ampk	oxphos	30796049	240	133	@TERM$1	@TERM$2	as a result of iis inhibition  @TERM$1  and pka drive a catabolic shift underlying lifespan extension of nematodes carrying  @TERM$2  defects	0.9999962	3.796793e-06
30796049	iis	ampk	30796049	240	133	@TERM$1	@TERM$2	as a result of  @TERM$1  inhibition  @TERM$2  and pka drive a catabolic shift underlying lifespan extension of nematodes carrying oxphos defects	0.9999963	3.7233071e-06
30796049	iis	oxphos	30796049	240	133	@TERM$1	@TERM$2	as a result of  @TERM$1  inhibition ampk and pka drive a catabolic shift underlying lifespan extension of nematodes carrying  @TERM$2  defects	0.9999958	4.187219e-06
30796049	longterm	rapamycin	30796049	247	66	@TERM$1	@TERM$2	however  @TERM$1  administration of  @TERM$2  has troubling caveats	0.9999937	6.3201715e-06
30796049	rapamycin	insulin	30796049	248	199	@TERM$1	@TERM$2	for example it is known that  @TERM$1  possesses immunosuppressive properties may accelerate the growth of certain solid tumors and induces  @TERM$2  resistance hypertriglyceridemia and hyperglycemia m	0.9999938	6.224929e-06
30796049	iis	atp	30796049	252	187	@TERM$1	@TERM$2	we found that genetic  @TERM$1  inhibition promotes the survival and fitness of mitochondriadeficient animals likely attributable to the boosted  @TERM$2  levels despite having severe genetic lesions	0.0011280687	0.99887186
30796049	age1	gas1	30796049	255	109	@TERM$1	@TERM$2	re indeed surprised that fzo1 rnai does not alter  @TERM$1   @TERM$2  survival since prior evidence shows that a fused 	0.99998796	1.2053399e-05
30796049	fzo1	age1	30796049	255	108	@TERM$1	@TERM$2	we are indeed surprised that  @TERM$1  rnai does not alter  @TERM$2  gas1 survival since prior evidence shows that a f	0.9999424	5.757946e-05
30796049	gas1	weir	30796049	255	248	@TERM$1	@TERM$2	deed surprised that fzo1 rnai does not alter age1  @TERM$1  survival since prior evidence shows that a fused mitochondrial network is required for the establishment of distinct prolongevity programs yang etal 2011 chaudhari  kipreos 2017  @TERM$2  etal 201	0.9999896	1.03748935e-05
30796049	atp	signature	30796049	239	182	@TERM$1	@TERM$2	oxphosdeficient nematodes display decreased lifespan diminished  @TERM$1  production fragmented mitochondrial network and a phosphoproteome  @TERM$2  associated with enhanced iis signaling	0.9999987	1.3173358e-06
30796049	fzo1	gas1	30796049	255	113	@TERM$1	@TERM$2	we are indeed surprised that  @TERM$1  rnai does not alter age1  @TERM$2  survival since prior evidence shows that a fused 	0.99999106	8.8958805e-06
30796049	iis	glycogen	30796049	258	225	@TERM$1	@TERM$2	mics and genetic epistatic analyses indicate that  @TERM$1  inhibition efficiently decreases atpconsuming anabolic processes ie protein synthesis and enhances catabolism eg  @TERM$2  degradation and fatty acid betaoxidation in anima	0.99999714	2.8236664e-06
30796049	glycogen	fatty	30796049	258	133	@TERM$1	@TERM$2	s ie protein synthesis and enhances catabolism eg  @TERM$1  degradation and  @TERM$2  acid betaoxidation in animals carrying mitochondrial	0.99999785	2.118835e-06
30796049	iis	fatty	30796049	258	247	@TERM$1	@TERM$2	mics and genetic epistatic analyses indicate that  @TERM$1  inhibition efficiently decreases atpconsuming anabolic processes ie protein synthesis and enhances catabolism eg glycogen degradation and  @TERM$2  acid betaoxidation in animals carrying mitochondr	0.9999964	3.523426e-06
30796049	ipa	iis	30796049	261	238	@TERM$1	@TERM$2	not only did  @TERM$1  reveal that five of the seven most hyperactive pathways converge on  @TERM$2  but also that 97 of significantly affected phosphorylated proteins in gas1 mutants were found to revert back to wt levels in age1 gas1 double mutants	0.99999857	1.3948792e-06
30796049	ipa	gas1	30796049	261	238	@TERM$1	@TERM$2	not only did  @TERM$1  reveal that five of the seven most hyperactive pathways converge on iis but also that 97 of significantly affected phosphorylated proteins in  @TERM$2  mutants were found to revert back to wt levels in age1 gas1 double mutants	0.999998	2.0826462e-06
30796049	gas1	age1	30796049	261	238	@TERM$1	@TERM$2	not only did ipa reveal that five of the seven most hyperactive pathways converge on iis but also that 97 of significantly affected phosphorylated proteins in  @TERM$1  mutants were found to revert back to wt levels in  @TERM$2  gas1 double mutants	0.9999548	4.5226236e-05
30796049	iis	age1	30796049	261	238	@TERM$1	@TERM$2	not only did ipa reveal that five of the seven most hyperactive pathways converge on  @TERM$1  but also that 97 of significantly affected phosphorylated proteins in gas1 mutants were found to revert back to wt levels in  @TERM$2  gas1 double mutants	0.9999913	8.644069e-06
30796049	iis	gas1	30796049	261	238	@TERM$1	@TERM$2	not only did ipa reveal that five of the seven most hyperactive pathways converge on  @TERM$1  but also that 97 of significantly affected phosphorylated proteins in  @TERM$2  mutants were found to revert back to wt levels in age1 gas1 double mutants	0.9999498	5.014128e-05
30796049	ipa	age1	30796049	261	238	@TERM$1	@TERM$2	not only did  @TERM$1  reveal that five of the seven most hyperactive pathways converge on iis but also that 97 of significantly affected phosphorylated proteins in gas1 mutants were found to revert back to wt levels in  @TERM$2  gas1 double mutants	0.99999833	1.6724775e-06
30796049	age1	gas1	30796049	262	223	@TERM$1	@TERM$2	in fact there were very few differentially phosphorylated proteins between wt and  @TERM$1   @TERM$2  mutants data not shown which further strengthened the hypothesis that the inhibition of iis may counteract mitochondrial deficiency	0.9999982	1.8301425e-06
30796049	age1	iis	30796049	262	223	@TERM$1	@TERM$2	in fact there were very few differentially phosphorylated proteins between wt and  @TERM$1  gas1 mutants data not shown which further strengthened the hypothesis that the inhibition of  @TERM$2  may counteract mitochondrial deficiency	0.9999968	3.2561584e-06
30796049	age1	gas1	30796049	257	85	@TERM$1	@TERM$2	rather we believe that in  @TERM$1   @TERM$2  animals enhanced mitochondrial connectivity is si	0.999995	5.0214826e-06
30796049	methylxanthines	actin	30796049	220	131	@TERM$1	@TERM$2	as1 mutant nematodes treated with vehicle dmso or  @TERM$1   @TERM$2  loading controlgleft panel frap in vehicle or ptxtreated ga	0.9999918	8.205301e-06
30796049	actin	frap	30796049	220	124	@TERM$1	@TERM$2	odes treated with vehicle dmso or methylxanthines  @TERM$1  loading controlgleft panel  @TERM$2  in vehicle or ptxtreated gas1 animal	0.99999785	2.1731896e-06
30796049	sem	methylxanthines	30796049	218	189	@TERM$1	@TERM$2	average median lifespans @TERM$1  from all replicates indicated beneath representative curvesdpharyngeal pumpsminute in young adult gas1 mutant nematodes treated with vehicle or  @TERM$2 	0.99999225	7.767686e-06
30796049	ban286	ban287	30796049	287	146	@TERM$1	@TERM$2	x zcis14myo3pgfpmit ban285 age1hx546ii mev1kn1iii  @TERM$1  daf16mu86i age1hx546ii gas1fc21x  @TERM$2  daf16mu86i age1hx546ii ban308 age1hx546ii aak2ok5	0.53946	0.4605401
30796049	kda	abcam	30796049	286	216	@TERM$1	@TERM$2	the deproteinization step was conducted with 10 @TERM$1  cutoff spin columns  @TERM$2  in a chilled microcentrifuge for 1h at 9600g absorbance was measured with a multiskan fc plate reader thermo fisher scientific at 570nm	0.99999845	1.6001719e-06
30796049	sigma	abcam	30796049	280	112	@TERM$1	@TERM$2	mouse monoclonal antibodies against mammalian and nematode actin were obtained from  @TERM$1  and  @TERM$2  respectively	0.9999938	6.181277e-06
30796049	actin	abcam	30796049	280	112	@TERM$1	@TERM$2	mouse monoclonal antibodies against mammalian and nematode  @TERM$1  were obtained from sigma and  @TERM$2  respectively	0.9999976	2.413498e-06
30796049	actin	sigma	30796049	280	112	@TERM$1	@TERM$2	mouse monoclonal antibodies against mammalian and nematode  @TERM$1  were obtained from  @TERM$2  and abcam respectively	0.999998	2.066459e-06
30796049	iis	oxphos	30796049	278	201	@TERM$1	@TERM$2	as an additional value we show that methylxanthines can attenuate hyperactive  @TERM$1  in  @TERM$2  impaired cells as well as have positive effects on the survival of shortlived celegans mitochondrial mutants	0.9999676	3.2454966e-05
30796049	methylxanthines	oxphos	30796049	278	201	@TERM$1	@TERM$2	as an additional value we show that  @TERM$1  can attenuate hyperactive iis in  @TERM$2  impaired cells as well as have positive effects on the survival of shortlived celegans mitochondrial mutants	0.99999356	6.496692e-06
30796049	methylxanthines	iis	30796049	278	201	@TERM$1	@TERM$2	as an additional value we show that  @TERM$1  can attenuate hyperactive  @TERM$2  in oxphos impaired cells as well as have positive effects on the survival of shortlived celegans mitochondrial mutants	0.99999785	2.1810984e-06
30796049	methylxanthines	iis	30796049	276	205	@TERM$1	@TERM$2	finally it is worth noting that  @TERM$1  stimulate aak2ampk and kin1pka activity and promote a more fused mitochondrial network in gas1 mutants mimicking in part the genetic effect of  @TERM$2  inhibition	0.99999905	9.784609e-07
30796049	gas1	iis	30796049	276	205	@TERM$1	@TERM$2	finally it is worth noting that methylxanthines stimulate aak2ampk and kin1pka activity and promote a more fused mitochondrial network in  @TERM$1  mutants mimicking in part the genetic effect of  @TERM$2  inhibition	0.9999982	1.775873e-06
30796049	iis	pde	30796049	203	187	@TERM$1	@TERM$2	this effect on  @TERM$1  was not a common feature of  @TERM$2  inhibitors since the pde3 inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of akt appendixfig s4d	0.99999213	7.853665e-06
30796049	methylxanthines	adenosine receptor antagonists	30796049	204	139	@TERM$1	@TERM$2	in the range of concentrations that we used  @TERM$1  may act as  @TERM$2  snyder etal 1981 monteiro etal 2016	0.99999785	2.1311484e-06
30796049	methylxanthines	adenosine	30796049	204	139	@TERM$1	@TERM$2	in the range of concentrations that we used  @TERM$1  may act as  @TERM$2  receptor antagonists snyder etal 1981 monteiro etal 2016	0.9999982	1.7994713e-06
30796049	methylxanthines	adenosine receptor	30796049	204	139	@TERM$1	@TERM$2	in the range of concentrations that we used  @TERM$1  may act as  @TERM$2  antagonists snyder etal 1981 monteiro etal 2016	0.99999666	3.3340655e-06
30796049	adenosine receptor antagonists	s4e	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  msx3 and sch58261 had no effect on either pka or akt phosphorylation appendixfig  @TERM$2  it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999845	1.5979683e-06
30796049	adenosine receptor	sch58261	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  antagonists msx3 and  @TERM$2  had no effect on either pka or akt phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.9999987	1.352616e-06
30796049	sch58261	akt	30796049	205	248	@TERM$1	@TERM$2	however since adenosine receptor antagonists msx3 and  @TERM$1  had no effect on either pka or  @TERM$2  phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999726	2.7643634e-06
30796049	ban153	ban203	30796049	287	198	@TERM$1	@TERM$2	ckcrossed ban57 daf16mu86i daf2e1370iii gas1fc21x  @TERM$1  gas1fc21x zcis14myo3pgfpmit ban201 ife2ok306x gas1fc21x ban202 age1hx546ii gas1fc21x  @TERM$2  gas1fc21x uthex299aak2genomic aa1aa321gfpunc54 3u	0.99999845	1.5895115e-06
30796049	cw152	tj1052	30796049	287	167	@TERM$1	@TERM$2	 pdk1mg142x gas1fc21x ban324 daf16mu86i gas1fc21x  @TERM$1  gas1fc21x gr1318 pdk1mg142x rb579 ife2ok306x sj4103 zcis14myo3pgfpmit  @TERM$2  age1hx546ii daf16mu86i daf2e1370ii	0.99999833	1.6344297e-06
30796049	ban287	ban324	30796049	287	204	@TERM$1	@TERM$2	ev1kn1iii ban286 daf16mu86i age1hx546ii gas1fc21x  @TERM$1  daf16mu86i age1hx546ii ban308 age1hx546ii aak2ok524x gas1fc21x ban323 pdk1mg142x gas1fc21x  @TERM$2  daf16mu86i gas1fc21x cw152 gas1fc21x gr1318 pdk1m	0.99999833	1.6807666e-06
30796049	ban287	cw152	30796049	287	232	@TERM$1	@TERM$2	ev1kn1iii ban286 daf16mu86i age1hx546ii gas1fc21x  @TERM$1  daf16mu86i age1hx546ii ban308 age1hx546ii aak2ok524x gas1fc21x ban323 pdk1mg142x gas1fc21x ban324 daf16mu86i gas1fc21x  @TERM$2  gas1fc21x gr1318 pdk1mg142x rb579 ife2ok306x sj410	0.99999774	2.2662296e-06
30796049	levamisole	agarose	30796049	323	161	@TERM$1	@TERM$2	in all the experiments nematodes were paralyzed with 25mm  @TERM$1  applichem in m9 buffer mounted on 2  @TERM$2  pads on glass slides and closed with coverslips	0.9998363	0.000163642
30796049	levamisole	glass	30796049	323	161	@TERM$1	@TERM$2	in all the experiments nematodes were paralyzed with 25mm  @TERM$1  applichem in m9 buffer mounted on 2 agarose pads on  @TERM$2  slides and closed with coverslips	0.999998	2.0417315e-06
30796049	applichem	glass	30796049	323	161	@TERM$1	@TERM$2	in all the experiments nematodes were paralyzed with 25mm levamisole  @TERM$1  in m9 buffer mounted on 2 agarose pads on  @TERM$2  slides and closed with coverslips	0.99999785	2.2025047e-06
30796049	agarose	glass	30796049	323	161	@TERM$1	@TERM$2	in all the experiments nematodes were paralyzed with 25mm levamisole applichem in m9 buffer mounted on 2  @TERM$1  pads on  @TERM$2  slides and closed with coverslips	0.99998796	1.2016212e-05
30796049	frap	bit	30796049	313	216	@TERM$1	@TERM$2	the  @TERM$1  assay was performed on an inverted fully motorized nikon microscope in association with a yokogawa spinning disk connected to a backilluminated emccd camera andor ixon du897 512512pixels 16  @TERM$2  35framess	0.9999876	1.23934e-05
30796049	applichem	agarose	30796049	312	217	@TERM$1	@TERM$2	in each independent assay at least 3 wells per condition were measuredl4 stage nematodes were paralyzed with 25mm levamisole  @TERM$1  in m9 buffer mounted on 2  @TERM$2  pads on glass slides and closed with coverslips	0.99999785	2.1738904e-06
30796049	levamisole	applichem	30796049	312	217	@TERM$1	@TERM$2	in each independent assay at least 3 wells per condition were measuredl4 stage nematodes were paralyzed with 25mm  @TERM$1   @TERM$2  in m9 buffer mounted on 2 agarose pads on glass slides and closed with coverslips	0.9999976	2.4123613e-06
30796049	levamisole	agarose	30796049	312	217	@TERM$1	@TERM$2	in each independent assay at least 3 wells per condition were measuredl4 stage nematodes were paralyzed with 25mm  @TERM$1  applichem in m9 buffer mounted on 2  @TERM$2  pads on glass slides and closed with coverslips	0.9999982	1.7749891e-06
30796049	levamisole	glass	30796049	312	217	@TERM$1	@TERM$2	in each independent assay at least 3 wells per condition were measuredl4 stage nematodes were paralyzed with 25mm  @TERM$1  applichem in m9 buffer mounted on 2 agarose pads on  @TERM$2  slides and closed with coverslips	0.99999666	3.2927442e-06
30796049	applichem	glass	30796049	312	217	@TERM$1	@TERM$2	in each independent assay at least 3 wells per condition were measuredl4 stage nematodes were paralyzed with 25mm levamisole  @TERM$1  in m9 buffer mounted on 2 agarose pads on  @TERM$2  slides and closed with coverslips	0.99999726	2.6972307e-06
30796049	agarose	glass	30796049	312	217	@TERM$1	@TERM$2	in each independent assay at least 3 wells per condition were measuredl4 stage nematodes were paralyzed with 25mm levamisole applichem in m9 buffer mounted on 2  @TERM$1  pads on  @TERM$2  slides and closed with coverslips	0.999998	2.0437947e-06
30796049	s4e	methylxanthines	30796049	205	248	@TERM$1	@TERM$2	however since adenosine receptor antagonists msx3 and sch58261 had no effect on either pka or akt phosphorylation appendixfig  @TERM$1  it is likely that  @TERM$2  acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.9999945	5.4926886e-06
30796049	313	dmso	30796049	308	235	@TERM$1	@TERM$2	the volcano plot was generated with an r  @TERM$1  r core team 2015gravid nematodes were treated with hypochlorite solution and eggs were placed on ngm plates seeded with op50 in the presence of vehicle  @TERM$2  or one of the indicated compounds	0.99931836	0.00068161817
30796049	carbohydrates	sigma	30796049	294	149	@TERM$1	@TERM$2	lifespan assays of compoundtreated nematodes were performed blindedtotal  @TERM$1  were measured with a total carbohydrate assay kit  @TERM$2  mak104	0.999998	2.015106e-06
30796049	ban57	ban203	30796049	287	238	@TERM$1	@TERM$2	3utrmyo2ptdtomato ban1 daf2e1370iii 7 backcrossed  @TERM$1  daf16mu86i daf2e1370iii gas1fc21x ban153 gas1fc21x zcis14myo3pgfpmit ban201 ife2ok306x gas1fc21x ban202 age1hx546ii gas1fc21x  @TERM$2  gas1fc21x uthex299aak2genomic aa1aa321gfpunc54 3u	0.99999523	4.7328385e-06
30796049	ban324	cw152	30796049	287	134	@TERM$1	@TERM$2	 aak2ok524x gas1fc21x ban323 pdk1mg142x gas1fc21x  @TERM$1  daf16mu86i gas1fc21x  @TERM$2  gas1fc21x gr1318 pdk1mg142x rb579 ife2ok306x sj410	0.9999981	1.9104334e-06
30796049	atp	gas1	30796049	287	132	@TERM$1	@TERM$2	for each sample  @TERM$1  concentration was normalized to animal number for wt age1  @TERM$2  and age1 gas1 nematodes or protein content for ag	0.9999974	2.6750672e-06
30796049	ban324	tj1052	30796049	287	195	@TERM$1	@TERM$2	 aak2ok524x gas1fc21x ban323 pdk1mg142x gas1fc21x  @TERM$1  daf16mu86i gas1fc21x cw152 gas1fc21x gr1318 pdk1mg142x rb579 ife2ok306x sj4103 zcis14myo3pgfpmit  @TERM$2  age1hx546ii daf16mu86i daf2e1370ii	0.9999896	1.0410782e-05
30796049	atp	age1	30796049	287	127	@TERM$1	@TERM$2	for each sample  @TERM$1  concentration was normalized to animal number for wt  @TERM$2  gas1 and age1 gas1 nematodes or protein content f	0.9999949	5.175212e-06
30796049	ban286	ban324	30796049	287	244	@TERM$1	@TERM$2	x zcis14myo3pgfpmit ban285 age1hx546ii mev1kn1iii  @TERM$1  daf16mu86i age1hx546ii gas1fc21x ban287 daf16mu86i age1hx546ii ban308 age1hx546ii aak2ok524x gas1fc21x ban323 pdk1mg142x gas1fc21x  @TERM$2  daf16mu86i gas1fc21x cw152 gas1fc21x gr1318 pdk1m	0.99999833	1.6889774e-06
30796049	ban1	ban153	30796049	287	178	@TERM$1	@TERM$2	299aak2genomic aa1aa321gfpunc54 3utrmyo2ptdtomato  @TERM$1  daf2e1370iii 7 backcrossed ban57 daf16mu86i daf2e1370iii gas1fc21x  @TERM$2  gas1fc21x zcis14myo3pgfpmit ban201 ife2ok306x gas	0.99999833	1.7111958e-06
30796049	age1	gas1	30796049	287	109	@TERM$1	@TERM$2	centration was normalized to animal number for wt  @TERM$1   @TERM$2  and age1 gas1 nematodes or protein content for ag	0.999997	3.0056622e-06
30796049	ban1	ban57	30796049	287	137	@TERM$1	@TERM$2	299aak2genomic aa1aa321gfpunc54 3utrmyo2ptdtomato  @TERM$1  daf2e1370iii 7 backcrossed  @TERM$2  daf16mu86i daf2e1370iii gas1fc21x ban153 gas1fc21	0.9999974	2.582907e-06
30796049	ban57	ban153	30796049	287	146	@TERM$1	@TERM$2	3utrmyo2ptdtomato ban1 daf2e1370iii 7 backcrossed  @TERM$1  daf16mu86i daf2e1370iii gas1fc21x  @TERM$2  gas1fc21x zcis14myo3pgfpmit ban201 ife2ok306x gas	0.99999774	2.2251836e-06
30796049	age1	gas1	30796049	305	200	@TERM$1	@TERM$2	creative proteomics inc usa performed a highperformance liquid chromatography and mass spectrometry uplcms analysis to determine the lipids present in wildtype  @TERM$1   @TERM$2  and age1 gas1 mutant nematodes	0.9999956	4.428801e-06
30796049	adenosine receptor	methylxanthines	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  antagonists msx3 and sch58261 had no effect on either pka or akt phosphorylation appendixfig s4e it is likely that  @TERM$2  acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999845	1.5394237e-06
30796049	akt	methylxanthines	30796049	205	248	@TERM$1	@TERM$2	however since adenosine receptor antagonists msx3 and sch58261 had no effect on either pka or  @TERM$1  phosphorylation appendixfig s4e it is likely that  @TERM$2  acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99979585	0.00020411515
30796049	adenosine receptor antagonists	adenosine receptor	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  msx3 and sch58261 had no effect on either pka or akt phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of  @TERM$2  antagonism	0.9999795	2.0553114e-05
30796049	ptx	s4f	30796049	206	93	@TERM$1	@TERM$2	notably treatment with  @TERM$1  appendixfig  @TERM$2  and other methylxanthines data not shown did not 	0.99999726	2.7039268e-06
30796049	s4f	xanthine	30796049	206	230	@TERM$1	@TERM$2	notably treatment with ptx appendixfig  @TERM$1  and other methyl @TERM$2 s data not shown did not improve mitochondrial respirationhaving established the pleiotropic effects of xanthine derivatives on aktmtor and pka activity we sought	0.99999857	1.4021092e-06
30796049	xanthine	pka	30796049	206	144	@TERM$1	@TERM$2	tionhaving established the pleiotropic effects of  @TERM$1  derivatives on aktmtor and  @TERM$2  activity we sought to determine whether increased xant	0.9999988	1.2500758e-06
30796049	gas1	xanthine	30796049	207	108	@TERM$1	@TERM$2	thus we exposed wt and  @TERM$1  mutant nematodes to  @TERM$2  derivatives by supplementing them with the bacteria	0.9999988	1.2304757e-06
30796049	methylxanthines	gas1	30796049	208	249	@TERM$1	@TERM$2	while xanthine derivatives did not affect the lifespan of wt animals fig5a we found that these three  @TERM$1  significantly improved locomotor activity and extended the survival of complex ideficient  @TERM$2  mutants fig5b and c and datasetev1	0.9999981	1.9171664e-06
30796049	xanthine	gas1	30796049	208	249	@TERM$1	@TERM$2	while  @TERM$1  derivatives did not affect the lifespan of wt animals fig5a we found that these three methylxanthines significantly improved locomotor activity and extended the survival of complex ideficient  @TERM$2  mutants fig5b and c and datasetev1	0.9999976	2.3382743e-06
30796049	xanthine	methylxanthines	30796049	208	249	@TERM$1	@TERM$2	while  @TERM$1  derivatives did not affect the lifespan of wt animals fig5a we found that these three  @TERM$2  significantly improved locomotor activity and extended the survival of complex ideficient gas1 mutants fig5b and c and datasetev1	0.99999654	3.4636273e-06
30796049	ptx	gas1	30796049	211	168	@TERM$1	@TERM$2	notably  @TERM$1  treatment promoted mitochondrial connectivity in  @TERM$2  mutant nematodes fig5g phenocopying in part what we observed in age1 gas1 double mutants fig1i and j	0.99999833	1.6514863e-06
30796049	gas1	age1	30796049	211	168	@TERM$1	@TERM$2	notably ptx treatment promoted mitochondrial connectivity in  @TERM$1  mutant nematodes fig5g phenocopying in part what we observed in  @TERM$2  gas1 double mutants fig1i and j	0.9999945	5.438117e-06
30796049	ptx	age1	30796049	211	168	@TERM$1	@TERM$2	notably  @TERM$1  treatment promoted mitochondrial connectivity in gas1 mutant nematodes fig5g phenocopying in part what we observed in  @TERM$2  gas1 double mutants fig1i and j	0.999998	2.0592743e-06
30796049	iis	methylxanthines	30796049	213	175	@TERM$1	@TERM$2	to a certain extent  @TERM$1  inhibition and treatment with  @TERM$2  share common molecular processes that underlie the increased survival of shortlived mitochondrial mutants	0.9999988	1.1700058e-06
30796049	xanthine	aktmtor	30796049	206	132	@TERM$1	@TERM$2	tionhaving established the pleiotropic effects of  @TERM$1  derivatives on  @TERM$2  and pka activity we sought to determine whether in	0.999987	1.302165e-05
30796049	sem	dmso	30796049	215	186	@TERM$1	@TERM$2	average median lifespans @TERM$1  from all replicates indicated beneath representative curveblocomotor activity of 10dayold gas1 mutant nematodes treated with vehicle  @TERM$2  or methylxanthines	0.9999982	1.7634045e-06
30796049	gas1	methylxanthines	30796049	215	186	@TERM$1	@TERM$2	average median lifespanssem from all replicates indicated beneath representative curveblocomotor activity of 10dayold  @TERM$1  mutant nematodes treated with vehicle dmso or  @TERM$2 	0.99999833	1.6531425e-06
30796049	sem	methylxanthines	30796049	215	186	@TERM$1	@TERM$2	average median lifespans @TERM$1  from all replicates indicated beneath representative curveblocomotor activity of 10dayold gas1 mutant nematodes treated with vehicle dmso or  @TERM$2 	0.999998	1.9746515e-06
30796049	dmso	methylxanthines	30796049	215	186	@TERM$1	@TERM$2	average median lifespanssem from all replicates indicated beneath representative curveblocomotor activity of 10dayold gas1 mutant nematodes treated with vehicle  @TERM$1  or  @TERM$2 	0.99999785	2.1165974e-06
30796049	sem	gas1	30796049	215	186	@TERM$1	@TERM$2	average median lifespans @TERM$1  from all replicates indicated beneath representative curveblocomotor activity of 10dayold  @TERM$2  mutant nematodes treated with vehicle dmso or methylxanthines	0.999992	8.011215e-06
30796049	post	methylxanthines	30796049	217	139	@TERM$1	@TERM$2	bars meansem pvalue001 pvalue0001 oneway anova dunnetts  @TERM$1  hoc correctionceffect of  @TERM$2  on the survival of gas1 mutants	0.9998078	0.00019225208
30796049	sem	post	30796049	217	139	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue001 pvalue0001 oneway anova dunnetts  @TERM$2  hoc correctionceffect of methylxanthines on the survival of gas1 mutants	0.9999982	1.7400536e-06
30796049	methylxanthines	gas1	30796049	217	139	@TERM$1	@TERM$2	bars meansem pvalue001 pvalue0001 oneway anova dunnetts post hoc correctionceffect of  @TERM$1  on the survival of  @TERM$2  mutants	0.9999987	1.3242208e-06
30796049	sem	methylxanthines	30796049	217	139	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue001 pvalue0001 oneway anova dunnetts post hoc correctionceffect of  @TERM$2  on the survival of gas1 mutants	0.9999	0.000100031
30796049	sem	gas1	30796049	217	139	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue001 pvalue0001 oneway anova dunnetts post hoc correctionceffect of methylxanthines on the survival of  @TERM$2  mutants	0.9999957	4.3131245e-06
30796049	gas1	methylxanthines	30796049	218	189	@TERM$1	@TERM$2	average median lifespanssem from all replicates indicated beneath representative curvesdpharyngeal pumpsminute in young adult  @TERM$1  mutant nematodes treated with vehicle or  @TERM$2 	0.9999975	2.5131108e-06
30796049	sem	gas1	30796049	218	189	@TERM$1	@TERM$2	average median lifespans @TERM$1  from all replicates indicated beneath representative curvesdpharyngeal pumpsminute in young adult  @TERM$2  mutant nematodes treated with vehicle or methylxanthines	0.9999745	2.5526828e-05
30796049	gas1	dmso	30796049	215	186	@TERM$1	@TERM$2	average median lifespanssem from all replicates indicated beneath representative curveblocomotor activity of 10dayold  @TERM$1  mutant nematodes treated with vehicle  @TERM$2  or methylxanthines	0.99999845	1.5924626e-06
30796049	applichem	agarose	30796049	323	161	@TERM$1	@TERM$2	in all the experiments nematodes were paralyzed with 25mm levamisole  @TERM$1  in m9 buffer mounted on 2  @TERM$2  pads on glass slides and closed with coverslips	0.999998	2.0110456e-06
30796049	s4f	methylxanthines	30796049	206	119	@TERM$1	@TERM$2	notably treatment with ptx appendixfig  @TERM$1  and other  @TERM$2  data not shown did not improve mitochondrial resp	0.9999982	1.8388446e-06
30796049	methylxanthines	gas1	30796049	276	205	@TERM$1	@TERM$2	finally it is worth noting that  @TERM$1  stimulate aak2ampk and kin1pka activity and promote a more fused mitochondrial network in  @TERM$2  mutants mimicking in part the genetic effect of iis inhibition	0.9999987	1.2788504e-06
30796049	adenosine receptor	akt	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  antagonists msx3 and sch58261 had no effect on either pka or  @TERM$2  phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99995637	4.3586268e-05
30796049	sch58261	s4e	30796049	205	248	@TERM$1	@TERM$2	however since adenosine receptor antagonists msx3 and  @TERM$1  had no effect on either pka or akt phosphorylation appendixfig  @TERM$2  it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99993277	6.724213e-05
30796049	adenosine receptor antagonists	pka	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  msx3 and sch58261 had no effect on either  @TERM$2  or akt phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.9999093	9.076431e-05
30796049	adenosine	sch58261	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  receptor antagonists msx3 and  @TERM$2  had no effect on either pka or akt phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999833	1.6321494e-06
30796049	adenosine receptor	s4e	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  antagonists msx3 and sch58261 had no effect on either pka or akt phosphorylation appendixfig  @TERM$2  it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999356	6.44544e-06
30796049	adenosine receptor antagonists	adenosine	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  msx3 and sch58261 had no effect on either pka or akt phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of  @TERM$2  receptor antagonism	0.9999926	7.369907e-06
30796049	adenosine	akt	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  receptor antagonists msx3 and sch58261 had no effect on either pka or  @TERM$2  phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999607	3.9646184e-06
30796049	akt	s4e	30796049	205	248	@TERM$1	@TERM$2	however since adenosine receptor antagonists msx3 and sch58261 had no effect on either pka or  @TERM$1  phosphorylation appendixfig  @TERM$2  it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.9999956	4.4522235e-06
30796049	adenosine	methylxanthines	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  receptor antagonists msx3 and sch58261 had no effect on either pka or akt phosphorylation appendixfig s4e it is likely that  @TERM$2  acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999	9.95576e-06
30796049	pka	methylxanthines	30796049	205	248	@TERM$1	@TERM$2	however since adenosine receptor antagonists msx3 and sch58261 had no effect on either  @TERM$1  or akt phosphorylation appendixfig s4e it is likely that  @TERM$2  acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999464	5.3144645e-06
30796049	sch58261	pka	30796049	205	248	@TERM$1	@TERM$2	however since adenosine receptor antagonists msx3 and  @TERM$1  had no effect on either  @TERM$2  or akt phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999714	2.9167575e-06
30796049	methylxanthines	xanthine	30796049	206	233	@TERM$1	@TERM$2	bly treatment with ptx appendixfig s4f and other  @TERM$1  data not shown did not improve mitochondrial respirationhaving established the pleiotropic effects of  @TERM$2  derivatives on aktmtor and pka activity we sought to det	0.9999974	2.6217413e-06
30796049	adenosine	s4e	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  receptor antagonists msx3 and sch58261 had no effect on either pka or akt phosphorylation appendixfig  @TERM$2  it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.9999939	6.134257e-06
30796049	adenosine receptor	pka	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  antagonists msx3 and sch58261 had no effect on either  @TERM$2  or akt phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.9999964	3.603495e-06
30796049	pka	s4e	30796049	205	248	@TERM$1	@TERM$2	however since adenosine receptor antagonists msx3 and sch58261 had no effect on either  @TERM$1  or akt phosphorylation appendixfig  @TERM$2  it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.24157788	0.7584221
30796049	adenosine receptor antagonists	sch58261	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  msx3 and  @TERM$2  had no effect on either pka or akt phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999726	2.6860441e-06
30796049	adenosine receptor antagonists	methylxanthines	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  msx3 and sch58261 had no effect on either pka or akt phosphorylation appendixfig s4e it is likely that  @TERM$2  acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.9999976	2.3930447e-06
30796049	adenosine	pka	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  receptor antagonists msx3 and sch58261 had no effect on either  @TERM$2  or akt phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.9999968	3.2725086e-06
30796049	sch58261	methylxanthines	30796049	205	248	@TERM$1	@TERM$2	however since adenosine receptor antagonists msx3 and  @TERM$1  had no effect on either pka or akt phosphorylation appendixfig s4e it is likely that  @TERM$2  acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999595	4.0152017e-06
30796049	adenosine receptor	adenosine	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  antagonists msx3 and sch58261 had no effect on either pka or akt phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of  @TERM$2  receptor antagonism	0.99999607	3.934366e-06
30796049	adenosine receptor antagonists	akt	30796049	205	248	@TERM$1	@TERM$2	however since  @TERM$1  msx3 and sch58261 had no effect on either pka or  @TERM$2  phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.999998	2.0244443e-06
30796049	aktmtor	pka	30796049	206	119	@TERM$1	@TERM$2	he pleiotropic effects of xanthine derivatives on  @TERM$1  and  @TERM$2  activity we sought to determine whether increased xan	0.99999774	2.2223758e-06
30796049	ptx	xanthine	30796049	206	230	@TERM$1	@TERM$2	notably treatment with  @TERM$1  appendixfig s4f and other methyl @TERM$2 s data not shown did not improve mitochondrial respirationhaving established the pleiotropic effects of xanthine derivatives on aktmtor and pka activity we sought	0.9999987	1.2749317e-06
30796049	ptx	methylxanthines	30796049	206	119	@TERM$1	@TERM$2	notably treatment with  @TERM$1  appendixfig s4f and other  @TERM$2  data not shown did not improve mitochondrial resp	0.99999714	2.9136547e-06
30796049	pka	akt	30796049	205	248	@TERM$1	@TERM$2	however since adenosine receptor antagonists msx3 and sch58261 had no effect on either  @TERM$1  or  @TERM$2  phosphorylation appendixfig s4e it is likely that methylxanthines acted on pka and akt phosphorylation independently of adenosine receptor antagonism	0.99999845	1.5397981e-06
30796049	dmso	actin	30796049	183	157	@TERM$1	@TERM$2	40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$1   or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.9999988	1.2001345e-06
30796049	age1	gas1	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of phosphoenolpyruvate carboxykinase pepck was equally altered in  @TERM$1   @TERM$2  compared to gas1 appendixfig s2d	0.9999974	2.6230166e-06
30796049	pan	akt	30796049	183	107	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phospho @TERM$2  s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and ndu	0.99998605	1.3998424e-05
30796049	age1	daf16	30796049	50	122	@TERM$1	@TERM$2	fespan of wt and gas1fc21 nematodes compared to b  @TERM$1  and age1 gas1 mutants and c  @TERM$2  and daf16 age1 gas1 mutant animal	0.99999547	4.519873e-06
30796049	sem	post	30796049	50	142	@TERM$1	@TERM$2	one representative curve is shown mean @TERM$1  n3 pvalue00001 kruskalwallis test dunns  @TERM$2  hoc correctionb crepresentative curves show the l	0.99999785	2.1964886e-06
30796049	post	age1	30796049	50	209	@TERM$1	@TERM$2	sem n3 pvalue00001 kruskalwallis test dunns  @TERM$1  hoc correctionb crepresentative curves show the lifespan of wt and gas1fc21 nematodes compared to b  @TERM$2  and age1 gas1 mutants and c daf16 and daf16 age1 	0.9999987	1.317582e-06
30796049	iis	s1e	30796049	48	142	@TERM$1	@TERM$2	in line with our prior data we found that  @TERM$1  inhibition increased the lifespan of wah1silenced animals appendixfig  @TERM$2  and f and datasetev1	0.9999919	8.151835e-06
30796049	daf16	s1d	30796049	44	111	@TERM$1	@TERM$2	consistently  @TERM$1  loss of function alone did not affect the gas1fc21 survival appendixfig  @TERM$2  and datasetev1	0.9999932	6.747961e-06
30796049	age1	gas1	30796049	43	89	@TERM$1	@TERM$2	it is worth noting that daf16  @TERM$1   @TERM$2  triple mutants did live a few days longer than ga	0.9999982	1.8354544e-06
30796049	daf16	gas1	30796049	43	90	@TERM$1	@TERM$2	it is worth noting that  @TERM$1  age1  @TERM$2  triple mutants did live a few days longer than gas	0.99999774	2.2663874e-06
30796049	daf16	age1	30796049	43	85	@TERM$1	@TERM$2	it is worth noting that  @TERM$1   @TERM$2  gas1 triple mutants did live a few days longer tha	0.9999974	2.5839986e-06
30796049	daf16foxo	gas1	30796049	42	219	@TERM$1	@TERM$2	furthermore we found that the lifespan extension depended primarily on the transcription factor  @TERM$1  since daf16 age1  @TERM$2  triple mutants lived significantly less than age1 gas1 animals fig1b and c and datasetev1	0.99998736	1.26677e-05
30796049	daf16foxo	daf16	30796049	42	219	@TERM$1	@TERM$2	furthermore we found that the lifespan extension depended primarily on the transcription factor  @TERM$1  since  @TERM$2  age1 gas1 triple mutants lived significantly less than age1 gas1 animals fig1b and c and datasetev1	0.99999785	2.1354188e-06
30796049	age1	gas1	30796049	42	219	@TERM$1	@TERM$2	furthermore we found that the lifespan extension depended primarily on the transcription factor daf16foxo since daf16  @TERM$1   @TERM$2  triple mutants lived significantly less than age1 gas1 animals fig1b and c and datasetev1	0.9999975	2.499489e-06
30796049	daf16	gas1	30796049	42	219	@TERM$1	@TERM$2	furthermore we found that the lifespan extension depended primarily on the transcription factor  @TERM$1 foxo since daf16 age1  @TERM$2  triple mutants lived significantly less than age1 gas1 animals fig1b and c and datasetev1	0.9999974	2.6368764e-06
30796049	daf16	age1	30796049	42	219	@TERM$1	@TERM$2	furthermore we found that the lifespan extension depended primarily on the transcription factor  @TERM$1 foxo since daf16  @TERM$2  gas1 triple mutants lived significantly less than age1 gas1 animals fig1b and c and datasetev1	0.99998724	1.2758118e-05
30796049	daf16foxo	age1	30796049	42	219	@TERM$1	@TERM$2	furthermore we found that the lifespan extension depended primarily on the transcription factor  @TERM$1  since daf16  @TERM$2  gas1 triple mutants lived significantly less than age1 gas1 animals fig1b and c and datasetev1	0.99995625	4.378236e-05
30796049	gas1	s1c	30796049	41	97	@TERM$1	@TERM$2	in a similar manner pdk1 loss of function extended  @TERM$1  lifespan appendixfig  @TERM$2  and datasetev1	0.9999938	6.1858827e-06
30796049	age1	gas1	30796049	40	220	@TERM$1	@TERM$2	most importantly we found that the lifespan of  @TERM$1   @TERM$2  double mutant nematodes was significantly longer compared to gas1 mutants as well as of wildtype wt and even age1hx546 single mutant animals fig1b and datasetev1	0.99998975	1.0307153e-05
30796049	daf16	ogg	30796049	38	214	@TERM$1	@TERM$2	in celegans the sole insulinigf1 receptor daf2 regulates the activity of pi3kage1 and through the downstream kinases pdk1 and akt12 controls the transcription factor  @TERM$1  lin etal 1997  @TERM$2  etal 1997 kenyon 2010	0.999984	1.6004944e-05
30796049	pi3kage1	daf16	30796049	38	214	@TERM$1	@TERM$2	in celegans the sole insulinigf1 receptor daf2 regulates the activity of  @TERM$1  and through the downstream kinases pdk1 and akt12 controls the transcription factor  @TERM$2  lin etal 1997 ogg etal 1997 kenyon 2010	0.99998343	1.657229e-05
30796049	lin	ogg	30796049	38	214	@TERM$1	@TERM$2	in celegans the sole insu @TERM$1 igf1 receptor daf2 regulates the activity of pi3kage1 and through the downstream kinases pdk1 and akt12 controls the transcription factor daf16 lin etal 1997  @TERM$2  etal 1997 kenyon 2010	0.9999939	6.0501297e-06
30796049	daf16	lin	30796049	38	214	@TERM$1	@TERM$2	in celegans the sole insu @TERM$2 igf1 receptor daf2 regulates the activity of pi3kage1 and through the downstream kinases pdk1 and akt12 controls the transcription factor  @TERM$1  lin etal 1997 ogg etal 1997 kenyon 2010	0.9999976	2.378583e-06
30796049	pi3kage1	lin	30796049	38	214	@TERM$1	@TERM$2	in celegans the sole insu @TERM$2 igf1 receptor daf2 regulates the activity of  @TERM$1  and through the downstream kinases pdk1 and akt12 controls the transcription factor daf16 lin etal 1997 ogg etal 1997 kenyon 2010	0.9999982	1.7678634e-06
30796049	pi3kage1	ogg	30796049	38	214	@TERM$1	@TERM$2	in celegans the sole insulinigf1 receptor daf2 regulates the activity of  @TERM$1  and through the downstream kinases pdk1 and akt12 controls the transcription factor daf16 lin etal 1997  @TERM$2  etal 1997 kenyon 2010	0.99999833	1.6344297e-06
30796049	sem	age1	30796049	50	247	@TERM$1	@TERM$2	one representative curve is shown mean @TERM$1  n3 pvalue00001 kruskalwallis test dunns post hoc correctionb crepresentative curves show the lifespan of wt and gas1fc21 nematodes compared to b  @TERM$2  and age1 gas1 mutants and c daf16 and daf16 age1 	0.9999976	2.441966e-06
30796049	post	gas1	30796049	50	223	@TERM$1	@TERM$2	sem n3 pvalue00001 kruskalwallis test dunns  @TERM$1  hoc correctionb crepresentative curves show the lifespan of wt and  @TERM$2 fc21 nematodes compared to b age1 and age1 gas1 mutants and c daf16 and daf16 age1 gas1 mutant an	0.9999943	5.747642e-06
30796049	gas1	daf16	30796049	50	108	@TERM$1	@TERM$2	nd  @TERM$1 fc21 nematodes compared to b age1 and age1 gas1 mutants and c  @TERM$2  and daf16 age1 gas1 mutant animal	0.9999776	2.2368504e-05
30796049	age1	gas1	30796049	50	118	@TERM$1	@TERM$2	fespan of wt and  @TERM$2 fc21 nematodes compared to b  @TERM$1  and age1 gas1 mutants and c daf16 and daf16 age1 gas1 mutant an	0.9999939	6.0825973e-06
30796049	age1	gas1	30796049	61	59	@TERM$1	@TERM$2	for all panels wtwild type a @TERM$1  g @TERM$2  a gage1 gas1	0.9999944	5.576674e-06
30796049	gas1	fzo1	30796049	59	226	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionkrepresentative lifespan of age1  @TERM$1  nematodes fed with empty vector ev and  @TERM$2  rnai bacteria	0.9998578	0.00014214286
30796049	sem	gas1	30796049	59	226	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strain @TERM$1  pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionkrepresentative lifespan of age1  @TERM$2  nematodes fed with empty vector ev and fzo1 rnai bacteria	0.99999785	2.1519065e-06
30796049	age1	fzo1	30796049	59	226	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionkrepresentative lifespan of  @TERM$1  gas1 nematodes fed with empty vector ev and  @TERM$2  rnai bacteria	0.9999882	1.1827259e-05
30796049	age1	gas1	30796049	59	226	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionkrepresentative lifespan of  @TERM$1   @TERM$2  nematodes fed with empty vector ev and fzo1 rnai bacteria	0.99342924	0.00657072
30796049	post	gas1	30796049	59	226	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys  @TERM$1  hoc correctionkrepresentative lifespan of age1  @TERM$2  nematodes fed with empty vector ev and fzo1 rnai bacteria	0.9999988	1.2453709e-06
30796049	sem	age1	30796049	59	226	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strain @TERM$1  pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionkrepresentative lifespan of  @TERM$2  gas1 nematodes fed with empty vector ev and fzo1 rnai bacteria	0.9999981	1.8620893e-06
30796049	sem	fzo1	30796049	59	226	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strain @TERM$1  pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionkrepresentative lifespan of age1 gas1 nematodes fed with empty vector ev and  @TERM$2  rnai bacteria	0.9999925	7.5409953e-06
30796049	sem	post	30796049	59	226	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strain @TERM$1  pvalue0001 pvalue00001 oneway anova tukeys  @TERM$2  hoc correctionkrepresentative lifespan of age1 gas1 nematodes fed with empty vector ev and fzo1 rnai bacteria	0.9989882	0.0010117375
30796049	post	fzo1	30796049	59	226	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys  @TERM$1  hoc correctionkrepresentative lifespan of age1 gas1 nematodes fed with empty vector ev and  @TERM$2  rnai bacteria	0.99999094	9.014125e-06
30796049	post	age1	30796049	59	226	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys  @TERM$1  hoc correctionkrepresentative lifespan of  @TERM$2  gas1 nematodes fed with empty vector ev and fzo1 rnai bacteria	0.9999981	1.8852666e-06
30796049	s1a	iis	30796049	36	224	@TERM$1	@TERM$2	of the top upregulated signaling networks appendixfig  @TERM$1  five pathways were predicted to converge and enhance  @TERM$2  fig1e indicating that an aberrant iis may be a shared feature of mitochondrial mutant nematodes and mammals	0.99999785	2.1465466e-06
30796049	gas1	post	30796049	56	215	@TERM$1	@TERM$2	right panel basal respiration in wt  @TERM$1  and age1 gas1 animals pooled from three biological replicates pvalue00001 nsnonsignificant kruskalwallis test dunns  @TERM$2  hoc correctionisted images of representative mito	0.999998	2.0609168e-06
30796049	age1	post	30796049	56	215	@TERM$1	@TERM$2	right panel basal respiration in wt gas1 and  @TERM$1  gas1 animals pooled from three biological replicates pvalue00001 nsnonsignificant kruskalwallis test dunns  @TERM$2  hoc correctionisted images of representative mito	0.99999595	4.0029977e-06
30796049	sem	gas1	30796049	54	145	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue005 pvalue 0001 kruskalwallis test dunns post hoc correctionhocr of  @TERM$2  and age1 gas1 mutant nematodes normalized to tof	0.999997	2.935899e-06
30796049	gas1	age1	30796049	54	145	@TERM$1	@TERM$2	bars meansem pvalue005 pvalue 0001 kruskalwallis test dunns post hoc correctionhocr of  @TERM$1  and  @TERM$2  gas1 mutant nematodes normalized to tof	0.99997425	2.5771551e-05
30796049	post	gas1	30796049	54	145	@TERM$1	@TERM$2	bars meansem pvalue005 pvalue 0001 kruskalwallis test dunns  @TERM$1  hoc correctionhocr of  @TERM$2  and age1 gas1 mutant nematodes normalized to tof	0.99958533	0.0004146383
30796049	sem	age1	30796049	54	145	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue005 pvalue 0001 kruskalwallis test dunns post hoc correctionhocr of gas1 and  @TERM$2  gas1 mutant nematodes normalized to tof	0.99713457	0.0028653664
30796049	sem	post	30796049	54	145	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue005 pvalue 0001 kruskalwallis test dunns  @TERM$2  hoc correctionhocr of gas1 and age1 gas1 mutant nematodes normalized to tof	0.9999981	1.8821211e-06
30796049	post	age1	30796049	54	145	@TERM$1	@TERM$2	bars meansem pvalue005 pvalue 0001 kruskalwallis test dunns  @TERM$1  hoc correctionhocr of gas1 and  @TERM$2  gas1 mutant nematodes normalized to tof	0.99999857	1.4137612e-06
30796049	red	age1	30796049	53	248	@TERM$1	@TERM$2	shades of  @TERM$1  and green are proportional to fold change as calculated by ipaflifespan analysis of mev1kn1 nematodes compared to wt  @TERM$2 hx546 and age1hx546 mev1kn1 animalsgatp measurements in wt age1 gas1 and age1 gas1 mutant nematodes normalized to	0.9999913	8.667232e-06
30796049	age1	gas1	30796049	53	109	@TERM$1	@TERM$2	  @TERM$1 hx546 mev1kn1 animalsgatp measurements in wt age1  @TERM$2  and age1 gas1 mutant nematodes normalized to wt n	0.9999981	1.9055259e-06
30796049	iis	ipa	30796049	52	176	@TERM$1	@TERM$2	cutoffs 20 fdr and log2fold change0345 in redeschematic representation of  @TERM$1  pathway including results and predictions from  @TERM$2  of phosphoproteome of gas1fc21 compared to wt	0.9999974	2.564112e-06
30796049	post	daf16	30796049	50	227	@TERM$1	@TERM$2	sem n3 pvalue00001 kruskalwallis test dunns  @TERM$1  hoc correctionb crepresentative curves show the lifespan of wt and gas1fc21 nematodes compared to b age1 and age1 gas1 mutants and c  @TERM$2  and daf16 age1 gas1 mutant animal	0.99999833	1.6814639e-06
30796049	gas1	age1	30796049	56	99	@TERM$1	@TERM$2	right panel basal respiration in wt  @TERM$1  and  @TERM$2  gas1 animals pooled from three biological replica	0.99992454	7.54171e-05
30796049	ipa	s1a	30796049	35	158	@TERM$1	@TERM$2	unbiased pathway analysis ie ingenuity pathway analysis  @TERM$1  predicted several signaling pathways dysregulated in complex ideficient nematodes appendixfig  @TERM$2 	0.99998796	1.2071126e-05
30796049	gas1	ndufs2	30796049	32	136	@TERM$1	@TERM$2	the  @TERM$1  gene encodes for a respiratory complex i subunit that is homologous to the human nadh dehydrogenase ironsulfur protein 2  @TERM$2 	0.99999726	2.7725453e-06
30796049	nadh	ndufs2	30796049	32	136	@TERM$1	@TERM$2	the gas1 gene encodes for a respiratory complex i subunit that is homologous to the human  @TERM$1  dehydrogenase ironsulfur protein 2  @TERM$2 	0.999998	2.0601465e-06
30796049	oxphos	iis	30796049	25	169	@TERM$1	@TERM$2	using a crossspecies approach and unbiased methods we explored the link between  @TERM$1  impairment  @TERM$2  and the molecular cascades that counteract mitochondrial deficiency	0.99994946	5.0542723e-05
30796049	mtor	akt	30796049	22	124	@TERM$1	@TERM$2	her this line of evidence suggests that decreased  @TERM$1  and eventually  @TERM$2  pathway preserves energy and metabolite supply pre	0.99981576	0.00018423513
30796049	peng	atp	30796049	21	218	@TERM$1	@TERM$2	moreover rapamycin partially ameliorates kidney failure in coenzyme qdeficient mutant mice  @TERM$1  etal 2015 and maintains cellular  @TERM$2  levels in human differentiated neurons exposed to oxphos inhibitors zheng etal 2016	0.9999937	6.3312114e-06
30796049	peng	oxphos	30796049	21	218	@TERM$1	@TERM$2	moreover rapamycin partially ameliorates kidney failure in coenzyme qdeficient mutant mice  @TERM$1  etal 2015 and maintains cellular atp levels in human differentiated neurons exposed to  @TERM$2  inhibitors zheng etal 2016	0.99999535	4.6394925e-06
30796049	atp	oxphos	30796049	21	218	@TERM$1	@TERM$2	moreover rapamycin partially ameliorates kidney failure in coenzyme qdeficient mutant mice peng etal 2015 and maintains cellular  @TERM$1  levels in human differentiated neurons exposed to  @TERM$2  inhibitors zheng etal 2016	0.99999845	1.5983874e-06
30796049	rapamycin	oxphos	30796049	21	218	@TERM$1	@TERM$2	moreover  @TERM$1  partially ameliorates kidney failure in coenzyme qdeficient mutant mice peng etal 2015 and maintains cellular atp levels in human differentiated neurons exposed to  @TERM$2  inhibitors zheng etal 2016	0.99999404	5.9401536e-06
30796049	rapamycin	atp	30796049	21	218	@TERM$1	@TERM$2	moreover  @TERM$1  partially ameliorates kidney failure in coenzyme qdeficient mutant mice peng etal 2015 and maintains cellular  @TERM$2  levels in human differentiated neurons exposed to oxphos inhibitors zheng etal 2016	0.999926	7.4024974e-05
30796049	rapamycin	peng	30796049	21	218	@TERM$1	@TERM$2	moreover  @TERM$1  partially ameliorates kidney failure in coenzyme qdeficient mutant mice  @TERM$2  etal 2015 and maintains cellular atp levels in human differentiated neurons exposed to oxphos inhibitors zheng etal 2016	0.99999297	7.0848155e-06
30796049	rapamycin	ndufs4	30796049	20	215	@TERM$1	@TERM$2	in this regard treatment with the mtor inhibitor  @TERM$1  extends the lifespan of complex ideficient nematodes peng etal 2015 and alleviates pathology in  @TERM$2  knockout tk2 knockin podocytespecific phb2 knockout 	0.9999901	9.9264e-06
30796049	peng	pathology	30796049	20	140	@TERM$1	@TERM$2	ends the lifespan of complex ideficient nematodes  @TERM$1  etal 2015 and alleviates  @TERM$2  in ndufs4 knockout tk2 knockin podocytespecific p	0.99999845	1.5139248e-06
30796049	mtor	inhibitor	30796049	20	98	@TERM$1	@TERM$2	in this regard treatment with the  @TERM$1   @TERM$2  rapamycin extends the lifespan of complex idefici	0.9999931	6.9670123e-06
30796049	iis	xanthine	30796049	27	162	@TERM$1	@TERM$2	mechanistically  @TERM$1  inhibition stimulates a metabolic shift toward catabolic processes associated with  @TERM$2  buildup as a result of enhanced purine degradation	0.9999832	1.678365e-05
30796049	peng	phb2	30796049	20	193	@TERM$1	@TERM$2	ends the lifespan of complex ideficient nematodes  @TERM$1  etal 2015 and alleviates pathology in ndufs4 knockout tk2 knockin podocytespecific  @TERM$2  knockout mitochondrial dna mutant and aifdeficien	0.9999629	3.7070924e-05
30796049	inhibitor	peng	30796049	20	171	@TERM$1	@TERM$2	in this regard treatment with the mtor  @TERM$1  rapamycin extends the lifespan of complex ideficient nematodes  @TERM$2  etal 2015 and alleviates pathology in ndufs4 knockout	0.99962974	0.0003702083
30796049	pathology	phb2	30796049	20	167	@TERM$1	@TERM$2	eficient nematodes peng etal 2015 and alleviates  @TERM$1  in ndufs4 knockout tk2 knockin podocytespecific  @TERM$2  knockout mitochondrial dna mutant and aifdeficient mic	0.999992	7.956523e-06
30796049	rapamycin	peng	30796049	20	171	@TERM$1	@TERM$2	in this regard treatment with the mtor inhibitor  @TERM$1  extends the lifespan of complex ideficient nematodes  @TERM$2  etal 2015 and alleviates pathology in ndufs4 knockout	0.999995	4.9567934e-06
30796049	rapamycin	pathology	30796049	20	202	@TERM$1	@TERM$2	in this regard treatment with the mtor inhibitor  @TERM$1  extends the lifespan of complex ideficient nematodes peng etal 2015 and alleviates  @TERM$2  in ndufs4 knockout tk2 knockin podocytespecific p	0.9999943	5.6639533e-06
30796049	inhibitor	pathology	30796049	20	202	@TERM$1	@TERM$2	in this regard treatment with the mtor  @TERM$1  rapamycin extends the lifespan of complex ideficient nematodes peng etal 2015 and alleviates  @TERM$2  in ndufs4 knockout tk2 knockin podocytespecific p	0.99999785	2.166035e-06
30796049	mtor	pathology	30796049	20	202	@TERM$1	@TERM$2	in this regard treatment with the  @TERM$1  inhibitor rapamycin extends the lifespan of complex ideficient nematodes peng etal 2015 and alleviates  @TERM$2  in ndufs4 knockout tk2 knockin podocytespecific p	0.99999905	9.871673e-07
30796049	mtor	rapamycin	30796049	20	108	@TERM$1	@TERM$2	in this regard treatment with the  @TERM$1  inhibitor  @TERM$2  extends the lifespan of complex ideficient nemato	0.99999523	4.71365e-06
30796049	inhibitor	rapamycin	30796049	20	108	@TERM$1	@TERM$2	in this regard treatment with the mtor  @TERM$1   @TERM$2  extends the lifespan of complex ideficient nemato	0.9999796	2.0426318e-05
30796049	mtor	ndufs4	30796049	20	212	@TERM$1	@TERM$2	in this regard treatment with the  @TERM$1  inhibitor rapamycin extends the lifespan of complex ideficient nematodes peng etal 2015 and alleviates pathology in  @TERM$2  knockout tk2 knockin podocytespecific phb2 knocko	0.9999969	3.1244697e-06
30796049	inhibitor	ndufs4	30796049	20	215	@TERM$1	@TERM$2	in this regard treatment with the mtor  @TERM$1  rapamycin extends the lifespan of complex ideficient nematodes peng etal 2015 and alleviates pathology in  @TERM$2  knockout tk2 knockin podocytespecific phb2 knockout 	0.9999987	1.3377644e-06
30796049	peng	ndufs4	30796049	20	150	@TERM$1	@TERM$2	ends the lifespan of complex ideficient nematodes  @TERM$1  etal 2015 and alleviates pathology in  @TERM$2  knockout tk2 knockin podocytespecific phb2 knocko	0.9999987	1.2683781e-06
30796049	mtor	peng	30796049	20	166	@TERM$1	@TERM$2	in this regard treatment with the  @TERM$1  inhibitor rapamycin extends the lifespan of complex ideficient nematodes  @TERM$2  etal 2015 and alleviates pathology in ndufs4 kno	0.9999988	1.2091101e-06
30796049	ocr	gas1	30796049	62	111	@TERM$1	@TERM$2	 @TERM$1  of wt and  @TERM$2  mutant nematodes normalized to nematode size as given by the copas biosort time of flighttof	0.9999981	1.8810372e-06
30796049	oxphos	protein kinase a	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying  @TERM$1  defects xanthine derivatives can mimic several aspects of the iis inhibition such as activation of ampactivated  @TERM$2 mpk and protein kinase a pka	0.99999774	2.2261006e-06
30796049	ampactivated protein kinase	protein kinase a	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects xanthine derivatives can mimic several aspects of the iis inhibition such as activation of  @TERM$1  ampk and  @TERM$2  pka	0.9999982	1.7351502e-06
30796049	nadh	dehydrogenase	30796049	32	136	@TERM$1	@TERM$2	the gas1 gene encodes for a respiratory complex i subunit that is homologous to the human  @TERM$1   @TERM$2  ironsulfur protein 2 ndufs2	0.9999987	1.3242208e-06
30796049	gas1	dehydrogenase	30796049	32	136	@TERM$1	@TERM$2	the  @TERM$1  gene encodes for a respiratory complex i subunit that is homologous to the human nadh  @TERM$2  ironsulfur protein 2 ndufs2	0.99999404	5.9075114e-06
30796049	gas1	nadh	30796049	32	136	@TERM$1	@TERM$2	the  @TERM$1  gene encodes for a respiratory complex i subunit that is homologous to the human  @TERM$2  dehydrogenase ironsulfur protein 2 ndufs2	0.99999774	2.2132028e-06
30796049	dehydrogenase	ndufs2	30796049	32	136	@TERM$1	@TERM$2	the gas1 gene encodes for a respiratory complex i subunit that is homologous to the human nadh  @TERM$1  ironsulfur protein 2  @TERM$2 	0.99995553	4.449946e-05
30796049	xanthine	iis	30796049	29	152	@TERM$1	@TERM$2	as a proof of principle we provide evidence that  @TERM$1  derivatives can counteract aberrant  @TERM$2  due to mitochondrial lesionsseveral lines of evidence 	0.99999857	1.3836137e-06
30796049	iis	protein kinase a	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects xanthine derivatives can mimic several aspects of the  @TERM$1  inhibition such as activation of ampactivated  @TERM$2 mpk and protein kinase a pka	0.9999982	1.7818377e-06
30796049	oxphos	iis	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying  @TERM$1  defects xanthine derivatives can mimic several aspects of the  @TERM$2  inhibition such as activation of ampactivated protein kinase ampk and protein kinase a pka	0.9999982	1.7620899e-06
30796049	ampk	protein kinase a	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects xanthine derivatives can mimic several aspects of the iis inhibition such as activation of ampactivated protein kinase  @TERM$1  and  @TERM$2  pka	0.99999774	2.2886547e-06
30796049	oxphos	ampk	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying  @TERM$1  defects xanthine derivatives can mimic several aspects of the iis inhibition such as activation of ampactivated protein kinase  @TERM$2  and protein kinase a pka	0.999998	2.0648042e-06
30796049	ampactivated protein kinase	ampk	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects xanthine derivatives can mimic several aspects of the iis inhibition such as activation of  @TERM$1   @TERM$2  and protein kinase a pka	0.99999523	4.767089e-06
30796049	xanthine	ampactivated protein kinase	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects  @TERM$1  derivatives can mimic several aspects of the iis inhibition such as activation of  @TERM$2  ampk and protein kinase a pka	0.9999813	1.8668918e-05
30796049	oxphos	ampactivated protein kinase	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying  @TERM$1  defects xanthine derivatives can mimic several aspects of the iis inhibition such as activation of  @TERM$2  ampk and protein kinase a pka	0.9999981	1.8735216e-06
30796049	oxphos	xanthine	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying  @TERM$1  defects  @TERM$2  derivatives can mimic several aspects of the iis inhibition such as activation of ampactivated protein kinase ampk and protein kinase a pka	0.9999974	2.582907e-06
30796049	oxphos	pka	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying  @TERM$1  defects xanthine derivatives can mimic several aspects of the iis inhibition such as activation of ampactivated protein kinase ampk and protein kinase a  @TERM$2 	0.999997	3.0056622e-06
30796049	xanthine	protein kinase a	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects  @TERM$1  derivatives can mimic several aspects of the iis inhibition such as activation of ampactivated  @TERM$2 mpk and protein kinase a pka	0.9999982	1.7480872e-06
30796049	ampactivated protein kinase	pka	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects xanthine derivatives can mimic several aspects of the iis inhibition such as activation of  @TERM$1  ampk and protein kinase a  @TERM$2 	0.9999981	1.953937e-06
30796049	xanthine	iis	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects  @TERM$1  derivatives can mimic several aspects of the  @TERM$2  inhibition such as activation of ampactivated protein kinase ampk and protein kinase a pka	0.9999809	1.9098916e-05
30796049	xanthine	ampk	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects  @TERM$1  derivatives can mimic several aspects of the iis inhibition such as activation of ampactivated protein kinase  @TERM$2  and protein kinase a pka	0.99996483	3.5176323e-05
30796049	iis	pka	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects xanthine derivatives can mimic several aspects of the  @TERM$1  inhibition such as activation of ampactivated protein kinase ampk and protein kinase a  @TERM$2 	0.99999833	1.6502929e-06
30796049	ampk	pka	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects xanthine derivatives can mimic several aspects of the iis inhibition such as activation of ampactivated protein kinase  @TERM$1  and protein kinase a  @TERM$2 	0.9999981	1.8743347e-06
30796049	protein kinase a	pka	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects xanthine derivatives can mimic several aspects of the iis inhibition such as activation of ampactivated  @TERM$1 mpk and protein kinase a  @TERM$2 	0.9999951	4.8909415e-06
30796049	iis	ampactivated protein kinase	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects xanthine derivatives can mimic several aspects of the  @TERM$1  inhibition such as activation of  @TERM$2  ampk and protein kinase a pka	0.9999949	5.094424e-06
30796049	iis	ampk	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects xanthine derivatives can mimic several aspects of the  @TERM$1  inhibition such as activation of ampactivated protein kinase  @TERM$2  and protein kinase a pka	0.9999949	5.1669467e-06
30796049	xanthine	pka	30796049	28	198	@TERM$1	@TERM$2	in cells and in nematodes carrying oxphos defects  @TERM$1  derivatives can mimic several aspects of the iis inhibition such as activation of ampactivated protein kinase ampk and protein kinase a  @TERM$2 	0.99999356	6.4836013e-06
30796049	pka	akt	30796049	203	187	@TERM$1	@TERM$2	this effect on iis was not a common feature of pde inhibitors since the pde3 inhibitor cilostazol enhanced  @TERM$1  activity without altering the phosphorylation status of  @TERM$2  appendixfig s4d	0.99999535	4.648651e-06
30796049	post	age1	30796049	63	206	@TERM$1	@TERM$2	sem n3 pvalue00001 kruskalwallis test dunns  @TERM$1  hoc correctionrepresentative curves show the lifespan of wt and gas1fc21 nematodes compared to b  @TERM$2  and age1 gas1 mutants and c daf16 and daf16 age1 	0.99999774	2.2787106e-06
30796049	sem	post	30796049	63	142	@TERM$1	@TERM$2	one representative curve is shown mean @TERM$1  n3 pvalue00001 kruskalwallis test dunns  @TERM$2  hoc correctionrepresentative curves show the life	0.99999726	2.7813003e-06
30796049	age1	daf16	30796049	63	122	@TERM$1	@TERM$2	fespan of wt and gas1fc21 nematodes compared to b  @TERM$1  and age1 gas1 mutants and c  @TERM$2  and daf16 age1 gas1 mutant animal	0.99993753	6.244304e-05
30796049	glucose	gas1	30796049	97	166	@TERM$1	@TERM$2	we observed a significant reduction in total carbohydrates however there were no differences in  @TERM$1  levels between age1  @TERM$2  mutant and gas1 mutant animals fig2h	0.9990257	0.0009742721
30796049	sugar	carbohydrates	30796049	96	195	@TERM$1	@TERM$2	since genes in  @TERM$1  metabolism seem particularly enriched in both the transcriptome and the proteome we measured simple and complex  @TERM$2  using the phenolsulfuric acid colorimetric assay	0.99999464	5.3523477e-06
30796049	ipa	age1	30796049	93	167	@TERM$1	@TERM$2	 @TERM$1  of the proteomic data predicted energy production ie atp synthesis and lipid metabolism to be differentially regulated in  @TERM$2  gas1 compared to gas1 mutants fig2f	0.9999957	4.2360953e-06
30796049	atp	gas1	30796049	93	167	@TERM$1	@TERM$2	ipa of the proteomic data predicted energy production ie  @TERM$1  synthesis and lipid metabolism to be differentially regulated in age1  @TERM$2  compared to gas1 mutants fig2f	0.9999949	5.148364e-06
30796049	age1	gas1	30796049	93	167	@TERM$1	@TERM$2	ipa of the proteomic data predicted energy production ie atp synthesis and lipid metabolism to be differentially regulated in  @TERM$1   @TERM$2  compared to gas1 mutants fig2f	0.99993706	6.2928135e-05
30796049	ipa	gas1	30796049	93	167	@TERM$1	@TERM$2	 @TERM$1  of the proteomic data predicted energy production ie atp synthesis and lipid metabolism to be differentially regulated in age1  @TERM$2  compared to gas1 mutants fig2f	0.9999957	4.3039286e-06
30796049	atp	age1	30796049	93	167	@TERM$1	@TERM$2	ipa of the proteomic data predicted energy production ie  @TERM$1  synthesis and lipid metabolism to be differentially regulated in  @TERM$2  gas1 compared to gas1 mutants fig2f	0.99999046	9.5814175e-06
30796049	ipa	atp	30796049	93	167	@TERM$1	@TERM$2	 @TERM$1  of the proteomic data predicted energy production ie  @TERM$2  synthesis and lipid metabolism to be differentially regulated in age1 gas1 compared to gas1 mutants fig2f	0.99999607	3.9880238e-06
30796049	tmtitraq	gas1	30796049	91	147	@TERM$1	@TERM$2	as a complementary approach to ngs we obtained quantitative proteomic profiling using isobaric tags  @TERM$1  in  @TERM$2  and age1 gas1 nematodes fig2d	0.9999976	2.4062585e-06
30796049	tags	tmtitraq	30796049	91	147	@TERM$1	@TERM$2	as a complementary approach to ngs we obtained quantitative proteomic profiling using isobaric  @TERM$1   @TERM$2  in gas1 and age1 gas1 nematodes fig2d	0.9974439	0.0025561105
30796049	carbohydrates	age1	30796049	97	166	@TERM$1	@TERM$2	we observed a significant reduction in total  @TERM$1  however there were no differences in glucose levels between  @TERM$2  gas1 mutant and gas1 mutant animals fig2h	0.9999963	3.6447514e-06
30796049	tmtitraq	age1	30796049	91	147	@TERM$1	@TERM$2	as a complementary approach to ngs we obtained quantitative proteomic profiling using isobaric tags  @TERM$1  in gas1 and  @TERM$2  gas1 nematodes fig2d	0.999997	2.9331452e-06
30796049	tags	gas1	30796049	91	147	@TERM$1	@TERM$2	as a complementary approach to ngs we obtained quantitative proteomic profiling using isobaric  @TERM$1  tmtitraq in  @TERM$2  and age1 gas1 nematodes fig2d	0.99960166	0.00039836424
30796049	tags	age1	30796049	91	147	@TERM$1	@TERM$2	as a complementary approach to ngs we obtained quantitative proteomic profiling using isobaric  @TERM$1  tmtitraq in gas1 and  @TERM$2  gas1 nematodes fig2d	0.9999974	2.664854e-06
30796049	gas1	iis	30796049	90	199	@TERM$1	@TERM$2	since ife2  @TERM$1  did not fully phenocopy the lifespanextending effect of diminished  @TERM$2  in gas1 animals it is likely that inhibition of protein synthesis contributes only in part to age1 gas1 survival	0.9999919	8.06179e-06
30796049	iis	age1	30796049	90	199	@TERM$1	@TERM$2	since ife2 gas1 did not fully phenocopy the lifespanextending effect of diminished  @TERM$1  in gas1 animals it is likely that inhibition of protein synthesis contributes only in part to  @TERM$2  gas1 survival	0.99999416	5.8764954e-06
30796049	gas1	age1	30796049	90	199	@TERM$1	@TERM$2	since ife2  @TERM$1  did not fully phenocopy the lifespanextending effect of diminished iis in gas1 animals it is likely that inhibition of protein synthesis contributes only in part to  @TERM$2  gas1 survival	0.9999975	2.5527986e-06
30796049	age1	gas1	30796049	89	140	@TERM$1	@TERM$2	moreover we found that  @TERM$1  ife2  @TERM$2  triple mutants lived approximately as long as age1 gas1 double mutant nematodes fig2c and datasetev1	0.99999857	1.4394594e-06
30796049	gas1	age1	30796049	88	197	@TERM$1	@TERM$2	we observed that ife2  @TERM$1  double mutants had an increased lifespan compared to gas1 mutants although they displayed a shorter survival compared to  @TERM$2  gas1 mutant nematodes fig2c and datasetev1	0.99999774	2.217646e-06
30796049	age1	gas1	30796049	86	134	@TERM$1	@TERM$2	specifically eif2 eif4p70s6k and mtor signaling pathways were significantly downregulated in  @TERM$1   @TERM$2  compared to gas1 mutants fig2b	0.99999845	1.5640345e-06
30796049	eif2	gas1	30796049	86	134	@TERM$1	@TERM$2	specifically  @TERM$1  eif4p70s6k and mtor signaling pathways were significantly downregulated in age1  @TERM$2  compared to gas1 mutants fig2b	0.9999976	2.436755e-06
30796049	mtor	gas1	30796049	86	134	@TERM$1	@TERM$2	specifically eif2 eif4p70s6k and  @TERM$1  signaling pathways were significantly downregulated in age1  @TERM$2  compared to gas1 mutants fig2b	0.9999968	3.1652123e-06
30796049	eif2	age1	30796049	86	134	@TERM$1	@TERM$2	specifically  @TERM$1  eif4p70s6k and mtor signaling pathways were significantly downregulated in  @TERM$2  gas1 compared to gas1 mutants fig2b	0.9999988	1.2362675e-06
30796049	gas1	age1	30796049	91	147	@TERM$1	@TERM$2	as a complementary approach to ngs we obtained quantitative proteomic profiling using isobaric tags tmtitraq in  @TERM$1  and  @TERM$2  gas1 nematodes fig2d	0.9999981	1.8694344e-06
30796049	mtor	age1	30796049	86	134	@TERM$1	@TERM$2	specifically eif2 eif4p70s6k and  @TERM$1  signaling pathways were significantly downregulated in  @TERM$2  gas1 compared to gas1 mutants fig2b	0.9999975	2.4654125e-06
30796049	carbohydrates	glucose	30796049	97	166	@TERM$1	@TERM$2	we observed a significant reduction in total  @TERM$1  however there were no differences in  @TERM$2  levels between age1 gas1 mutant and gas1 mutant animals fig2h	0.99999774	2.2214053e-06
30796049	glucose	age1	30796049	97	166	@TERM$1	@TERM$2	we observed a significant reduction in total carbohydrates however there were no differences in  @TERM$1  levels between  @TERM$2  gas1 mutant and gas1 mutant animals fig2h	0.9999981	1.9301513e-06
30796049	phosphoenolpyruvate carboxykinase	age1	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of  @TERM$1  pepck was equally altered in  @TERM$2  gas1 compared to gas1 appendixfig s2d	0.99999344	6.604546e-06
30796049	age1	s2d	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of phosphoenolpyruvate carboxykinase pepck was equally altered in  @TERM$1  gas1 compared to gas1 appendixfig  @TERM$2 	0.9999665	3.345458e-05
30796049	phosphoenolpyruvate carboxykinase	s2d	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of  @TERM$1  pepck was equally altered in age1 gas1 compared to gas1 appendixfig  @TERM$2 	0.99999845	1.5718474e-06
30796049	phosphoenolpyruvate	gas1	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of  @TERM$1  carboxykinase pepck was equally altered in age1  @TERM$2  compared to gas1 appendixfig s2d	0.99999845	1.6043342e-06
30796049	pepck	gas1	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of phosphoenolpyruvate carboxykinase  @TERM$1  was equally altered in age1  @TERM$2  compared to gas1 appendixfig s2d	0.99999535	4.626741e-06
30796049	phosphoenolpyruvate	pepck	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of  @TERM$1  carboxykinase  @TERM$2  was equally altered in age1 gas1 compared to gas1 appendixfig s2d	0.99999595	4.083406e-06
30796049	aagr2	gas1	30796049	101	132	@TERM$1	@TERM$2	ydrate metabolism the alphaglucosidases aagr1 and  @TERM$1  were upregulated on mrna level in age1  @TERM$2  compared to gas1 appendixfig s2	0.9999981	1.940981e-06
30796049	age1	gas1	30796049	101	92	@TERM$1	@TERM$2	aagr1 and aagr2 were upregulated on mrna level in  @TERM$1   @TERM$2  compared to gas1 appendixfig s2	0.9999956	4.3664386e-06
30796049	aagr2	age1	30796049	101	132	@TERM$1	@TERM$2	ydrate metabolism the alphaglucosidases aagr1 and  @TERM$1  were upregulated on mrna level in  @TERM$2  gas1 compared to gas1 appendixfig s2	0.99999857	1.4124917e-06
30796049	carbohydrates	gas1	30796049	97	166	@TERM$1	@TERM$2	we observed a significant reduction in total  @TERM$1  however there were no differences in glucose levels between age1  @TERM$2  mutant and gas1 mutant animals fig2h	0.9999981	1.885094e-06
30796049	age1	glycogen	30796049	99	218	@TERM$1	@TERM$2	in  @TERM$1  gas1 compared to gas1 mutant animals we found that fatty acid oxidation gluconeogenesis and glycolysis were all upregulated whereas  @TERM$2  turnover ie lysis and synthesis was highly enhanced appendixfig s2b	0.9999951	4.9073037e-06
30796049	age1	s2b	30796049	99	218	@TERM$1	@TERM$2	in  @TERM$1  gas1 compared to gas1 mutant animals we found that fatty acid oxidation gluconeogenesis and glycolysis were all upregulated whereas glycogen turnover ie lysis and synthesis was highly enhanced appendixfig  @TERM$2 	0.9999974	2.6433825e-06
30796049	age1	fatty	30796049	99	218	@TERM$1	@TERM$2	in  @TERM$1  gas1 compared to gas1 mutant animals we found that  @TERM$2  acid oxidation gluconeogenesis and glycolysis were all upregulated whereas glycogen turnover ie lysis and synthesis was highly enhanced appendixfig s2b	0.9999982	1.7465958e-06
30796049	age1	gas1	30796049	99	218	@TERM$1	@TERM$2	in  @TERM$1   @TERM$2  compared to gas1 mutant animals we found that fatty acid oxidation gluconeogenesis and glycolysis were all upregulated whereas glycogen turnover ie lysis and synthesis was highly enhanced appendixfig s2b	0.99999774	2.2394602e-06
30796049	fatty	glycogen	30796049	99	218	@TERM$1	@TERM$2	in age1 gas1 compared to gas1 mutant animals we found that  @TERM$1  acid oxidation gluconeogenesis and glycolysis were all upregulated whereas  @TERM$2  turnover ie lysis and synthesis was highly enhanced appendixfig s2b	0.99999404	5.9544236e-06
30796049	gas1	glycogen	30796049	99	218	@TERM$1	@TERM$2	in age1  @TERM$1  compared to gas1 mutant animals we found that fatty acid oxidation gluconeogenesis and glycolysis were all upregulated whereas  @TERM$2  turnover ie lysis and synthesis was highly enhanced appendixfig s2b	0.9999918	8.206945e-06
30796049	fatty	s2b	30796049	99	218	@TERM$1	@TERM$2	in age1 gas1 compared to gas1 mutant animals we found that  @TERM$1  acid oxidation gluconeogenesis and glycolysis were all upregulated whereas glycogen turnover ie lysis and synthesis was highly enhanced appendixfig  @TERM$2 	0.9999982	1.7794976e-06
30796049	glycogen	s2b	30796049	99	218	@TERM$1	@TERM$2	in age1 gas1 compared to gas1 mutant animals we found that fatty acid oxidation gluconeogenesis and glycolysis were all upregulated whereas  @TERM$1  turnover ie lysis and synthesis was highly enhanced appendixfig  @TERM$2 	0.99998283	1.7218088e-05
30796049	gas1	s2b	30796049	99	218	@TERM$1	@TERM$2	in age1  @TERM$1  compared to gas1 mutant animals we found that fatty acid oxidation gluconeogenesis and glycolysis were all upregulated whereas glycogen turnover ie lysis and synthesis was highly enhanced appendixfig  @TERM$2 	0.9999788	2.1196265e-05
30796049	gas1	fatty	30796049	99	218	@TERM$1	@TERM$2	in age1  @TERM$1  compared to gas1 mutant animals we found that  @TERM$2  acid oxidation gluconeogenesis and glycolysis were all upregulated whereas glycogen turnover ie lysis and synthesis was highly enhanced appendixfig s2b	0.9999981	1.917627e-06
30796049	age1	gas1	30796049	97	166	@TERM$1	@TERM$2	we observed a significant reduction in total carbohydrates however there were no differences in glucose levels between  @TERM$1   @TERM$2  mutant and gas1 mutant animals fig2h	0.9999646	3.5349574e-05
30796049	iis	glucose	30796049	100	154	@TERM$1	@TERM$2	based on this pathway analysis it seems that  @TERM$1  inhibition supports the maintenance of  @TERM$2  through the engagement of multiple gluconeogenic processes	0.99999666	3.288219e-06
30796049	ndufs4	phb2	30796049	20	151	@TERM$1	@TERM$2	todes peng etal 2015 and alleviates pathology in  @TERM$1  knockout tk2 knockin podocytespecific  @TERM$2  knockout mitochondrial dna mutant and aifdeficient 	0.999979	2.1022677e-05
30796049	eif2	mtor	30796049	86	134	@TERM$1	@TERM$2	specifically  @TERM$1  eif4p70s6k and  @TERM$2  signaling pathways were significantly downregulated in age1 gas1 compared to gas1 mutants fig2b	0.9999956	4.427618e-06
30796049	gas1	ipa	30796049	84	138	@TERM$1	@TERM$2	to compare transcriptomic profiles from  @TERM$1  mutant and age1 gas1 double mutant animals we conducted an unbiased pathway analysis with  @TERM$2 	0.99999607	3.9853203e-06
30796049	age1	gas1	30796049	72	225	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionrepresentative lifespan of  @TERM$1   @TERM$2  nematodes fed with empty vector ev and fzo1 rnai bacteria	0.99999714	2.8611962e-06
30796049	post	gas1	30796049	72	225	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys  @TERM$1  hoc correctionrepresentative lifespan of age1  @TERM$2  nematodes fed with empty vector ev and fzo1 rnai bacteria	0.99999726	2.7879341e-06
30796049	sem	age1	30796049	72	225	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strain @TERM$1  pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionrepresentative lifespan of  @TERM$2  gas1 nematodes fed with empty vector ev and fzo1 rnai bacteria	0.9999974	2.5743e-06
30796049	sem	fzo1	30796049	72	225	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strain @TERM$1  pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionrepresentative lifespan of age1 gas1 nematodes fed with empty vector ev and  @TERM$2  rnai bacteria	0.9999908	9.179305e-06
30796049	sem	post	30796049	72	225	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strain @TERM$1  pvalue0001 pvalue00001 oneway anova tukeys  @TERM$2  hoc correctionrepresentative lifespan of age1 gas1 nematodes fed with empty vector ev and fzo1 rnai bacteria	0.99999547	4.4961075e-06
30796049	post	fzo1	30796049	72	225	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys  @TERM$1  hoc correctionrepresentative lifespan of age1 gas1 nematodes fed with empty vector ev and  @TERM$2  rnai bacteria	0.99999845	1.4924562e-06
30796049	post	age1	30796049	72	225	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys  @TERM$1  hoc correctionrepresentative lifespan of  @TERM$2  gas1 nematodes fed with empty vector ev and fzo1 rnai bacteria	0.99999297	7.04751e-06
30796049	gas1	post	30796049	69	215	@TERM$1	@TERM$2	right panel basal respiration in wt  @TERM$1  and age1 gas1 animals pooled from three biological replicates pvalue00001 nsnonsignificant kruskalwallis test dunns  @TERM$2  hoc correctionsted images of representative mitoc	0.99999714	2.9099947e-06
30796049	gas1	age1	30796049	69	99	@TERM$1	@TERM$2	right panel basal respiration in wt  @TERM$1  and  @TERM$2  gas1 animals pooled from three biological replica	0.99999523	4.727272e-06
30796049	age1	post	30796049	69	215	@TERM$1	@TERM$2	right panel basal respiration in wt gas1 and  @TERM$1  gas1 animals pooled from three biological replicates pvalue00001 nsnonsignificant kruskalwallis test dunns  @TERM$2  hoc correctionsted images of representative mitoc	0.99999213	7.906813e-06
30796049	sem	gas1	30796049	67	144	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue005 pvalue 0001 kruskalwallis test dunns post hoc correctionocr of  @TERM$2  and age1 gas1 mutant nematodes normalized to tof	0.999997	2.9702655e-06
30796049	age1	fzo1	30796049	72	225	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionrepresentative lifespan of  @TERM$1  gas1 nematodes fed with empty vector ev and  @TERM$2  rnai bacteria	0.9999968	3.2039436e-06
30796049	gas1	age1	30796049	67	144	@TERM$1	@TERM$2	bars meansem pvalue005 pvalue 0001 kruskalwallis test dunns post hoc correctionocr of  @TERM$1  and  @TERM$2  gas1 mutant nematodes normalized to tof	0.9999958	4.1464245e-06
30796049	sem	age1	30796049	67	144	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue005 pvalue 0001 kruskalwallis test dunns post hoc correctionocr of gas1 and  @TERM$2  gas1 mutant nematodes normalized to tof	0.99998057	1.9402965e-05
30796049	sem	post	30796049	67	144	@TERM$1	@TERM$2	bars mean @TERM$1  pvalue005 pvalue 0001 kruskalwallis test dunns  @TERM$2  hoc correctionocr of gas1 and age1 gas1 mutant nematodes normalized to tof	0.99999833	1.7215489e-06
30796049	post	age1	30796049	67	144	@TERM$1	@TERM$2	bars meansem pvalue005 pvalue 0001 kruskalwallis test dunns  @TERM$1  hoc correctionocr of gas1 and  @TERM$2  gas1 mutant nematodes normalized to tof	0.999997	2.9939843e-06
30796049	red	age1	30796049	66	246	@TERM$1	@TERM$2	shades of  @TERM$1  and green are proportional to fold change as calculated by ipalifespan analysis of mev1kn1 nematodes compared to wt  @TERM$2 hx546 and age1hx546 mev1kn1 animalsatp measurements in wt age1 gas1 and age1 gas1 mutant nematodes normalized to	0.99999595	4.038189e-06
30796049	age1	gas1	30796049	66	109	@TERM$1	@TERM$2	d  @TERM$1 hx546 mev1kn1 animalsatp measurements in wt age1  @TERM$2  and age1 gas1 mutant nematodes normalized to wt n	0.9999981	1.9194183e-06
30796049	iis	ipa	30796049	65	175	@TERM$1	@TERM$2	cutoffs 20 fdr and log2fold change0345 in redschematic representation of  @TERM$1  pathway including results and predictions from  @TERM$2  of phosphoproteome of gas1fc21 compared to wt	0.99999785	2.1329743e-06
30796049	post	daf16	30796049	63	224	@TERM$1	@TERM$2	sem n3 pvalue00001 kruskalwallis test dunns  @TERM$1  hoc correctionrepresentative curves show the lifespan of wt and gas1fc21 nematodes compared to b age1 and age1 gas1 mutants and c  @TERM$2  and daf16 age1 gas1 mutant animal	0.99999774	2.324328e-06
30796049	age1	gas1	30796049	63	118	@TERM$1	@TERM$2	fespan of wt and  @TERM$2 fc21 nematodes compared to b  @TERM$1  and age1 gas1 mutants and c daf16 and daf16 age1 gas1 mutant an	0.9999989	1.1207488e-06
30796049	gas1	daf16	30796049	63	108	@TERM$1	@TERM$2	nd  @TERM$1 fc21 nematodes compared to b age1 and age1 gas1 mutants and c  @TERM$2  and daf16 age1 gas1 mutant animal	0.9999938	6.240205e-06
30796049	post	gas1	30796049	63	220	@TERM$1	@TERM$2	sem n3 pvalue00001 kruskalwallis test dunns  @TERM$1  hoc correctionrepresentative curves show the lifespan of wt and  @TERM$2 fc21 nematodes compared to b age1 and age1 gas1 mutants and c daf16 and daf16 age1 gas1 mutant an	0.9999987	1.3547655e-06
30796049	sem	age1	30796049	63	244	@TERM$1	@TERM$2	one representative curve is shown mean @TERM$1  n3 pvalue00001 kruskalwallis test dunns post hoc correctionrepresentative curves show the lifespan of wt and gas1fc21 nematodes compared to b  @TERM$2  and age1 gas1 mutants and c daf16 and daf16 age1 	0.99999666	3.281274e-06
30796049	post	gas1	30796049	67	144	@TERM$1	@TERM$2	bars meansem pvalue005 pvalue 0001 kruskalwallis test dunns  @TERM$1  hoc correctionocr of  @TERM$2  and age1 gas1 mutant nematodes normalized to tof	0.9999988	1.1550974e-06
30796049	age1	ipa	30796049	84	138	@TERM$1	@TERM$2	to compare transcriptomic profiles from gas1 mutant and  @TERM$1  gas1 double mutant animals we conducted an unbiased pathway analysis with  @TERM$2 	0.9999969	3.129447e-06
30796049	sem	gas1	30796049	72	225	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strain @TERM$1  pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionrepresentative lifespan of age1  @TERM$2  nematodes fed with empty vector ev and fzo1 rnai bacteria	0.9999974	2.6728233e-06
30796049	age1	gas1	30796049	74	171	@TERM$1	@TERM$2	for all panels wtwild type a @TERM$1  g @TERM$2  a gage1 gas1we wondered whether the increased longevity of age1 gas1 mutants could be due to improved mitochondrial function	0.99999774	2.2739714e-06
30796049	gas1	age1	30796049	84	138	@TERM$1	@TERM$2	to compare transcriptomic profiles from  @TERM$1  mutant and  @TERM$2  gas1 double mutant animals we conducted an unbiased pathway analysis with ipa	0.99999905	1.0082996e-06
30796049	gas1	iis	30796049	83	213	@TERM$1	@TERM$2	however most of the dysregulated gene expression in  @TERM$1  mutants was not rescued upon  @TERM$2  inhibition with only approximately 13 of genes dysregulated in gas1 reverting back to wt levels in age1 gas1 mutants fig2a	0.99999857	1.3791295e-06
30796049	iis	age1	30796049	83	213	@TERM$1	@TERM$2	however most of the dysregulated gene expression in gas1 mutants was not rescued upon  @TERM$1  inhibition with only approximately 13 of genes dysregulated in gas1 reverting back to wt levels in  @TERM$2  gas1 mutants fig2a	0.9999974	2.5932043e-06
30796049	gas1	age1	30796049	83	213	@TERM$1	@TERM$2	however most of the dysregulated gene expression in  @TERM$1  mutants was not rescued upon iis inhibition with only approximately 13 of genes dysregulated in gas1 reverting back to wt levels in  @TERM$2  gas1 mutants fig2a	0.9999975	2.4771023e-06
30796049	gas1	age1	30796049	82	157	@TERM$1	@TERM$2	a global analysis of the genomewide expression profiling revealed that over 2800 genes were significantly dysregulated in  @TERM$1  versus  @TERM$2  gas1 mutants 5 fdr	0.99999726	2.7372796e-06
30796049	genomewide	age1	30796049	82	157	@TERM$1	@TERM$2	a global analysis of the  @TERM$1  expression profiling revealed that over 2800 genes were significantly dysregulated in gas1 versus  @TERM$2  gas1 mutants 5 fdr	0.9999975	2.4630156e-06
30796049	genomewide	gas1	30796049	82	157	@TERM$1	@TERM$2	a global analysis of the  @TERM$1  expression profiling revealed that over 2800 genes were significantly dysregulated in  @TERM$2  versus age1 gas1 mutants 5 fdr	0.9999633	3.670879e-05
30796049	iis	atp	30796049	81	128	@TERM$1	@TERM$2	taken together our findings suggest that  @TERM$1  inhibition is associated with  @TERM$2  maintenance results in a more fused mitochondrial	0.9999987	1.3001023e-06
30796049	age1	gas1	30796049	81	109	@TERM$1	@TERM$2	desto gain insight into the mechanisms underlying  @TERM$1   @TERM$2  longevity we performed mrna nextgeneration sequen	0.9999988	1.2340223e-06
30796049	weir	age1	30796049	78	166	@TERM$1	@TERM$2	etal 2011 chaudhari  kipreos 2017 han etal 2017  @TERM$1  etal 2017 we reasoned that a more fused mitochondrial network may play a causative role for  @TERM$2  gas1 longevit	0.9999987	1.3297814e-06
30796049	weir	gas1	30796049	78	166	@TERM$1	@TERM$2	etal 2011 chaudhari  kipreos 2017 han etal 2017  @TERM$1  etal 2017 we reasoned that a more fused mitochondrial network may play a causative role for age1  @TERM$2  longevit	0.9980726	0.0019273234
30796049	gas1	fzo1	30796049	72	225	@TERM$1	@TERM$2	right panel values of the maximum total recovery per strainsem pvalue0001 pvalue00001 oneway anova tukeys post hoc correctionrepresentative lifespan of age1  @TERM$1  nematodes fed with empty vector ev and  @TERM$2  rnai bacteria	0.99999833	1.7275602e-06
30796049	age1	gas1	30796049	78	68	@TERM$1	@TERM$2	tochondrial network may play a causative role for  @TERM$1   @TERM$2  longevit	0.99999833	1.6124129e-06
30796049	frap	gfp	30796049	77	155	@TERM$1	@TERM$2	py and fluorescence recovery after photobleaching  @TERM$1  experiments in animals expressing a mitochondrial  @TERM$2  in the muscle fig1i and j and appendixfig s1	0.99999845	1.594093e-06
30796049	age1	atp	30796049	76	179	@TERM$1	@TERM$2	compared to gas1 mutants  @TERM$1  gas1 double mutant nematodes exhibited a large increase of  @TERM$2  levels despite the lack of improvement in basal mitochondrial respiration fig1g and h	0.9999932	6.838152e-06
30796049	gas1	atp	30796049	76	179	@TERM$1	@TERM$2	compared to  @TERM$1  mutants age1 gas1 double mutant nematodes exhibited a large increase of  @TERM$2  levels despite the lack of improvement in basal mitochondrial respiration fig1g and h	0.99993336	6.669305e-05
30796049	gas1	age1	30796049	76	179	@TERM$1	@TERM$2	compared to  @TERM$1  mutants  @TERM$2  gas1 double mutant nematodes exhibited a large increase of atp levels despite the lack of improvement in basal mitochondrial respiration fig1g and h	0.9999901	9.927489e-06
30796049	ocr	age1	30796049	75	77	@TERM$1	@TERM$2	we measured atp and oxygen consumption rate  @TERM$1  in gas1 and  @TERM$2  gas1 mutants	0.9999764	2.3563087e-05
30796049	atp	gas1	30796049	75	77	@TERM$1	@TERM$2	we measured  @TERM$1  and oxygen consumption rate ocr in  @TERM$2  and age1 gas1 mutants	0.9999975	2.4607427e-06
30796049	gas1	age1	30796049	75	77	@TERM$1	@TERM$2	we measured atp and oxygen consumption rate ocr in  @TERM$1  and  @TERM$2  gas1 mutants	0.9999894	1.0584786e-05
30796049	atp	age1	30796049	75	77	@TERM$1	@TERM$2	we measured  @TERM$1  and oxygen consumption rate ocr in gas1 and  @TERM$2  gas1 mutants	0.9999981	1.8573822e-06
30796049	ocr	gas1	30796049	75	77	@TERM$1	@TERM$2	we measured atp and oxygen consumption rate  @TERM$1  in  @TERM$2  and age1 gas1 mutants	0.9999981	1.8750517e-06
30796049	atp	ocr	30796049	75	77	@TERM$1	@TERM$2	we measured  @TERM$1  and oxygen consumption rate  @TERM$2  in gas1 and age1 gas1 mutants	0.9999876	1.242559e-05
30796049	pepck	s2d	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of phosphoenolpyruvate carboxykinase  @TERM$1  was equally altered in age1 gas1 compared to gas1 appendixfig  @TERM$2 	0.999726	0.0002740358
30796049	pathology	ndufs4	30796049	20	122	@TERM$1	@TERM$2	eficient nematodes peng etal 2015 and alleviates  @TERM$1  in  @TERM$2  knockout tk2 knockin podocytespecific phb2 knockout 	0.99999774	2.2539314e-06
30796049	phosphoenolpyruvate carboxykinase	pepck	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of  @TERM$1   @TERM$2  was equally altered in age1 gas1 compared to gas1 appendixfig s2d	0.99999046	9.576156e-06
30796049	dehydrogenase	xanthine oxidase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that xanthine  @TERM$1  xdh1 was significantly reduced in age1 gas1 compared to gas1 mutant animals while  @TERM$2  activity was not significantly affected fig4d	0.9999927	7.2282846e-06
30796049	xanthine	age1	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that  @TERM$1  dehydrogenase xdh1 was significantly reduced in  @TERM$2  gas1 compared to gas1 mutant animals while xanthine oxidase activity was not significantly affected fig4d	0.99999225	7.793589e-06
30796049	dehydrogenase	age1	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that xanthine  @TERM$1  xdh1 was significantly reduced in  @TERM$2  gas1 compared to gas1 mutant animals while xanthine oxidase activity was not significantly affected fig4d	0.9999976	2.3282923e-06
30796049	xanthine	dehydrogenase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that  @TERM$1   @TERM$2  xdh1 was significantly reduced in age1 gas1 compared to gas1 mutant animals while xanthine oxidase activity was not significantly affected fig4d	0.9999982	1.8348192e-06
30796049	age1	gas1	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that xanthine dehydrogenase xdh1 was significantly reduced in  @TERM$1   @TERM$2  compared to gas1 mutant animals while xanthine oxidase activity was not significantly affected fig4d	0.9999976	2.3356267e-06
30796049	xanthine dehydrogenase	xanthine	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that  @TERM$1  xdh1 was significantly reduced in age1 gas1 compared to gas1 mutant animals while  @TERM$2  oxidase activity was not significantly affected fig4d	0.9999981	1.8922483e-06
30796049	xanthine dehydrogenase	age1	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that  @TERM$1  xdh1 was significantly reduced in  @TERM$2  gas1 compared to gas1 mutant animals while xanthine oxidase activity was not significantly affected fig4d	0.99999857	1.4760861e-06
30796049	gas1	oxidase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that xanthine dehydrogenase xdh1 was significantly reduced in age1  @TERM$1  compared to gas1 mutant animals while xanthine  @TERM$2  activity was not significantly affected fig4d	0.99977976	0.00022022743
30796049	gas1	xanthine oxidase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that xanthine dehydrogenase xdh1 was significantly reduced in age1  @TERM$1  compared to gas1 mutant animals while  @TERM$2  activity was not significantly affected fig4d	0.9999728	2.7174054e-05
30796049	xanthine	oxidase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that  @TERM$1  dehydrogenase xdh1 was significantly reduced in age1 gas1 compared to gas1 mutant animals while xanthine  @TERM$2  activity was not significantly affected fig4d	0.99997175	2.824878e-05
30796049	dehydrogenase	gas1	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that xanthine  @TERM$1  xdh1 was significantly reduced in age1  @TERM$2  compared to gas1 mutant animals while xanthine oxidase activity was not significantly affected fig4d	0.99999726	2.687033e-06
30796049	xanthine	gas1	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that  @TERM$1  dehydrogenase xdh1 was significantly reduced in age1  @TERM$2  compared to gas1 mutant animals while xanthine oxidase activity was not significantly affected fig4d	0.9999981	1.8553145e-06
30796049	xanthine dehydrogenase	xanthine oxidase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that  @TERM$1  xdh1 was significantly reduced in age1 gas1 compared to gas1 mutant animals while  @TERM$2  activity was not significantly affected fig4d	0.99976677	0.00023327305
30796049	xanthine	xanthine oxidase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that  @TERM$1  dehydrogenase xdh1 was significantly reduced in age1 gas1 compared to gas1 mutant animals while  @TERM$2  activity was not significantly affected fig4d	0.99998605	1.4005234e-05
30796049	age1	oxidase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that xanthine dehydrogenase xdh1 was significantly reduced in  @TERM$1  gas1 compared to gas1 mutant animals while xanthine  @TERM$2  activity was not significantly affected fig4d	0.9997917	0.00020832258
30796049	age1	xanthine oxidase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that xanthine dehydrogenase xdh1 was significantly reduced in  @TERM$1  gas1 compared to gas1 mutant animals while  @TERM$2  activity was not significantly affected fig4d	0.9999925	7.4793998e-06
30796049	xanthine dehydrogenase	oxidase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that  @TERM$1  xdh1 was significantly reduced in age1 gas1 compared to gas1 mutant animals while xanthine  @TERM$2  activity was not significantly affected fig4d	0.9224987	0.077501364
30796049	xanthine	dehydrogenase	30796049	173	205	@TERM$1	@TERM$2	these data point toward a scenario in which  @TERM$1  buildup occurs through inhibition of xanthine  @TERM$2  ie xanthine degradation and not through activation of xanthine oxidase ie xanthine synthesis	0.9999827	1.7322753e-05
30796049	dehydrogenase	oxidase	30796049	173	205	@TERM$1	@TERM$2	these data point toward a scenario in which xanthine buildup occurs through inhibition of xanthine  @TERM$1  ie xanthine degradation and not through activation of xanthine  @TERM$2  ie xanthine synthesis	0.9999814	1.8642162e-05
30796049	xanthine	oxidase	30796049	173	205	@TERM$1	@TERM$2	these data point toward a scenario in which  @TERM$1  buildup occurs through inhibition of xanthine dehydrogenase ie xanthine degradation and not through activation of xanthine  @TERM$2  ie xanthine synthesis	0.999995	4.967697e-06
30796049	dehydrogenase	xanthine oxidase	30796049	173	205	@TERM$1	@TERM$2	these data point toward a scenario in which xanthine buildup occurs through inhibition of xanthine  @TERM$1  ie xanthine degradation and not through activation of  @TERM$2  ie xanthine synthesis	0.9999962	3.8574376e-06
30796049	dehydrogenase	oxidase	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that xanthine  @TERM$1  xdh1 was significantly reduced in age1 gas1 compared to gas1 mutant animals while xanthine  @TERM$2  activity was not significantly affected fig4d	0.99999547	4.5839806e-06
30796049	xanthine dehydrogenase	gas1	30796049	172	200	@TERM$1	@TERM$2	consistently qrtpcr showed that  @TERM$1  xdh1 was significantly reduced in age1  @TERM$2  compared to gas1 mutant animals while xanthine oxidase activity was not significantly affected fig4d	0.99999654	3.4409497e-06
30796049	ipa	age1	30796049	171	164	@TERM$1	@TERM$2	based on the  @TERM$1  of the transcriptomic data it seems that the observed xanthine buildup is a consequence of increased purine degradation in  @TERM$2  gas1 animals fig4c	0.99999785	2.1302544e-06
30796049	xanthine	gas1	30796049	171	164	@TERM$1	@TERM$2	based on the ipa of the transcriptomic data it seems that the observed  @TERM$1  buildup is a consequence of increased purine degradation in age1  @TERM$2  animals fig4c	0.9999988	1.2472452e-06
30796049	sem	frap	30796049	161	169	@TERM$1	@TERM$2	bars mean @TERM$1  n4 pvalue005 mannwhitney utestleft panel curves represent  @TERM$2  in age1 gas1 animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.99996674	3.3230415e-05
30796049	sem	fzo1	30796049	161	169	@TERM$1	@TERM$2	bars mean @TERM$1  n4 pvalue005 mannwhitney utestleft panel curves represent frap in age1 gas1 animals grown on rnai from larval l1 or from egg for  @TERM$2  rnai to l4 stage	0.9999975	2.49614e-06
30796049	frap	gas1	30796049	161	169	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestleft panel curves represent  @TERM$1  in age1  @TERM$2  animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.9999584	4.1605985e-05
30796049	frap	fzo1	30796049	161	169	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestleft panel curves represent  @TERM$1  in age1 gas1 animals grown on rnai from larval l1 or from egg for  @TERM$2  rnai to l4 stage	0.99999833	1.715462e-06
30796049	sem	age1	30796049	161	169	@TERM$1	@TERM$2	bars mean @TERM$1  n4 pvalue005 mannwhitney utestleft panel curves represent frap in  @TERM$2  gas1 animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.99999845	1.6021997e-06
30796049	age1	gas1	30796049	161	169	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestleft panel curves represent frap in  @TERM$1   @TERM$2  animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.99999857	1.3972317e-06
30796049	age1	fzo1	30796049	161	169	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestleft panel curves represent frap in  @TERM$1  gas1 animals grown on rnai from larval l1 or from egg for  @TERM$2  rnai to l4 stage	0.99936575	0.0006342823
30796049	sem	gas1	30796049	161	169	@TERM$1	@TERM$2	bars mean @TERM$1  n4 pvalue005 mannwhitney utestleft panel curves represent frap in age1  @TERM$2  animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.9999856	1.4472806e-05
30796049	gas1	fzo1	30796049	161	169	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestleft panel curves represent frap in age1  @TERM$1  animals grown on rnai from larval l1 or from egg for  @TERM$2  rnai to l4 stage	0.999998	2.0217894e-06
30796049	frap	age1	30796049	161	169	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestleft panel curves represent  @TERM$1  in  @TERM$2  gas1 animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.9999944	5.635505e-06
30796049	age1	gas1	30796049	167	140	@TERM$1	@TERM$2	we reasoned that enhanced catabolism would result in different metabolic profiles in  @TERM$1   @TERM$2  double mutant compared to gas1 mutant animals	0.9999939	6.1125797e-06
30796049	age1	triacylglycerols	30796049	168	231	@TERM$1	@TERM$2	first we performed a lipid analysis and to our surprise found that the lipid profiling showed only minor differences between gas1 and  @TERM$1  gas1 mutants with no significant reduction of the storage lipid  @TERM$2  tags fig4a	0.9999368	6.31213e-05
30796049	age1	tags	30796049	168	231	@TERM$1	@TERM$2	first we performed a lipid analysis and to our surprise found that the lipid profiling showed only minor differences between gas1 and  @TERM$1  gas1 mutants with no significant reduction of the storage lipid triacylglycerols  @TERM$2  fig4a	0.9999852	1.4779688e-05
30796049	gas1	triacylglycerols	30796049	168	231	@TERM$1	@TERM$2	first we performed a lipid analysis and to our surprise found that the lipid profiling showed only minor differences between  @TERM$1  and age1 gas1 mutants with no significant reduction of the storage lipid  @TERM$2  tags fig4a	0.99999094	9.061496e-06
30796049	gas1	age1	30796049	168	231	@TERM$1	@TERM$2	first we performed a lipid analysis and to our surprise found that the lipid profiling showed only minor differences between  @TERM$1  and  @TERM$2  gas1 mutants with no significant reduction of the storage lipid triacylglycerols tags fig4a	0.9999988	1.2235973e-06
30796049	gas1	tags	30796049	168	231	@TERM$1	@TERM$2	first we performed a lipid analysis and to our surprise found that the lipid profiling showed only minor differences between  @TERM$1  and age1 gas1 mutants with no significant reduction of the storage lipid triacylglycerols  @TERM$2  fig4a	0.99999833	1.7015458e-06
30796049	age1	gas1	30796049	170	225	@TERM$1	@TERM$2	on the metabolite level an nmr targeted profiling on nematode lysates showed only few changes with an almost sixfold increase in xanthine being the most prominent alteration in  @TERM$1   @TERM$2  compared to gas1 mutant animals fig4b	0.9999889	1.1092025e-05
30796049	xanthine	gas1	30796049	170	225	@TERM$1	@TERM$2	on the metabolite level an nmr targeted profiling on nematode lysates showed only few changes with an almost sixfold increase in  @TERM$1  being the most prominent alteration in age1  @TERM$2  compared to gas1 mutant animals fig4b	0.9999939	6.1125797e-06
30796049	xanthine	age1	30796049	170	225	@TERM$1	@TERM$2	on the metabolite level an nmr targeted profiling on nematode lysates showed only few changes with an almost sixfold increase in  @TERM$1  being the most prominent alteration in  @TERM$2  gas1 compared to gas1 mutant animals fig4b	0.9999962	3.8574376e-06
30796049	ipa	xanthine	30796049	171	164	@TERM$1	@TERM$2	based on the  @TERM$1  of the transcriptomic data it seems that the observed  @TERM$2  buildup is a consequence of increased purine degradation in age1 gas1 animals fig4c	0.99999726	2.687033e-06
30796049	xanthine	age1	30796049	171	164	@TERM$1	@TERM$2	based on the ipa of the transcriptomic data it seems that the observed  @TERM$1  buildup is a consequence of increased purine degradation in  @TERM$2  gas1 animals fig4c	0.999997	3.0198296e-06
30796049	ipa	gas1	30796049	171	164	@TERM$1	@TERM$2	based on the  @TERM$1  of the transcriptomic data it seems that the observed xanthine buildup is a consequence of increased purine degradation in age1  @TERM$2  animals fig4c	0.9999889	1.1092025e-05
30796049	age1	gas1	30796049	171	164	@TERM$1	@TERM$2	based on the ipa of the transcriptomic data it seems that the observed xanthine buildup is a consequence of increased purine degradation in  @TERM$1   @TERM$2  animals fig4c	0.9999981	1.8553145e-06
30796049	triacylglycerols	tags	30796049	168	231	@TERM$1	@TERM$2	first we performed a lipid analysis and to our surprise found that the lipid profiling showed only minor differences between gas1 and age1 gas1 mutants with no significant reduction of the storage lipid  @TERM$1   @TERM$2  fig4a	0.99998605	1.4005234e-05
30796049	xanthine	xanthine oxidase	30796049	173	205	@TERM$1	@TERM$2	these data point toward a scenario in which  @TERM$1  buildup occurs through inhibition of xanthine dehydrogenase ie xanthine degradation and not through activation of  @TERM$2  ie xanthine synthesis	0.9997917	0.00020832258
30796049	xanthine	xanthine dehydrogenase	30796049	173	205	@TERM$1	@TERM$2	these data point toward a scenario in which  @TERM$1  buildup occurs through inhibition of  @TERM$2  ie xanthine degradation and not through activation of xanthine oxidase ie xanthine synthesis	0.9224987	0.077501364
30796049	ndufa9	dmso	30796049	183	143	@TERM$1	@TERM$2	akt phosphopras40 t246 and total pras40 in wt and  @TERM$1  ko hap1 cells treated with 02  @TERM$2   or amp 2m enpf 2m and ptx 36m  for 24h acti	0.9999827	1.7322753e-05
30796049	pan	actin	30796049	183	248	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.9999814	1.8642162e-05
30796049	pan	ndufa9	30796049	183	160	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and  @TERM$2  ko hap1 cells treated with 02 dmso  or amp 2m e	0.999995	4.967697e-06
30796049	methylxanthines	akt	30796049	183	192	@TERM$1	@TERM$2	testschematic representations of xanthine and the  @TERM$1  used in this studyimmunoblot analysis of phospho @TERM$2  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 	0.99999547	4.5839806e-06
30796049	t246	dmso	30796049	183	173	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phosphopras40  @TERM$1  and total pras40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$2   or amp 2m enpf 2m and ptx 36m  for 24h ac	0.999998	2.0217894e-06
30796049	sem	pan	30796049	183	228	@TERM$1	@TERM$2	bars mean @TERM$1  n2 nsnonsignificant mannwhitney utestschematic representations of xanthine and the methylxanthines used in this studyimmunoblot analysis of phosphoakt s473  @TERM$2  akt phosphopras40 t246 and total pras40 in wt and	0.99999654	3.4409497e-06
30796049	t246	pras40	30796049	183	121	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phospho @TERM$2   @TERM$1  and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dm	0.99999785	2.1302544e-06
30796049	akt	ptx	30796049	183	222	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot a	0.99976677	0.00023327305
30796049	sem	methylxanthines	30796049	183	167	@TERM$1	@TERM$2	bars mean @TERM$1  n2 nsnonsignificant mannwhitney utestschematic representations of xanthine and the  @TERM$2  used in this studyimmunoblot analysis of phosphoa	0.99999475	5.2061005e-06
30796049	pras40	actin	30796049	183	212	@TERM$1	@TERM$2	sphoakt s473 pan akt phospho @TERM$1  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka s	0.99999785	2.1038584e-06
30796049	pras40	ndufa9	30796049	183	123	@TERM$1	@TERM$2	sphoakt s473 pan akt phospho @TERM$1  t246 and total pras40 in wt and  @TERM$2  ko hap1 cells treated with 02 dmso  or amp 2m e	0.9999893	1.0729714e-05
30796049	akt	amp	30796049	183	199	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin load	0.99999404	5.974811e-06
30796049	methylxanthines	pan	30796049	183	188	@TERM$1	@TERM$2	testschematic representations of xanthine and the  @TERM$1  used in this studyimmunoblot analysis of phosphoakt s473  @TERM$2  akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko h	0.99822587	0.0017741158
30796049	ndufa9	actin	30796049	183	195	@TERM$1	@TERM$2	akt phosphopras40 t246 and total pras40 in wt and  @TERM$1  ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka s	0.999908	9.197187e-05
30796049	pan	pras40	30796049	183	143	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phospho @TERM$2  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dm	0.9997948	0.0002052553
30796049	dmso	ptx	30796049	183	136	@TERM$1	@TERM$2	40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$1   or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot an	0.99999833	1.6692333e-06
30796049	t246	actin	30796049	183	226	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phosphopras40  @TERM$1  and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and ptx 36m  for 24h  @TERM$2  loading controlimmunoblot analysis of phosphopka 	0.9999981	1.9006656e-06
30796049	t246	ndufa9	30796049	183	138	@TERM$1	@TERM$2	analysis of phosphoakt s473 pan akt phosphopras40  @TERM$1  and total pras40 in wt and  @TERM$2  ko hap1 cells treated with 02 dmso  or amp 2m e	0.9999937	6.333651e-06
30796049	methylxanthines	pras40	30796049	183	225	@TERM$1	@TERM$2	testschematic representations of xanthine and the  @TERM$1  used in this studyimmunoblot analysis of phosphoakt s473 pan akt phospho @TERM$2  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or am	0.99999416	5.8846044e-06
30796049	xanthine	pan	30796049	183	198	@TERM$1	@TERM$2	ant mannwhitney utestschematic representations of  @TERM$1  and the methylxanthines used in this studyimmunoblot analysis of phosphoakt s473  @TERM$2  akt phosphopras40 t246 and total pras40 in wt and nduf	0.9999982	1.7570993e-06
30796049	sem	akt	30796049	183	232	@TERM$1	@TERM$2	bars mean @TERM$1  n2 nsnonsignificant mannwhitney utestschematic representations of xanthine and the methylxanthines used in this studyimmunoblot analysis of phospho @TERM$2  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndu	0.99997723	2.2803542e-05
30796049	xanthine	methylxanthines	30796049	183	132	@TERM$1	@TERM$2	ant mannwhitney utestschematic representations of  @TERM$1  and the  @TERM$2  used in this studyimmunoblot analysis of phosphoa	0.99999094	9.085222e-06
30796049	pras40	ptx	30796049	183	192	@TERM$1	@TERM$2	sphoakt s473 pan akt phospho @TERM$1  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot anal	0.99997175	2.824878e-05
30796049	pras40	amp	30796049	183	169	@TERM$1	@TERM$2	sphoakt s473 pan akt phospho @TERM$1  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin loading	0.9999981	1.9289826e-06
30796049	pan	amp	30796049	183	203	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$2  2m enpf 2m and ptx 36m  for 24h actin load	0.9999963	3.7435377e-06
30796049	age1	sem	30796049	160	203	@TERM$1	@TERM$2	osubstraterepresentative lifespan assay of wt and  @TERM$1  gas1 nematodes fed with empty vector ev and kin1 rnai bacteria with average median lifespans @TERM$2  from all replicates indicated beneath representati	0.99997294	2.7012542e-05
30796049	amp	ptx	30796049	183	126	@TERM$1	@TERM$2	and ndufa9 ko hap1 cells treated with 02 dmso  or  @TERM$1  2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot a	0.9999747	2.5317917e-05
30796049	xanthine	pras40	30796049	183	235	@TERM$1	@TERM$2	ant mannwhitney utestschematic representations of  @TERM$1  and the methylxanthines used in this studyimmunoblot analysis of phosphoakt s473 pan akt phospho @TERM$2  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso	0.99999154	8.421692e-06
30796049	xanthine dehydrogenase	oxidase	30796049	173	205	@TERM$1	@TERM$2	these data point toward a scenario in which xanthine buildup occurs through inhibition of  @TERM$1  ie xanthine degradation and not through activation of xanthine  @TERM$2  ie xanthine synthesis	0.999998	2.0135174e-06
30796049	xanthine dehydrogenase	xanthine oxidase	30796049	173	205	@TERM$1	@TERM$2	these data point toward a scenario in which xanthine buildup occurs through inhibition of  @TERM$1  ie xanthine degradation and not through activation of  @TERM$2  ie xanthine synthesis	0.9999982	1.8456544e-06
30796049	gas1	age1	30796049	174	68	@TERM$1	@TERM$2	volcano plot of lipidomic profiling in  @TERM$1  versus  @TERM$2  gas1 mutants	0.99999857	1.4756414e-06
30796049	age1	gas1	30796049	175	148	@TERM$1	@TERM$2	red stars significantly altered lipids in  @TERM$1   @TERM$2  versus gas1 5 fdr n5nmr1d targeted metabolic profiling in age1 gas1 mutants normalized to gas1	0.999964	3.5949088e-05
30796049	red	age1	30796049	175	148	@TERM$1	@TERM$2	 @TERM$1  stars significantly altered lipids in  @TERM$2  gas1 versus gas1 5 fdr n5nmr1d targeted metabolic profiling in age1 gas1 mutants normalized to gas1	0.9999901	9.9311255e-06
30796049	red	gas1	30796049	175	148	@TERM$1	@TERM$2	 @TERM$1  stars significantly altered lipids in age1  @TERM$2  versus gas1 5 fdr n5nmr1d targeted metabolic profiling in age1 gas1 mutants normalized to gas1	0.9999728	2.7201953e-05
30796049	map	age1	30796049	178	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor  @TERM$1  analysis showing increased purine degradation in  @TERM$2  gas1 mutants and the consequent xanthine accumulation	0.9999976	2.4175893e-06
30796049	map	xanthine	30796049	178	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor  @TERM$1  analysis showing increased purine degradation in age1 gas1 mutants and the consequent  @TERM$2  accumulation	0.9999709	2.9033614e-05
30796049	sem	age1	30796049	178	226	@TERM$1	@TERM$2	bar mean @TERM$1  n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in  @TERM$2  gas1 mutants and the consequent xanthine accumulation	0.99994326	5.6747667e-05
30796049	map	gas1	30796049	178	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor  @TERM$1  analysis showing increased purine degradation in age1  @TERM$2  mutants and the consequent xanthine accumulation	0.9999976	2.4175893e-06
30796049	age1	xanthine	30796049	178	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in  @TERM$1  gas1 mutants and the consequent  @TERM$2  accumulation	0.99998486	1.5178356e-05
30796049	akt	dmso	30796049	183	191	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$2   or amp 2m enpf 2m and ptx 36m  for 24h ac	0.9999808	1.9173865e-05
30796049	age1	gas1	30796049	178	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in  @TERM$1   @TERM$2  mutants and the consequent xanthine accumulation	0.9999616	3.8325332e-05
30796049	sem	map	30796049	178	226	@TERM$1	@TERM$2	bar mean @TERM$1  n7schematic representation of purine degradation pathway with overlaid molecule activity predictor  @TERM$2  analysis showing increased purine degradation in age1 gas1 mutants and the consequent xanthine accumulation	0.9999865	1.3517892e-05
30796049	sem	xanthine	30796049	178	226	@TERM$1	@TERM$2	bar mean @TERM$1  n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in age1 gas1 mutants and the consequent  @TERM$2  accumulation	0.9999809	1.9049363e-05
30796049	gas1	xanthine	30796049	178	226	@TERM$1	@TERM$2	bar meansem n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in age1  @TERM$1  mutants and the consequent  @TERM$2  accumulation	0.999995	5.0421263e-06
30796049	xanthine	oxidase	30796049	182	66	@TERM$1	@TERM$2	right  @TERM$1   @TERM$2  activity levels normalized to animal number	0.9999974	2.6337925e-06
30796049	akt	ndufa9	30796049	183	156	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40 t246 and total pras40 in wt and  @TERM$2  ko hap1 cells treated with 02 dmso  or amp 2m e	0.99999607	3.885504e-06
30796049	pras40	dmso	30796049	183	160	@TERM$1	@TERM$2	sphoakt s473 pan akt phospho @TERM$1  t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02  @TERM$2   or amp 2m enpf 2m and ptx 36m  for 24h acti	0.9999962	3.7825826e-06
30796049	akt	t246	30796049	183	122	@TERM$1	@TERM$2	s studyimmunoblot analysis of phospho @TERM$1  s473 pan akt phosphopras40  @TERM$2  and total pras40 in wt and ndufa9 ko hap1 cells t	0.9999882	1.1849172e-05
30796049	pan	ptx	30796049	183	226	@TERM$1	@TERM$2	 this studyimmunoblot analysis of phosphoakt s473  @TERM$1  akt phosphopras40 t246 and total pras40 in wt and ndufa9 ko hap1 cells treated with 02 dmso  or amp 2m enpf 2m and  @TERM$2  36m  for 24h actin loading controlimmunoblot a	0.999969	3.0969084e-05
30796049	xanthine	t246	30796049	183	220	@TERM$1	@TERM$2	ant mannwhitney utestschematic representations of  @TERM$1  and the methylxanthines used in this studyimmunoblot analysis of phosphoakt s473 pan akt phosphopras40  @TERM$2  and total pras40 in wt and ndufa9 ko hap1 cells treat	0.99999666	3.3746535e-06
30796049	sem	gas1	30796049	178	226	@TERM$1	@TERM$2	bar mean @TERM$1  n7schematic representation of purine degradation pathway with overlaid molecule activity predictor map analysis showing increased purine degradation in age1  @TERM$2  mutants and the consequent xanthine accumulation	0.99999666	3.3234815e-06
30796049	gas1	sem	30796049	160	198	@TERM$1	@TERM$2	traterepresentative lifespan assay of wt and age1  @TERM$1  nematodes fed with empty vector ev and kin1 rnai bacteria with average median lifespans @TERM$2  from all replicates indicated beneath representati	0.999995	4.9838877e-06
30796049	age1	gas1	30796049	160	109	@TERM$1	@TERM$2	osubstraterepresentative lifespan assay of wt and  @TERM$1   @TERM$2  nematodes fed with empty vector ev and kin1 rnai 	0.99999714	2.8216634e-06
30796049	age1	gas1	30796049	157	148	@TERM$1	@TERM$2	right panel immunoblot analysis of phosphokin1 substrates in  @TERM$1   @TERM$2  animals grown on bacteria carrying an empty vector ev or expressing kin1 rnai	0.9999937	6.37092e-06
30796049	gas1	age1	30796049	117	151	@TERM$1	@TERM$2	right panel scatter plots of the expression of genes significantly downregulated left or upregulated right in  @TERM$1  and  @TERM$2  gas1 mutants compared to wt	0.99998915	1.0898847e-05
30796049	red	age1	30796049	119	100	@TERM$1	@TERM$2	in  @TERM$1  expression levels of the same genes in  @TERM$2  gas1 mutants compared to wtipa indicating the ove	0.99996936	3.064913e-05
30796049	red	gas1	30796049	119	105	@TERM$1	@TERM$2	in  @TERM$1  expression levels of the same genes in age1  @TERM$2  mutants compared to wtipa indicating the overrepr	0.9999908	9.197804e-06
30796049	age1	gas1	30796049	119	105	@TERM$1	@TERM$2	in red expression levels of the same genes in  @TERM$1   @TERM$2  mutants compared to wtipa indicating the overrepr	0.9999981	1.963623e-06
30796049	gas1	log2	30796049	120	102	@TERM$1	@TERM$2	in red proteins significantly dysregulated in age1  @TERM$1  compared to gas1 fdr20  @TERM$2  fold change047	0.99999774	2.314924e-06
30796049	red	age1	30796049	120	102	@TERM$1	@TERM$2	in  @TERM$1  proteins significantly dysregulated in  @TERM$2  gas1 compared to gas1 fdr20 log2 fold change047	0.999998	1.9870402e-06
30796049	red	log2	30796049	120	102	@TERM$1	@TERM$2	in  @TERM$1  proteins significantly dysregulated in age1 gas1 compared to gas1 fdr20  @TERM$2  fold change047	0.9999856	1.4408876e-05
30796049	red	gas1	30796049	120	102	@TERM$1	@TERM$2	in  @TERM$1  proteins significantly dysregulated in age1  @TERM$2  compared to gas1 fdr20 log2 fold change047	0.9999976	2.4387055e-06
30796049	age1	gas1	30796049	120	102	@TERM$1	@TERM$2	in red proteins significantly dysregulated in  @TERM$1   @TERM$2  compared to gas1 fdr20 log2 fold change047	0.9982621	0.0017379533
30796049	age1	log2	30796049	120	102	@TERM$1	@TERM$2	in red proteins significantly dysregulated in  @TERM$1  gas1 compared to gas1 fdr20  @TERM$2  fold change047	0.9999976	2.4244234e-06
30796049	age1	gas1	30796049	122	245	@TERM$1	@TERM$2	proteins involved in carbohydrate green and lipid blue metabolism are labeledstring analysis on dysregulated proteins in  @TERM$1   @TERM$2  versus gas1 nematodes 20 fdr log2fold change047ipa of tmtitraq scan results and prediction of downstream effects	0.99999857	1.4724868e-06
30796049	gas1	red	30796049	116	125	@TERM$1	@TERM$2	left panel venn diagram of the number of genes significantly dysregulated in age1  @TERM$1  versus wt green and gas1 versus wt  @TERM$2 	0.999998	1.9908375e-06
30796049	age1	tmtitraq	30796049	122	245	@TERM$1	@TERM$2	proteins involved in carbohydrate green and lipid blue metabolism are labeledstring analysis on dysregulated proteins in  @TERM$1  gas1 versus gas1 nematodes 20 fdr log2fold change047ipa of  @TERM$2  scan results and prediction of downstream effects	0.999998	2.0236162e-06
30796049	glucose	gas1	30796049	125	182	@TERM$1	@TERM$2	legend indicates the nature of each indicated connectionleft panel  @TERM$1  quantification in wt  @TERM$2  and age1 gas1 nematode lysates with nmr n7 nsnonsignificant mannwhitney utest	0.9999982	1.7592388e-06
30796049	glucose	age1	30796049	125	182	@TERM$1	@TERM$2	legend indicates the nature of each indicated connectionleft panel  @TERM$1  quantification in wt gas1 and  @TERM$2  gas1 nematode lysates with nmr n7 nsnonsignificant mannwhitney utest	0.9999962	3.795106e-06
30796049	gas1	age1	30796049	125	182	@TERM$1	@TERM$2	legend indicates the nature of each indicated connectionleft panel glucose quantification in wt  @TERM$1  and  @TERM$2  gas1 nematode lysates with nmr n7 nsnonsignificant mannwhitney utest	0.9999976	2.366848e-06
30796049	age1	gas1	30796049	128	159	@TERM$1	@TERM$2	pvalue001 nsnonsignificant mannwhitney utestnext we sought to identify the molecular players underlying these metabolic changes in  @TERM$1   @TERM$2  mutant animals	0.99999833	1.7213831e-06
30796049	fatty	gas1	30796049	129	162	@TERM$1	@TERM$2	t effect on distinct catabolic pathways including  @TERM$1  acid betaoxidation and glycogen metabolism in age1  @TERM$2  double mutants compared to gas1 animals fig3a and	0.999998	2.0810005e-06
30796049	ipa	ampactivated protein kinase	30796049	129	135	@TERM$1	@TERM$2	a further  @TERM$1  of our ngs data supported the activation of  @TERM$2  aak2ampk and protein kinase a kin1pka and the con	0.999998	2.0012976e-06
30796049	protein kinase a	fatty	30796049	129	208	@TERM$1	@TERM$2	ation of ampactivated  @TERM$1 ak2ampk and protein kinase a kin1pka and the consequent effect on distinct catabolic pathways including  @TERM$2  acid betaoxidation and glycogen metabolism in age1 gas1 doub	0.99999857	1.4718227e-06
30796049	ampactivated protein kinase	protein kinase a	30796049	129	168	@TERM$1	@TERM$2	r ipa of our ngs data supported the activation of  @TERM$1  aak2ampk and  @TERM$2  kin1pka and the consequent effect on distinct catabolic path	0.9999963	3.677705e-06
30796049	protein kinase a	glycogen	30796049	129	237	@TERM$1	@TERM$2	ation of ampactivated  @TERM$1 ak2ampk and protein kinase a kin1pka and the consequent effect on distinct catabolic pathways including fatty acid betaoxidation and  @TERM$2  metabolism in age1 gas1 double mutants compared to gas1 a	0.99999726	2.7702752e-06
30796049	age1	gas1	30796049	129	109	@TERM$1	@TERM$2	tty acid betaoxidation and glycogen metabolism in  @TERM$1   @TERM$2  double mutants compared to gas1 animals fig3a an	0.999998	2.029422e-06
30796049	fatty	age1	30796049	129	157	@TERM$1	@TERM$2	t effect on distinct catabolic pathways including  @TERM$1  acid betaoxidation and glycogen metabolism in  @TERM$2  gas1 double mutants compared to gas1 animals fig3	0.99999833	1.6419475e-06
30796049	gas1	tmtitraq	30796049	122	245	@TERM$1	@TERM$2	proteins involved in carbohydrate green and lipid blue metabolism are labeledstring analysis on dysregulated proteins in age1  @TERM$1  versus gas1 nematodes 20 fdr log2fold change047ipa of  @TERM$2  scan results and prediction of downstream effects	0.9999957	4.266959e-06
30796049	glycogen	gas1	30796049	129	134	@TERM$1	@TERM$2	c pathways including fatty acid betaoxidation and  @TERM$1  metabolism in age1  @TERM$2  double mutants compared to gas1 animals fig3a and 	0.9999981	1.8822575e-06
30796049	age1	red	30796049	116	125	@TERM$1	@TERM$2	left panel venn diagram of the number of genes significantly dysregulated in  @TERM$1  gas1 versus wt green and gas1 versus wt  @TERM$2 	0.9999981	1.8547095e-06
30796049	gas1	age1	30796049	112	182	@TERM$1	@TERM$2	legend indicates the nature of each indicated connectionleft panel glucose quantification in wt  @TERM$1  and  @TERM$2  gas1 nematode lysates with nmr n7 nsnonsignificant mannwhitney utest	0.9999975	2.5501924e-06
30796049	gas1	s2d	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of phosphoenolpyruvate carboxykinase pepck was equally altered in age1  @TERM$1  compared to gas1 appendixfig  @TERM$2 	0.9999976	2.367801e-06
30796049	phosphoenolpyruvate	s2d	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of  @TERM$1  carboxykinase pepck was equally altered in age1 gas1 compared to gas1 appendixfig  @TERM$2 	0.999998	2.056005e-06
30796049	phosphoenolpyruvate carboxykinase	gas1	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of  @TERM$1  pepck was equally altered in age1  @TERM$2  compared to gas1 appendixfig s2d	0.9999974	2.626223e-06
30796049	pepck	age1	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of phosphoenolpyruvate carboxykinase  @TERM$1  was equally altered in  @TERM$2  gas1 compared to gas1 appendixfig s2d	0.99999833	1.7247584e-06
30796049	phosphoenolpyruvate	age1	30796049	102	164	@TERM$1	@TERM$2	moreover the expression of the two celegans orthologs of  @TERM$1  carboxykinase pepck was equally altered in  @TERM$2  gas1 compared to gas1 appendixfig s2d	0.99999774	2.2539678e-06
30796049	age1	gas1	30796049	103	125	@TERM$1	@TERM$2	left panel venn diagram of the number of genes significantly dysregulated in  @TERM$1   @TERM$2  versus wt green and gas1 versus wt red	0.999998	2.0334903e-06
30796049	age1	red	30796049	103	125	@TERM$1	@TERM$2	left panel venn diagram of the number of genes significantly dysregulated in  @TERM$1  gas1 versus wt green and gas1 versus wt  @TERM$2 	0.99999845	1.5898981e-06
30796049	gas1	red	30796049	103	125	@TERM$1	@TERM$2	left panel venn diagram of the number of genes significantly dysregulated in age1  @TERM$1  versus wt green and gas1 versus wt  @TERM$2 	0.999998	2.0624898e-06
30796049	gas1	age1	30796049	104	151	@TERM$1	@TERM$2	right panel scatter plots of the expression of genes significantly downregulated left or upregulated right in  @TERM$1  and  @TERM$2  gas1 mutants compared to wt	0.9999975	2.524439e-06
30796049	red	age1	30796049	106	100	@TERM$1	@TERM$2	in  @TERM$1  expression levels of the same genes in  @TERM$2  gas1 mutants compared to wtipa indicating the ove	0.99999785	2.1673989e-06
30796049	age1	gas1	30796049	116	125	@TERM$1	@TERM$2	left panel venn diagram of the number of genes significantly dysregulated in  @TERM$1   @TERM$2  versus wt green and gas1 versus wt red	0.9999981	1.955738e-06
30796049	red	gas1	30796049	106	105	@TERM$1	@TERM$2	in  @TERM$1  expression levels of the same genes in age1  @TERM$2  mutants compared to wtipa indicating the overrepr	0.999998	1.9976271e-06
30796049	gas1	log2	30796049	107	102	@TERM$1	@TERM$2	in red proteins significantly dysregulated in age1  @TERM$1  compared to gas1 fdr20  @TERM$2  fold change047	0.9999982	1.7881652e-06
30796049	red	age1	30796049	107	102	@TERM$1	@TERM$2	in  @TERM$1  proteins significantly dysregulated in  @TERM$2  gas1 compared to gas1 fdr20 log2 fold change047	0.999995	5.0577205e-06
30796049	red	log2	30796049	107	102	@TERM$1	@TERM$2	in  @TERM$1  proteins significantly dysregulated in age1 gas1 compared to gas1 fdr20  @TERM$2  fold change047	0.99999845	1.5280046e-06
30796049	red	gas1	30796049	107	102	@TERM$1	@TERM$2	in  @TERM$1  proteins significantly dysregulated in age1  @TERM$2  compared to gas1 fdr20 log2 fold change047	0.9999981	1.9571971e-06
30796049	age1	gas1	30796049	107	102	@TERM$1	@TERM$2	in red proteins significantly dysregulated in  @TERM$1   @TERM$2  compared to gas1 fdr20 log2 fold change047	0.9999937	6.28489e-06
30796049	age1	log2	30796049	107	102	@TERM$1	@TERM$2	in red proteins significantly dysregulated in  @TERM$1  gas1 compared to gas1 fdr20  @TERM$2  fold change047	0.9999982	1.7473538e-06
30796049	age1	gas1	30796049	109	245	@TERM$1	@TERM$2	proteins involved in carbohydrate green and lipid blue metabolism are labeledstring analysis on dysregulated proteins in  @TERM$1   @TERM$2  versus gas1 nematodes 20 fdr log2fold change047ipa of tmtitraq scan results and prediction of downstream effects	0.9999974	2.5717382e-06
30796049	age1	tmtitraq	30796049	109	245	@TERM$1	@TERM$2	proteins involved in carbohydrate green and lipid blue metabolism are labeledstring analysis on dysregulated proteins in  @TERM$1  gas1 versus gas1 nematodes 20 fdr log2fold change047ipa of  @TERM$2  scan results and prediction of downstream effects	0.999998	2.0652533e-06
30796049	gas1	tmtitraq	30796049	109	245	@TERM$1	@TERM$2	proteins involved in carbohydrate green and lipid blue metabolism are labeledstring analysis on dysregulated proteins in age1  @TERM$1  versus gas1 nematodes 20 fdr log2fold change047ipa of  @TERM$2  scan results and prediction of downstream effects	0.99999833	1.7209875e-06
30796049	glucose	gas1	30796049	112	182	@TERM$1	@TERM$2	legend indicates the nature of each indicated connectionleft panel  @TERM$1  quantification in wt  @TERM$2  and age1 gas1 nematode lysates with nmr n7 nsnonsignificant mannwhitney utest	0.999398	0.0006020175
30796049	glucose	age1	30796049	112	182	@TERM$1	@TERM$2	legend indicates the nature of each indicated connectionleft panel  @TERM$1  quantification in wt gas1 and  @TERM$2  gas1 nematode lysates with nmr n7 nsnonsignificant mannwhitney utest	0.99999785	2.1125259e-06
30796049	age1	gas1	30796049	106	105	@TERM$1	@TERM$2	in red expression levels of the same genes in  @TERM$1   @TERM$2  mutants compared to wtipa indicating the overrepr	0.9999975	2.4781964e-06
30796049	xanthine	iis	30796049	4	106	@TERM$1	@TERM$2	furthermore we identify  @TERM$1  accumulation as a prominent downstream metabolic output of  @TERM$2  inhibition	0.99999726	2.7325614e-06
30796049	fatty	glycogen	30796049	129	137	@TERM$1	@TERM$2	t effect on distinct catabolic pathways including  @TERM$1  acid betaoxidation and  @TERM$2  metabolism in age1 gas1 double mutants compared t	0.9999981	1.8677343e-06
30796049	ipa	fatty	30796049	129	246	@TERM$1	@TERM$2	a further  @TERM$1  of our ngs data supported the activation of ampactivated protein kinase aak2ampk and protein kinase a kin1pka and the consequent effect on distinct catabolic pathways including  @TERM$2  acid betaoxidation and glycogen metabolism in age	0.999998	2.0406824e-06
30796049	sem	iatp	30796049	146	169	@TERM$1	@TERM$2	kin1 rnai bacteria with average median lifespans @TERM$1  from all replicates indicated beneath representative curvesh  @TERM$2  measurements in h age1hx546 gas1fc21 a g and age1	0.99999845	1.5264317e-06
30796049	age1	sem	30796049	146	203	@TERM$1	@TERM$2	substrategrepresentative lifespan assay of wt and  @TERM$1  gas1 nematodes fed with empty vector ev and kin1 rnai bacteria with average median lifespans @TERM$2  from all replicates indicated beneath representati	0.99999857	1.4044565e-06
30796049	age1	gas1	30796049	146	109	@TERM$1	@TERM$2	substrategrepresentative lifespan assay of wt and  @TERM$1   @TERM$2  nematodes fed with empty vector ev and kin1 rnai 	0.9999976	2.3749383e-06
30796049	gas1	sem	30796049	146	198	@TERM$1	@TERM$2	rategrepresentative lifespan assay of wt and age1  @TERM$1  nematodes fed with empty vector ev and kin1 rnai bacteria with average median lifespans @TERM$2  from all replicates indicated beneath representati	0.99999833	1.641791e-06
30796049	sem	frap	30796049	147	170	@TERM$1	@TERM$2	bars mean @TERM$1  n4 pvalue005 mannwhitney utestjleft panel curves represent  @TERM$2  in age1 gas1 animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.9999982	1.7898252e-06
30796049	sem	fzo1	30796049	147	170	@TERM$1	@TERM$2	bars mean @TERM$1  n4 pvalue005 mannwhitney utestjleft panel curves represent frap in age1 gas1 animals grown on rnai from larval l1 or from egg for  @TERM$2  rnai to l4 stage	0.99999774	2.2363056e-06
30796049	frap	gas1	30796049	147	170	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestjleft panel curves represent  @TERM$1  in age1  @TERM$2  animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.9999981	1.9438078e-06
30796049	frap	fzo1	30796049	147	170	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestjleft panel curves represent  @TERM$1  in age1 gas1 animals grown on rnai from larval l1 or from egg for  @TERM$2  rnai to l4 stage	0.99999833	1.7120266e-06
30796049	sem	age1	30796049	147	170	@TERM$1	@TERM$2	bars mean @TERM$1  n4 pvalue005 mannwhitney utestjleft panel curves represent frap in  @TERM$2  gas1 animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.99999785	2.112419e-06
30796049	age1	gas1	30796049	147	170	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestjleft panel curves represent frap in  @TERM$1   @TERM$2  animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.9999976	2.3407554e-06
30796049	age1	fzo1	30796049	147	170	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestjleft panel curves represent frap in  @TERM$1  gas1 animals grown on rnai from larval l1 or from egg for  @TERM$2  rnai to l4 stage	0.9999951	4.882507e-06
30796049	age1	gas1	30796049	143	148	@TERM$1	@TERM$2	right panel immunoblot analysis of phosphokin1 substrates in  @TERM$1   @TERM$2  animals grown on bacteria carrying an empty vector ev or expressing kin1 rnai	0.999998	1.9945585e-06
30796049	sem	gas1	30796049	147	170	@TERM$1	@TERM$2	bars mean @TERM$1  n4 pvalue005 mannwhitney utestjleft panel curves represent frap in age1  @TERM$2  animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.9999981	1.8972047e-06
30796049	frap	age1	30796049	147	170	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestjleft panel curves represent  @TERM$1  in  @TERM$2  gas1 animals grown on rnai from larval l1 or from egg for fzo1 rnai to l4 stage	0.99999785	2.1303274e-06
30796049	age1	gas1	30796049	152	169	@TERM$1	@TERM$2	schematic representation with overlaid molecule activity predictor map analysis of a aak2ampk and b kin1pkaregulated metabolic processes in  @TERM$1   @TERM$2  versus gas1 mutants	0.999998	2.0165055e-06
30796049	map	gas1	30796049	152	169	@TERM$1	@TERM$2	schematic representation with overlaid molecule activity predictor  @TERM$1  analysis of a aak2ampk and b kin1pkaregulated metabolic processes in age1  @TERM$2  versus gas1 mutants	0.99999785	2.1803185e-06
30796049	map	age1	30796049	152	169	@TERM$1	@TERM$2	schematic representation with overlaid molecule activity predictor  @TERM$1  analysis of a aak2ampk and b kin1pkaregulated metabolic processes in  @TERM$2  gas1 versus gas1 mutants	0.9999974	2.66998e-06
30796049	age1	gas1	30796049	153	173	@TERM$1	@TERM$2	color intensity corresponds to effect intensity or prediction strengthimmunoblot analysis of phosphoaak2 in wt  @TERM$1   @TERM$2  and age1 gas1 mutant nematodes actin loading control	0.9999982	1.7501538e-06
30796049	age1	actin	30796049	153	173	@TERM$1	@TERM$2	color intensity corresponds to effect intensity or prediction strengthimmunoblot analysis of phosphoaak2 in wt  @TERM$1  gas1 and age1 gas1 mutant nematodes  @TERM$2  loading control	0.999998	2.0058626e-06
30796049	gas1	actin	30796049	153	173	@TERM$1	@TERM$2	color intensity corresponds to effect intensity or prediction strengthimmunoblot analysis of phosphoaak2 in wt age1  @TERM$1  and age1 gas1 mutant nematodes  @TERM$2  loading control	0.99999607	3.9299857e-06
30796049	age1	gas1	30796049	154	109	@TERM$1	@TERM$2	e biological replicatesrepresentative lifespan of  @TERM$1   @TERM$2  double mutant and age1 aak2 gas1 triple mutant ne	0.99999785	2.136957e-06
30796049	gas1	sem	30796049	154	197	@TERM$1	@TERM$2	logical replicatesrepresentative lifespan of age1  @TERM$1  double mutant and age1 aak2 gas1 triple mutant nematodes with average median lifespans @TERM$2  from all replicates indicated beneath representati	0.9999981	1.9030433e-06
30796049	age1	sem	30796049	154	202	@TERM$1	@TERM$2	e biological replicatesrepresentative lifespan of  @TERM$1  gas1 double mutant and age1 aak2 gas1 triple mutant nematodes with average median lifespans @TERM$2  from all replicates indicated beneath representati	0.99999785	2.1506016e-06
30796049	gas1	actin	30796049	155	138	@TERM$1	@TERM$2	inset immunoblot analysis of phosphoaak2 in  @TERM$1  g and gas1 aak2 oe g a oe animals  @TERM$2  loading control showing the overexpressed protein	0.99999774	2.3138534e-06
30796049	gas1	fzo1	30796049	147	170	@TERM$1	@TERM$2	bars meansem n4 pvalue005 mannwhitney utestjleft panel curves represent frap in age1  @TERM$1  animals grown on rnai from larval l1 or from egg for  @TERM$2  rnai to l4 stage	0.999998	1.9927388e-06
30796049	ipa	protein kinase a	30796049	129	165	@TERM$1	@TERM$2	a further  @TERM$1  of our ngs data supported the activation of ampactivated  @TERM$2 ak2ampk and protein kinase a kin1pka and the consequent effect on distinct cat	0.99999785	2.1652997e-06
30796049	gas1	actin	30796049	141	138	@TERM$1	@TERM$2	inset immunoblot analysis of phosphoaak2 in  @TERM$1  g and gas1 aak2 oe g a oe animals  @TERM$2  loading control showing the overexpressed protein	0.99999774	2.251422e-06
30796049	gas1	sem	30796049	140	197	@TERM$1	@TERM$2	ogical replicatesdrepresentative lifespan of age1  @TERM$1  double mutant and age1 aak2 gas1 triple mutant nematodes with average median lifespans @TERM$2  from all replicates indicated beneath representati	0.99999774	2.2622262e-06
30796049	glycogen	age1	30796049	129	131	@TERM$1	@TERM$2	c pathways including fatty acid betaoxidation and  @TERM$1  metabolism in  @TERM$2  gas1 double mutants compared to gas1 animals fig3a a	0.9999974	2.6518233e-06
30796049	age1	gas1	30796049	130	109	@TERM$1	@TERM$2	e 2014 and with our ipa predictions we found that  @TERM$1   @TERM$2  double mutants had increased levels of phosphoaak	0.9999981	1.9403517e-06
30796049	ipa	gas1	30796049	130	139	@TERM$1	@TERM$2	ion burkewitz etal 2014 hardie 2014 and with our  @TERM$1  predictions we found that age1  @TERM$2  double mutants had increased levels of phosphoaak	0.9999974	2.6037112e-06
30796049	ipa	age1	30796049	130	134	@TERM$1	@TERM$2	ion burkewitz etal 2014 hardie 2014 and with our  @TERM$1  predictions we found that  @TERM$2  gas1 double mutants had increased levels of phosp	0.9999981	1.929899e-06
30796049	age1	gas1	30796049	131	231	@TERM$1	@TERM$2	importantly aak2 loss of function and silencing significantly reduced the lifespan of  @TERM$1   @TERM$2  double mutants whereas overexpression of aak2 promoted the survival of gas1 mutants fig3d and e appendixfig s3a and b and datasetev1	0.9999975	2.5568359e-06
30796049	age1	s3a	30796049	131	231	@TERM$1	@TERM$2	importantly aak2 loss of function and silencing significantly reduced the lifespan of  @TERM$1  gas1 double mutants whereas overexpression of aak2 promoted the survival of gas1 mutants fig3d and e appendixfig  @TERM$2  and b and datasetev1	0.9999982	1.7928148e-06
30796049	gas1	s3a	30796049	131	231	@TERM$1	@TERM$2	importantly aak2 loss of function and silencing significantly reduced the lifespan of age1  @TERM$1  double mutants whereas overexpression of aak2 promoted the survival of gas1 mutants fig3d and e appendixfig  @TERM$2  and b and datasetev1	0.999998	2.030024e-06
30796049	age1	gas1	30796049	133	146	@TERM$1	@TERM$2	in line with the ipa prediction we found that  @TERM$1   @TERM$2  double mutants displayed an increased kin1 activity compared to gas1 mutant animals fig3f	0.99999785	2.1172455e-06
30796049	ipa	gas1	30796049	133	146	@TERM$1	@TERM$2	in line with the  @TERM$1  prediction we found that age1  @TERM$2  double mutants displayed an increased kin1 activity compared to gas1 mutant animals fig3f	0.9999982	1.8204745e-06
30796049	ipa	age1	30796049	133	146	@TERM$1	@TERM$2	in line with the  @TERM$1  prediction we found that  @TERM$2  gas1 double mutants displayed an increased kin1 activity compared to gas1 mutant animals fig3f	0.99999785	2.1932901e-06
30796049	age1	s3c	30796049	134	165	@TERM$1	@TERM$2	furthermore rnaimediated downregulation of kin1 almost completely abolished the lifespan extension of  @TERM$1  gas1 animals fig3g appendixfig  @TERM$2  and d and datasetev1	0.999998	1.9938736e-06
30796049	age1	sem	30796049	140	202	@TERM$1	@TERM$2	 biological replicatesdrepresentative lifespan of  @TERM$1  gas1 double mutant and age1 aak2 gas1 triple mutant nematodes with average median lifespans @TERM$2  from all replicates indicated beneath representati	0.99999774	2.2873915e-06
30796049	age1	gas1	30796049	134	165	@TERM$1	@TERM$2	furthermore rnaimediated downregulation of kin1 almost completely abolished the lifespan extension of  @TERM$1   @TERM$2  animals fig3g appendixfig s3c and d and datasetev1	0.9999981	1.9455438e-06
30796049	age1	gas1	30796049	135	101	@TERM$1	@TERM$2	moreover downregulation of aak2 and kin1 affected atp levels in  @TERM$1   @TERM$2  double mutants fig3h and i	0.999998	2.0393088e-06
30796049	atp	gas1	30796049	135	101	@TERM$1	@TERM$2	moreover downregulation of aak2 and kin1 affected  @TERM$1  levels in age1  @TERM$2  double mutants fig3h and i	0.99999845	1.5256807e-06
30796049	atp	age1	30796049	135	101	@TERM$1	@TERM$2	moreover downregulation of aak2 and kin1 affected  @TERM$1  levels in  @TERM$2  gas1 double mutants fig3h and i	0.9999981	1.904296e-06
30796049	iis	pkakin12	30796049	137	138	@TERM$1	@TERM$2	taken together  @TERM$1  inhibition decreases atpconsuming processes in complex ideficient nematodes and sustains ampkaak2 and  @TERM$2  activity	0.9999976	2.3401258e-06
30796049	age1	gas1	30796049	138	172	@TERM$1	@TERM$2	a bschematic representation with overlaid molecule activity predictor map analysis of a aak2ampk and b kin1pkaregulated metabolic processes in  @TERM$1   @TERM$2  versus gas1 mutants	0.99999654	3.4205075e-06
30796049	map	gas1	30796049	138	172	@TERM$1	@TERM$2	a bschematic representation with overlaid molecule activity predictor  @TERM$1  analysis of a aak2ampk and b kin1pkaregulated metabolic processes in age1  @TERM$2  versus gas1 mutants	0.9999981	1.910404e-06
30796049	map	age1	30796049	138	172	@TERM$1	@TERM$2	a bschematic representation with overlaid molecule activity predictor  @TERM$1  analysis of a aak2ampk and b kin1pkaregulated metabolic processes in  @TERM$2  gas1 versus gas1 mutants	0.999998	1.9956449e-06
30796049	age1	gas1	30796049	139	174	@TERM$1	@TERM$2	color intensity corresponds to effect intensity or prediction strengthcimmunoblot analysis of phosphoaak2 in wt  @TERM$1   @TERM$2  and age1 gas1 mutant nematodes actin loading control	0.9999974	2.5987647e-06
30796049	age1	actin	30796049	139	174	@TERM$1	@TERM$2	color intensity corresponds to effect intensity or prediction strengthcimmunoblot analysis of phosphoaak2 in wt  @TERM$1  gas1 and age1 gas1 mutant nematodes  @TERM$2  loading control	0.99999785	2.1997903e-06
30796049	gas1	actin	30796049	139	174	@TERM$1	@TERM$2	color intensity corresponds to effect intensity or prediction strengthcimmunoblot analysis of phosphoaak2 in wt age1  @TERM$1  and age1 gas1 mutant nematodes  @TERM$2  loading control	0.99999833	1.6392532e-06
30796049	age1	gas1	30796049	140	109	@TERM$1	@TERM$2	 biological replicatesdrepresentative lifespan of  @TERM$1   @TERM$2  double mutant and age1 aak2 gas1 triple mutant ne	0.999997	2.946049e-06
30796049	gas1	s3c	30796049	134	165	@TERM$1	@TERM$2	furthermore rnaimediated downregulation of kin1 almost completely abolished the lifespan extension of age1  @TERM$1  animals fig3g appendixfig  @TERM$2  and d and datasetev1	0.99999785	2.1099568e-06
30796049	iis	s4d	30796049	203	187	@TERM$1	@TERM$2	this effect on  @TERM$1  was not a common feature of pde inhibitors since the pde3 inhibitor cilostazol enhanced pka activity without altering the phosphorylation status of akt appendixfig  @TERM$2 	0.999998	2.0502819e-06
33693628	leu	uracil	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a ura his  @TERM$1  mets cerevisiae strain and selected for in sc media without  @TERM$2  and histidine and facs was used again for enrichment of clones with the highest red to blue ratio	0.9999976	2.3863856e-06
33693628	w144	m164	33693628	77	144	@TERM$1	@TERM$2	 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$1  e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.99999785	2.0920659e-06
33693628	k46	k75	33693628	77	151	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.9999969	3.0522692e-06
33693628	f15	r71	33693628	77	159	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.99999726	2.794797e-06
33693628	s63	k75	33693628	77	131	@TERM$1	@TERM$2	itions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$1  p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.99999607	3.8802496e-06
33693628	nnk	k46	33693628	77	151	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45  @TERM$2  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d	0.9999975	2.4830626e-06
33693628	rollingcircle	s63	33693628	77	209	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$2  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 	0.99999845	1.6074125e-06
33693628	k10	r71	33693628	77	163	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.9999989	1.0726416e-06
33693628	e115	f178	33693628	77	184	@TERM$1	@TERM$2	66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$1  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$2  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208	0.9999784	2.1576236e-05
33693628	g53	t74	33693628	77	135	@TERM$1	@TERM$2	s at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$1  d60 s63 p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.99988353	0.00011642482
33693628	k10	e115	33693628	77	207	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.99998105	1.8962508e-05
33693628	k10	g32	33693628	77	111	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15  @TERM$2  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r	0.99990463	9.5346426e-05
33693628	rollingcircle	g53	33693628	77	201	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$2  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v1	0.99998784	1.2135579e-05
33693628	p64	s70	33693628	77	115	@TERM$1	@TERM$2	ns i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$1  q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.99999785	2.1472733e-06
33693628	w144	t203 s204 d208 y209	33693628	77	209	@TERM$1	@TERM$2	 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$1  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178 k179 k183 k185 k186 n195 r198 i202  @TERM$2  t210 v211 v212 e213 q214 y215 e216 r217 s218 e219	0.99999845	1.5606314e-06
33693628	nnk	q43	33693628	77	143	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32  @TERM$2  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t	0.99999785	2.1795368e-06
33693628	g52	p64	33693628	77	119	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1  g53 d60 s63  @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108	0.9999974	2.644865e-06
33693628	r71	m164	33693628	77	217	@TERM$1	@TERM$2	2 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$1  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.9999975	2.4543563e-06
33693628	g32	w144	33693628	77	229	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999982	1.8335527e-06
33693628	q43	w144	33693628	77	225	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999975	2.5383515e-06
33693628	q43	k46	33693628	77	111	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45  @TERM$2  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d	0.99999845	1.6003489e-06
33693628	m164	s218	33693628	77	214	@TERM$1	@TERM$2	k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$1  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203 s204 d208 y209 t210 v211 v212 e213 q214 y215 e216 r217  @TERM$2  e219 a220 h222 s223 t224 g225 g226 m227 d228 and 	0.9999982	1.8061318e-06
33693628	g53	s63	33693628	77	111	@TERM$1	@TERM$2	s at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$1  d60  @TERM$2  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 	0.99999833	1.6762556e-06
33693628	g53	s70	33693628	77	127	@TERM$1	@TERM$2	s at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$1  d60 s63 p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.99999785	2.1286094e-06
33693628	f15	g52	33693628	77	127	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47  @TERM$2  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w	0.99999785	2.1732974e-06
33693628	rollingcircle	s70	33693628	77	225	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t	0.99999845	1.5490832e-06
33693628	s223	polymerase	33693628	77	162	@TERM$1	@TERM$2	v212 e213 q214 y215 e216 r217 s218 e219 a220 h222  @TERM$1  t224 g225 g226 m227 d228 and e229 with phusion  @TERM$2  neb in gc buffer followed by pooling of the pcr p	0.9999914	8.553398e-06
33693628	rollingcircle	f66	33693628	77	221	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r1	0.9999981	1.8976499e-06
33693628	s70	t74	33693628	77	111	@TERM$1	@TERM$2	5 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$1  r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.999998	2.0004716e-06
33693628	k10	q43	33693628	77	115	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32  @TERM$2  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t	0.9999945	5.5029914e-06
33693628	a45	k75	33693628	77	155	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.99997115	2.8871598e-05
33693628	k46	p64	33693628	77	127	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47 g52 g53 d60 s63  @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108	0.99998903	1.0911503e-05
33693628	k10	g53	33693628	77	135	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47 g52  @TERM$2  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r	0.9999924	7.5797275e-06
33693628	nnk	a45	33693628	77	147	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43  @TERM$2  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k	0.9998636	0.00013632473
33693628	f66	m164	33693628	77	225	@TERM$1	@TERM$2	0 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$1  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.99994755	5.247553e-05
33693628	r71	e115	33693628	77	147	@TERM$1	@TERM$2	2 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$1  t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.99997723	2.274963e-05
33693628	nnk	g32	33693628	77	139	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15  @TERM$2  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r	0.99999857	1.3966455e-06
33693628	g52	s70	33693628	77	131	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1  g53 d60 s63 p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.999995	5.0249896e-06
33693628	r71	k75	33693628	77	111	@TERM$1	@TERM$2	2 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$1  t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.45002994	0.5499701
33693628	q43	a45	33693628	77	107	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1   @TERM$2  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k	0.016301483	0.9836985
33693628	g53	p64	33693628	77	115	@TERM$1	@TERM$2	s at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$1  d60 s63  @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108	0.06553986	0.93446016
33693628	splitwrmscarlet	agy	33693628	300	32	@TERM$1	@TERM$2	developed  @TERM$1  in  @TERM$2 	0.99999774	2.2062086e-06
33693628	a45	f66	33693628	77	139	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47 g52 g53 d60 s63 p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.9999852	1.481289e-05
33693628	f15	w144	33693628	77	233	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999659	3.4044064e-05
33693628	g52	s63	33693628	77	115	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1  g53 d60  @TERM$2  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 	0.99990666	9.334724e-05
33693628	g32	q43	33693628	77	107	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1   @TERM$2  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t	0.99994254	5.7469577e-05
33693628	rollingcircle	t74	33693628	77	233	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139	0.99996805	3.2005762e-05
33693628	s218	phusion polymerase	33693628	77	182	@TERM$1	@TERM$2	d208 y209 t210 v211 v212 e213 q214 y215 e216 r217  @TERM$1  e219 a220 h222 s223 t224 g225 g226 m227 d228 and e229 with  @TERM$2  neb in gc buffer followed by pooling of the pcr p	0.9999908	9.23574e-06
33693628	s63	w144	33693628	77	197	@TERM$1	@TERM$2	itions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$1  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.99999785	2.1175301e-06
33693628	s70	k75	33693628	77	115	@TERM$1	@TERM$2	5 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$1  r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.99999774	2.262975e-06
33693628	s63	p64	33693628	77	107	@TERM$1	@TERM$2	itions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$1   @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108	0.9999976	2.384029e-06
33693628	k75	w144	33693628	77	169	@TERM$1	@TERM$2	5 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$1  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999982	1.7553575e-06
33693628	s63	s70	33693628	77	119	@TERM$1	@TERM$2	itions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$1  p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.9999976	2.3786195e-06
33693628	k46	f66	33693628	77	135	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47 g52 g53 d60 s63 p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.999998	1.9691602e-06
33693628	t74	e115	33693628	77	143	@TERM$1	@TERM$2	3 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$1  k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.9999981	1.8641985e-06
33693628	t203 s204 d208 y209	t210	33693628	77	139	@TERM$1	@TERM$2	m164 l175 f178 k179 k183 k185 k186 n195 r198 i202  @TERM$1   @TERM$2  v211 v212 e213 q214 y215 e216 r217 s218 e219 a220 h222 s223 t224	0.99999726	2.7625213e-06
33693628	q43	f66	33693628	77	143	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.99999833	1.6406952e-06
33693628	nnk	g52	33693628	77	159	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$2  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w	0.999998	1.9953309e-06
33693628	rollingcircle	r71	33693628	77	229	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 	0.99999833	1.6555626e-06
33693628	f15	p64	33693628	77	143	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108	0.99999833	1.6759167e-06
33693628	s70	r71	33693628	77	107	@TERM$1	@TERM$2	5 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$1   @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.99999845	1.5860031e-06
33693628	t74	k75	33693628	77	107	@TERM$1	@TERM$2	3 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$1   @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.9999976	2.4303126e-06
33693628	g32	s63	33693628	77	135	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47 g52 g53 d60  @TERM$2  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 	0.9999982	1.7772181e-06
33693628	q43	s63	33693628	77	131	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47 g52 g53 d60  @TERM$2  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 	0.9999976	2.3918813e-06
33693628	g52	m164	33693628	77	249	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.99999774	2.313432e-06
33693628	f178	t203 s204 d208 y209	33693628	77	159	@TERM$1	@TERM$2	w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$1  k179 k183 k185 k186 n195 r198 i202  @TERM$2  t210 v211 v212 e213 q214 y215 e216 r217 s218 e219	0.9999982	1.8033401e-06
33693628	nnk	r71	33693628	77	191	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.99999213	7.852085e-06
33693628	e115	t203 s204 d208 y209	33693628	77	239	@TERM$1	@TERM$2	66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$1  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163 m164 l175 f178 k179 k183 k185 k186 n195 r198 i202  @TERM$2  t210 v211 v212 e213 q214 y215 e216 r217 s218 e219	0.9999982	1.7730554e-06
33693628	s70	e115	33693628	77	151	@TERM$1	@TERM$2	5 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$1  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.9999981	1.8521288e-06
33693628	k10	w144	33693628	77	237	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999937	6.2950276e-06
33693628	k46	r71	33693628	77	143	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.99999833	1.6412633e-06
33693628	rollingcircle	k75	33693628	77	237	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k14	0.9999975	2.4484204e-06
33693628	f178	t210	33693628	77	164	@TERM$1	@TERM$2	w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$1  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208 y209  @TERM$2  v211 v212 e213 q214 y215 e216 r217 s218 e219 a220	0.999998	1.9915913e-06
33693628	k10	a45	33693628	77	119	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43  @TERM$2  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k	0.9999976	2.4250755e-06
33693628	e115	t210	33693628	77	244	@TERM$1	@TERM$2	66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$1  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163 m164 l175 f178 k179 k183 k185 k186 n195 r198 i202 t203 s204 d208 y209  @TERM$2  v211 v212 e213 q214 y215 e216 r217 s218 e219 a220	0.99999785	2.147634e-06
33693628	s70	f178	33693628	77	231	@TERM$1	@TERM$2	5 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$1  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$2  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208	0.9999975	2.5000707e-06
33693628	g52	k75	33693628	77	143	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1  g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.9999982	1.8451827e-06
33693628	r71	t74	33693628	77	107	@TERM$1	@TERM$2	2 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$1   @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.999998	2.0090808e-06
33693628	s218	s223	33693628	77	124	@TERM$1	@TERM$2	d208 y209 t210 v211 v212 e213 q214 y215 e216 r217  @TERM$1  e219 a220 h222  @TERM$2  t224 g225 g226 m227 d228 and e229 with phusion po	0.99999833	1.661971e-06
33693628	a45	r71	33693628	77	147	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.999998	2.0072825e-06
33693628	w144	f178	33693628	77	154	@TERM$1	@TERM$2	 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$1  e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$2  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208	0.9999975	2.5195493e-06
33693628	g53	f66	33693628	77	123	@TERM$1	@TERM$2	s at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$1  d60 s63 p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.9999981	1.8504921e-06
33693628	g32	g52	33693628	77	123	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47  @TERM$2  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w	0.9999982	1.7790394e-06
33693628	e115	w144	33693628	77	134	@TERM$1	@TERM$2	66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$1  l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999982	1.8209172e-06
33693628	g32	r71	33693628	77	155	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.99999857	1.4220449e-06
33693628	p64	k75	33693628	77	127	@TERM$1	@TERM$2	ns i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$1  q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.9999969	3.0658143e-06
33693628	m164	t203 s204 d208 y209	33693628	77	169	@TERM$1	@TERM$2	k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$1  l175 f178 k179 k183 k185 k186 n195 r198 i202  @TERM$2  t210 v211 v212 e213 q214 y215 e216 r217 s218 e219	0.9999982	1.8180576e-06
33693628	s70	m164	33693628	77	221	@TERM$1	@TERM$2	5 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$1  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.99999654	3.4074126e-06
33693628	f66	k75	33693628	77	119	@TERM$1	@TERM$2	0 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$1  s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.99999845	1.5845925e-06
33693628	g52	e115	33693628	77	179	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.9999969	3.101693e-06
33693628	m164	t210	33693628	77	174	@TERM$1	@TERM$2	k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$1  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203 s204 d208 y209  @TERM$2  v211 v212 e213 q214 y215 e216 r217 s218 e219 a220	0.999998	2.0158961e-06
33693628	k46	g52	33693628	77	111	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47  @TERM$2  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w	0.99999785	2.1163592e-06
33693628	nnk	f66	33693628	77	183	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.999982	1.8022854e-05
33693628	g52	g53	33693628	77	107	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1   @TERM$2  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r	0.999997	2.9512628e-06
33693628	g52	t74	33693628	77	139	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1  g53 d60 s63 p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.99999774	2.2836991e-06
33693628	k10	f15	33693628	77	107	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1   @TERM$2  g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s	0.999998	2.0429957e-06
33693628	r71	f178	33693628	77	227	@TERM$1	@TERM$2	2 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$1  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$2  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208	0.999998	2.0014027e-06
33693628	s63	m164	33693628	77	237	@TERM$1	@TERM$2	itions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$1  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.999998	2.0227228e-06
33693628	rollingcircle	g52	33693628	77	197	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$2  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t10	0.999998	2.07499e-06
33693628	f178	s218	33693628	77	204	@TERM$1	@TERM$2	w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$1  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208 y209 t210 v211 v212 e213 q214 y215 e216 r217  @TERM$2  e219 a220 h222 s223 t224 g225 g226 m227 d228 and 	0.99999833	1.6276168e-06
33693628	g32	s70	33693628	77	151	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.99999774	2.3021746e-06
33693628	q43	s70	33693628	77	147	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.9999981	1.8831013e-06
33693628	r71	w144	33693628	77	177	@TERM$1	@TERM$2	2 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$1  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999982	1.7746303e-06
33693628	s63	r71	33693628	77	123	@TERM$1	@TERM$2	itions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$1  p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.999998	2.0749922e-06
33693628	q43	r71	33693628	77	151	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.99999833	1.6506691e-06
33693628	rollingcircle	a45	33693628	77	185	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43  @TERM$2  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84	0.99999857	1.4146675e-06
33693628	red	green fluorescence	33693628	48	203	@TERM$1	@TERM$2	the images are representative displays of the ratio of  @TERM$1  to  @TERM$2  intensity from images acquired under identical conditions after background subtraction and masking with the same threshold	0.999995	4.952824e-06
33693628	fp110	hefel	33693628	57	216	@TERM$1	@TERM$2	to the best of our knowledge there is only one available unbound  @TERM$1  stable c elegans line which expresses sfgfp110 in the germline  @TERM$2  and smolikove 2019 and there are no available lines with red fp110 fragments	0.9999938	6.256306e-06
33693628	fp110	red	33693628	57	216	@TERM$1	@TERM$2	to the best of our knowledge there is only one available unbound  @TERM$1  stable c elegans line which expresses sfgfp110 in the germline hefel and smolikove 2019 and there are no available lines with  @TERM$2  fp110 fragments	0.9999974	2.6133885e-06
33693628	hefel	red	33693628	57	216	@TERM$1	@TERM$2	to the best of our knowledge there is only one available unbound fp110 stable c elegans line which expresses sfgfp110 in the germline  @TERM$1  and smolikove 2019 and there are no available lines with  @TERM$2  fp110 fragments	0.9999981	1.8930696e-06
33693628	red	fluorophores	33693628	58	140	@TERM$1	@TERM$2	existing  @TERM$1  split  @TERM$2  are also much dimmer in c elegans than green ones despite recent improvements like splitsfcherry3 feng et al	0.99997985	2.0179956e-05
33693628	splitwrmscarlet	mscarlet	33693628	61	95	@TERM$1	@TERM$2	we engineer  @TERM$1  a new split red fluorescent protein based on  @TERM$2  bindels et al	0.99999666	3.3498484e-06
33693628	red	mscarlet	33693628	61	95	@TERM$1	@TERM$2	we engineer splitwr @TERM$2  a new split  @TERM$1  fluorescent protein based on mscarlet bindels et al	0.9999976	2.3423029e-06
33693628	splitwrmscarlet	red	33693628	61	95	@TERM$1	@TERM$2	we engineer  @TERM$1  a new split  @TERM$2  fluorescent protein based on mscarlet bindels et al	0.9999957	4.3351456e-06
33693628	fp11s	crisprcas9	33693628	66	122	@TERM$1	@TERM$2	cloningfree method to label endogenous genes with  @TERM$1  using  @TERM$2  commercially available synthetic ssodn and microi	0.99999785	2.0953205e-06
33693628	fp110	fp11	33693628	46	129	@TERM$1	@TERM$2	each plasmid consists of the large  @TERM$1  sequence fused to mneongreen and the corresponding small  @TERM$2  sequence fused to mtagbfp2	0.9999968	3.272618e-06
33693628	mscarlet	prset	33693628	74	86	@TERM$1	@TERM$2	 between the 10th and 11th strands of fulllength  @TERM$1  in a  @TERM$2  vector feng et a	0.99999666	3.3523186e-06
33693628	k46	w144	33693628	77	217	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999987	1.2518974e-06
33693628	rollingcircle	g32	33693628	77	177	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15  @TERM$2  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75	0.9999964	3.546691e-06
33693628	rollingcircle	q43	33693628	77	181	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32  @TERM$2  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79	0.9999988	1.2499054e-06
33693628	t74	f178	33693628	77	223	@TERM$1	@TERM$2	3 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$1  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$2  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208	0.99999714	2.906126e-06
33693628	a45	s63	33693628	77	127	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47 g52 g53 d60  @TERM$2  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 	0.99999785	2.127205e-06
33693628	k46	e115	33693628	77	187	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.9999969	3.1089544e-06
33693628	g32	k75	33693628	77	163	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.9999982	1.7451922e-06
33693628	g53	e115	33693628	77	175	@TERM$1	@TERM$2	s at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$1  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.9999982	1.7695603e-06
33693628	f15	g32	33693628	77	107	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1   @TERM$2  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r	0.9579153	0.04208465
33693628	s63	f66	33693628	77	115	@TERM$1	@TERM$2	itions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$1  p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.9999969	3.1425493e-06
33693628	f66	s70	33693628	77	107	@TERM$1	@TERM$2	0 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$1   @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.999944	5.5978155e-05
33693628	red	fp110	33693628	42	170	@TERM$1	@TERM$2	stable lines with  @TERM$1   @TERM$2  fragments would be especially useful given c elegans substantial autofluorescence in the gfp channelengineering and evaluating splitwrmscarlet	0.9999982	1.7685952e-06
33693628	fp110	splitwrmscarlet	33693628	42	170	@TERM$1	@TERM$2	stable lines with red  @TERM$1  fragments would be especially useful given c elegans substantial autofluorescence in the gfp channelengineering and evaluating  @TERM$2 	0.9491504	0.05084963
33693628	red	splitwrmscarlet	33693628	42	170	@TERM$1	@TERM$2	stable lines with  @TERM$1  fp110 fragments would be especially useful given c elegans substantial autofluorescence in the gfp channelengineering and evaluating  @TERM$2 	0.9999796	2.0434736e-05
33693628	red	tags	33693628	0	195	@TERM$1	@TERM$2	we create and share a new  @TERM$1  fluorophore along with a set of strains reagents and protocols to make it faster and easier to label endogenous caenorhabditis elegans proteins with fluorescent  @TERM$2 	0.999998	2.060229e-06
33693628	red	dim	33693628	4	201	@TERM$1	@TERM$2	no available c elegans lines express unbound large fragments of split  @TERM$1  fluorescent proteins and even stateoftheart split red fluorescent proteins are  @TERM$2  compared to the canonical splitsfgfp protein	0.9999988	1.178465e-06
33693628	red	splitsfgfp	33693628	4	201	@TERM$1	@TERM$2	no available c elegans lines express unbound large fragments of split  @TERM$1  fluorescent proteins and even stateoftheart split red fluorescent proteins are dim compared to the canonical  @TERM$2  protein	0.9999981	1.943526e-06
33693628	dim	splitsfgfp	33693628	4	201	@TERM$1	@TERM$2	no available c elegans lines express unbound large fragments of split red fluorescent proteins and even stateoftheart split red fluorescent proteins are  @TERM$1  compared to the canonical  @TERM$2  protein	1.7350827e-05	0.9999826
33693628	red	splitwrmscarlet	33693628	5	89	@TERM$1	@TERM$2	in this study we engineer a bright highaffinity new split  @TERM$1  fluorophore  @TERM$2 	0.99999094	9.008993e-06
33693628	splitwrmscarlet	crisprcas9	33693628	8	178	@TERM$1	@TERM$2	we validate these strains by targeting  @TERM$1  to several genes whose products label distinct organelles and we provide a protocol for easy cloningfree  @TERM$2  editing	0.99999416	5.8504147e-06
33693628	post	fluorophores	33693628	9	246	@TERM$1	@TERM$2	as the collection of splitfp strains for labeling in different tissues or organelles expands we will  @TERM$1  updates at doiorg105281zenodo3993663genetically expressed  @TERM$2  are essential tools for visualizing and quantifying cellular proteins	0.9999981	1.932658e-06
33693628	gfplike	fp11	33693628	30	181	@TERM$1	@TERM$2	these fluorophores typically separate a  @TERM$1  protein between the 10th and 11th strands of the beta barrel splitting it asymmetrically into a large  @TERM$2 0 and a small fp11 fragment	0.9999908	9.140041e-06
33693628	beta barrel	fp11	33693628	30	181	@TERM$1	@TERM$2	these fluorophores typically separate a gfplike protein between the 10th and 11th strands of the  @TERM$1  splitting it asymmetrically into a large  @TERM$2 0 and a small fp11 fragment	0.99999547	4.5587435e-06
33693628	fluorophores	gfplike	33693628	30	181	@TERM$1	@TERM$2	these  @TERM$1  typically separate a  @TERM$2  protein between the 10th and 11th strands of the beta barrel splitting it asymmetrically into a large fp110 and a small fp11 fragment	0.99999344	6.5076483e-06
33693628	gfplike	beta barrel	33693628	30	181	@TERM$1	@TERM$2	these fluorophores typically separate a  @TERM$1  protein between the 10th and 11th strands of the  @TERM$2  splitting it asymmetrically into a large fp110 and a small fp11 fragment	0.99999666	3.292518e-06
33693628	fluorophores	beta barrel	33693628	30	181	@TERM$1	@TERM$2	these  @TERM$1  typically separate a gfplike protein between the 10th and 11th strands of the  @TERM$2  splitting it asymmetrically into a large fp110 and a small fp11 fragment	0.99999845	1.4930584e-06
33693628	fluorophores	fp11	33693628	30	181	@TERM$1	@TERM$2	these  @TERM$1  typically separate a gfplike protein between the 10th and 11th strands of the beta barrel splitting it asymmetrically into a large  @TERM$2 0 and a small fp11 fragment	0.99999785	2.1694048e-06
33693628	gfplike	fp110	33693628	30	181	@TERM$1	@TERM$2	these fluorophores typically separate a  @TERM$1  protein between the 10th and 11th strands of the beta barrel splitting it asymmetrically into a large  @TERM$2  and a small fp11 fragment	0.99999905	9.046764e-07
33693628	fp110	fp11	33693628	30	181	@TERM$1	@TERM$2	these fluorophores typically separate a gfplike protein between the 10th and 11th strands of the beta barrel splitting it asymmetrically into a large  @TERM$1  and a small  @TERM$2  fragment	0.99999785	2.1908736e-06
33693628	beta barrel	fp110	33693628	30	181	@TERM$1	@TERM$2	these fluorophores typically separate a gfplike protein between the 10th and 11th strands of the  @TERM$1  splitting it asymmetrically into a large  @TERM$2  and a small fp11 fragment	0.9999989	1.0951701e-06
33693628	fluorophores	fp110	33693628	30	181	@TERM$1	@TERM$2	these  @TERM$1  typically separate a gfplike protein between the 10th and 11th strands of the beta barrel splitting it asymmetrically into a large  @TERM$2  and a small fp11 fragment	0.99999845	1.4917518e-06
33693628	fp11	tag	33693628	35	169	@TERM$1	@TERM$2	this way only the small  @TERM$1  fragment 72nt needs to be inserted to  @TERM$2  the target protein which will only fluoresce in compartments where it can bind the large fragment	0.9999912	8.801537e-06
33693628	gfp	splitwrmscarlet	33693628	42	170	@TERM$1	@TERM$2	stable lines with red fp110 fragments would be especially useful given c elegans substantial autofluorescence in the  @TERM$1  channelengineering and evaluating  @TERM$2 	0.9999989	1.0882061e-06
33693628	fp110	gfp	33693628	42	170	@TERM$1	@TERM$2	stable lines with red  @TERM$1  fragments would be especially useful given c elegans substantial autofluorescence in the  @TERM$2  channelengineering and evaluating splitwrmscarlet	0.9999882	1.1821407e-05
33693628	red	gfp	33693628	42	170	@TERM$1	@TERM$2	stable lines with  @TERM$1  fp110 fragments would be especially useful given c elegans substantial autofluorescence in the  @TERM$2  channelengineering and evaluating splitwrmscarlet	0.99999785	2.1020735e-06
33693628	f178	s223	33693628	77	224	@TERM$1	@TERM$2	w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$1  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208 y209 t210 v211 v212 e213 q214 y215 e216 r217 s218 e219 a220 h222  @TERM$2  t224 g225 g226 m227 d228 and e229 with phusion po	0.99979573	0.00020433949
33693628	g32	g53	33693628	77	127	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47 g52  @TERM$2  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r	0.9999976	2.3487853e-06
33693628	w144	t210	33693628	77	214	@TERM$1	@TERM$2	 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$1  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178 k179 k183 k185 k186 n195 r198 i202 t203 s204 d208 y209  @TERM$2  v211 v212 e213 q214 y215 e216 r217 s218 e219 a220	0.9999969	3.0899305e-06
33693628	k10	p64	33693628	77	147	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108	0.999998	2.0715636e-06
33693628	p64	f66	33693628	77	111	@TERM$1	@TERM$2	ns i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$1  q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.9999963	3.7548004e-06
33693628	f15	a45	33693628	77	115	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43  @TERM$2  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k	0.99999726	2.713627e-06
33693628	f66	e115	33693628	77	155	@TERM$1	@TERM$2	0 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$1  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.99999654	3.4054765e-06
33693628	q43	k75	33693628	77	159	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.99999654	3.4594743e-06
33693628	t210	polymerase	33693628	77	222	@TERM$1	@TERM$2	k183 k185 k186 n195 r198 i202 t203 s204 d208 y209  @TERM$1  v211 v212 e213 q214 y215 e216 r217 s218 e219 a220 h222 s223 t224 g225 g226 m227 d228 and e229 with phusion  @TERM$2  neb in gc buffer followed by pooling of the pcr p	0.99999654	3.456091e-06
33693628	k10	k46	33693628	77	123	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45  @TERM$2  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d	0.9999974	2.6629182e-06
33693628	k10	t74	33693628	77	167	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.999997	2.9380835e-06
33693628	polymerase	neb	33693628	77	121	@TERM$1	@TERM$2	23 t224 g225 g226 m227 d228 and e229 with phusion  @TERM$1   @TERM$2  in gc buffer followed by pooling of the pcr products dpn	0.9999461	5.393733e-05
33693628	t210	s223	33693628	77	164	@TERM$1	@TERM$2	k183 k185 k186 n195 r198 i202 t203 s204 d208 y209  @TERM$1  v211 v212 e213 q214 y215 e216 r217 s218 e219 a220 h222  @TERM$2  t224 g225 g226 m227 d228 and e229 with phusion po	0.99999106	8.957071e-06
33693628	k46	s63	33693628	77	123	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47 g52 g53 d60  @TERM$2  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 	0.999998	2.0205655e-06
33693628	f66	f178	33693628	77	235	@TERM$1	@TERM$2	0 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$1  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$2  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208	0.9999969	3.135e-06
33693628	f15	k75	33693628	77	167	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.99999785	2.107634e-06
33693628	nnk	f15	33693628	77	135	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10  @TERM$2  g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s	0.9999988	1.1945097e-06
33693628	g52	w144	33693628	77	209	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.99999845	1.4941168e-06
33693628	k10	k75	33693628	77	171	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.99999774	2.2926897e-06
33693628	s223	neb	33693628	77	167	@TERM$1	@TERM$2	v212 e213 q214 y215 e216 r217 s218 e219 a220 h222  @TERM$1  t224 g225 g226 m227 d228 and e229 with phusion polymerase  @TERM$2  in gc buffer followed by pooling of the pcr produc	0.9999778	2.2190477e-05
33693628	nnk	k10	33693628	77	131	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8  @TERM$2  f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f	0.99999666	3.3942194e-06
33693628	a45	k46	33693628	77	107	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1   @TERM$2  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d	0.9999964	3.6119486e-06
33693628	a45	g53	33693628	77	119	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47 g52  @TERM$2  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r	0.99999523	4.7644216e-06
33693628	a45	t74	33693628	77	151	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.9999962	3.87351e-06
33693628	f66	t74	33693628	77	115	@TERM$1	@TERM$2	0 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$1  s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.9995297	0.00047030588
33693628	f15	q43	33693628	77	111	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32  @TERM$2  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t	0.9999976	2.4059395e-06
33693628	rollingcircle	k10	33693628	77	169	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8  @TERM$2  f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71	0.9999949	5.0999074e-06
33693628	f15	g53	33693628	77	131	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47 g52  @TERM$2  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r	0.9999964	3.6133338e-06
33693628	t203 s204 d208 y209	s223	33693628	77	199	@TERM$1	@TERM$2	m164 l175 f178 k179 k183 k185 k186 n195 r198 i202  @TERM$1  t210 v211 v212 e213 q214 y215 e216 r217 s218 e219 a220 h222  @TERM$2  t224 g225 g226 m227 d228 and e229 with phusion polymerase neb in	0.99788445	0.0021155726
33693628	f15	k46	33693628	77	119	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45  @TERM$2  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d	0.9979241	0.002075894
33693628	k75	f178	33693628	77	219	@TERM$1	@TERM$2	5 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$1  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$2  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208	0.99999666	3.2951723e-06
33693628	m164	f178	33693628	77	114	@TERM$1	@TERM$2	k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$1  l175  @TERM$2  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208	0.9999975	2.5531078e-06
33693628	k75	e115	33693628	77	139	@TERM$1	@TERM$2	5 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$1  d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.99999785	2.1853186e-06
33693628	g53	w144	33693628	77	205	@TERM$1	@TERM$2	s at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$1  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999869	1.3156059e-05
33693628	t203 s204 d208 y209	s218	33693628	77	179	@TERM$1	@TERM$2	m164 l175 f178 k179 k183 k185 k186 n195 r198 i202  @TERM$1  t210 v211 v212 e213 q214 y215 e216 r217  @TERM$2  e219 a220 h222 s223 t224 g225 g226 m227 d228 and e229 with phusi	0.9999987	1.3665192e-06
33693628	e115	m164	33693628	77	174	@TERM$1	@TERM$2	66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$1  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.9999988	1.2283734e-06
33693628	nnk	e115	33693628	77	235	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.9999968	3.2052515e-06
33693628	k10	f66	33693628	77	155	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.9999981	1.9279896e-06
33693628	nnk	t74	33693628	77	195	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.9999987	1.3222319e-06
33693628	s223	phusion polymerase	33693628	77	162	@TERM$1	@TERM$2	v212 e213 q214 y215 e216 r217 s218 e219 a220 h222  @TERM$1  t224 g225 g226 m227 d228 and e229 with  @TERM$2  neb in gc buffer followed by pooling of the pcr p	0.99999666	3.3079934e-06
33693628	nnk	k75	33693628	77	199	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.9999976	2.343507e-06
33693628	t210	s218	33693628	77	144	@TERM$1	@TERM$2	k183 k185 k186 n195 r198 i202 t203 s204 d208 y209  @TERM$1  v211 v212 e213 q214 y215 e216 r217  @TERM$2  e219 a220 h222 s223 t224 g225 g226 m227 d228 and 	0.99999094	9.050199e-06
33693628	k46	t74	33693628	77	147	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.9999964	3.6220833e-06
33693628	rollingcircle	nnk	33693628	77	141	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with  @TERM$2  primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53	0.99999666	3.354455e-06
33693628	g32	a45	33693628	77	111	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43  @TERM$2  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k	0.99999774	2.3243879e-06
33693628	rollingcircle	k46	33693628	77	189	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$2  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94	0.9999932	6.8330146e-06
33693628	g53	r71	33693628	77	131	@TERM$1	@TERM$2	s at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$1  d60 s63 p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.9999275	7.247399e-05
33693628	k46	s70	33693628	77	139	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47 g52 g53 d60 s63 p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.9999728	2.718507e-05
33693628	g32	f66	33693628	77	147	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.9999976	2.371792e-06
33693628	p64	r71	33693628	77	119	@TERM$1	@TERM$2	ns i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$1  q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.99999726	2.769076e-06
33693628	q43	e115	33693628	77	195	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.99999845	1.5619418e-06
33693628	a45	p64	33693628	77	131	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47 g52 g53 d60 s63  @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108	0.99999845	1.5824677e-06
33693628	k10	g52	33693628	77	131	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47  @TERM$2  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w	0.99999774	2.2433035e-06
33693628	t74	w144	33693628	77	173	@TERM$1	@TERM$2	3 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$1  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999974	2.6496011e-06
33693628	s63	f178	33693628	77	247	@TERM$1	@TERM$2	itions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$1  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$2  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208	0.9999981	1.915052e-06
33693628	p64	w144	33693628	77	193	@TERM$1	@TERM$2	ns i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$1  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999974	2.6343228e-06
33693628	s63	e115	33693628	77	167	@TERM$1	@TERM$2	itions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$1  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.99999845	1.5949233e-06
33693628	musclespecific	fib1	33693628	193	194	@TERM$1	@TERM$2	to test the  @TERM$1  splitwrmscarlet110line cf4610 we tagged the nterminus of endogenous  @TERM$2  with splitwrmscarlet11 and confirmed the fluorescence from nucleoli in muscle cells figure3g	0.99999785	2.108999e-06
33693628	mscarlet	glygly	33693628	205	157	@TERM$1	@TERM$2	we also do not detect differences in protein abundance of  @TERM$1  truncated to end in  @TERM$2  compared to mscarlet ending in mdelyk via fluorescence in yeast	0.99999726	2.7115498e-06
33693628	green fluorescence	red	33693628	208	144	@TERM$1	@TERM$2	 encoding mneongreensplitwrmscarlet11 we observed  @TERM$1  but no  @TERM$2  fluorescence supplementary figure s7 a and b suggesting the abse	0.99999785	2.1789049e-06
33693628	mossci	red	33693628	208	219	@TERM$1	@TERM$2	rated psun1splitwrmscarlet110sun1 3utr strain via  @TERM$1  but when we injected a plasmid encoding mneongreensplitwrmscarlet11 we observed green fluorescence but no  @TERM$2  fluorescence supplementary figure s7 a and b suggest	0.99999833	1.6819852e-06
33693628	singlecopy	psun1splitwrmscarlet110sun1	33693628	208	109	@TERM$1	@TERM$2	we made a  @TERM$1  integrated  @TERM$2  3utr strain via mossci but when we injected a pla	0.99999833	1.6672416e-06
33693628	mossci	green fluorescence	33693628	208	205	@TERM$1	@TERM$2	rated psun1splitwrmscarlet110sun1 3utr strain via  @TERM$1  but when we injected a plasmid encoding mneongreensplitwrmscarlet11 we observed  @TERM$2  but no red fluorescence supplementary figure s7 a	0.9999982	1.7477705e-06
33693628	singlecopy	red	33693628	208	249	@TERM$1	@TERM$2	we made a  @TERM$1  integrated psun1splitwrmscarlet110sun1 3utr strain via mossci but when we injected a plasmid encoding mneongreensplitwrmscarlet11 we observed green fluorescence but no  @TERM$2  fluorescence supplementary figure s7 a and b suggesting 	0.999998	2.0581317e-06
33693628	singlecopy	green fluorescence	33693628	208	231	@TERM$1	@TERM$2	we made a  @TERM$1  integrated psun1splitwrmscarlet110sun1 3utr strain via mossci but when we injected a plasmid encoding mneongreensplitwrmscarlet11 we observed  @TERM$2  but no red fluorescence supplementary figure s7 a	0.99999774	2.250074e-06
33693628	psun1splitwrmscarlet110sun1	green fluorescence	33693628	208	240	@TERM$1	@TERM$2	we made a singlecopy integrated  @TERM$1  3utr strain via mossci but when we injected a plasmid encoding mneongreensplitwrmscarlet11 we observed  @TERM$2  but no red fluorescence supplementary figure s7 a and b su	0.99999785	2.1147189e-06
33693628	psun1splitwrmscarlet110sun1	mossci	33693628	208	153	@TERM$1	@TERM$2	we made a singlecopy integrated  @TERM$1  3utr strain via  @TERM$2  but when we injected a plasmid encoding mneongreensplitwrmscarlet11 we	0.9999951	4.86568e-06
33693628	germlineexpressed	germlinespecific	33693628	209	243	@TERM$1	@TERM$2	we suspected germline silencing of the  @TERM$1  splitwrmscarlet110 so we attempted an alternative expression approach by taking advantage of the germlinehelicase protein glh1 which is highly expressed and  @TERM$2  marnik et al	1.9851836e-05	0.9999801
33693628	germlineexpressed	glh1	33693628	209	243	@TERM$1	@TERM$2	we suspected germline silencing of the  @TERM$1  splitwrmscarlet110 so we attempted an alternative expression approach by taking advantage of the germlinehelicase protein  @TERM$2  which is highly expressed and germlinespecific marnik et al	0.99999464	5.348888e-06
33693628	glh1	germlinespecific	33693628	209	243	@TERM$1	@TERM$2	we suspected germline silencing of the germlineexpressed splitwrmscarlet110 so we attempted an alternative expression approach by taking advantage of the germlinehelicase protein  @TERM$1  which is highly expressed and  @TERM$2  marnik et al	0.9999982	1.8017518e-06
33693628	germlineexpressed	germlinehelicase	33693628	209	243	@TERM$1	@TERM$2	we suspected germline silencing of the  @TERM$1  splitwrmscarlet110 so we attempted an alternative expression approach by taking advantage of the  @TERM$2  protein glh1 which is highly expressed and germlinespecific marnik et al	0.9999975	2.547312e-06
33693628	germlinehelicase	germlinespecific	33693628	209	243	@TERM$1	@TERM$2	we suspected germline silencing of the germlineexpressed splitwrmscarlet110 so we attempted an alternative expression approach by taking advantage of the  @TERM$1  protein glh1 which is highly expressed and  @TERM$2  marnik et al	0.99999845	1.5782416e-06
33693628	germlinehelicase	glh1	33693628	209	243	@TERM$1	@TERM$2	we suspected germline silencing of the germlineexpressed splitwrmscarlet110 so we attempted an alternative expression approach by taking advantage of the  @TERM$1  protein  @TERM$2  which is highly expressed and germlinespecific marnik et al	0.99999833	1.690663e-06
33693628	glh1	crisprcas9	33693628	211	103	@TERM$1	@TERM$2	we fused a t2asplitwrmscarlet110 sequence to the cterminus of the endogenous  @TERM$1  gene using  @TERM$2 	0.999998	2.05748e-06
33693628	red	figure s8	33693628	215	239	@TERM$1	@TERM$2	to demonstrate this we tagged the nterminus of endogenous fib1 with splitwrmscarlet11 and we observed  @TERM$1  fluorescence localized to the nucleoli specifically in the germline and embryos as we hoped figure3h supplementary  @TERM$2  a and c	0.9999964	3.5473e-06
33693628	fib1	red	33693628	215	239	@TERM$1	@TERM$2	to demonstrate this we tagged the nterminus of endogenous  @TERM$1  with splitwrmscarlet11 and we observed  @TERM$2  fluorescence localized to the nucleoli specifically in the germline and embryos as we hoped figure3h supplementary figure s8 a and c	0.9999982	1.7616716e-06
33693628	fib1	figure s8	33693628	215	239	@TERM$1	@TERM$2	to demonstrate this we tagged the nterminus of endogenous  @TERM$1  with splitwrmscarlet11 and we observed red fluorescence localized to the nucleoli specifically in the germline and embryos as we hoped figure3h supplementary  @TERM$2  a and c	0.99999845	1.5879615e-06
33693628	singlecopy	mossci	33693628	208	136	@TERM$1	@TERM$2	we made a  @TERM$1  integrated psun1splitwrmscarlet110sun1 3utr strain via  @TERM$2  but when we injected a plasmid encoding mneongreenspl	0.9999981	1.8824836e-06
33693628	tbb2	vha13	33693628	189	205	@TERM$1	@TERM$2	starting with the somatic splitwrmscarlet110 parental strain cf4582 we introduced splitwrmscarlet11 at the nterminus of  @TERM$1  fib1 or  @TERM$2  or at the cterminus of eat6 his3 and tomm20 supplementary table s4	0.99999845	1.5060549e-06
33693628	cf4582	vha13	33693628	189	205	@TERM$1	@TERM$2	starting with the somatic splitwrmscarlet110 parental strain  @TERM$1  we introduced splitwrmscarlet11 at the nterminus of tbb2 fib1 or  @TERM$2  or at the cterminus of eat6 his3 and tomm20 supplementary table s4	0.9999964	3.5234193e-06
33693628	cf4582	eat6	33693628	189	205	@TERM$1	@TERM$2	starting with the somatic splitwrmscarlet110 parental strain  @TERM$1  we introduced splitwrmscarlet11 at the nterminus of tbb2 fib1 or vha13 or at the cterminus of  @TERM$2  his3 and tomm20 supplementary table s4	0.9999975	2.4789645e-06
33693628	fp110	s3a	33693628	153	242	@TERM$1	@TERM$2	specifically we generated wormcodonoptimized plasmids encoding three nuclear localization signals nls mtagbfp2 fp11 a t2a peptidebondskipping sequence mneongreen and the corresponding  @TERM$1  driven by the eft3 promoter supplementary figure  @TERM$2 	0.999998	2.0715459e-06
33693628	fp110	eft3	33693628	153	242	@TERM$1	@TERM$2	specifically we generated wormcodonoptimized plasmids encoding three nuclear localization signals nls mtagbfp2 fp11 a t2a peptidebondskipping sequence mneongreen and the corresponding  @TERM$1  driven by the  @TERM$2  promoter supplementary figure s3a	0.9999976	2.3985833e-06
33693628	fp11	fp110	33693628	153	242	@TERM$1	@TERM$2	specifically we generated wormcodonoptimized plasmids encoding three nuclear localization signals nls mtagbfp2  @TERM$1  a t2a peptidebondskipping sequence mneongreen and the corresponding  @TERM$2  driven by the eft3 promoter supplementary figure s3a	0.99999845	1.5906685e-06
33693628	fp11	eft3	33693628	153	242	@TERM$1	@TERM$2	specifically we generated wormcodonoptimized plasmids encoding three nuclear localization signals nls mtagbfp2  @TERM$1  a t2a peptidebondskipping sequence mneongreen and the corresponding fp110 driven by the  @TERM$2  promoter supplementary figure s3a	0.9999981	1.9010516e-06
33693628	fp11	fp110	33693628	154	188	@TERM$1	@TERM$2	each  @TERM$1  was linked to mtagbfp2 in order to reduce the risk of proteolysis of the short peptide and mneongreen was linked to  @TERM$2  to monitor its expression and for normalization purposes	0.999998	1.9776894e-06
33693628	red	splitwrmscarlet	33693628	158	177	@TERM$1	@TERM$2	 @TERM$1  fluorescence emitted from  @TERM$2  was 29fold higher than that of splitsfcherry3 when normalized to the mneongreen signal figure1 b and c and supplementary figure s4	0.99999547	4.5111874e-06
33693628	fps	singlecopy	33693628	161	153	@TERM$1	@TERM$2	a more controlled way to compare the split  @TERM$1  at similar expression levels would be to make  @TERM$2  genomic insertions of these constructs at a neutr	0.9999981	1.9372012e-06
33693628	tag	singlecopy	33693628	164	173	@TERM$1	@TERM$2	fragment to be inserted at an endogenous locus to  @TERM$1  a protein of interest figure1ato build strains expressing  @TERM$2  insertions of splitwrmscarlet110 we first optimiz	0.99999654	3.4545983e-06
33693628	mossci	ca1200	33693628	166	186	@TERM$1	@TERM$2	the strain expressing splitwrmscarlet110 throughout the soma driven by the eft3 promoter and unc54 3utr was generated by editing the genome of the existing  @TERM$1  line  @TERM$2  zhang et al	0.999998	1.9722988e-06
33693628	eft3	ca1200	33693628	166	186	@TERM$1	@TERM$2	the strain expressing splitwrmscarlet110 throughout the soma driven by the  @TERM$1  promoter and unc54 3utr was generated by editing the genome of the existing mossci line  @TERM$2  zhang et al	0.999998	2.0479017e-06
33693628	eft3	mossci	33693628	166	186	@TERM$1	@TERM$2	the strain expressing splitwrmscarlet110 throughout the soma driven by the  @TERM$1  promoter and unc54 3utr was generated by editing the genome of the existing  @TERM$2  line ca1200 zhang et al	0.9999975	2.484588e-06
33693628	tag	cas9 ribonucleoproteins	33693628	173	202	@TERM$1	@TERM$2	to  @TERM$1  a gene of interest with the splitwrmscarlet11 fragment we used microinjection of preassembled  @TERM$2  because this method enables highefficiency genome editing in worms paix et al	0.9999982	1.824646e-06
33693628	tag	cas9	33693628	173	202	@TERM$1	@TERM$2	to  @TERM$1  a gene of interest with the splitwrmscarlet11 fragment we used microinjection of preassembled  @TERM$2  ribonucleoproteins because this method enables highefficiency genome editing in worms paix et al	0.9999982	1.7653902e-06
33693628	6684	6758	33693628	182	178	@TERM$1	@TERM$2	the small size of splitwrmscarlet11 1824 aa is key 200nt can encompass splitwrmscarlet11  @TERM$1 nt including a 4 aa linker flanked by two homology arms 34nt up to  @TERM$2 nt for hdr	0.99999523	4.728183e-06
33693628	musclespecific	red	33693628	183	200	@TERM$1	@TERM$2	in principle a few days after the somatic andor  @TERM$1  splitwrmscarlet110 strains are microinjected progeny can be screened for  @TERM$2  fluorescence genotyped and sequenced to check the accuracy o	0.99999833	1.6591205e-06
33693628	tbb2	eat6	33693628	189	205	@TERM$1	@TERM$2	starting with the somatic splitwrmscarlet110 parental strain cf4582 we introduced splitwrmscarlet11 at the nterminus of  @TERM$1  fib1 or vha13 or at the cterminus of  @TERM$2  his3 and tomm20 supplementary table s4	0.9999958	4.1621806e-06
33693628	tbb2	fib1	33693628	189	205	@TERM$1	@TERM$2	starting with the somatic splitwrmscarlet110 parental strain cf4582 we introduced splitwrmscarlet11 at the nterminus of  @TERM$1   @TERM$2  or vha13 or at the cterminus of eat6 his3 and tomm20 supplementary table s4	0.99999833	1.6689706e-06
33693628	fib1	eat6	33693628	189	205	@TERM$1	@TERM$2	starting with the somatic splitwrmscarlet110 parental strain cf4582 we introduced splitwrmscarlet11 at the nterminus of tbb2  @TERM$1  or vha13 or at the cterminus of  @TERM$2  his3 and tomm20 supplementary table s4	0.99999857	1.4708671e-06
33693628	cf4582	tbb2	33693628	189	205	@TERM$1	@TERM$2	starting with the somatic splitwrmscarlet110 parental strain  @TERM$1  we introduced splitwrmscarlet11 at the nterminus of  @TERM$2  fib1 or vha13 or at the cterminus of eat6 his3 and tomm20 supplementary table s4	0.99999845	1.5970984e-06
33693628	vha13	eat6	33693628	189	205	@TERM$1	@TERM$2	starting with the somatic splitwrmscarlet110 parental strain cf4582 we introduced splitwrmscarlet11 at the nterminus of tbb2 fib1 or  @TERM$1  or at the cterminus of  @TERM$2  his3 and tomm20 supplementary table s4	0.9999988	1.2248722e-06
33693628	fib1	vha13	33693628	189	205	@TERM$1	@TERM$2	starting with the somatic splitwrmscarlet110 parental strain cf4582 we introduced splitwrmscarlet11 at the nterminus of tbb2  @TERM$1  or  @TERM$2  or at the cterminus of eat6 his3 and tomm20 supplementary table s4	0.99999726	2.8007523e-06
33693628	cf4582	fib1	33693628	189	205	@TERM$1	@TERM$2	starting with the somatic splitwrmscarlet110 parental strain  @TERM$1  we introduced splitwrmscarlet11 at the nterminus of tbb2  @TERM$2  or vha13 or at the cterminus of eat6 his3 and tomm20 supplementary table s4	0.99999845	1.568767e-06
33693628	glh1	splitwrmscarlet	33693628	216	245	@TERM$1	@TERM$2	e germline by tagging the 3 end of the endogenous  @TERM$1  with t2afp110 with crisprcas9 could be used to express any other protein of choiceto benchmark the fluorescence intensity of  @TERM$2  against its fulllength counterpart we first gener	0.9999958	4.1133408e-06
33693628	fp11	s3a	33693628	153	242	@TERM$1	@TERM$2	specifically we generated wormcodonoptimized plasmids encoding three nuclear localization signals nls mtagbfp2  @TERM$1  a t2a peptidebondskipping sequence mneongreen and the corresponding fp110 driven by the eft3 promoter supplementary figure  @TERM$2 	0.9999958	4.118628e-06
33693628	crisprcas9	splitwrmscarlet	33693628	216	221	@TERM$1	@TERM$2	e 3 end of the endogenous glh1 with t2afp110 with  @TERM$1  could be used to express any other protein of choiceto benchmark the fluorescence intensity of  @TERM$2  against its fulllength counterpart we first gener	0.9999975	2.490419e-06
33693628	glh1	crisprcas9	33693628	216	134	@TERM$1	@TERM$2	e germline by tagging the 3 end of the endogenous  @TERM$1  with t2afp110 with  @TERM$2  could be used to express any other protein of cho	0.99603575	0.00396422
33693628	germlinespecific	pgranules	33693628	259	233	@TERM$1	@TERM$2	to test this  @TERM$1  line dup223 httpscgcumnedustraindup223 we tagged the cterminus of endogenous pgl1 with sgfp211 and confirmed the green fluorescence from  @TERM$2  supplementary figure s8b lower panelfinally to allow two	0.99651057	0.0034894012
33693628	pgranules	s8b	33693628	259	140	@TERM$1	@TERM$2	sgfp211 and confirmed the green fluorescence from  @TERM$1  supplementary figure  @TERM$2  lower panelfinally to allow twocolor imaging in the som	0.99999845	1.5235142e-06
33693628	germlinespecific	pgl1	33693628	259	173	@TERM$1	@TERM$2	to test this  @TERM$1  line dup223 httpscgcumnedustraindup223 we tagged the cterminus of endogenous  @TERM$2  with sgfp211 and confirmed the green fluorescence from pgranu	0.00020661247	0.99979335
33693628	germlinespecific line	green fluorescence	33693628	259	214	@TERM$1	@TERM$2	to test this  @TERM$1  dup223 httpscgcumnedustraindup223 we tagged the cterminus of endogenous pgl1 with sgfp211 and confirmed the  @TERM$2  from pgranules supplementary figure s8b lower panelf	0.9999975	2.4716253e-06
33693628	germlinespecific	green fluorescence	33693628	259	211	@TERM$1	@TERM$2	to test this  @TERM$1  line dup223 httpscgcumnedustraindup223 we tagged the cterminus of endogenous pgl1 with sgfp211 and confirmed the  @TERM$2  from pgranules supplementary figure s8b lower pan	0.9999981	1.9542874e-06
33693628	q43	g52	33693628	77	119	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47  @TERM$2  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w	0.9999913	8.755743e-06
33693628	pgl1	s8b	33693628	259	195	@TERM$1	@TERM$2	traindup223 we tagged the cterminus of endogenous  @TERM$1  with sgfp211 and confirmed the green fluorescence from pgranules supplementary figure  @TERM$2  lower panelfinally to allow twocolor imaging in th	0.9999987	1.3281135e-06
33693628	dup223	pgl1	33693628	259	163	@TERM$1	@TERM$2	to test this germlinespecific line  @TERM$1  httpscgcumnedustraindup223 we tagged the cterminus of endogenous  @TERM$2  with sgfp211 and confirmed the green fluorescence f	0.999998	1.9902755e-06
33693628	germlinespecific line	pgl1	33693628	259	178	@TERM$1	@TERM$2	to test this  @TERM$1  dup223 httpscgcumnedustraindup223 we tagged the cterminus of endogenous  @TERM$2  with sgfp211 and confirmed the green fluorescence from pgranules s	0.9999976	2.360129e-06
33693628	cf4602	splitwrmscarlet11fib1	33693628	260	229	@TERM$1	@TERM$2	this cross resulted in the line cf4588 peft3sfgfp110 peft3splitwrmscarlet110 httpscgcumnedustraincf4588 as well as the dually labeled strain  @TERM$1  peft3sfgfp110 peft3splitwrmscarlet110  @TERM$2  his3sfgfp11 figure5c	0.9999951	4.8396064e-06
33693628	splitsfgfp	erresident polypeptides	33693628	267	131	@TERM$1	@TERM$2	these approaches have been used successfully in mammalian cells with  @TERM$1  when tagging  @TERM$2  kamiyama et al	0.9999974	2.663896e-06
33693628	organelleresident	ctermini	33693628	273	190	@TERM$1	@TERM$2	for example ntermini of membrane and  @TERM$1  proteins often contain signal peptides or localization signals and  @TERM$2  may contain degron sequences that regulate protein turnover	0.99999857	1.4340321e-06
33693628	gfp	hefel	33693628	275	109	@TERM$1	@TERM$2	e but not functional when labeled with fulllength  @TERM$1   @TERM$2  and smolikove 2019fourth for proteins of interest	0.99999833	1.6446587e-06
33693628	hefel	bifc	33693628	279	154	@TERM$1	@TERM$2	2019  @TERM$1  and smolikove 2019fifth we would like to emphasize differences between our technique and the bimolecular fluorescencecomplementation  @TERM$2  assay	0.99999845	1.4936195e-06
33693628	red	bifc	33693628	280	154	@TERM$1	@TERM$2	when used together highaffinity green and  @TERM$1  split fluorescent proteins can provide information on colocalization but unlike  @TERM$2  split proteins hu et al	0.9999981	1.8717785e-06
33693628	p20	calvin	33693628	296	168	@TERM$1	@TERM$2	13933 with use of equipment supported by nihnigms  @TERM$1  gm103423none declaredwe thank katie podshivalova rex kerr  @TERM$2  jan and david botstein for comments on the manusc	0.9999285	7.1556315e-05
33693628	p20	rex	33693628	296	156	@TERM$1	@TERM$2	13933 with use of equipment supported by nihnigms  @TERM$1  gm103423none declaredwe thank katie podshivalova  @TERM$2  kerr calvin jan and david botstein for comments o	0.9999981	1.9491465e-06
33693628	rex	calvin	33693628	296	115	@TERM$1	@TERM$2	 gm103423none declaredwe thank katie podshivalova  @TERM$1  kerr  @TERM$2  jan and david botstein for comments on the manusc	0.99999845	1.5117937e-06
33693628	crisprcas9	ca1200	33693628	298	187	@TERM$1	@TERM$2	we also thank behnom farboud from barbara meyers laboratory for discussing  @TERM$1  protocols and liangyu zhang from abby dernburgs laboratory for sharing sequences of the  @TERM$2  strain	0.99999845	1.5450848e-06
33693628	fp11	fp110	33693628	264	135	@TERM$1	@TERM$2	irst detection of a given protein labeled with an  @TERM$1  can only occur in a cellular compartment where the corresponding  @TERM$2  is presen	0.9999987	1.26642e-06
33693628	germlinespecific line	pgranules	33693628	259	238	@TERM$1	@TERM$2	to test this  @TERM$1  dup223 httpscgcumnedustraindup223 we tagged the cterminus of endogenous pgl1 with sgfp211 and confirmed the green fluorescence from  @TERM$2  supplementary figure s8b lower panelfinally to allow twocolor	0.9999974	2.6045059e-06
33693628	pgl1	pgranules	33693628	259	169	@TERM$1	@TERM$2	traindup223 we tagged the cterminus of endogenous  @TERM$1  with sgfp211 and confirmed the green fluorescence from  @TERM$2  supplementary figure s8b lower panelfinally to al	0.999998	2.0094124e-06
33693628	green fluorescence	s8b	33693628	259	173	@TERM$1	@TERM$2	of endogenous pgl1 with sgfp211 and confirmed the  @TERM$1  from pgranules supplementary figure  @TERM$2  lower panelfinally to allow twocolor imaging in the soma we cros	0.999997	2.9386356e-06
33693628	vha13	splitwrmscarlet	33693628	218	194	@TERM$1	@TERM$2	at the  @TERM$1  locus  @TERM$2  was about half as bright as a fulllength fluorophore 48 a ratio comparable to that of splitmneongreen2 and its fulllength counterpart in human cells feng et al	0.99999785	2.180672e-06
33693628	wrmscarlet	vha13	33693628	220	150	@TERM$1	@TERM$2	a images of animals carrying either  @TERM$1  splitwrmscarlet11 or two tandem repeats of splitwrmscarlet11 inserted at the endogenous  @TERM$2  nterminus	0.9999981	1.855042e-06
33693628	wrmscarlet	vha13	33693628	221	129	@TERM$1	@TERM$2	b emission intensities of animals carrying  @TERM$1  splitwrmscarlet11 or dual splitwrmscarlet11 inserted at the  @TERM$2  nterminus	0.9999981	1.9591803e-06
33693628	splitwrmscarlet fluorescence	splitwrmscarlet	33693628	237	98	@TERM$1	@TERM$2	to demonstrate that  @TERM$1  is enhanced by  @TERM$2 11 tandem repeats w	0.9999982	1.8134774e-06
33693628	splitwrmscarlet fluorescence	vha13	33693628	237	239	@TERM$1	@TERM$2	to demonstrate that  @TERM$1  is enhanced by splitwrmscarlet11 tandem repeats we introduced two splitwrmscarlet11 domains at the nterminus of  @TERM$2  and three splitwrmscarlet11 domains at the cterminus of his3 in animals 	0.99999833	1.6171514e-06
33693628	splitwrmscarlet	vha13	33693628	237	226	@TERM$1	@TERM$2	to demonstrate that  @TERM$1  fluorescence is enhanced by splitwrmscarlet11 tandem repeats we introduced two splitwrmscarlet11 domains at the nterminus of  @TERM$2  and three splitwrmscarlet11 domains at the cterminus of his	0.9999981	1.9500112e-06
33693628	eft3	crisprcas9	33693628	246	130	@TERM$1	@TERM$2	i but later replaced the let858 promoter with the  @TERM$1  promoter using  @TERM$2  and hybrid dna donor template because we observed	0.999509	0.00049101695
33693628	mossci	crisprcas9	33693628	246	185	@TERM$1	@TERM$2	riven by the let858 promoter and unc54 3utr using  @TERM$1  but later replaced the let858 promoter with the eft3 promoter using  @TERM$2  and hybrid dna donor template because we observed	0.9999988	1.1774517e-06
33693628	mossci	eft3	33693628	246	161	@TERM$1	@TERM$2	riven by the let858 promoter and unc54 3utr using  @TERM$1  but later replaced the let858 promoter with the  @TERM$2  promoter using crisprcas9 and hybrid dna donor temp	0.9999964	3.539136e-06
33693628	vha13	splitsfgfp	33693628	252	78	@TERM$1	@TERM$2	at the  @TERM$1  locus  @TERM$2  was about a third as bright as a fulllength egfp	0.992732	0.0072680195
33693628	n105t	splitwrmscarlet	33693628	253	235	@TERM$1	@TERM$2	it is worth noting that this comparison is not perfect in part due to the presence of the six superfolder mutations s30r y39n  @TERM$1  y145f i171v and a206v in sfgfp but not in egfpsplitsfgfp and  @TERM$2  dualcolor protein labeling	9.741759e-05	0.9999026
33693628	n105t	splitwrmscarlet dualcolor protein	33693628	253	235	@TERM$1	@TERM$2	it is worth noting that this comparison is not perfect in part due to the presence of the six superfolder mutations s30r y39n  @TERM$1  y145f i171v and a206v in sfgfp but not in egfpsplitsfgfp and  @TERM$2  labeling	0.9999721	2.7864116e-05
33693628	splitwrmscarlet	splitsfgfp	33693628	254	96	@TERM$1	@TERM$2	sfgfp11vha13 v c dual color protein labeling with  @TERM$1  and  @TERM$2  in somatic cell	0.99999547	4.483408e-06
33693628	red	cf4602	33693628	255	211	@TERM$1	@TERM$2	composite display of  @TERM$1  and green channels of animals expressing splitwrmscarlet110 and sfgfp110 in somatic tissues his3sfgfp11 and splitwrmscarlet11fib1  @TERM$2  muis253peft3sfgfp110unc54 3utr cbrunc119 muis252p	0.99999094	9.04102e-06
33693628	red	splitwrmscarlet11fib1	33693628	255	204	@TERM$1	@TERM$2	composite display of  @TERM$1  and green channels of animals expressing splitwrmscarlet110 and sfgfp110 in somatic tissues his3sfgfp11 and  @TERM$2  cf4602 muis253peft3sfgfp110unc54 3utr cbrunc119 m	0.9999933	6.7024125e-06
33693628	splitwrmscarlet11fib1	cf4602	33693628	255	143	@TERM$1	@TERM$2	0 and sfgfp110 in somatic tissues his3sfgfp11 and  @TERM$1   @TERM$2  muis253peft3sfgfp110unc54 3utr cbrunc119 muis252peft3splitwrmsca	0.9999988	1.1397276e-06
33693628	germlinespecific	s8b	33693628	256	141	@TERM$1	@TERM$2	scale bars 50 mwe also generated a  @TERM$1  sgfp2110 strain using a similar strategy supplementary figure  @TERM$2  supplementary table s1	0.99999857	1.3972184e-06
33693628	germlinespecific line	dup223	33693628	259	106	@TERM$1	@TERM$2	to test this  @TERM$1   @TERM$2  httpscgcumnedustraindup223 we tagged the cterminus of endogenous	0.99999547	4.497055e-06
33693628	dup223	green fluorescence	33693628	259	211	@TERM$1	@TERM$2	to test this germlinespecific line  @TERM$1  httpscgcumnedustraindup223 we tagged the cterminus of endogenous pgl1 with sgfp211 and confirmed the  @TERM$2  from pgranules supplementary figure s8b lower pan	0.99999535	4.6819937e-06
33693628	germlinespecific	dup223	33693628	259	101	@TERM$1	@TERM$2	to test this  @TERM$1  line  @TERM$2  httpscgcumnedustraindup223 we tagged the cterminus of endog	0.9999969	3.0605852e-06
33693628	green fluorescence	pgranules	33693628	259	142	@TERM$1	@TERM$2	of endogenous pgl1 with sgfp211 and confirmed the  @TERM$1  from  @TERM$2  supplementary figure s8b lower panelfinally to allow twoco	0.99999833	1.6614243e-06
33693628	pgl1	green fluorescence	33693628	259	154	@TERM$1	@TERM$2	traindup223 we tagged the cterminus of endogenous  @TERM$1  with sgfp211 and confirmed the  @TERM$2  from pgranules supplementary figure s8b lower pan	0.9999976	2.3509995e-06
33693628	splitwrmscarlet	endogenouslyexpressed	33693628	216	173	@TERM$1	@TERM$2	 choiceto benchmark the fluorescence intensity of  @TERM$1  against its fulllength counterpart we first generated  @TERM$2  wrmscarletvha13 el mouridi et a	0.999997	3.005708e-06
33693628	eft3	s3a	33693628	153	242	@TERM$1	@TERM$2	specifically we generated wormcodonoptimized plasmids encoding three nuclear localization signals nls mtagbfp2 fp11 a t2a peptidebondskipping sequence mneongreen and the corresponding fp110 driven by the  @TERM$1  promoter supplementary figure  @TERM$2 	0.99999845	1.5986466e-06
33693628	dup223	pgranules	33693628	259	226	@TERM$1	@TERM$2	to test this germlinespecific line  @TERM$1  httpscgcumnedustraindup223 we tagged the cterminus of endogenous pgl1 with sgfp211 and confirmed the green fluorescence from  @TERM$2  supplementary figure s8b lower panelfinally to al	0.99999785	2.1273431e-06
33693628	mscarlet	red	33693628	152	235	@TERM$1	@TERM$2	can reach brightness comparable to that of intact  @TERM$1  in yeast supplementary figure s2 a and bin order to compare splitwrmscarlet to splitsfcherry3 the brightest published  @TERM$2  splitfp at the time of the experiment we combined the 	0.99999833	1.6717536e-06
33693628	t74	m164	33693628	77	213	@TERM$1	@TERM$2	3 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$1  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.9999907	9.2786e-06
33693628	p64	e115	33693628	77	163	@TERM$1	@TERM$2	ns i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$1  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.99999654	3.406074e-06
33693628	f15	s63	33693628	77	139	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47 g52 g53 d60  @TERM$2  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 	0.999998	2.0384202e-06
33693628	f66	r71	33693628	77	111	@TERM$1	@TERM$2	0 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$1  s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.99999714	2.8753739e-06
33693628	a45	e115	33693628	77	191	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.9999982	1.7423484e-06
33693628	m164	s223	33693628	77	234	@TERM$1	@TERM$2	k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$1  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203 s204 d208 y209 t210 v211 v212 e213 q214 y215 e216 r217 s218 e219 a220 h222  @TERM$2  t224 g225 g226 m227 d228 and e229 with phusion po	0.9999958	4.1989233e-06
33693628	f15	e115	33693628	77	203	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.999998	2.023817e-06
33693628	k10	s63	33693628	77	143	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$2  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 	0.9999981	1.868643e-06
33693628	q43	g53	33693628	77	123	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47 g52  @TERM$2  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r	0.99999475	5.2152936e-06
33693628	q43	p64	33693628	77	135	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47 g52 g53 d60 s63  @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108	0.999997	2.963181e-06
33693628	p64	f178	33693628	77	243	@TERM$1	@TERM$2	ns i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$1  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163 m164 l175  @TERM$2  k179 k183 k185 k186 n195 r198 i202 t203 s204 d208	0.9999958	4.1215826e-06
33693628	t210	neb	33693628	77	227	@TERM$1	@TERM$2	k183 k185 k186 n195 r198 i202 t203 s204 d208 y209  @TERM$1  v211 v212 e213 q214 y215 e216 r217 s218 e219 a220 h222 s223 t224 g225 g226 m227 d228 and e229 with phusion polymerase  @TERM$2  in gc buffer followed by pooling of the pcr produc	0.99999666	3.2798537e-06
33693628	g32	k46	33693628	77	115	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45  @TERM$2  l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d	0.9999931	6.963412e-06
33693628	g32	t74	33693628	77	159	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.99999726	2.7985575e-06
33693628	g52	r71	33693628	77	135	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1  g53 d60 s63 p64 q65 f66 s70  @TERM$2  t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 	0.0036322107	0.9963678
33693628	q43	t74	33693628	77	155	@TERM$1	@TERM$2	tion with nnk primers at positions i8 k10 f15 g32  @TERM$1  a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.99998605	1.3888058e-05
33693628	a45	s70	33693628	77	143	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.9998393	0.00016070418
33693628	f15	f66	33693628	77	151	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.99999845	1.5758654e-06
33693628	nnk	p64	33693628	77	175	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108	0.9999987	1.3666521e-06
33693628	fp11	fp110	33693628	78	115	@TERM$1	@TERM$2	these positions covered areas deemed important for brightness or stability and the interface between  @TERM$1  and  @TERM$2 	0.9999989	1.0937401e-06
33693628	splitwrmscarlet	mscarlet	33693628	81	185	@TERM$1	@TERM$2	after five rounds we separated the two fragments of a version of  @TERM$1  which had fluorescence comparable to  @TERM$2  into two s cerevisiae plasmids to test for complementation	0.99999857	1.455107e-06
33693628	rhamnose	iptg	33693628	84	104	@TERM$1	@TERM$2	the libraries were coelectroporated into e coli and expression was induced with 1  @TERM$1  and 1mm  @TERM$2 	0.9998234	0.0001766171
33693628	phusion polymerase	neb	33693628	77	137	@TERM$1	@TERM$2	 h222 s223 t224 g225 g226 m227 d228 and e229 with  @TERM$1   @TERM$2  in gc buffer followed by pooling of the pcr products dpni digest	0.99999535	4.59921e-06
33693628	g32	e115	33693628	77	199	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110  @TERM$2  l125 r126 t128 k139 k140 w144 e145 s147 t148 e149	0.99405104	0.0059489594
33693628	k10	s70	33693628	77	159	@TERM$1	@TERM$2	le amplification with nnk primers at positions i8  @TERM$1  f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.9999974	2.6439977e-06
33693628	g52	f66	33693628	77	127	@TERM$1	@TERM$2	imers at positions i8 k10 f15 g32 q43 a45 k46 l47  @TERM$1  g53 d60 s63 p64 q65  @TERM$2  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e1	0.9999968	3.19387e-06
33693628	red	fp110	33693628	152	163	@TERM$1	@TERM$2	scarlet to splitsfcherry3 the brightest published  @TERM$1  splitfp at the time of the experiment we combined the  @TERM$2  and fp11 fragments into a single plasmid for each	0.9999968	3.2448593e-06
33693628	k75	m164	33693628	77	209	@TERM$1	@TERM$2	5 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74  @TERM$1  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.9999908	9.199172e-06
33693628	s218	polymerase	33693628	77	182	@TERM$1	@TERM$2	d208 y209 t210 v211 v212 e213 q214 y215 e216 r217  @TERM$1  e219 a220 h222 s223 t224 g225 g226 m227 d228 and e229 with phusion  @TERM$2  neb in gc buffer followed by pooling of the pcr p	0.9999964	3.6095382e-06
33693628	p64	m164	33693628	77	233	@TERM$1	@TERM$2	ns i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$1  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.9999926	7.3643914e-06
33693628	t203 s204 d208 y209	phusion polymerase	33693628	77	243	@TERM$1	@TERM$2	m164 l175 f178 k179 k183 k185 k186 n195 r198 i202  @TERM$1  t210 v211 v212 e213 q214 y215 e216 r217 s218 e219 a220 h222 s223 t224 g225 g226 m227 d228 and e229 with  @TERM$2  neb in gc buffer followed by pooling of the pcr pr	0.9999949	5.179488e-06
33693628	nnk	s70	33693628	77	187	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.9999974	2.6342123e-06
33693628	k46	g53	33693628	77	115	@TERM$1	@TERM$2	h nnk primers at positions i8 k10 f15 g32 q43 a45  @TERM$1  l47 g52  @TERM$2  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r	0.9999937	6.284698e-06
33693628	p64	t74	33693628	77	123	@TERM$1	@TERM$2	ns i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$1  q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.9999988	1.1336084e-06
33693628	a45	w144	33693628	77	221	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999963	3.6468793e-06
33693628	f15	t74	33693628	77	163	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.9999988	1.2098357e-06
33693628	f66	w144	33693628	77	185	@TERM$1	@TERM$2	0 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65  @TERM$1  s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999981	1.9015883e-06
33693628	rollingcircle	p64	33693628	77	213	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60 s63  @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115	0.9999975	2.4442538e-06
33693628	nnk	s63	33693628	77	171	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$2  p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 	0.9999113	8.870693e-05
33693628	g32	p64	33693628	77	139	@TERM$1	@TERM$2	fication with nnk primers at positions i8 k10 f15  @TERM$1  q43 a45 k46 l47 g52 g53 d60 s63  @TERM$2  q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108	0.9999968	3.1832726e-06
33693628	rollingcircle	f15	33693628	77	173	@TERM$1	@TERM$2	semirandom mutagenesis was carried out using  @TERM$1  amplification with nnk primers at positions i8 k10  @TERM$2  g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66 s70 r71 t74	0.99999547	4.542733e-06
33693628	g53	k75	33693628	77	139	@TERM$1	@TERM$2	s at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$1  d60 s63 p64 q65 f66 s70 r71 t74  @TERM$2  d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t12	0.9999975	2.4853464e-06
33693628	f15	s70	33693628	77	155	@TERM$1	@TERM$2	mplification with nnk primers at positions i8 k10  @TERM$1  g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$2  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l	0.9999981	1.9521324e-06
33693628	s70	w144	33693628	77	181	@TERM$1	@TERM$2	5 g32 q43 a45 k46 l47 g52 g53 d60 s63 p64 q65 f66  @TERM$1  r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140  @TERM$2  e145 s147 t148 e149 r150 i162 k163 m164 l175 f178	0.9999976	2.4266303e-06
33693628	s63	t74	33693628	77	127	@TERM$1	@TERM$2	itions i8 k10 f15 g32 q43 a45 k46 l47 g52 g53 d60  @TERM$1  p64 q65 f66 s70 r71  @TERM$2  k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126	0.9999751	2.4911293e-05
33693628	g53	m164	33693628	77	245	@TERM$1	@TERM$2	s at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$1  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r96 t107 v108 q110 e115 l125 r126 t128 k139 k140 w144 e145 s147 t148 e149 r150 i162 k163  @TERM$2  l175 f178 k179 k183 k185 k186 n195 r198 i202 t203	0.9999945	5.496503e-06
33693628	a45	g52	33693628	77	115	@TERM$1	@TERM$2	 with nnk primers at positions i8 k10 f15 g32 q43  @TERM$1  k46 l47  @TERM$2  g53 d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w	0.9999968	3.1710256e-06
33693628	nnk	g53	33693628	77	163	@TERM$1	@TERM$2	arried out using rollingcircle amplification with  @TERM$1  primers at positions i8 k10 f15 g32 q43 a45 k46 l47 g52  @TERM$2  d60 s63 p64 q65 f66 s70 r71 t74 k75 d79 y84 w94 r	0.999998	1.9999106e-06
33693628	s218	neb	33693628	77	187	@TERM$1	@TERM$2	d208 y209 t210 v211 v212 e213 q214 y215 e216 r217  @TERM$1  e219 a220 h222 s223 t224 g225 g226 m227 d228 and e229 with phusion polymerase  @TERM$2  in gc buffer followed by pooling of the pcr produc	0.99999774	2.2720378e-06
33693628	ura	leu	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a  @TERM$1  his  @TERM$2  mets cerevisiae strain and selected for in sc media without uracil and histidine and facs was used again for enrichment of clones with the highest red to blue ratio	0.9999559	4.4088967e-05
33693628	leu	facs	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a ura his  @TERM$1  mets cerevisiae strain and selected for in sc media without uracil and histidine and  @TERM$2  was used again for enrichment of clones with the highest red to blue ratio	0.9999982	1.8064626e-06
33693628	t210	phusion polymerase	33693628	77	222	@TERM$1	@TERM$2	k183 k185 k186 n195 r198 i202 t203 s204 d208 y209  @TERM$1  v211 v212 e213 q214 y215 e216 r217 s218 e219 a220 h222 s223 t224 g225 g226 m227 d228 and e229 with  @TERM$2  neb in gc buffer followed by pooling of the pcr p	0.999998	2.080284e-06
33693628	uracil	facs	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a ura his leu mets cerevisiae strain and selected for in sc media without  @TERM$1  and histidine and  @TERM$2  was used again for enrichment of clones with the highest red to blue ratio	0.99999845	1.6017246e-06
33693628	fp110	figure s8	33693628	120	237	@TERM$1	@TERM$2	11 or sgfp211 to convert these fp111 strains into  @TERM$1  strains dup237 glh1sam140glh1t2asplitwrmscarlet110 i and dup223 glh1sam129glh1t2asgfp2110 i and corroborated the absence of fluorescence supplementary  @TERM$2  a and b middle panel	0.9999976	2.3318967e-06
33693628	fp110	dup237	33693628	120	120	@TERM$1	@TERM$2	11 or sgfp211 to convert these fp111 strains into  @TERM$1  strains  @TERM$2  glh1sam140glh1t2asplitwrmscarlet110 i and dup223 	0.9999981	1.9612703e-06
33693628	fp110	dup223	33693628	120	169	@TERM$1	@TERM$2	11 or sgfp211 to convert these fp111 strains into  @TERM$1  strains dup237 glh1sam140glh1t2asplitwrmscarlet110 i and  @TERM$2  glh1sam129glh1t2asgfp2110 i and corroborated the 	0.99999833	1.6469597e-06
33693628	splitwrmscarlet	red	33693628	126	217	@TERM$1	@TERM$2	when performing normalizations for splitsfcherry3 versus  @TERM$1  the  @TERM$2  channel was divided by the green channel mneongreenfp110 because the localization of both fragments is expected to be the same cytosolic	0.99999297	6.9863e-06
33693628	agarose	genemate	33693628	127	237	@TERM$1	@TERM$2	for normalization of signals where mtagbfpfp11 was targeted to the membrane the blue channel was used instead of the green channelpads made of 3  @TERM$1   @TERM$2  were dried briefly on kimwipes kimtech and transferred to microscope slides	0.9999981	1.9423292e-06
33693628	levamisole	sigma	33693628	128	92	@TERM$1	@TERM$2	approximately 10l of 2mm  @TERM$1   @TERM$2  was pipetted onto the center of the agarose pad	0.99999845	1.5433912e-06
33693628	sigma	agarose	33693628	128	92	@TERM$1	@TERM$2	approximately 10l of 2mm levamisole  @TERM$1  was pipetted onto the center of the  @TERM$2  pad	0.9999962	3.8065386e-06
33693628	levamisole	agarose	33693628	128	92	@TERM$1	@TERM$2	approximately 10l of 2mm  @TERM$1  sigma was pipetted onto the center of the  @TERM$2  pad	0.9999887	1.12980915e-05
33693628	peft33nlsmtagbfp2splitwrmscarlet11t2amneongreensplitwrmscarlet110fib1	peft33nlsmtagbfp2sfcherry311t2amneongreensfcherry3110fib1	33693628	129	227	@TERM$1	@TERM$2	e wildtype animals were microinjected with either  @TERM$1  3utr or  @TERM$2  3utr construct at 20ngl and were single	0.9999988	1.1837332e-06
33693628	n2e	peft33nlsmtagbfp2splitwrmscarlet11t2amneongreensplitwrmscarlet110fib1	33693628	129	221	@TERM$1	@TERM$2	iable progeny produced by each worm was scoredten  @TERM$1  wildtype animals were microinjected with either  @TERM$2  3utr or peft33nlsmtagbfp2sfcherry311t2amneongreen	0.9999976	2.357931e-06
33693628	n2e	pmyo3mtagbfp2splitwrmscarlet11t2amneongreensplitwrmscarlet110fib1	33693628	131	217	@TERM$1	@TERM$2	adulthood or adults were scored for each groupten  @TERM$1  wildtype animals were microinjected with either  @TERM$2  3utr or pmyo3mtagbfp2sfcherry311t2amneongreensfch	0.99999857	1.3970185e-06
33693628	5fluorouracil	sigma	33693628	132	148	@TERM$1	@TERM$2	f1 animals expressing mneongreen in muscle were selected for comparisonngm plates were supplemented with  @TERM$1  5fu  @TERM$2  15m goudeau et al	0.99933785	0.0006620781
33693628	5fluorouracil	5fu	33693628	132	148	@TERM$1	@TERM$2	f1 animals expressing mneongreen in muscle were selected for comparisonngm plates were supplemented with  @TERM$1   @TERM$2  sigma 15m goudeau et al	0.9999958	4.114035e-06
33693628	5fu	sigma	33693628	132	148	@TERM$1	@TERM$2	f1 animals expressing mneongreen in muscle were selected for comparisonngm plates were supplemented with 5fluorouracil  @TERM$1   @TERM$2  15m goudeau et al	0.9999989	1.1240628e-06
33693628	sulfate	sigma	33693628	133	122	@TERM$1	@TERM$2	2011 in order to prevent progeny from hatching and with kanamycin  @TERM$1  to prevent bacterial contamination  @TERM$2  25gml	0.9999988	1.2024258e-06
33693628	cf4582	dup223	33693628	141	242	@TERM$1	@TERM$2	a singlecopy of splitwrmscarlet110 andor sfgfp110  @TERM$1  httpscgcumnedustraincf4582 cf4587 httpscgcumnedustraincf4587 cf4588 httpscgcumnedustraincf4588 cf4610 httpscgcumnedustraincf4610  @TERM$2  httpscgcumnedustraindup223 and dup237 httpscgcumn	0.9999987	1.2549624e-06
33693628	singlecopy	cf4582	33693628	141	158	@TERM$1	@TERM$2	dicated in the figure legendsstrains expressing a  @TERM$1  of splitwrmscarlet110 andor sfgfp110  @TERM$2  httpscgcumnedustraincf4582 cf4587 httpscgcumnedustrai	0.99999547	4.4932954e-06
33693628	dup223	dup237	33693628	141	144	@TERM$1	@TERM$2	edustraincf4588 cf4610 httpscgcumnedustraincf4610  @TERM$1  httpscgcumnedustraindup223 and  @TERM$2  httpscgcumnedustraindup237 are available via the 	0.999998	1.9825936e-06
33693628	splitwrmscarlet	mscarlet	33693628	151	177	@TERM$1	@TERM$2	the brightest resulting protein which we named  @TERM$1  contained 10 amino acid substitutions relative to the cterminal truncated  @TERM$2  supplementary figure s1 a and b	0.999998	2.0103246e-06
33693628	splitwrmscarlet	mscarlet	33693628	152	218	@TERM$1	@TERM$2	 yeast containing both plasmids corroborated that  @TERM$1  showed the expected localization and can reach brightness comparable to that of intact  @TERM$2  in yeast supplementary figure s2 a and bin order to comp	0.9999974	2.6380208e-06
33693628	red	fp11	33693628	152	172	@TERM$1	@TERM$2	scarlet to splitsfcherry3 the brightest published  @TERM$1  splitfp at the time of the experiment we combined the  @TERM$2 0 and fp11 fragments into a single plasmid for each fluoroph	0.9999988	1.1518358e-06
33693628	histidine	facs	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a ura his leu mets cerevisiae strain and selected for in sc media without uracil and  @TERM$1  and  @TERM$2  was used again for enrichment of clones with the highest red to blue ratio	0.99999344	6.5575687e-06
33693628	fp110	fp11	33693628	152	115	@TERM$1	@TERM$2	tfp at the time of the experiment we combined the  @TERM$1  and  @TERM$2  fragments into a single plasmid for each fluoropho	0.99998605	1.3988775e-05
33693628	dup237	dup223	33693628	120	155	@TERM$1	@TERM$2	to convert these fp111 strains into fp110 strains  @TERM$1  glh1sam140glh1t2asplitwrmscarlet110 i and  @TERM$2  glh1sam129glh1t2asgfp2110 i and corroborated the 	0.9999987	1.3309563e-06
33693628	crisprcas9	fp110	33693628	120	202	@TERM$1	@TERM$2	after verifying fluorescence we used a precise  @TERM$1  deletion of either splitwrmscarlet11 or sgfp211 to convert these fp111 strains into  @TERM$2  strains dup237 glh1sam140glh1t2asplitwrmscarlet110 i a	0.9629448	0.037055217
33693628	splitwrmscarlet	mscarlet	33693628	146	239	@TERM$1	@TERM$2	are httpsdoiorg1025386genetics13635614to engineer  @TERM$1  first we introduced a 32 amino acid spacer between the 10th and 11th strands of fulllength yeastcodon optimized  @TERM$2  following a strategy described previously feng et a	0.9999987	1.2849238e-06
33693628	dup223	figure s8	33693628	120	174	@TERM$1	@TERM$2	 dup237 glh1sam140glh1t2asplitwrmscarlet110 i and  @TERM$1  glh1sam129glh1t2asgfp2110 i and corroborated the absence of fluorescence supplementary  @TERM$2  a and b middle panel	0.9999987	1.359811e-06
33693628	crisprcas9	dup237	33693628	120	216	@TERM$1	@TERM$2	after verifying fluorescence we used a precise  @TERM$1  deletion of either splitwrmscarlet11 or sgfp211 to convert these fp111 strains into fp110 strains  @TERM$2  glh1sam140glh1t2asplitwrmscarlet110 i and dup223 glh1	0.90999997	0.09
33693628	ura	red	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a  @TERM$1  his leu mets cerevisiae strain and selected for in sc media without uracil and histidine and facs was used again for enrichment of clones with the highest  @TERM$2  to blue ratio	0.99999857	1.3873517e-06
33693628	ura	facs	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a  @TERM$1  his leu mets cerevisiae strain and selected for in sc media without uracil and histidine and  @TERM$2  was used again for enrichment of clones with the highest red to blue ratio	0.6049608	0.39503917
33693628	leu	histidine	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a ura his  @TERM$1  mets cerevisiae strain and selected for in sc media without uracil and  @TERM$2  and facs was used again for enrichment of clones with the highest red to blue ratio	0.9999974	2.6193195e-06
33693628	ura	uracil	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a  @TERM$1  his leu mets cerevisiae strain and selected for in sc media without  @TERM$2  and histidine and facs was used again for enrichment of clones with the highest red to blue ratio	0.9999975	2.4743965e-06
33693628	uracil	histidine	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a ura his leu mets cerevisiae strain and selected for in sc media without  @TERM$1  and  @TERM$2  and facs was used again for enrichment of clones with the highest red to blue ratio	0.8983297	0.10167034
33693628	ura	histidine	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a  @TERM$1  his leu mets cerevisiae strain and selected for in sc media without uracil and  @TERM$2  and facs was used again for enrichment of clones with the highest red to blue ratio	0.9999989	1.10276e-06
33693628	leu	red	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a ura his  @TERM$1  mets cerevisiae strain and selected for in sc media without uracil and histidine and facs was used again for enrichment of clones with the highest  @TERM$2  to blue ratio	0.94861895	0.051380996
33693628	facs	red	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a ura his leu mets cerevisiae strain and selected for in sc media without uracil and histidine and  @TERM$1  was used again for enrichment of clones with the highest  @TERM$2  to blue ratio	0.9999976	2.4091448e-06
33693628	histidine	red	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a ura his leu mets cerevisiae strain and selected for in sc media without uracil and  @TERM$1  and facs was used again for enrichment of clones with the highest  @TERM$2  to blue ratio	0.9999988	1.1673743e-06
33693628	cf4582	ca1200	33693628	101	194	@TERM$1	@TERM$2	the  @TERM$1  strain muis252peft3splitwrmscarlet110unc54 3utr cbrunc119 ii unc119ed3 iii was generated by replacing the tir1mruby sequence from the strain  @TERM$2  iesi57 ii unc119ed3 iii zhang et al	0.99999857	1.401688e-06
33693628	uracil	red	33693628	86	221	@TERM$1	@TERM$2	the yeast plasmids were cotransformed into a ura his leu mets cerevisiae strain and selected for in sc media without  @TERM$1  and histidine and facs was used again for enrichment of clones with the highest  @TERM$2  to blue ratio	0.9999963	3.75032e-06
33693628	unc119	eft3	33693628	103	116	@TERM$1	@TERM$2	cop1795 knusi785 pnu1687plet858sfgfp110unc54 3utr  @TERM$1  ii unc119ed3 iii with the  @TERM$2  also known as eef1a1 promote	0.99999726	2.6928872e-06
33693628	cop1795 knusi785	unc119	33693628	103	166	@TERM$1	@TERM$2	 by replacing the let858 promoter from the strain  @TERM$1  pnu1687plet858sfgfp110unc54 3utr  @TERM$2  ii unc119ed3 iii with the eft3 also known as eef1a1 promote	0.9999988	1.2213961e-06
33693628	crisprcas9	glh1	33693628	117	240	@TERM$1	@TERM$2	plasmid sequences are listed in supplementary table s5using  @TERM$1  the cterminus of  @TERM$2  was tagged with either t2asplitwrmscarlet111 or t2asgfp2111 a split superfolder gfp variant optimized for brightness and photostability kker et al	0.99999726	2.7325066e-06
33693628	glh1	gfp	33693628	117	240	@TERM$1	@TERM$2	plasmid sequences are listed in supplementary table s5using crisprcas9 the cterminus of  @TERM$1  was tagged with either t2asplitwrmscarlet111 or t2as @TERM$2 2111 a split superfolder gfp variant optimized for brightness and photostability kker et al	0.99999785	2.1430142e-06
33693628	crisprcas9	t2asplitwrmscarlet111	33693628	117	240	@TERM$1	@TERM$2	plasmid sequences are listed in supplementary table s5using  @TERM$1  the cterminus of glh1 was tagged with either  @TERM$2  or t2asgfp2111 a split superfolder gfp variant optimized for brightness and photostability kker et al	0.9999981	1.922793e-06
33693628	glh1	t2asplitwrmscarlet111	33693628	117	240	@TERM$1	@TERM$2	plasmid sequences are listed in supplementary table s5using crisprcas9 the cterminus of  @TERM$1  was tagged with either  @TERM$2  or t2asgfp2111 a split superfolder gfp variant optimized for brightness and photostability kker et al	0.9999987	1.341541e-06
33693628	crisprcas9	gfp	33693628	117	240	@TERM$1	@TERM$2	plasmid sequences are listed in supplementary table s5using  @TERM$1  the cterminus of glh1 was tagged with either t2asplitwrmscarlet111 or t2as @TERM$2 2111 a split superfolder gfp variant optimized for brightness and photostability kker et al	0.99999654	3.4078937e-06
33693628	peft33nlsmtagbfp2splitwrmscarlet11t2amneongreensplitwrmscarlet110fib1	peft33nlsmtagbfp2sfcherry311t2amneongreensfcherry3110fib1	33693628	113	194	@TERM$1	@TERM$2	 @TERM$1  3utr  @TERM$2  3utr pmyo3mtagbfp2splitwrmscarlet11t2amneongreensplitwrmscarl	0.9999976	2.435851e-06
33693628	peft33nlsmtagbfp2sfcherry311t2amneongreensfcherry3110fib1	pmyo3mtagbfp2splitwrmscarlet11t2amneongreensplitwrmscarlet110fib1	33693628	113	228	@TERM$1	@TERM$2	scarlet11t2amneongreensplitwrmscarlet110fib1 3utr  @TERM$1  3utr  @TERM$2  3utr or pmyo3mtagbfp2sfcherry311t2amneongreensfch	0.99999714	2.8837608e-06
33693628	cop1795 knusi785	eft3	33693628	103	166	@TERM$1	@TERM$2	 by replacing the let858 promoter from the strain  @TERM$1  pnu1687plet858sfgfp110unc54 3utr unc119 ii unc119ed3 iii with the  @TERM$2  also known as eef1a1 promote	0.9999976	2.3736409e-06
33693628	t2asplitwrmscarlet111	gfp	33693628	117	240	@TERM$1	@TERM$2	plasmid sequences are listed in supplementary table s5using crisprcas9 the cterminus of glh1 was tagged with either  @TERM$1  or t2as @TERM$2 2111 a split superfolder gfp variant optimized for brightness and photostability kker et al	0.99999595	4.034294e-06
33693628	dup237	figure s8	33693628	120	223	@TERM$1	@TERM$2	to convert these fp111 strains into fp110 strains  @TERM$1  glh1sam140glh1t2asplitwrmscarlet110 i and dup223 glh1sam129glh1t2asgfp2110 i and corroborated the absence of fluorescence supplementary  @TERM$2  a and b middle panel	0.9999981	1.8504833e-06
35228596	bcaa	succinylcoa	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to  @TERM$1  metabolism including lvaline module 6  @TERM$2  module 3 and thiamin diphosphate module 1	0.9999975	2.463671e-06
35228596	bcaa	diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to  @TERM$1  metabolism including lvaline module 6 succinylcoa module 3 and thiamin  @TERM$2  module 1	0.9999974	2.6231567e-06
35228596	module	thiamin diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these  @TERM$1 s consisted of metabolites related to bcaa metabolism including lvaline module 6 succinylcoa module 3 and  @TERM$2  module 1	0.9999964	3.6053204e-06
35228596	module 6	thiamin	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including lvaline  @TERM$1  succinylcoa module 3 and  @TERM$2  diphosphate module 1	0.9999894	1.0630825e-05
35228596	succinylcoa	thiamin	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including lvaline module 6  @TERM$1  module 3 and  @TERM$2  diphosphate module 1	0.99999666	3.39144e-06
35228596	module	diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these  @TERM$1 s consisted of metabolites related to bcaa metabolism including lvaline module 6 succinylcoa module 3 and thiamin  @TERM$2  module 1	0.9999926	7.4239565e-06
35228596	lvaline	thiamin diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including  @TERM$1  module 6 succinylcoa module 3 and  @TERM$2  module 1	0.9999969	3.0727983e-06
35228596	module 6	succinylcoa	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including lvaline  @TERM$1   @TERM$2  module 3 and thiamin diphosphate module 1	0.9999919	8.059945e-06
35228596	succinylcoa	diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including lvaline module 6  @TERM$1  module 3 and thiamin  @TERM$2  module 1	0.99999547	4.509041e-06
35228596	thiamin	diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including lvaline module 6 succinylcoa module 3 and  @TERM$1   @TERM$2  module 1	0.9999975	2.5614681e-06
35228596	module	thiamin	35228596	43	157	@TERM$1	@TERM$2	several of these  @TERM$1 s consisted of metabolites related to bcaa metabolism including lvaline module 6 succinylcoa module 3 and  @TERM$2  diphosphate module 1	0.9999969	3.135897e-06
35228596	lvaline	module	35228596	43	157	@TERM$1	@TERM$2	several of these  @TERM$2 s consisted of metabolites related to bcaa metabolism including  @TERM$1  module 6 succinylcoa module 3 and thiamin diphosphate module 1	0.9999677	3.2348642e-05
35228596	module	succinylcoa	35228596	43	157	@TERM$1	@TERM$2	several of these  @TERM$1 s consisted of metabolites related to bcaa metabolism including lvaline module 6  @TERM$2  module 3 and thiamin diphosphate module 1	0.99295455	0.0070454143
35228596	lvaline	thiamin	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including  @TERM$1  module 6 succinylcoa module 3 and  @TERM$2  diphosphate module 1	0.06279254	0.9372074
35228596	bcaa	lvaline	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to  @TERM$1  metabolism including  @TERM$2  module 6 succinylcoa module 3 and thiamin diphosphate module 1	0.99994314	5.683112e-05
35228596	lvaline	succinylcoa	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including  @TERM$1  module 6  @TERM$2  module 3 and thiamin diphosphate module 1	0.99994314	5.683112e-05
35228596	module 6	diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including lvaline  @TERM$1  succinylcoa module 3 and thiamin  @TERM$2  module 1	0.99999416	5.846332e-06
35228596	bcaa	module 6	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to  @TERM$1  metabolism including lvaline  @TERM$2  succinylcoa module 3 and thiamin diphosphate module 1	0.99999857	1.4069151e-06
35228596	module 6	valine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of  @TERM$1  revealed a negative correlation between l @TERM$2  and the valine leucine and isoleucine degradation pathway fig	0.99999833	1.6418865e-06
35228596	module 6	leucine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of  @TERM$1  revealed a negative correlation between lvaline and the valine  @TERM$2  and isoleucine degradation pathway fig	0.99999845	1.5273885e-06
35228596	module	valine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of  @TERM$1  6 revealed a negative correlation between l @TERM$2  and the valine leucine and isoleucine degradation pathway fig	0.9999982	1.7383187e-06
35228596	tca	malate	35228596	62	177	@TERM$1	@TERM$2	genes significantly downregulated in bcat1rnai worms are blue and genes significantly upregulated in bcat1rnai worms are redmodule 9 included the  @TERM$1  cycle metabolite  @TERM$2  fig	0.99999774	2.3130704e-06
35228596	phenylalanine	tyrosine	35228596	47	127	@TERM$1	@TERM$2	dition lvaline was positively correlated with the  @TERM$1   @TERM$2  and tryptophan biosynthesis pathway and negatively cor	0.99999523	4.7392073e-06
35228596	lvaline	tyrosine	35228596	47	127	@TERM$1	@TERM$2	in addition  @TERM$1  was positively correlated with the phenylalanine  @TERM$2  and tryptophan biosynthesis pathway and negativel	0.9999987	1.255725e-06
35228596	lvaline	tryptophan	35228596	47	142	@TERM$1	@TERM$2	in addition  @TERM$1  was positively correlated with the phenylalanine tyrosine and  @TERM$2  biosynthesis pathway and negatively correlated wi	0.9999981	1.903882e-06
35228596	lvaline	phenylalanine	35228596	47	118	@TERM$1	@TERM$2	in addition  @TERM$1  was positively correlated with the  @TERM$2  tyrosine and tryptophan biosynthesis pathway and 	0.9999989	1.1024467e-06
35228596	phenylalanine	tryptophan	35228596	47	140	@TERM$1	@TERM$2	dition lvaline was positively correlated with the  @TERM$1  tyrosine and  @TERM$2  biosynthesis pathway and negatively correlated with 	0.9999943	5.722499e-06
35228596	tyrosine	tryptophan	35228596	47	123	@TERM$1	@TERM$2	 was positively correlated with the phenylalanine  @TERM$1  and  @TERM$2  biosynthesis pathway and negatively correlated wi	0.99999285	7.110577e-06
35228596	leucine	isoleucine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of module 6 revealed a negative correlation between lvaline and the valine  @TERM$1  and  @TERM$2  degradation pathway fig	0.9999962	3.8003577e-06
35228596	valine	isoleucine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of module 6 revealed a negative correlation between l @TERM$1  and the valine leucine and  @TERM$2  degradation pathway fig	0.99911815	0.0008818956
35228596	lvaline	valine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of module 6 revealed a negative correlation between  @TERM$1  and the  @TERM$2  leucine and isoleucine degradation pathway fig	0.9999989	1.0855691e-06
35228596	module	leucine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of  @TERM$1  6 revealed a negative correlation between lvaline and the valine  @TERM$2  and isoleucine degradation pathway fig	0.9999987	1.335796e-06
35228596	lvaline	leucine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of module 6 revealed a negative correlation between  @TERM$1  and the valine  @TERM$2  and isoleucine degradation pathway fig	0.9999989	1.1144807e-06
35228596	module 6	isoleucine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of  @TERM$1  revealed a negative correlation between lvaline and the valine leucine and  @TERM$2  degradation pathway fig	0.99999607	3.913996e-06
35228596	module 6	lvaline	35228596	44	135	@TERM$1	@TERM$2	spls analysis of  @TERM$1  revealed a negative correlation between  @TERM$2  and the valine leucine and isoleucine degradation pathway fig	0.00012184859	0.99987817
35228596	module	isoleucine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of  @TERM$1  6 revealed a negative correlation between lvaline and the valine leucine and  @TERM$2  degradation pathway fig	0.9999957	4.3101145e-06
35228596	lvaline	isoleucine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of module 6 revealed a negative correlation between  @TERM$1  and the valine leucine and  @TERM$2  degradation pathway fig	0.99999726	2.7075032e-06
35228596	module	lvaline	35228596	44	135	@TERM$1	@TERM$2	spls analysis of  @TERM$1  6 revealed a negative correlation between  @TERM$2  and the valine leucine and isoleucine degradation pathway fig	0.9999969	3.130462e-06
35228596	valine	leucine	35228596	44	135	@TERM$1	@TERM$2	spls analysis of module 6 revealed a negative correlation between l @TERM$1  and the valine  @TERM$2  and isoleucine degradation pathway fig	0.9999958	4.1478916e-06
35228596	bcaa	thiamin diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to  @TERM$1  metabolism including lvaline module 6 succinylcoa module 3 and  @TERM$2  module 1	0.99999046	9.501741e-06
35228596	isoleucine	tca	35228596	40	222	@TERM$1	@TERM$2	 and genes were found included valine leucine and  @TERM$1  degradation alanine aspartate and glutamate metabolism glycolysis  gluconeogenesis and citrate cycle  @TERM$2  cycle which recapitulates the pathway identification obt	0.9999958	4.1213784e-06
35228596	bcaa	module	35228596	43	157	@TERM$1	@TERM$2	several of these  @TERM$2 s consisted of metabolites related to  @TERM$1  metabolism including lvaline module 6 succinylcoa module 3 and thiamin diphosphate module 1	0.99999774	2.2688637e-06
35228596	valine	citrate	35228596	40	224	@TERM$1	@TERM$2	re both metabolites and genes were found included  @TERM$1  leucine and isoleucine degradation alanine aspartate and glutamate metabolism glycolysis  gluconeogenesis and  @TERM$2  cycle tca cycle which recapitulates the pathway i	0.99999654	3.478925e-06
35228596	alanine	tca	35228596	40	196	@TERM$1	@TERM$2	ncluded valine leucine and isoleucine degradation  @TERM$1  aspartate and glutamate metabolism glycolysis  gluconeogenesis and citrate cycle  @TERM$2  cycle which recapitulates the pathway identification 	0.9999689	3.11139e-05
35228596	leucine	isoleucine	35228596	40	122	@TERM$1	@TERM$2	 metabolites and genes were found included valine  @TERM$1  and  @TERM$2  degradation alanine aspartate and glutamate metab	0.9999974	2.635481e-06
35228596	alanine	citrate	35228596	40	182	@TERM$1	@TERM$2	ncluded valine leucine and isoleucine degradation  @TERM$1  aspartate and glutamate metabolism glycolysis  gluconeogenesis and  @TERM$2  cycle tca cycle which recapitulates the pathway i	0.9999969	3.0798778e-06
35228596	isoleucine	glutamate	35228596	40	155	@TERM$1	@TERM$2	 and genes were found included valine leucine and  @TERM$1  degradation alanine aspartate and  @TERM$2  metabolism glycolysis  gluconeogenesis and citrate	0.9999987	1.2922111e-06
35228596	isoleucine	aspartate	35228596	40	141	@TERM$1	@TERM$2	 and genes were found included valine leucine and  @TERM$1  degradation alanine  @TERM$2  and glutamate metabolism glycolysis  gluconeogenes	0.999997	3.0015688e-06
35228596	glutamate	citrate	35228596	40	162	@TERM$1	@TERM$2	 and isoleucine degradation alanine aspartate and  @TERM$1  metabolism glycolysis  gluconeogenesis and  @TERM$2  cycle tca cycle which recapitulates the pathway ide	0.9999937	6.338582e-06
35228596	alanine	aspartate	35228596	40	117	@TERM$1	@TERM$2	ncluded valine leucine and isoleucine degradation  @TERM$1   @TERM$2  and glutamate metabolism glycolysis  gluconeogene	0.999997	2.9580226e-06
35228596	valine	leucine	35228596	40	114	@TERM$1	@TERM$2	re both metabolites and genes were found included  @TERM$1   @TERM$2  and isoleucine degradation alanine aspartate and 	0.9999789	2.1121223e-05
35228596	leucine	alanine	35228596	40	142	@TERM$1	@TERM$2	 metabolites and genes were found included valine  @TERM$1  and isoleucine degradation  @TERM$2  aspartate and glutamate metabolism glycolysis  gl	0.9999964	3.600503e-06
35228596	branchedchain amino acid	transferase	35228596	14	154	@TERM$1	@TERM$2	elegans model of pd rnaimediated reduction of the  @TERM$1  bcaa  @TERM$2  bcat1 recapitulated several features of pd including agedepend	0.9999987	1.3124114e-06
35228596	branchedchain amino acid	bcaa	35228596	14	149	@TERM$1	@TERM$2	elegans model of pd rnaimediated reduction of the  @TERM$1   @TERM$2  transferase bcat1 recapitulated several features of pd including aged	0.9999975	2.5492054e-06
35228596	bcaa	transferase	35228596	14	116	@TERM$1	@TERM$2	ediated reduction of the branchedchain amino acid  @TERM$1   @TERM$2  bcat1 recapitulated several features of pd includ	0.9999968	3.1772067e-06
35228596	dopamine	gaba	35228596	13	210	@TERM$1	@TERM$2	c elegans possess orthologs for 6080 of human genes and the worm nervous system utilizes many of the same neurotransmitters as in mammals including  @TERM$1  acetylcholine amino butyric acid  @TERM$2  and glutamate4	0.999998	1.9963816e-06
35228596	dopamine	acetylcholine	35228596	13	210	@TERM$1	@TERM$2	c elegans possess orthologs for 6080 of human genes and the worm nervous system utilizes many of the same neurotransmitters as in mammals including  @TERM$1   @TERM$2  amino butyric acid gaba and glutamate4	0.99999857	1.3816833e-06
35228596	acetylcholine	gaba	35228596	13	210	@TERM$1	@TERM$2	c elegans possess orthologs for 6080 of human genes and the worm nervous system utilizes many of the same neurotransmitters as in mammals including dopamine  @TERM$1  amino butyric acid  @TERM$2  and glutamate4	0.9999981	1.9161976e-06
35228596	malate	notch	35228596	64	96	@TERM$1	@TERM$2	in module 9  @TERM$1  was highly positively correlated with dna replication and  @TERM$2  signaling fig	0.99999726	2.7761118e-06
35228596	alanine	glutamate	35228596	40	131	@TERM$1	@TERM$2	ncluded valine leucine and isoleucine degradation  @TERM$1  aspartate and  @TERM$2  metabolism glycolysis  gluconeogenesis and citrat	0.9999982	1.8265733e-06
35228596	module 6	module	35228596	43	157	@TERM$1	@TERM$2	several of these  @TERM$2 s consisted of metabolites related to bcaa metabolism including lvaline  @TERM$1  succinylcoa module 3 and thiamin diphosphate module 1	0.999998	1.990811e-06
35228596	leucine	aspartate	35228596	40	152	@TERM$1	@TERM$2	 metabolites and genes were found included valine  @TERM$1  and isoleucine degradation alanine  @TERM$2  and glutamate metabolism glycolysis  gluconeogene	0.9999894	1.0627936e-05
35228596	isoleucine	citrate	35228596	40	208	@TERM$1	@TERM$2	 and genes were found included valine leucine and  @TERM$1  degradation alanine aspartate and glutamate metabolism glycolysis  gluconeogenesis and  @TERM$2  cycle tca cycle which recapitulates the pathway iden	0.99999833	1.6128342e-06
35228596	lvaline	module 6	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including  @TERM$1   @TERM$2  succinylcoa module 3 and thiamin diphosphate module 1	0.9999962	3.831728e-06
35228596	lvaline	diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including  @TERM$1  module 6 succinylcoa module 3 and thiamin  @TERM$2  module 1	0.9999956	4.429451e-06
35228596	bcaa	thiamin	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to  @TERM$1  metabolism including lvaline module 6 succinylcoa module 3 and  @TERM$2  diphosphate module 1	0.999998	2.0221694e-06
35228596	module 6	thiamin diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including lvaline  @TERM$1  succinylcoa module 3 and  @TERM$2  module 1	0.9999982	1.8133909e-06
35228596	succinylcoa	thiamin diphosphate	35228596	43	157	@TERM$1	@TERM$2	several of these modules consisted of metabolites related to bcaa metabolism including lvaline module 6  @TERM$1  module 3 and  @TERM$2  module 1	0.9999987	1.3553289e-06
35228596	mmc	pana9	35228596	41	171	@TERM$1	@TERM$2	to explore this idea we used  @TERM$1  to cluster metabolites into modules and summarized pathway transcriptional activity by obtaining metagene profiles using  @TERM$2  see methods	0.9999982	1.8453323e-06
35228596	citrate	tca	35228596	40	121	@TERM$1	@TERM$2	tamate metabolism glycolysis  gluconeogenesis and  @TERM$1  cycle  @TERM$2  cycle which recapitulates the pathway identification 	0.999967	3.2992994e-05
35228596	valine	glutamate	35228596	40	173	@TERM$1	@TERM$2	re both metabolites and genes were found included  @TERM$1  leucine and isoleucine degradation alanine aspartate and  @TERM$2  metabolism glycolysis  gluconeogenesis and citrat	0.99999547	4.521408e-06
35228596	valine	aspartate	35228596	40	159	@TERM$1	@TERM$2	re both metabolites and genes were found included  @TERM$1  leucine and isoleucine degradation alanine  @TERM$2  and glutamate metabolism glycolysis  gluconeogene	0.99999535	4.702094e-06
35228596	valine	tca	35228596	40	237	@TERM$1	@TERM$2	re both metabolites and genes were found included  @TERM$1  leucine and isoleucine degradation alanine aspartate and glutamate metabolism glycolysis  gluconeogenesis and citrate cycle  @TERM$2  cycle which recapitulates the pathway identification	0.99999774	2.2786692e-06
35228596	isoleucine	alanine	35228596	40	133	@TERM$1	@TERM$2	 and genes were found included valine leucine and  @TERM$1  degradation  @TERM$2  aspartate and glutamate metabolism glycolysis  gluco	0.9999814	1.8655252e-05
35228596	aspartate	glutamate	35228596	40	123	@TERM$1	@TERM$2	valine leucine and isoleucine degradation alanine  @TERM$1  and  @TERM$2  metabolism glycolysis  gluconeogenesis and citrat	0.99996054	3.951129e-05
35228596	leucine	citrate	35228596	40	217	@TERM$1	@TERM$2	 metabolites and genes were found included valine  @TERM$1  and isoleucine degradation alanine aspartate and glutamate metabolism glycolysis  gluconeogenesis and  @TERM$2  cycle tca cycle which recapitulates the pathway i	0.999982	1.7948496e-05
35228596	leucine	tca	35228596	40	231	@TERM$1	@TERM$2	 metabolites and genes were found included valine  @TERM$1  and isoleucine degradation alanine aspartate and glutamate metabolism glycolysis  gluconeogenesis and citrate cycle  @TERM$2  cycle which recapitulates the pathway identification 	0.99999547	4.5289125e-06
35228596	valine	isoleucine	35228596	40	129	@TERM$1	@TERM$2	re both metabolites and genes were found included  @TERM$1  leucine and  @TERM$2  degradation alanine aspartate and glutamate metab	0.9999944	5.6199196e-06
35228596	glutamate	tca	35228596	40	176	@TERM$1	@TERM$2	 and isoleucine degradation alanine aspartate and  @TERM$1  metabolism glycolysis  gluconeogenesis and citrate cycle  @TERM$2  cycle which recapitulates the pathway identification ob	0.9999968	3.228204e-06
35228596	aspartate	tca	35228596	40	190	@TERM$1	@TERM$2	valine leucine and isoleucine degradation alanine  @TERM$1  and glutamate metabolism glycolysis  gluconeogenesis and citrate cycle  @TERM$2  cycle which recapitulates the pathway identification ob	0.99999774	2.267743e-06
35228596	aspartate	citrate	35228596	40	176	@TERM$1	@TERM$2	valine leucine and isoleucine degradation alanine  @TERM$1  and glutamate metabolism glycolysis  gluconeogenesis and  @TERM$2  cycle tca cycle which recapitulates the pathway ide	0.99998415	1.5810581e-05
35228596	valine	alanine	35228596	40	149	@TERM$1	@TERM$2	re both metabolites and genes were found included  @TERM$1  leucine and isoleucine degradation  @TERM$2  aspartate and glutamate metabolism glycolysis  gl	0.99999833	1.6271698e-06
35228596	leucine	glutamate	35228596	40	166	@TERM$1	@TERM$2	 metabolites and genes were found included valine  @TERM$1  and isoleucine degradation alanine aspartate and  @TERM$2  metabolism glycolysis  gluconeogenesis and citrat	0.9999616	3.8376096e-05
35228596	module	malate	35228596	64	96	@TERM$1	@TERM$2	in  @TERM$1  9  @TERM$2  was highly positively correlated with dna replication and notch signaling fig	0.9999974	2.679142e-06
35228596	modules 6	fatty	35228596	66	201	@TERM$1	@TERM$2	interestingly both  @TERM$1  and 9 involved several pathways related to  @TERM$2  acid metabolism including fatty acid biosynthesis fatty acid elongation and biosynthesis of unsaturated fatty acids fig2bc	0.999998	2.058693e-06
35228596	carboxylase 1	bckdk	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$1  mccc1 and branchedchain ketoacid dehydrogenase kinase  @TERM$2  as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999933	6.6712223e-06
35228596	carboxylase 1	pd22	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$1  mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with  @TERM$2  further implicating bcaa metabolism in pd pathogenesis	0.99999857	1.3996764e-06
35228596	mccc1	branchedchain ketoacid dehydrogenase kinase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1  @TERM$1  and  @TERM$2  bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99999845	1.5534237e-06
35228596	methylcrotonoylcoa	dehydrogenase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes  @TERM$1  carboxylase 1 mccc1 and branchedchain ketoacid  @TERM$2  kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999981	1.855725e-06
35228596	carboxylase	pd22	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$1  1 mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with  @TERM$2  further implicating bcaa metabolism in pd pathogenesis	0.99999833	1.6202728e-06
35228596	carboxylase	bckdk	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$1  1 mccc1 and branchedchain ketoacid dehydrogenase kinase  @TERM$2  as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999988	1.2270996e-06
35228596	mccc1	pd22	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1  @TERM$1  and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with  @TERM$2  further implicating bcaa metabolism in pd pathogenesis	0.9999989	1.1160538e-06
35228596	bcaa	carboxylase 1	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other  @TERM$1  pathway genes methylcrotonoylcoa  @TERM$2  mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999987	1.2697433e-06
35228596	carboxylase	mccc1	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$1  1  @TERM$2  and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999982	1.8332835e-06
35228596	branchedchain ketoacid dehydrogenase kinase	pd22	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and  @TERM$1  bckdk as being associated with  @TERM$2  further implicating bcaa metabolism in pd pathogenesis	0.99999857	1.3840638e-06
35228596	carboxylase 1	dehydrogenase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$1  mccc1 and branchedchain ketoacid  @TERM$2  kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.999998	2.0618133e-06
35228596	methylcrotonoylcoa	pd22	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes  @TERM$1  carboxylase 1 mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with  @TERM$2  further implicating bcaa metabolism in pd pathogenesis	0.9999987	1.261028e-06
35228596	bcaa	carboxylase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other  @TERM$1  pathway genes methylcrotonoylcoa  @TERM$2  1 mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999987	1.3695812e-06
35228596	carboxylase	dehydrogenase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$1  1 mccc1 and branchedchain ketoacid  @TERM$2  kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999963	3.7304014e-06
35228596	methylcrotonoylcoa	bckdk	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes  @TERM$1  carboxylase 1 mccc1 and branchedchain ketoacid dehydrogenase kinase  @TERM$2  as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99996746	3.257481e-05
35228596	genomewide	bckdk	35228596	131	249	@TERM$1	@TERM$2	 @TERM$1  association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and branchedchain ketoacid dehydrogenase kinase  @TERM$2  as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99999726	2.722204e-06
35228596	bcaa	bckdk	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other  @TERM$1  pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and branchedchain ketoacid dehydrogenase kinase  @TERM$2  as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999944	5.5839487e-06
35228596	mccc1	dehydrogenase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1  @TERM$1  and branchedchain ketoacid  @TERM$2  kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99999654	3.512429e-06
35228596	genomewide	dehydrogenase	35228596	131	249	@TERM$1	@TERM$2	 @TERM$1  association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and branchedchain ketoacid  @TERM$2  kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999987	1.2854313e-06
35228596	bcaa	dehydrogenase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other  @TERM$1  pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and branchedchain ketoacid  @TERM$2  kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999957	4.317956e-06
35228596	carboxylase 1	mccc1	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$1   @TERM$2  and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999987	1.2576161e-06
35228596	bcaas23	tca	35228596	132	127	@TERM$1	@TERM$2	cerebrospinal fluid have shown elevated levels of  @TERM$1  and altered  @TERM$2  cycle metabolites24 respectively consistent with our 	0.999998	1.9702384e-06
35228596	u24 dk097209	ctm	35228596	189	218	@TERM$1	@TERM$2	d by the national institute of health secim grant  @TERM$1  lmm and r03 ca222444 ac lmm u2c es030163 gwm and r01 es023839 gwm pioneer award dp1 gm119167  @TERM$2  and the glenn foundation for medical research cnv1001899 c	0.9999988	1.1794544e-06
35228596	u24 dk097209	dp1	35228596	189	205	@TERM$1	@TERM$2	d by the national institute of health secim grant  @TERM$1  lmm and r03 ca222444 ac lmm u2c es030163 gwm and r01 es023839 gwm pioneer award  @TERM$2  gm119167 ctm and the glenn foundation for medical research	0.9999937	6.303774e-06
35228596	u24 dk097209	u2c es030163	35228596	189	153	@TERM$1	@TERM$2	d by the national institute of health secim grant  @TERM$1  lmm and r03 ca222444 ac lmm  @TERM$2  gwm and r01 es023839 gwm pioneer award dp1 gm1191	0.9999939	6.1026076e-06
35228596	u2c es030163	ctm	35228596	189	177	@TERM$1	@TERM$2	im grant u24 dk097209 lmm and r03 ca222444 ac lmm  @TERM$1  gwm and r01 es023839 gwm pioneer award dp1 gm119167  @TERM$2  and the glenn foundation for medical research cnv1001899 c	0.99999845	1.5363173e-06
35228596	dp1	ctm	35228596	189	116	@TERM$1	@TERM$2	c es030163 gwm and r01 es023839 gwm pioneer award  @TERM$1  gm119167  @TERM$2  and the glenn foundation for medical research cnv	0.99999785	2.0991006e-06
35228596	u2c es030163	dp1	35228596	189	164	@TERM$1	@TERM$2	im grant u24 dk097209 lmm and r03 ca222444 ac lmm  @TERM$1  gwm and r01 es023839 gwm pioneer award  @TERM$2  gm119167 ctm and the glenn foundation for medical research	0.999998	1.9886572e-06
35228596	amm	ctm	35228596	178	153	@TERM$1	@TERM$2	we thank the c elegans genetics center for strains p40 od010440 and the confocal imaging facility at princeton universitydem  @TERM$1  rk  @TERM$2  vk gwm ac and lmm	0.99999833	1.6568531e-06
35228596	p40	amm	35228596	178	153	@TERM$1	@TERM$2	we thank the c elegans genetics center for strains  @TERM$1  od010440 and the confocal imaging facility at princeton universitydem  @TERM$2  rk ctm vk gwm ac and lmm	0.99998856	1.1444796e-05
35228596	p40	ctm	35228596	178	153	@TERM$1	@TERM$2	we thank the c elegans genetics center for strains  @TERM$1  od010440 and the confocal imaging facility at princeton universitydem amm rk  @TERM$2  vk gwm ac and lmm	0.999998	2.0688785e-06
35228596	agarose	sodium	35228596	172	101	@TERM$1	@TERM$2	on day 8 animals were mounted on 2  @TERM$1  pads in m9 and  @TERM$2  azide for cholinergic neuron imaging	0.9999914	8.542597e-06
35228596	agarose	azide	35228596	172	101	@TERM$1	@TERM$2	on day 8 animals were mounted on 2  @TERM$1  pads in m9 and sodium  @TERM$2  for cholinergic neuron imaging	0.9999913	8.689329e-06
35228596	sodium	azide	35228596	172	101	@TERM$1	@TERM$2	on day 8 animals were mounted on 2 agarose pads in m9 and  @TERM$1   @TERM$2  for cholinergic neuron imaging	0.9999987	1.3443866e-06
35228596	agarose	sodium azide	35228596	172	101	@TERM$1	@TERM$2	on day 8 animals were mounted on 2  @TERM$1  pads in m9 and  @TERM$2  for cholinergic neuron imaging	0.99999404	5.9259064e-06
35228596	carbenicillin	iptg	35228596	170	166	@TERM$1	@TERM$2	matode growth medium ngm plates supplemented with  @TERM$1  and isopropyl d1thiogalactopyranoside  @TERM$2  seeded with ht115 rnai e coli either bcat1 or l4440 empty 	0.99999464	5.3572294e-06
35228596	isomers	110	35228596	143	119	@TERM$1	@TERM$2	adducts and  @TERM$1  were manually curated for a final list of  @TERM$2  significantly increaseddecreased metabolites selected	0.99999654	3.4257373e-06
35228596	genomewide	methylcrotonoylcoa	35228596	131	249	@TERM$1	@TERM$2	 @TERM$1  association studies have pointed to other bcaa pathway genes  @TERM$2  carboxylase 1 mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99998724	1.2755502e-05
35228596	bcaa	methylcrotonoylcoa	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other  @TERM$1  pathway genes  @TERM$2  carboxylase 1 mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999795	2.0471754e-05
35228596	genomewide	bcaa	35228596	131	249	@TERM$1	@TERM$2	 @TERM$1  association studies have pointed to other  @TERM$2  pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99999726	2.7441617e-06
35228596	sodium	azide	35228596	111	113	@TERM$1	@TERM$2	 mitochondrial activity with lowdose treatment of  @TERM$1   @TERM$2  mitigates pdlike motor dysfunction and dopaminergi	0.99999666	3.30203e-06
35228596	lowdose	azide	35228596	111	122	@TERM$1	@TERM$2	reducing mitochondrial activity with  @TERM$1  treatment of sodium  @TERM$2  mitigates pdlike motor dysfunction and dopaminergic	0.99998975	1.030848e-05
35228596	lowdose	sodium azide	35228596	111	120	@TERM$1	@TERM$2	reducing mitochondrial activity with  @TERM$1  treatment of  @TERM$2  mitigates pdlike motor dysfunction and dopaminerg	0.9999968	3.1943391e-06
35228596	vnc	unc119psid1unc17pgfp	35228596	104	173	@TERM$1	@TERM$2	neuron projections in the head ventral nerve cord  @TERM$1  and dorsal nerve cord dnc of rnaisensitive worms  @TERM$2  were scored for the degree of degenerated appeara	0.99999726	2.78563e-06
35228596	vnc	unc119psid1unc17pgfp	35228596	98	173	@TERM$1	@TERM$2	neuron projections in the head ventral nerve cord  @TERM$1  and dorsal nerve cord dnc of rnaisensitive worms  @TERM$2  were scored for the degree of degenerated appeara	0.9999976	2.356809e-06
35228596	choline acetyltransferase chatcha1	choline	35228596	90	241	@TERM$1	@TERM$2	further examination of  @TERM$2 rgic synapse components revealed that the associated genes are largely upregulated in bcat1rnai worms including the vesicular acetylcholine transporter vachtunc17 and the  @TERM$1  fig4	0.9996325	0.00036750108
35228596	transporter	choline acetyltransferase chatcha1	35228596	90	241	@TERM$1	@TERM$2	further examination of cholinergic synapse components revealed that the associated genes are largely upregulated in bcat1rnai worms including the vesicular acetylcholine  @TERM$1  vachtunc17 and the  @TERM$2  fig4	0.99999595	4.0046702e-06
35228596	transporter	choline	35228596	90	241	@TERM$1	@TERM$2	further examination of  @TERM$2 rgic synapse components revealed that the associated genes are largely upregulated in bcat1rnai worms including the vesicular acetylcholine  @TERM$1  vachtunc17 and the choline acetyltransferase chatcha1 fig4	0.99999726	2.7420663e-06
35228596	acetylcholine	choline acetyltransferase chatcha1	35228596	90	241	@TERM$1	@TERM$2	further examination of cholinergic synapse components revealed that the associated genes are largely upregulated in bcat1rnai worms including the vesicular  @TERM$1  transporter vachtunc17 and the  @TERM$2  fig4	0.9999962	3.800307e-06
35228596	acetylcholine	choline	35228596	90	241	@TERM$1	@TERM$2	further examination of  @TERM$2 rgic synapse components revealed that the associated genes are largely upregulated in bcat1rnai worms including the vesicular  @TERM$1  transporter vachtunc17 and the choline acetyltransferase chatcha1 fig4	0.9999981	1.9101071e-06
35228596	acetylcholine	transporter	35228596	90	241	@TERM$1	@TERM$2	further examination of cholinergic synapse components revealed that the associated genes are largely upregulated in bcat1rnai worms including the vesicular  @TERM$1   @TERM$2  vachtunc17 and the choline acetyltransferase chatcha1 fig4	0.99999714	2.8867764e-06
35228596	acetylcholine	acetyltransferase	35228596	90	241	@TERM$1	@TERM$2	further examination of cholinergic synapse components revealed that the associated genes are largely upregulated in bcat1rnai worms including the vesicular  @TERM$1  transporter vachtunc17 and the choline  @TERM$2  chatcha1 fig4	0.9994301	0.0005698533
35228596	choline	acetyltransferase	35228596	90	241	@TERM$1	@TERM$2	further examination of  @TERM$1 rgic synapse components revealed that the associated genes are largely upregulated in bcat1rnai worms including the vesicular acetylcholine transporter vachtunc17 and the choline  @TERM$2  chatcha1 fig4	0.99999523	4.794331e-06
35228596	transporter	acetyltransferase	35228596	90	241	@TERM$1	@TERM$2	further examination of cholinergic synapse components revealed that the associated genes are largely upregulated in bcat1rnai worms including the vesicular acetylcholine  @TERM$1  vachtunc17 and the choline  @TERM$2  chatcha1 fig4	0.998566	0.0014340237
35228596	arachidonyltrifluoromethane	arachidonic acid	35228596	83	237	@TERM$1	@TERM$2	gene lists were analyzed using gprofiler29 and visualized using revigo30the second largest cluster was positively correlated with  @TERM$1  a derivative of  @TERM$2  which also plays a role in neuronal function13	0.99999833	1.7222435e-06
35228596	retinoate	amylopectin	35228596	71	198	@TERM$1	@TERM$2	in the larger cluster of genes which are positively correlated with the metabolites  @TERM$1  and  @TERM$2  several functional terms related to neurotransmission were significantly overrepresented	0.99999845	1.6082927e-06
35228596	fatty	tca	35228596	68	218	@TERM$1	@TERM$2	given that mitochondrial respiration is increased in bcat1rnai worms6 it possible that  @TERM$1  acid elongation is being downregulated in favor of fatty acid breakdown and utilization as a substrate for  @TERM$2  cycle activity	0.9999982	1.8382275e-06
35228596	module	notch	35228596	64	96	@TERM$1	@TERM$2	in  @TERM$1  9 malate was highly positively correlated with dna replication and  @TERM$2  signaling fig	0.999992	7.992122e-06
35228596	lowdose	sodium	35228596	111	115	@TERM$1	@TERM$2	reducing mitochondrial activity with  @TERM$1  treatment of  @TERM$2  azide mitigates pdlike motor dysfunction and dopam	0.99999726	2.7175663e-06
35228596	bcaas	bcaa	35228596	129	179	@TERM$1	@TERM$2	followup studies may wish to dissect which  @TERM$1  are particularly important for cholinergic signaling andor viability using  @TERM$2  and metabolite supplementation as well as rnai kno	0.999997	3.0153374e-06
35228596	dehydrogenase	pd22	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and branchedchain ketoacid  @TERM$1  kinase bckdk as being associated with  @TERM$2  further implicating bcaa metabolism in pd pathogenesis	0.9999968	3.2434855e-06
35228596	carboxylase 1	branchedchain ketoacid dehydrogenase kinase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$1  mccc1 and  @TERM$2  bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99999774	2.3053624e-06
35228596	mccc1	bckdk	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1  @TERM$1  and branchedchain ketoacid dehydrogenase kinase  @TERM$2  as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99999404	6.0066327e-06
35228596	carboxylase	branchedchain ketoacid dehydrogenase kinase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$1  1 mccc1 and  @TERM$2  bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99997747	2.2502354e-05
35228596	genomewide	mccc1	35228596	131	249	@TERM$1	@TERM$2	 @TERM$1  association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1  @TERM$2  and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99999404	6.0066327e-06
35228596	bckdk	pd22	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and branchedchain ketoacid dehydrogenase kinase  @TERM$1  as being associated with  @TERM$2  further implicating bcaa metabolism in pd pathogenesis	0.99999464	5.319261e-06
35228596	methylcrotonoylcoa	carboxylase 1	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes  @TERM$1   @TERM$2  mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99999547	4.5880743e-06
35228596	bcaa	mccc1	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other  @TERM$1  pathway genes methylcrotonoylcoa carboxylase 1  @TERM$2  and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99999475	5.2859264e-06
35228596	branchedchain ketoacid dehydrogenase kinase	bckdk	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and  @TERM$1   @TERM$2  as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999963	3.7369423e-06
35228596	genomewide	carboxylase 1	35228596	131	249	@TERM$1	@TERM$2	 @TERM$1  association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$2  mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.999998	1.9673093e-06
35228596	genomewide	pd22	35228596	131	249	@TERM$1	@TERM$2	 @TERM$1  association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with  @TERM$2  further implicating bcaa metabolism in pd pathogenesis	0.99999785	2.1892256e-06
35228596	methylcrotonoylcoa	carboxylase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes  @TERM$1   @TERM$2  1 mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999974	2.5698112e-06
35228596	bcaa	branchedchain ketoacid dehydrogenase kinase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other  @TERM$1  pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and  @TERM$2  bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999783	2.1692764e-05
35228596	genomewide	carboxylase	35228596	131	249	@TERM$1	@TERM$2	 @TERM$1  association studies have pointed to other bcaa pathway genes methylcrotonoylcoa  @TERM$2  1 mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99907494	0.0009250313
35228596	bcaa	pd22	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other  @TERM$1  pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with  @TERM$2  further implicating bcaa metabolism in pd pathogenesis	0.9999876	1.2455606e-05
35228596	methylcrotonoylcoa	mccc1	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes  @TERM$1  carboxylase 1  @TERM$2  and branchedchain ketoacid dehydrogenase kinase bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.99999094	9.065264e-06
35228596	dehydrogenase	bckdk	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and branchedchain ketoacid  @TERM$1  kinase  @TERM$2  as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999926	7.4229088e-06
35228596	methylcrotonoylcoa	branchedchain ketoacid dehydrogenase kinase	35228596	131	249	@TERM$1	@TERM$2	genomewide association studies have pointed to other bcaa pathway genes  @TERM$1  carboxylase 1 mccc1 and  @TERM$2  bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.9999895	1.0541318e-05
35228596	genomewide	branchedchain ketoacid dehydrogenase kinase	35228596	131	249	@TERM$1	@TERM$2	 @TERM$1  association studies have pointed to other bcaa pathway genes methylcrotonoylcoa carboxylase 1 mccc1 and  @TERM$2  bckdk as being associated with pd22 further implicating bcaa metabolism in pd pathogenesis	0.94600534	0.053994622
35228596	unc17	bcaa	35228596	128	209	@TERM$1	@TERM$2	c elegans  @TERM$1  and cha1 cholinergic synaptic mutants show highly similar motor dysfunction phenotypes to bcat1rnai worms21 further supporting a connection between  @TERM$2  metabolism and cholinergic neuron health	0.9997094	0.00029051295
36257965	phosphate	nadph	36257965	172	167	@TERM$1	@TERM$2	uconeogenesis provides substrates for the pentose  @TERM$1  pathway ppp which generates reducing equivalent  @TERM$2  5carbon sugars eg ribose5phosphate used to synthesize	0.999992	8.004823e-06
36257965	hif1	phosphoenolpyruvate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed  @TERM$1  directly and dramatically promotes the expression of pck1 pep carboxykinase which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to  @TERM$2  pep	0.9999945	5.443191e-06
36257965	malate dehydrogenase	tca	36257965	170	181	@TERM$1	@TERM$2	elevated malate and  @TERM$1  are indicative of activity in the glyoxylate cycle a variation of the  @TERM$2  cycle used in some organisms to convert citrate to oxaloacetate to	0.99999666	3.3189078e-06
36257965	malate	malate dehydrogenase	36257965	170	90	@TERM$1	@TERM$2	elevated  @TERM$1  and  @TERM$2  are indicative of activity in the glyoxylate cycl	0.9998254	0.00017456147
36257965	malate dehydrogenase	citrate	36257965	170	225	@TERM$1	@TERM$2	elevated malate and  @TERM$1  are indicative of activity in the glyoxylate cycle a variation of the tca cycle used in some organisms to convert  @TERM$2  to oxaloacetate to feed the gluconeogenesis pathwaywe also obs	0.99999154	8.472256e-06
36257965	glyoxylate	oxaloacetate	36257965	170	203	@TERM$1	@TERM$2	e dehydrogenase are indicative of activity in the  @TERM$1  cycle a variation of the tca cycle used in some organisms to convert citrate to  @TERM$2  to feed the gluconeogenesis pathwaywe also observ	0.9999933	6.7012174e-06
36257965	dehydrogenase	glyoxylate	36257965	170	138	@TERM$1	@TERM$2	elevated malate and malate  @TERM$1  are indicative of activity in the  @TERM$2  cycle a variation of the tca cycle used in some orga	0.9999896	1.0331578e-05
36257965	dehydrogenase	oxaloacetate	36257965	170	229	@TERM$1	@TERM$2	elevated malate and malate  @TERM$1  are indicative of activity in the glyoxylate cycle a variation of the tca cycle used in some organisms to convert citrate to  @TERM$2  to feed the gluconeogenesis pathwaywe also observe	0.9999944	5.5887062e-06
36257965	glyoxylate	tca	36257965	170	146	@TERM$1	@TERM$2	e dehydrogenase are indicative of activity in the  @TERM$1  cycle a variation of the  @TERM$2  cycle used in some organisms to convert citrate to oxalo	0.9999956	4.3676796e-06
36257965	malate	citrate	36257965	170	212	@TERM$1	@TERM$2	elevated  @TERM$1  and malate dehydrogenase are indicative of activity in the glyoxylate cycle a variation of the tca cycle used in some organisms to convert  @TERM$2  to oxaloacetate to feed the gluconeogenesis pathw	0.999998	2.0709037e-06
36257965	malate	glyoxylate	36257965	170	135	@TERM$1	@TERM$2	elevated  @TERM$1  and malate dehydrogenase are indicative of activity in the  @TERM$2  cycle a variation of the tca cycle used in some o	0.99997747	2.2492999e-05
36257965	tca	oxaloacetate	36257965	170	167	@TERM$1	@TERM$2	tivity in the glyoxylate cycle a variation of the  @TERM$1  cycle used in some organisms to convert citrate to  @TERM$2  to feed the gluconeogenesis pathwaywe also observ	0.9999964	3.6165607e-06
36257965	dehydrogenase	tca	36257965	170	174	@TERM$1	@TERM$2	elevated malate and malate  @TERM$1  are indicative of activity in the glyoxylate cycle a variation of the  @TERM$2  cycle used in some organisms to convert citrate to oxaloace	0.99999654	3.4680695e-06
36257965	malate	oxaloacetate	36257965	170	228	@TERM$1	@TERM$2	elevated  @TERM$1  and malate dehydrogenase are indicative of activity in the glyoxylate cycle a variation of the tca cycle used in some organisms to convert citrate to  @TERM$2  to feed the gluconeogenesis pathwaywe also observ	0.99998677	1.31892475e-05
36257965	citrate	oxaloacetate	36257965	170	123	@TERM$1	@TERM$2	f the tca cycle used in some organisms to convert  @TERM$1  to  @TERM$2  to feed the gluconeogenesis pathwaywe also observ	0.9999784	2.161205e-05
36257965	malate	dehydrogenase	36257965	170	90	@TERM$1	@TERM$2	elevated  @TERM$1  and malate  @TERM$2  are indicative of activity in the glyoxylate cycl	0.99999833	1.6360827e-06
36257965	malate dehydrogenase	glyoxylate	36257965	170	145	@TERM$1	@TERM$2	elevated malate and  @TERM$1  are indicative of activity in the  @TERM$2  cycle a variation of the tca cycle used in some organisms t	0.9999969	3.1229683e-06
36257965	malate dehydrogenase	oxaloacetate	36257965	170	236	@TERM$1	@TERM$2	elevated malate and  @TERM$1  are indicative of activity in the glyoxylate cycle a variation of the tca cycle used in some organisms to convert citrate to  @TERM$2  to feed the gluconeogenesis pathwaywe also observed indic	0.999997	2.9966466e-06
36257965	glyoxylate	citrate	36257965	170	190	@TERM$1	@TERM$2	e dehydrogenase are indicative of activity in the  @TERM$1  cycle a variation of the tca cycle used in some organisms to convert  @TERM$2  to oxaloacetate to feed the gluconeogenesis pathwayw	0.9999852	1.4789558e-05
36257965	tca	citrate	36257965	170	151	@TERM$1	@TERM$2	tivity in the glyoxylate cycle a variation of the  @TERM$1  cycle used in some organisms to convert  @TERM$2  to oxaloacetate to feed the gluconeogenesis pathw	0.9999765	2.350348e-05
36257965	dehydrogenase	citrate	36257965	170	218	@TERM$1	@TERM$2	elevated malate and malate  @TERM$1  are indicative of activity in the glyoxylate cycle a variation of the tca cycle used in some organisms to convert  @TERM$2  to oxaloacetate to feed the gluconeogenesis pathwaywe a	0.999997	2.9322473e-06
36257965	malate	tca	36257965	170	167	@TERM$1	@TERM$2	elevated  @TERM$1  and malate dehydrogenase are indicative of activity in the glyoxylate cycle a variation of the  @TERM$2  cycle used in some organisms to convert citrate to o	0.34329566	0.6567043
36257965	hif1	pep carboxykinase	36257965	171	237	@TERM$1	@TERM$2	as previously discussed  @TERM$1  directly and dramatically promotes the expression of pck1  @TERM$2  which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to phosphoenolpyruvate pep	0.99999845	1.5528445e-06
36257965	pck1 pep carboxykinase	phosphoenolpyruvate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of  @TERM$1  which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to  @TERM$2  pep	0.99999845	1.5232993e-06
36257965	oxaloacetate	phosphoenolpyruvate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of pck1 pep carboxykinase which catalyzes a key ratelimiting step specific to gluconeogenesis in which  @TERM$1  oa is converted to  @TERM$2  pep	0.9993254	0.0006746829
36257965	pep carboxykinase	oxaloacetate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of pck1  @TERM$1  which catalyzes a key ratelimiting step specific to gluconeogenesis in which  @TERM$2  oa is converted to phosphoenolpyruvate pep	0.99998474	1.5276612e-05
36257965	hif1	oxaloacetate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed  @TERM$1  directly and dramatically promotes the expression of pck1 pep carboxykinase which catalyzes a key ratelimiting step specific to gluconeogenesis in which  @TERM$2  oa is converted to phosphoenolpyruvate pep	0.9999931	6.8867635e-06
36257965	hif1	pck1 pep carboxykinase	36257965	171	237	@TERM$1	@TERM$2	as previously discussed  @TERM$1  directly and dramatically promotes the expression of  @TERM$2  which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to phosphoenolpyruvate pep	0.9998659	0.00013410175
36257965	hif1	pck1	36257965	171	237	@TERM$1	@TERM$2	as previously discussed  @TERM$1  directly and dramatically promotes the expression of  @TERM$2  pep carboxykinase which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to phosphoenolpyruvate pep	0.99999833	1.6652886e-06
36257965	pck1	oxaloacetate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of  @TERM$1  pep carboxykinase which catalyzes a key ratelimiting step specific to gluconeogenesis in which  @TERM$2  oa is converted to phosphoenolpyruvate pep	0.99996746	3.257481e-05
36257965	pck1 pep carboxykinase	oxaloacetate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of  @TERM$1  which catalyzes a key ratelimiting step specific to gluconeogenesis in which  @TERM$2  oa is converted to phosphoenolpyruvate pep	0.99999726	2.722204e-06
36257965	pck1	phosphoenolpyruvate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of  @TERM$1  pep carboxykinase which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to  @TERM$2  pep	0.9999944	5.5839487e-06
36257965	pck1	pep carboxykinase	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of  @TERM$1   @TERM$2  which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to phosphoenolpyruvate pep	0.99999297	7.001654e-06
36257965	hif1	pep	36257965	171	237	@TERM$1	@TERM$2	as previously discussed  @TERM$1  directly and dramatically promotes the expression of pck1  @TERM$2  carboxykinase which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to phosphoenolpyruvate pep	0.99999714	2.803935e-06
36257965	pep carboxykinase	phosphoenolpyruvate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of pck1  @TERM$1  which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to  @TERM$2  pep	0.99999774	2.2865845e-06
36257965	pck1 pep carboxykinase	pep	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of  @TERM$1  which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to phosphoenolpyruvate  @TERM$2 	0.99999523	4.764544e-06
36257965	pep	oxaloacetate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of pck1  @TERM$1  carboxykinase which catalyzes a key ratelimiting step specific to gluconeogenesis in which  @TERM$2  oa is converted to phosphoenolpyruvate pep	0.9999987	1.370654e-06
36257965	mdh1	dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of  @TERM$1  malate  @TERM$2  and ldh1 lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.99440056	0.0055994806
36257965	dehydrogenase	pyruvate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1 malate  @TERM$1  and ldh1 lactate dehydrogenase as well as their associated metabolites malate  @TERM$2  and lactate fig3d	0.99999833	1.6514737e-06
36257965	egl9	lactate dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however  @TERM$1  mutants had elevated levels of mdh1 malate dehydrogenase and ldh1  @TERM$2  as well as their associated metabolites malate pyruvate and lactate fig3d	0.99988914	0.00011082613
36257965	dehydrogenase	lactate dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1 malate  @TERM$1  and ldh1  @TERM$2  as well as their associated metabolites malate pyruvate and lactate fig3d	0.99999845	1.5486105e-06
36257965	malate	dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1   @TERM$2  and ldh1 lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.99999356	6.408847e-06
36257965	lactate dehydrogenase	pyruvate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1 malate dehydrogenase and ldh1  @TERM$1  as well as their associated metabolites malate  @TERM$2  and lactate fig3d	0.9999883	1.1693025e-05
36257965	mdh1	lactate dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of  @TERM$1  malate dehydrogenase and ldh1  @TERM$2  as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999976	2.420616e-06
36257965	dehydrogenase	ldh1	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1 malate  @TERM$1  and  @TERM$2  lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999976	2.349343e-06
36257965	malate dehydrogenase	lactate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1  and ldh1  @TERM$2  dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999914	8.554255e-06
36257965	malate dehydrogenase	ldh1	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1  and  @TERM$2  lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999968	3.261588e-06
36257965	lactate	pyruvate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1 malate dehydrogenase and ldh1  @TERM$1  dehydrogenase as well as their associated metabolites malate  @TERM$2  and lactate fig3d	0.99999416	5.8352584e-06
36257965	mdh1	lactate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of  @TERM$1  malate dehydrogenase and ldh1  @TERM$2  dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999938	6.15304e-06
36257965	ldh1	pyruvate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1 malate dehydrogenase and  @TERM$1  lactate dehydrogenase as well as their associated metabolites malate  @TERM$2  and lactate fig3d	0.999998	1.9981035e-06
36257965	mdh1	ldh1	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of  @TERM$1  malate dehydrogenase and  @TERM$2  lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.99999714	2.821755e-06
36257965	malate dehydrogenase	dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1  and ldh1 lactate  @TERM$2  as well as their associated metabolites malate pyruvate and lactate fig3d	0.999998	2.071915e-06
36257965	tca	egl9	36257965	168	76	@TERM$1	@TERM$2	most  @TERM$1  cycle enzymes and metabolites were unchanged in  @TERM$2  mutants fig3c	0.99999833	1.7137369e-06
36257965	hif1 binding sites	hif1	36257965	165	96	@TERM$1	@TERM$2	yellow arrowheads indicate genes with  @TERM$1  and that show direct regulation by  @TERM$2 	0.999998	2.038395e-06
36257965	log2	red	36257965	163	231	@TERM$1	@TERM$2	on the other side of each pathway arrow below for most arrows except gluconeogenesis differentially colo @TERM$2  boxes indicate metabolites levels  @TERM$1  fold change in egl9 mutants relative to wildtype metabolites are labeled in red text	0.9999399	6.006208e-05
36257965	egl9	red	36257965	163	231	@TERM$1	@TERM$2	on the other side of each pathway arrow below for most arrows except gluconeogenesis differentially colo @TERM$2  boxes indicate metabolites levels log2 fold change in  @TERM$1  mutants relative to wildtype metabolites are labeled in red text	0.99999607	3.8827925e-06
36257965	log2	egl9	36257965	163	231	@TERM$1	@TERM$2	on the other side of each pathway arrow below for most arrows except gluconeogenesis differentially colored boxes indicate metabolites levels  @TERM$1  fold change in  @TERM$2  mutants relative to wildtype metabolites are labeled in red text	0.9999709	2.9076786e-05
36257965	malate dehydrogenase	lactate dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1  and ldh1  @TERM$2  as well as their associated metabolites malate pyruvate and lactate fig3d	0.99998546	1.45771655e-05
36257965	pck1	pep	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of  @TERM$1   @TERM$2  carboxykinase which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to phosphoenolpyruvate pep	0.0015246919	0.99847525
36257965	malate	ldh1	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1  dehydrogenase and  @TERM$2  lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999056	9.4404626e-05
36257965	ldh1	lactate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1 malate dehydrogenase and  @TERM$1   @TERM$2  dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999982	1.8273416e-06
36257965	dehydrogenase	lactate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1 malate  @TERM$1  and ldh1  @TERM$2  dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.99999785	2.1914586e-06
36257965	egl9	ldh1	36257965	169	175	@TERM$1	@TERM$2	however  @TERM$1  mutants had elevated levels of mdh1 malate dehydrogenase and  @TERM$2  lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.99999845	1.5773028e-06
36257965	egl9	malate	36257965	169	175	@TERM$1	@TERM$2	however  @TERM$1  mutants had elevated levels of mdh1  @TERM$2  dehydrogenase and ldh1 lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.99999714	2.8633062e-06
36257965	malate dehydrogenase	malate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1  and ldh1 lactate dehydrogenase as well as their associated metabolites  @TERM$2  pyruvate and lactate fig3d	0.9999976	2.3791185e-06
36257965	mdh1	malate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of  @TERM$1   @TERM$2  dehydrogenase and ldh1 lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.99999785	2.1912497e-06
36257965	mdh1	pyruvate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of  @TERM$1  malate dehydrogenase and ldh1 lactate dehydrogenase as well as their associated metabolites malate  @TERM$2  and lactate fig3d	0.9999964	3.6160777e-06
36257965	malate	pyruvate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1  dehydrogenase and ldh1 lactate dehydrogenase as well as their associated metabolites malate  @TERM$2  and lactate fig3d	0.9999881	1.1896114e-05
36257965	egl9	malate dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however  @TERM$1  mutants had elevated levels of mdh1  @TERM$2  and ldh1 lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.99997926	2.0798536e-05
36257965	mdh1	malate dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of  @TERM$1   @TERM$2  and ldh1 lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999659	3.4035947e-05
36257965	egl9	pyruvate	36257965	169	175	@TERM$1	@TERM$2	however  @TERM$1  mutants had elevated levels of mdh1 malate dehydrogenase and ldh1 lactate dehydrogenase as well as their associated metabolites malate  @TERM$2  and lactate fig3d	0.0050498946	0.99495006
36257965	egl9	dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however  @TERM$1  mutants had elevated levels of mdh1 malate  @TERM$2  and ldh1 lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.99972993	0.00027000712
36257965	ldh1	lactate dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1 malate dehydrogenase and  @TERM$1   @TERM$2  as well as their associated metabolites malate pyruvate and lactate fig3d	0.99999654	3.4470424e-06
36257965	egl9	mdh1	36257965	169	175	@TERM$1	@TERM$2	however  @TERM$1  mutants had elevated levels of  @TERM$2  malate dehydrogenase and ldh1 lactate dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999912	8.78041e-06
36257965	malate	lactate dehydrogenase	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1  dehydrogenase and ldh1  @TERM$2  as well as their associated metabolites malate pyruvate and lactate fig3d	0.9790493	0.020950671
36257965	malate dehydrogenase	pyruvate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1  and ldh1 lactate dehydrogenase as well as their associated metabolites malate  @TERM$2  and lactate fig3d	0.99993217	6.786506e-05
36257965	egl9	lactate	36257965	169	175	@TERM$1	@TERM$2	however  @TERM$1  mutants had elevated levels of mdh1 malate dehydrogenase and ldh1  @TERM$2  dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999808	1.9243476e-05
36257965	lactate dehydrogenase	lactate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1 malate dehydrogenase and ldh1  @TERM$1  as well as their associated metabolites malate pyruvate and  @TERM$2  fig3d	0.056994002	0.943006
36257965	malate	lactate	36257965	169	175	@TERM$1	@TERM$2	however egl9 mutants had elevated levels of mdh1  @TERM$1  dehydrogenase and ldh1  @TERM$2  dehydrogenase as well as their associated metabolites malate pyruvate and lactate fig3d	0.9999975	2.5397753e-06
36257965	log2	egl9	36257965	162	124	@TERM$1	@TERM$2	ored boxes indicate enzyme mrna expression levels  @TERM$1  fold change in  @TERM$2  mutants relative to wild type enzymes are labeled	0.9999715	2.854616e-05
36257965	pep carboxykinase	pep	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of pck1  @TERM$1  which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to phosphoenolpyruvate  @TERM$2 	0.00024631317	0.99975365
36257965	nadph	erythrose4phosphate	36257965	172	186	@TERM$1	@TERM$2	e pathway ppp which generates reducing equivalent  @TERM$1  5carbon sugars eg ribose5phosphate used to synthesize nucleic acids and  @TERM$2  used to synthesize aromatic amino acid	0.020432418	0.9795675
36257965	cyanoalanine synthase	sqrd1	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2  @TERM$1  and  @TERM$2  sulfide quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.0010551016	0.99894494
36257965	quinone	oxidoreductase	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2 cyanoalanine synthase and sqrd1 sulfide  @TERM$1   @TERM$2  which converts these toxins to polysulfides and sulfates47	0.4800905	0.5199095
36257965	cyanoalanine	sulfide	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2  @TERM$1  synthase and sqrd1  @TERM$2  quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.9999883	1.1693025e-05
36257965	cyanoalanine	oxidoreductase	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2  @TERM$1  synthase and sqrd1 sulfide quinone  @TERM$2  which converts these toxins to polysulfides and sulfates47	0.9999976	2.420616e-06
36257965	sqrd1	oxidoreductase	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2 cyanoalanine synthase and  @TERM$1  sulfide quinone  @TERM$2  which converts these toxins to polysulfides and sulfates47	0.9999976	2.349343e-06
36257965	synthase	sqrd1	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2 cyanoalanine  @TERM$1  and  @TERM$2  sulfide quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.9999914	8.554255e-06
36257965	synthase	sulfide	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2 cyanoalanine  @TERM$1  and sqrd1  @TERM$2  quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.99999714	2.8633062e-06
36257965	cyanoalanine synthase	quinone	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2  @TERM$1  and sqrd1 sulfide  @TERM$2  oxidoreductase which converts these toxins to polysulfides and sulfates47	0.9999976	2.3791185e-06
36257965	cysl2	synthase	36257965	183	140	@TERM$1	@TERM$2	3i including  @TERM$1  cyanoalanine  @TERM$2  and sqrd1 sulfide quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.020432418	0.9795675
36257965	cysl2	sulfide	36257965	183	140	@TERM$1	@TERM$2	3i including  @TERM$1  cyanoalanine synthase and sqrd1  @TERM$2  quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.0010551016	0.99894494
36257965	cysl2	oxidoreductase	36257965	183	140	@TERM$1	@TERM$2	3i including  @TERM$1  cyanoalanine synthase and sqrd1 sulfide quinone  @TERM$2  which converts these toxins to polysulfides and sulfates47	0.4800905	0.5199095
36257965	synthase	quinone	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2 cyanoalanine  @TERM$1  and sqrd1 sulfide  @TERM$2  oxidoreductase which converts these toxins to polysulfides and sulfates47	0.9999883	1.1674974e-05
36257965	synthase	oxidoreductase	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2 cyanoalanine  @TERM$1  and sqrd1 sulfide quinone  @TERM$2  which converts these toxins to polysulfides and sulfates47	0.0003894188	0.9996106
36257965	sulfide	quinone	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2 cyanoalanine synthase and sqrd1  @TERM$1   @TERM$2  oxidoreductase which converts these toxins to polysulfides and sulfates47	0.9999621	3.788282e-05
36257965	cysl2	cyanoalanine synthase	36257965	183	140	@TERM$1	@TERM$2	3i including  @TERM$1   @TERM$2  and sqrd1 sulfide quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.999998	1.9986123e-06
36257965	sqrd1	sulfide	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2 cyanoalanine synthase and  @TERM$1   @TERM$2  quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.999995	5.0190984e-06
36257965	cysl2	cyanoalanine	36257965	183	140	@TERM$1	@TERM$2	3i including  @TERM$1   @TERM$2  synthase and sqrd1 sulfide quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.99999535	4.5911115e-06
36257965	sqrd1	quinone	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2 cyanoalanine synthase and  @TERM$1  sulfide  @TERM$2  oxidoreductase which converts these toxins to polysulfides and sulfates47	0.99998105	1.8935656e-05
36257965	cyanoalanine	synthase	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2  @TERM$1   @TERM$2  and sqrd1 sulfide quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.99999666	3.3932615e-06
36257965	cysteine	nac	36257965	218	225	@TERM$1	@TERM$2	the antioxidants glycolate and  @TERM$2 etyl  @TERM$1  nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued hif1 and pck1 mutants for survival during hypoxia fig	0.99999464	5.3509693e-06
36257965	glycolate	nacetyl cysteine	36257965	218	225	@TERM$1	@TERM$2	the antioxidants  @TERM$1  and  @TERM$2  nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued hif1 and pck1 mutants for survival during hypoxia fig	0.99999774	2.2305271e-06
36257965	glycolate	pck1	36257965	218	225	@TERM$1	@TERM$2	the antioxidants  @TERM$1  and nacetyl cysteine nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued hif1 and  @TERM$2  mutants for survival during hypoxia fig	0.9994006	0.000599407
36257965	nac	hif1	36257965	218	225	@TERM$1	@TERM$2	the antioxidants glycolate and  @TERM$1 etyl cysteine nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued  @TERM$2  and pck1 mutants for survival during hypoxia fig	0.9999982	1.8466333e-06
36257965	nacetyl cysteine	hif1	36257965	218	225	@TERM$1	@TERM$2	the antioxidants glycolate and  @TERM$1  nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued  @TERM$2  and pck1 mutants for survival during hypoxia fig	0.99981564	0.00018439822
36257965	glycolate	hif1	36257965	218	225	@TERM$1	@TERM$2	the antioxidants  @TERM$1  and nacetyl cysteine nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued  @TERM$2  and pck1 mutants for survival during hypoxia fig	0.9999268	7.3179086e-05
36257965	pep	hif1	36257965	214	156	@TERM$1	@TERM$2	4b and this susceptibility was rescued by supplementation with  @TERM$1  the product of the pck1catalyzed reaction that is elevated when  @TERM$2  is active as per fig	0.999995	5.0190984e-06
36257965	pck1	hif1	36257965	212	93	@TERM$1	@TERM$2	mutants for  @TERM$1  like  @TERM$2  mutants were viable under normoxic conditions supplementary fig7a	0.99999535	4.5911115e-06
36257965	hif1	pck1	36257965	209	99	@TERM$1	@TERM$2	f model illustrating how  @TERM$1  binds near the  @TERM$2  promoter to upregulate pck1 expression and drive 	0.99999666	3.3932615e-06
36257965	reactive oxygen species	ros	36257965	209	147	@TERM$1	@TERM$2	sequent reoxygenation result in the production of  @TERM$1   @TERM$2  and oxidative stress we reasoned that the upregulation of pck1 by hif	0.99999464	5.3509693e-06
36257965	hif1	pck1	36257965	199	99	@TERM$1	@TERM$2	f model illustrating how  @TERM$1  binds near the  @TERM$2  promoter to upregulate pck1 expression and drive 	0.99999774	2.2305271e-06
36257965	hif1	egl9	36257965	184	119	@TERM$1	@TERM$2	upregulation of h2shcn detoxification by  @TERM$1  is consistent with  @TERM$2  and hif1 mutants being resistant and sensitive re	0.9999268	7.3179086e-05
36257965	cysl2	quinone	36257965	183	140	@TERM$1	@TERM$2	3i including  @TERM$1  cyanoalanine synthase and sqrd1 sulfide  @TERM$2  oxidoreductase which converts these toxins to polysulfides and sulfates47	0.89644206	0.1035579
36257965	cysl2	sqrd1	36257965	183	140	@TERM$1	@TERM$2	3i including  @TERM$1  cyanoalanine synthase and  @TERM$2  sulfide quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.9999982	1.8466333e-06
36257965	sulfide	oxidoreductase	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2 cyanoalanine synthase and sqrd1  @TERM$1  quinone  @TERM$2  which converts these toxins to polysulfides and sulfates47	0.99999654	3.512429e-06
36257965	cyanoalanine synthase	sulfide	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2  @TERM$1  and sqrd1  @TERM$2  quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.99999654	3.4257373e-06
36257965	cyanoalanine synthase	oxidoreductase	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2  @TERM$1  and sqrd1 sulfide quinone  @TERM$2  which converts these toxins to polysulfides and sulfates47	0.99999666	3.3059025e-06
36257965	cyanoalanine	quinone	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2  @TERM$1  synthase and sqrd1 sulfide  @TERM$2  oxidoreductase which converts these toxins to polysulfides and sulfates47	0.9999907	9.258924e-06
36257965	pentose	ppp	36257965	172	133	@TERM$1	@TERM$2	ucose gluconeogenesis provides substrates for the  @TERM$1  phosphate pathway  @TERM$2  which generates reducing equivalent nadph 5carbon sug	0.9999888	1.115844e-05
36257965	ppp	erythrose4phosphate	36257965	172	226	@TERM$1	@TERM$2	ides substrates for the pentose phosphate pathway  @TERM$1  which generates reducing equivalent nadph 5carbon sugars eg ribose5phosphate used to synthesize nucleic acids and  @TERM$2  used to synthesize aromatic amino acid	0.99995685	4.319496e-05
36257965	phosphate	ppp	36257965	172	127	@TERM$1	@TERM$2	uconeogenesis provides substrates for the pentose  @TERM$1  pathway  @TERM$2  which generates reducing equivalent nadph 5carbon sugar	0.99998665	1.3349706e-05
36257965	glucose	phosphate	36257965	172	147	@TERM$1	@TERM$2	in addition to regenerating  @TERM$1  gluconeogenesis provides substrates for the pentose  @TERM$2  pathway ppp which generates reducing equivalent n	0.99999654	3.3987408e-06
36257965	glucose	nadph	36257965	172	203	@TERM$1	@TERM$2	in addition to regenerating  @TERM$1  gluconeogenesis provides substrates for the pentose phosphate pathway ppp which generates reducing equivalent  @TERM$2  5carbon sugars eg ribose5phosphate used to synthesi	0.9999976	2.3898656e-06
36257965	nadph	ribose5phosphate	36257965	172	140	@TERM$1	@TERM$2	e pathway ppp which generates reducing equivalent  @TERM$1  5carbon sugars eg  @TERM$2  used to synthesize nucleic acids and erythrose4ph	0.08616358	0.9138364
36257965	glucose	ppp	36257965	172	163	@TERM$1	@TERM$2	in addition to regenerating  @TERM$1  gluconeogenesis provides substrates for the pentose phosphate pathway  @TERM$2  which generates reducing equivalent nadph 5carbon sug	0.9999683	3.174159e-05
36257965	ppp	ribose5phosphate	36257965	172	180	@TERM$1	@TERM$2	ides substrates for the pentose phosphate pathway  @TERM$1  which generates reducing equivalent nadph 5carbon sugars eg  @TERM$2  used to synthesize nucleic acids and erythrose4ph	0.99997985	2.0167105e-05
36257965	glucose	pentose	36257965	172	137	@TERM$1	@TERM$2	in addition to regenerating  @TERM$1  gluconeogenesis provides substrates for the  @TERM$2  phosphate pathway ppp which generates reducing eq	0.99998903	1.0979834e-05
36257965	pentose	ribose5phosphate	36257965	172	206	@TERM$1	@TERM$2	ucose gluconeogenesis provides substrates for the  @TERM$1  phosphate pathway ppp which generates reducing equivalent nadph 5carbon sugars eg  @TERM$2  used to synthesize nucleic acids and erythrose4ph	0.20774874	0.7922512
36257965	ribose5phosphate	erythrose4phosphate	36257965	172	162	@TERM$1	@TERM$2	rates reducing equivalent nadph 5carbon sugars eg  @TERM$1  used to synthesize nucleic acids and  @TERM$2  used to synthesize aromatic amino acid	0.9697703	0.030229708
36257965	phosphate	ribose5phosphate	36257965	172	198	@TERM$1	@TERM$2	uconeogenesis provides substrates for the pentose  @TERM$1  pathway ppp which generates reducing equivalent nadph 5carbon sugars eg  @TERM$2  used to synthesize nucleic acids and erythrose4ph	0.9994006	0.000599407
36257965	ppp	nadph	36257965	172	145	@TERM$1	@TERM$2	ides substrates for the pentose phosphate pathway  @TERM$1  which generates reducing equivalent  @TERM$2  5carbon sugars eg ribose5phosphate used to synthe	0.99981564	0.00018439822
36257965	pentose	nadph	36257965	172	173	@TERM$1	@TERM$2	ucose gluconeogenesis provides substrates for the  @TERM$1  phosphate pathway ppp which generates reducing equivalent  @TERM$2  5carbon sugars eg ribose5phosphate used to synthesi	0.999995	5.029439e-06
36257965	phosphate	erythrose4phosphate	36257965	172	244	@TERM$1	@TERM$2	uconeogenesis provides substrates for the pentose  @TERM$1  pathway ppp which generates reducing equivalent nadph 5carbon sugars eg ribose5phosphate used to synthesize nucleic acids and  @TERM$2  used to synthesize aromatic amino acid	0.999049	0.0009509369
36257965	pentose	phosphate	36257965	172	117	@TERM$1	@TERM$2	ucose gluconeogenesis provides substrates for the  @TERM$1   @TERM$2  pathway ppp which generates reducing equivalent n	0.005495961	0.9945041
36257965	glucose	ribose5phosphate	36257965	172	236	@TERM$1	@TERM$2	in addition to regenerating  @TERM$1  gluconeogenesis provides substrates for the pentose phosphate pathway ppp which generates reducing equivalent nadph 5carbon sugars eg  @TERM$2  used to synthesize nucleic acids and erythrose4ph	0.00059578114	0.9994042
36257965	ppp	egl9	36257965	173	84	@TERM$1	@TERM$2	we observed an increase in  @TERM$1  metabolites in  @TERM$2  mutants relative to wild type fig	0.99999535	4.6353707e-06
36257965	pep	phosphoenolpyruvate	36257965	171	237	@TERM$1	@TERM$2	as previously discussed hif1 directly and dramatically promotes the expression of pck1  @TERM$1  carboxykinase which catalyzes a key ratelimiting step specific to gluconeogenesis in which oxaloacetate oa is converted to  @TERM$2  pep	0.99999833	1.727781e-06
36257965	glycerol3phosphate	g3p	36257965	174	104	@TERM$1	@TERM$2	nthesized and dietary fatty acids are attached to  @TERM$1   @TERM$2  for conversion to storage lipid	0.9999932	6.755314e-06
36257965	ppp	flux	36257965	174	163	@TERM$1	@TERM$2	3e although none of the key enzymes within the  @TERM$1  were direct targets of hif1 suggesting that increased ppp  @TERM$2  is an indirect effect of hif1 activation of gluco	0.99999845	1.6016559e-06
36257965	cyanoalanine	sqrd1	36257965	183	140	@TERM$1	@TERM$2	3i including cysl2  @TERM$1  synthase and  @TERM$2  sulfide quinone oxidoreductase which converts these toxins to polysulfides and sulfates47	0.999997	2.9720677e-06
36257965	catalases	superoxide	36257965	180	113	@TERM$1	@TERM$2	3g and the  @TERM$1  and  @TERM$2  dismutases that combat oxidative stress are all indirectly upregulated fig3h	0.9998455	0.00015441312
36257965	hif1	glutathione	36257965	179	125	@TERM$1	@TERM$2	indeed many of the direct target genes most dramatically upregulated by  @TERM$1  lie within pathways that produce  @TERM$2  fig	0.999998	1.997246e-06
36257965	glutathione	egl9	36257965	178	84	@TERM$1	@TERM$2	we observed higher levels of  @TERM$1  in  @TERM$2  mutants relative to wildtype fig3g	0.999998	2.0436191e-06
36257965	hif1	phospholipid	36257965	176	130	@TERM$1	@TERM$2	 @TERM$2 s are also synthesized from g3p and we found that active  @TERM$1  increased the levels of certain phospholipid species fig	0.9999908	9.219636e-06
36257965	phospholipids	phospholipid	36257965	176	130	@TERM$1	@TERM$2	 @TERM$1  are also synthesized from g3p and we found that active hif1 increased the levels of certain  @TERM$2  species fig	0.9994753	0.00052468537
36257965	g3p	phospholipid	36257965	176	130	@TERM$1	@TERM$2	 @TERM$2 s are also synthesized from  @TERM$1  and we found that active hif1 increased the levels of certain phospholipid species fig	0.9999709	2.91002e-05
36257965	g3p	hif1	36257965	176	130	@TERM$1	@TERM$2	phospholipids are also synthesized from  @TERM$1  and we found that active  @TERM$2  increased the levels of certain phospholipid species fig	0.9999974	2.6180833e-06
36257965	phospholipids	hif1	36257965	176	130	@TERM$1	@TERM$2	 @TERM$1  are also synthesized from g3p and we found that active  @TERM$2  increased the levels of certain phospholipid species fig	0.9999951	4.8414254e-06
36257965	phospholipids	g3p	36257965	176	130	@TERM$1	@TERM$2	 @TERM$1  are also synthesized from  @TERM$2  and we found that active hif1 increased the levels of certain phospholipid species fig	0.99998915	1.0883693e-05
36257965	g3p	fatty	36257965	175	135	@TERM$1	@TERM$2	consistent with this metabolic pathway we observed decreased  @TERM$1  and increased levels of certain  @TERM$2  acids when hif1 is active fig3f	0.9999944	5.5756955e-06
36257965	g3p	hif1	36257965	175	135	@TERM$1	@TERM$2	consistent with this metabolic pathway we observed decreased  @TERM$1  and increased levels of certain fatty acids when  @TERM$2  is active fig3f	0.9999975	2.5011248e-06
36257965	fatty	hif1	36257965	175	135	@TERM$1	@TERM$2	consistent with this metabolic pathway we observed decreased g3p and increased levels of certain  @TERM$1  acids when  @TERM$2  is active fig3f	0.9999881	1.1920827e-05
36257965	ppp	hif1	36257965	174	128	@TERM$1	@TERM$2	3e although none of the key enzymes within the  @TERM$1  were direct targets of  @TERM$2  suggesting that increased ppp flux is an indirect	0.99999464	5.420084e-06
36257965	hif1	flux	36257965	174	139	@TERM$1	@TERM$2	key enzymes within the ppp were direct targets of  @TERM$1  suggesting that increased ppp  @TERM$2  is an indirect effect of hif1 activation of gluco	0.9999912	8.801906e-06
36257965	fatty	glycerol3phosphate	36257965	174	186	@TERM$1	@TERM$2	 from the ppp serves as a reducing equivalent for  @TERM$1  acid synthesis and both synthesized and dietary fatty acids are attached to  @TERM$2  g3p for conversion to storage lipid	0.9999939	6.1349124e-06
36257965	fatty	g3p	36257965	174	186	@TERM$1	@TERM$2	 from the ppp serves as a reducing equivalent for  @TERM$1  acid synthesis and both synthesized and dietary fatty acids are attached to glycerol3phosphate  @TERM$2  for conversion to storage lipid	0.9999821	1.789787e-05
36257965	flux	fatty	36257965	174	234	@TERM$1	@TERM$2	ect targets of hif1 suggesting that increased ppp  @TERM$1  is an indirect effect of hif1 activation of gluconeogenesisnadph generated from the ppp serves as a reducing equivalent for  @TERM$2  acid synthesis and both synthesized and dietary f	0.99999714	2.8636666e-06
36257965	hif1 binding sites	hif1	36257965	157	96	@TERM$1	@TERM$2	yellow arrowheads indicate genes with  @TERM$1  and that show direct regulation by  @TERM$2 	0.9999871	1.2903593e-05
36257965	log2	red	36257965	155	231	@TERM$1	@TERM$2	on the other side of each pathway arrow below for most arrows except gluconeogenesis differentially colo @TERM$2  boxes indicate metabolites levels  @TERM$1  fold change in egl9 mutants relative to wildtype metabolites are labeled in red text	0.9999962	3.7659458e-06
36257965	egl9	red	36257965	155	231	@TERM$1	@TERM$2	on the other side of each pathway arrow below for most arrows except gluconeogenesis differentially colo @TERM$2  boxes indicate metabolites levels log2 fold change in  @TERM$1  mutants relative to wildtype metabolites are labeled in red text	0.9999858	1.4179703e-05
36257965	hif	dehydrogenase	36257965	43	187	@TERM$1	@TERM$2	 @TERM$1  upregulates enzymes that mediate glucose uptake and glycolysis as well as pyruvate  @TERM$2  kinase a negative regulator of metabolite entry into the tricarboxylic acid tca cycle6	0.9999981	1.8530334e-06
36257965	pyruvate dehydrogenase kinase	tricarboxylic acid	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate glucose uptake and glycolysis as well as  @TERM$1  a negative regulator of metabolite entry into the  @TERM$2  tca cycle6	0.99999225	7.730741e-06
36257965	dehydrogenase	tricarboxylic acid	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate glucose uptake and glycolysis as well as pyruvate  @TERM$1  kinase a negative regulator of metabolite entry into the  @TERM$2  tca cycle6	0.9999981	1.8808578e-06
36257965	glucose	tricarboxylic acid	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate  @TERM$1  uptake and glycolysis as well as pyruvate dehydrogenase kinase a negative regulator of metabolite entry into the  @TERM$2  tca cycle6	0.99999595	4.0116347e-06
36257965	hif	tca	36257965	43	187	@TERM$1	@TERM$2	 @TERM$1  upregulates enzymes that mediate glucose uptake and glycolysis as well as pyruvate dehydrogenase kinase a negative regulator of metabolite entry into the tricarboxylic acid  @TERM$2  cycle6	0.99999416	5.86372e-06
36257965	glucose	tca	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate  @TERM$1  uptake and glycolysis as well as pyruvate dehydrogenase kinase a negative regulator of metabolite entry into the tricarboxylic acid  @TERM$2  cycle6	0.9999957	4.2446886e-06
36257965	pyruvate dehydrogenase kinase	tca	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate glucose uptake and glycolysis as well as  @TERM$1  a negative regulator of metabolite entry into the tricarboxylic acid  @TERM$2  cycle6	0.99999475	5.194981e-06
36257965	hif	glucose	36257965	43	187	@TERM$1	@TERM$2	 @TERM$1  upregulates enzymes that mediate  @TERM$2  uptake and glycolysis as well as pyruvate dehydrogenase kinase a negative regulator of metabolite entry into the tricarboxylic acid tca cycle6	0.9998338	0.00016615028
36257965	dehydrogenase	tca	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate glucose uptake and glycolysis as well as pyruvate  @TERM$1  kinase a negative regulator of metabolite entry into the tricarboxylic acid  @TERM$2  cycle6	0.9999944	5.5595174e-06
36257965	hif	pyruvate dehydrogenase kinase	36257965	43	187	@TERM$1	@TERM$2	 @TERM$1  upregulates enzymes that mediate glucose uptake and glycolysis as well as  @TERM$2  a negative regulator of metabolite entry into the tricarboxylic acid tca cycle6	0.99999475	5.200057e-06
36257965	glucose	dehydrogenase	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate  @TERM$1  uptake and glycolysis as well as pyruvate  @TERM$2  kinase a negative regulator of metabolite entry into the tricarboxylic acid tca cycle6	0.99997187	2.810427e-05
36257965	hif	pyruvate	36257965	43	187	@TERM$1	@TERM$2	 @TERM$1  upregulates enzymes that mediate glucose uptake and glycolysis as well as  @TERM$2  dehydrogenase kinase a negative regulator of metabolite entry into the tricarboxylic acid tca cycle6	0.9999943	5.744529e-06
36257965	egl9	hif1 binding sites	36257965	39	178	@TERM$1	@TERM$2	g graph of log2 fold change in expression for individual genes in  @TERM$1  mutants relative to wild type versus the number of  @TERM$2  for those genes identified by chipseq	0.99999356	6.493279e-06
36257965	log2	egl9	36257965	39	178	@TERM$1	@TERM$2	g graph of  @TERM$1  fold change in expression for individual genes in  @TERM$2  mutants relative to wild type versus the number of hif1 binding sites for those genes identified by chipseq	0.999998	1.9698364e-06
36257965	log2	hif1	36257965	39	178	@TERM$1	@TERM$2	g graph of  @TERM$1  fold change in expression for individual genes in egl9 mutants relative to wild type versus the number of  @TERM$2  binding sites for those genes identified by chipseq	0.99999726	2.7307326e-06
36257965	egl9	hif1	36257965	39	178	@TERM$1	@TERM$2	g graph of log2 fold change in expression for individual genes in  @TERM$1  mutants relative to wild type versus the number of  @TERM$2  binding sites for those genes identified by chipseq	0.9999933	6.6175708e-06
36257965	pyruvate	tricarboxylic acid	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate glucose uptake and glycolysis as well as  @TERM$1  dehydrogenase kinase a negative regulator of metabolite entry into the  @TERM$2  tca cycle6	0.99999774	2.2634672e-06
36257965	hif	tricarboxylic acid	36257965	43	187	@TERM$1	@TERM$2	 @TERM$1  upregulates enzymes that mediate glucose uptake and glycolysis as well as pyruvate dehydrogenase kinase a negative regulator of metabolite entry into the  @TERM$2  tca cycle6	0.9999987	1.3103516e-06
36257965	tricarboxylic acid	tca	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate glucose uptake and glycolysis as well as pyruvate dehydrogenase kinase a negative regulator of metabolite entry into the  @TERM$1   @TERM$2  cycle6	0.99999857	1.3865357e-06
36257965	egl9	hif1	36257965	50	238	@TERM$1	@TERM$2	these nematodes employ single orthologs of the conserved hypoxia response pathway the prolyl hydroxylase ortholog  @TERM$1  and the hif ortholog  @TERM$2  with viable null mutants in hif1 and egl9 showing altered sensitivity to hypoxic stress32632	0.9999976	2.4238964e-06
36257965	prolyl	egl9	36257965	50	238	@TERM$1	@TERM$2	these nematodes employ single orthologs of the conserved hypoxia response pathway the  @TERM$1  hydroxylase ortholog  @TERM$2  and the hif ortholog hif1 with viable null mutants in hif1 and egl9 showing altered sensitivity to hypoxic stress32632	0.9999982	1.8086052e-06
36257965	prolyl	hif1	36257965	50	238	@TERM$1	@TERM$2	these nematodes employ single orthologs of the conserved hypoxia response pathway the  @TERM$1  hydroxylase ortholog egl9 and the hif ortholog  @TERM$2  with viable null mutants in hif1 and egl9 showing altered sensitivity to hypoxic stress32632	0.99999654	3.4178238e-06
36257965	prolyl	hydroxylase	36257965	50	238	@TERM$1	@TERM$2	these nematodes employ single orthologs of the conserved hypoxia response pathway the  @TERM$1   @TERM$2  ortholog egl9 and the hif ortholog hif1 with viable null mutants in hif1 and egl9 showing altered sensitivity to hypoxic stress32632	0.99999666	3.396538e-06
36257965	hydroxylase	hif1	36257965	50	238	@TERM$1	@TERM$2	these nematodes employ single orthologs of the conserved hypoxia response pathway the prolyl  @TERM$1  ortholog egl9 and the hif ortholog  @TERM$2  with viable null mutants in hif1 and egl9 showing altered sensitivity to hypoxic stress32632	0.9999975	2.463664e-06
36257965	hif	vegf	36257965	47	99	@TERM$1	@TERM$2	 @TERM$1  also regulates target genes like epo and  @TERM$2  which developmentally remodel oxygen delivery2021	0.9999933	6.645543e-06
36257965	hydroxylase	hif	36257965	46	150	@TERM$1	@TERM$2	lization and presumably patients receiving prolyl  @TERM$1  inhibitors to treat anemia  @TERM$2  activates this switch and promotes glycolysis despite aer	0.99999607	3.958181e-06
36257965	prolyl	hydroxylase	36257965	46	118	@TERM$1	@TERM$2	decidualization and presumably patients receiving  @TERM$1   @TERM$2  inhibitors to treat anemia hif activates this swi	0.9999864	1.3582062e-05
36257965	prolyl	hif	36257965	46	152	@TERM$1	@TERM$2	decidualization and presumably patients receiving  @TERM$1  hydroxylase inhibitors to treat anemia  @TERM$2  activates this switch and promotes glycolysis despit	0.9999976	2.3962855e-06
36257965	hif	oxphos	36257965	44	126	@TERM$1	@TERM$2	 @TERM$1  inhibits  @TERM$2  by altering subunit composition in the electron transport chain etc and by reducing mitochondrial number78	0.9999958	4.134535e-06
36257965	glucose	pyruvate dehydrogenase kinase	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate  @TERM$1  uptake and glycolysis as well as  @TERM$2  a negative regulator of metabolite entry into the tricarboxylic acid tca cycle6	0.9999974	2.675917e-06
36257965	pyruvate	tca	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate glucose uptake and glycolysis as well as  @TERM$1  dehydrogenase kinase a negative regulator of metabolite entry into the tricarboxylic acid  @TERM$2  cycle6	0.99999785	2.1393425e-06
36257965	glucose	pyruvate	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate  @TERM$1  uptake and glycolysis as well as  @TERM$2  dehydrogenase kinase a negative regulator of metabolite entry into the tricarboxylic acid tca cycle6	0.99999595	4.082877e-06
36257965	pyruvate	dehydrogenase	36257965	43	187	@TERM$1	@TERM$2	hif upregulates enzymes that mediate glucose uptake and glycolysis as well as  @TERM$1   @TERM$2  kinase a negative regulator of metabolite entry into the tricarboxylic acid tca cycle6	0.99999785	2.135775e-06
36257965	log2	hif1 binding sites	36257965	39	178	@TERM$1	@TERM$2	g graph of  @TERM$1  fold change in expression for individual genes in egl9 mutants relative to wild type versus the number of  @TERM$2  for those genes identified by chipseq	0.9999974	2.5650952e-06
36257965	log2	egl9	36257965	36	141	@TERM$1	@TERM$2	e volcano plot of rnaseq fdr values versus  @TERM$1  foldchange expression for individual genes blue squares in  @TERM$2  mutants relative to wild type	0.99999845	1.5980719e-06
36257965	atp	reactive oxygen species	36257965	10	205	@TERM$1	@TERM$2	in addition to reducing energy  @TERM$1  production by impairing oxidative phosphorylation oxphos hypoxia and subsequent reoxygenation also create oxidative stress by generating toxic  @TERM$2  ros	0.99999845	1.5775194e-06
36257965	oxphos	reactive oxygen species	36257965	10	205	@TERM$1	@TERM$2	in addition to reducing energy atp production by impairing oxidative phosphorylation  @TERM$1  hypoxia and subsequent reoxygenation also create oxidative stress by generating toxic  @TERM$2  ros	0.9999969	3.1010304e-06
36257965	atp	ros	36257965	10	205	@TERM$1	@TERM$2	in addition to reducing energy  @TERM$1  production by impairing oxidative phosphorylation oxphos hypoxia and subsequent reoxygenation also create oxidative stress by generating toxic reactive oxygen species  @TERM$2 	0.9999981	1.8937322e-06
36257965	oxphos	ros	36257965	10	205	@TERM$1	@TERM$2	in addition to reducing energy atp production by impairing oxidative phosphorylation  @TERM$1  hypoxia and subsequent reoxygenation also create oxidative stress by generating toxic reactive oxygen species  @TERM$2 	0.9999981	1.8597539e-06
36257965	hif1	counter	36257965	8	239	@TERM$1	@TERM$2	our work identifies functional direct targets of  @TERM$1  in vivo comprehensively describing the metabolome induced by hif1 activation in an organismthe hypoxia response pathway can  @TERM$2  pathological damage caused by low oxygen availability	0.9999981	1.9592662e-06
36257965	pck1	hif1	36257965	7	98	@TERM$1	@TERM$2	this activation of  @TERM$1  by  @TERM$2  promotes survival in response to both oxidative and hypoxic stress	0.9999987	1.3271323e-06
36257965	hif1	pck1	36257965	6	190	@TERM$1	@TERM$2	we integrate these approaches to identify over two hundred genes directly and functionally upregulated by  @TERM$1  including the pep carboxykinase  @TERM$2  a ratelimiting mediator of gluconeogenesis	0.9999981	1.9317736e-06
36257965	pep carboxykinase	pck1	36257965	6	190	@TERM$1	@TERM$2	we integrate these approaches to identify over two hundred genes directly and functionally upregulated by hif1 including the  @TERM$1   @TERM$2  a ratelimiting mediator of gluconeogenesis	0.99999833	1.6156222e-06
36257965	hif1	pep	36257965	6	190	@TERM$1	@TERM$2	we integrate these approaches to identify over two hundred genes directly and functionally upregulated by  @TERM$1  including the  @TERM$2  carboxykinase pck1 a ratelimiting mediator of gluconeogenesis	0.9999982	1.7971731e-06
36257965	hif1	pep carboxykinase pck1	36257965	6	190	@TERM$1	@TERM$2	we integrate these approaches to identify over two hundred genes directly and functionally upregulated by  @TERM$1  including the  @TERM$2  a ratelimiting mediator of gluconeogenesis	0.99999857	1.3921269e-06
36257965	pep	pck1	36257965	6	190	@TERM$1	@TERM$2	we integrate these approaches to identify over two hundred genes directly and functionally upregulated by hif1 including the  @TERM$1  carboxykinase  @TERM$2  a ratelimiting mediator of gluconeogenesis	0.99999714	2.8034244e-06
36257965	hif1	pep carboxykinase	36257965	6	190	@TERM$1	@TERM$2	we integrate these approaches to identify over two hundred genes directly and functionally upregulated by  @TERM$1  including the  @TERM$2  pck1 a ratelimiting mediator of gluconeogenesis	0.9999975	2.46946e-06
36257965	egl9	hif1	36257965	5	115	@TERM$1	@TERM$2	we use rnaseq and chipseq under aerobic conditions to analyze mutants lacking  @TERM$1  a key negative regulator of  @TERM$2 	0.9999981	1.8670594e-06
36257965	atp	oxphos	36257965	10	205	@TERM$1	@TERM$2	in addition to reducing energy  @TERM$1  production by impairing oxidative phosphorylation  @TERM$2  hypoxia and subsequent reoxygenation also create oxidative stress by generating toxic reactive oxygen species ros	0.9999695	3.050246e-05
36257965	reactive oxygen species	ros	36257965	10	205	@TERM$1	@TERM$2	in addition to reducing energy atp production by impairing oxidative phosphorylation oxphos hypoxia and subsequent reoxygenation also create oxidative stress by generating toxic  @TERM$1   @TERM$2 	0.9999938	6.1714936e-06
36257965	hydroxylase	hypoxiainducible factor	36257965	12	206	@TERM$1	@TERM$2	under aerobic normoxic conditions a prolyl  @TERM$1  senses oxygen and uses it to covalently modify and negatively regulate  @TERM$2  hif the transcriptional effector3 of the pathway fig1a	0.99999785	2.1888186e-06
36257965	hif1	egl9	36257965	30	81	@TERM$1	@TERM$2	 @TERM$1  is hydroxylated by  @TERM$2  ubiquitinated by vhl1 and degraded by the proteasome	0.999997	2.925619e-06
36257965	egl9	vhl1	36257965	30	81	@TERM$1	@TERM$2	hif1 is hydroxylated by  @TERM$1  ubiquitinated by  @TERM$2  and degraded by the proteasome	0.9999981	1.9511515e-06
36257965	hif1	vhl1	36257965	30	81	@TERM$1	@TERM$2	 @TERM$1  is hydroxylated by egl9 ubiquitinated by  @TERM$2  and degraded by the proteasome	0.99999726	2.7500669e-06
36257965	egl9	hif1 binding sites	36257965	26	178	@TERM$1	@TERM$2	g graph of log2 fold change in expression for individual genes in  @TERM$1  mutants relative to wild type versus the number of  @TERM$2  for those genes identified by chipseq	0.9999739	2.6083388e-05
36257965	log2	egl9	36257965	26	178	@TERM$1	@TERM$2	g graph of  @TERM$1  fold change in expression for individual genes in  @TERM$2  mutants relative to wild type versus the number of hif1 binding sites for those genes identified by chipseq	0.9999969	3.0856077e-06
36257965	log2	hif1	36257965	26	178	@TERM$1	@TERM$2	g graph of  @TERM$1  fold change in expression for individual genes in egl9 mutants relative to wild type versus the number of  @TERM$2  binding sites for those genes identified by chipseq	0.99999833	1.6411241e-06
36257965	egl9	hif1	36257965	26	178	@TERM$1	@TERM$2	g graph of log2 fold change in expression for individual genes in  @TERM$1  mutants relative to wild type versus the number of  @TERM$2  binding sites for those genes identified by chipseq	0.99999774	2.271128e-06
36257965	log2	hif1 binding sites	36257965	26	178	@TERM$1	@TERM$2	g graph of  @TERM$1  fold change in expression for individual genes in egl9 mutants relative to wild type versus the number of  @TERM$2  for those genes identified by chipseq	0.9999987	1.2752455e-06
36257965	log2	egl9	36257965	23	141	@TERM$1	@TERM$2	e volcano plot of rnaseq fdr values versus  @TERM$1  foldchange expression for individual genes blue squares in  @TERM$2  mutants relative to wild type	0.99999785	2.1918643e-06
36257965	hif1	egl9	36257965	17	81	@TERM$1	@TERM$2	 @TERM$1  is hydroxylated by  @TERM$2  ubiquitinated by vhl1 and degraded by the proteasome	0.99999857	1.4442378e-06
36257965	egl9	vhl1	36257965	17	81	@TERM$1	@TERM$2	hif1 is hydroxylated by  @TERM$1  ubiquitinated by  @TERM$2  and degraded by the proteasome	0.9999988	1.2321456e-06
36257965	hif1	vhl1	36257965	17	81	@TERM$1	@TERM$2	 @TERM$1  is hydroxylated by egl9 ubiquitinated by  @TERM$2  and degraded by the proteasome	0.99999845	1.5328533e-06
36257965	hif	longterm	36257965	15	177	@TERM$1	@TERM$2	activation of  @TERM$1  minimizes damage from acute hypoxia however  @TERM$2  adaptations and tissue remodeling triggered by the hypoxia response pathway itself can be detrimental45fig	0.99999857	1.3997204e-06
36257965	prolyl	hydroxylase	36257965	13	116	@TERM$1	@TERM$2	when hypoxia ensues the  @TERM$1   @TERM$2  is inhibited due to lack of oxygen resulting in the disinhibition of hif	0.9999981	1.8985097e-06
36257965	prolyl	hypoxiainducible factor	36257965	12	206	@TERM$1	@TERM$2	under aerobic normoxic conditions a  @TERM$1  hydroxylase senses oxygen and uses it to covalently modify and negatively regulate  @TERM$2  hif the transcriptional effector3 of the pathway fig1a	0.9999987	1.2572731e-06
36257965	prolyl	hydroxylase	36257965	12	206	@TERM$1	@TERM$2	under aerobic normoxic conditions a  @TERM$1   @TERM$2  senses oxygen and uses it to covalently modify and negatively regulate hypoxiainducible factor hif the transcriptional effector3 of the pathway fig1a	0.99999857	1.4576655e-06
36257965	hydroxylase	egl9	36257965	50	238	@TERM$1	@TERM$2	these nematodes employ single orthologs of the conserved hypoxia response pathway the prolyl  @TERM$1  ortholog  @TERM$2  and the hif ortholog hif1 with viable null mutants in hif1 and egl9 showing altered sensitivity to hypoxic stress32632	0.9999982	1.8225834e-06
36257965	bps	hif1	36257965	131	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment log2 of each indicated transcription factor bound within 400 @TERM$1  of a  @TERM$2  binding site chipseq peak center	0.99999785	2.1289668e-06
36257965	hif1 binding sites	hif1	36257965	127	231	@TERM$1	@TERM$2	the top violin plot indicates all  @TERM$1  whereas the middle green and bottom red violin plots indicate only the functional  @TERM$2  binding sites identified by beta alone or the combined loa and beta approaches respectively	0.9999982	1.7772691e-06
36257965	hif1	red	36257965	127	231	@TERM$1	@TERM$2	the top violin plot indicates all  @TERM$1  binding sites whereas the middle green and bottom  @TERM$2  violin plots indicate only the functional hif1 binding sites identified by beta alone or the combined loa and beta approaches respectively	0.9999982	1.7993787e-06
36257965	hif1 binding sites	red	36257965	127	231	@TERM$1	@TERM$2	the top violin plot indicates all  @TERM$1  whereas the middle green and bottom  @TERM$2  violin plots indicate only the functional hif1 binding sites identified by beta alone or the combined loa and beta approaches respectively	0.9999975	2.4571432e-06
36257965	hif1binding sites	bps	36257965	126	199	@TERM$1	@TERM$2	i violin plot of histogram counting the number of  @TERM$1  chipseq peaks against the number of other transcription factors tfs known to bind to each sites region of the genome within 400 @TERM$2 	0.99999857	1.436959e-06
36257965	hif1	magenta	36257965	119	143	@TERM$1	@TERM$2	fluorescence from mcherry used as an internal control in which fluorescence is not expected to change as it is not regulated by  @TERM$1  is  @TERM$2 	0.99999833	1.6164976e-06
36257965	hif1	peak	36257965	108	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment log2 of each indicated transcription factor bound within 400bps of a  @TERM$1  binding site chipseq  @TERM$2  center	0.9999939	6.118762e-06
36257965	bps	peak	36257965	108	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment log2 of each indicated transcription factor bound within 400 @TERM$1  of a hif1 binding site chipseq  @TERM$2  center	0.9999976	2.4043613e-06
36257965	log2	bps	36257965	108	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment  @TERM$1  of each indicated transcription factor bound within 400 @TERM$2  of a hif1 binding site chipseq peak center	0.9999987	1.3510728e-06
36257965	log2	peak	36257965	108	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment  @TERM$1  of each indicated transcription factor bound within 400bps of a hif1 binding site chipseq  @TERM$2  center	0.99999857	1.4501752e-06
36257965	log2	hif1	36257965	108	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment  @TERM$1  of each indicated transcription factor bound within 400bps of a  @TERM$2  binding site chipseq peak center	0.9999962	3.839424e-06
36257965	bps	hif1	36257965	108	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment log2 of each indicated transcription factor bound within 400 @TERM$1  of a  @TERM$2  binding site chipseq peak center	0.9999981	1.9600438e-06
36257965	hif1 binding sites	hif1	36257965	104	231	@TERM$1	@TERM$2	the top violin plot indicates all  @TERM$1  whereas the middle green and bottom red violin plots indicate only the functional  @TERM$2  binding sites identified by beta alone or the combined loa and beta approaches respectively	0.99999774	2.2341314e-06
36257965	hif1	red	36257965	104	231	@TERM$1	@TERM$2	the top violin plot indicates all  @TERM$1  binding sites whereas the middle green and bottom  @TERM$2  violin plots indicate only the functional hif1 binding sites identified by beta alone or the combined loa and beta approaches respectively	0.9999976	2.4277274e-06
36257965	hif1 binding sites	red	36257965	104	231	@TERM$1	@TERM$2	the top violin plot indicates all  @TERM$1  whereas the middle green and bottom  @TERM$2  violin plots indicate only the functional hif1 binding sites identified by beta alone or the combined loa and beta approaches respectively	0.99999785	2.1846415e-06
36257965	hif1binding sites	bps	36257965	103	199	@TERM$1	@TERM$2	i violin plot of histogram counting the number of  @TERM$1  chipseq peaks against the number of other transcription factors tfs known to bind to each sites region of the genome within 400 @TERM$2 	0.9999988	1.2231283e-06
36257965	hif1	magenta	36257965	96	143	@TERM$1	@TERM$2	fluorescence from mcherry used as an internal control in which fluorescence is not expected to change as it is not regulated by  @TERM$1  is  @TERM$2 	0.99999857	1.3782959e-06
36257965	log2	hif1	36257965	131	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment  @TERM$1  of each indicated transcription factor bound within 400bps of a  @TERM$2  binding site chipseq peak center	0.9999912	8.80676e-06
36257965	hif1	sitesa	36257965	87	120	@TERM$1	@TERM$2	2characterizing  @TERM$1  binding  @TERM$2  diagram of the pck1 locus and the different promoters used to drive venus expression	0.99999607	3.9038378e-06
36257965	log2	peak	36257965	131	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment  @TERM$1  of each indicated transcription factor bound within 400bps of a hif1 binding site chipseq  @TERM$2  center	0.99999905	9.680682e-07
36257965	bps	peak	36257965	131	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment log2 of each indicated transcription factor bound within 400 @TERM$1  of a hif1 binding site chipseq  @TERM$2  center	0.9999912	8.80676e-06
36257965	log2	egl9	36257965	155	231	@TERM$1	@TERM$2	on the other side of each pathway arrow below for most arrows except gluconeogenesis differentially colored boxes indicate metabolites levels  @TERM$1  fold change in  @TERM$2  mutants relative to wildtype metabolites are labeled in red text	0.99999607	3.9038378e-06
36257965	log2	egl9	36257965	154	124	@TERM$1	@TERM$2	ored boxes indicate enzyme mrna expression levels  @TERM$1  fold change in  @TERM$2  mutants relative to wild type enzymes are labeled	0.99999905	9.680682e-07
36257965	3hif1	hif1	36257965	150	93	@TERM$1	@TERM$2	 @TERM$1  reprograms metabolisma overview of major metabolic pathways impacted by  @TERM$2  activation	0.99969685	0.00030317943
36257965	hif1	carbohydrates	36257965	148	228	@TERM$1	@TERM$2	we observed differences p005 in the levels for 175 metabolites with  @TERM$1  activation resulting in elevated levels of various amino acids  @TERM$2  lipids and nucleotides suggesting changes in multiple metabolic pathways fig	0.9999728	2.718507e-05
36257965	hif1	sulfur	36257965	146	169	@TERM$1	@TERM$2	2a bfor the 216 direct targets upregulated by  @TERM$1  go terms for glycolysis gluconeogenesis amino acid metabolism  @TERM$2  oxidation fatty acid betaoxidation and oxidationr	0.9999902	9.806949e-06
36257965	sulfur	fatty	36257965	146	123	@TERM$1	@TERM$2	 glycolysis gluconeogenesis amino acid metabolism  @TERM$1  oxidation  @TERM$2  acid betaoxidation and oxidationreduction metaboli	0.99967825	0.00032178243
36257965	hif1	fatty	36257965	146	185	@TERM$1	@TERM$2	2a bfor the 216 direct targets upregulated by  @TERM$1  go terms for glycolysis gluconeogenesis amino acid metabolism sulfur oxidation  @TERM$2  acid betaoxidation and oxidationreduction metabol	0.9999963	3.6634647e-06
36257965	zinc	hif1	36257965	144	197	@TERM$1	@TERM$2	by contrast sites bound by pqm1 a  @TERM$1  finger transcriptional antagonist of daf16foxo were underrepresented near  @TERM$2  sites consistent with the increased hypoxia survival observed in pqm1 mutants45	0.9999976	2.374295e-06
36257965	daf16foxo	hif1	36257965	144	197	@TERM$1	@TERM$2	by contrast sites bound by pqm1 a zinc finger transcriptional antagonist of  @TERM$1  were underrepresented near  @TERM$2  sites consistent with the increased hypoxia survival observed in pqm1 mutants45	0.9999975	2.4961614e-06
36257965	pqm1	daf16foxo	36257965	144	197	@TERM$1	@TERM$2	by contrast sites bound by  @TERM$1  a zinc finger transcriptional antagonist of  @TERM$2  were underrepresented near hif1 sites consistent with the increased hypoxia survival observed in pqm1 mutants45	0.9999945	5.4500374e-06
36257965	pqm1	zinc	36257965	144	197	@TERM$1	@TERM$2	by contrast sites bound by  @TERM$1  a  @TERM$2  finger transcriptional antagonist of daf16foxo were underrepresented near hif1 sites consistent with the increased hypoxia survival observed in pqm1 mutants45	0.9999968	3.2416672e-06
36257965	pqm1	hif1	36257965	144	197	@TERM$1	@TERM$2	by contrast sites bound by  @TERM$1  a zinc finger transcriptional antagonist of daf16foxo were underrepresented near  @TERM$2  sites consistent with the increased hypoxia survival observed in pqm1 mutants45	0.99996746	3.254655e-05
36257965	zinc	daf16foxo	36257965	144	197	@TERM$1	@TERM$2	by contrast sites bound by pqm1 a  @TERM$1  finger transcriptional antagonist of  @TERM$2  were underrepresented near hif1 sites consistent with the increased hypoxia survival observed in pqm1 mutants45	0.9999945	5.4636043e-06
36257965	skn1	nrf2	36257965	143	178	@TERM$1	@TERM$2	sites bound by  @TERM$1  the c elegans  @TERM$2  ortholog that promotes an antioxidant response44 were also enriched suggesting shared targets between the hypoxia and antioxidant responses	0.99999774	2.2897268e-06
36257965	aha1	hif1	36257965	141	52	@TERM$1	@TERM$2	 @TERM$1  binding sites were enriched near  @TERM$2  sites fig	0.99999654	3.480156e-06
36257965	hif1	peak	36257965	131	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment log2 of each indicated transcription factor bound within 400bps of a  @TERM$1  binding site chipseq  @TERM$2  center	0.99999833	1.631306e-06
36257965	log2	bps	36257965	131	148	@TERM$1	@TERM$2	j graph of the fold change in enrichment  @TERM$1  of each indicated transcription factor bound within 400 @TERM$2  of a hif1 binding site chipseq peak center	0.9999944	5.5619935e-06
36257965	nac	pck1	36257965	218	225	@TERM$1	@TERM$2	the antioxidants glycolate and  @TERM$1 etyl cysteine nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued hif1 and  @TERM$2  mutants for survival during hypoxia fig	0.9999937	6.3010334e-06
36257965	hif1	pck1	36257965	87	120	@TERM$1	@TERM$2	2characterizing  @TERM$1  binding sitesa diagram of the  @TERM$2  locus and the different promoters used to drive venus expression	0.99998724	1.2787231e-05
36257965	hres	hif1	36257965	86	88	@TERM$1	@TERM$2	4b showing that  @TERM$1  are required in vivo for  @TERM$2  to regulate target gene expressionfig	0.99999654	3.4227264e-06
36257965	hif1	pck1	36257965	54	92	@TERM$1	@TERM$2	 @TERM$1  working through  @TERM$2  promotes survival in response to both oxidative and hypoxic stress	0.99999774	2.30208e-06
36257965	hif1	pck1	36257965	53	203	@TERM$1	@TERM$2	whereas the role of hif in promoting glycolysis is well appreciated we find that  @TERM$1  also promotes gluconeogenesis and the generation of antioxidants through the activation of the  @TERM$2  pep carboxykinase	0.99999416	5.7887387e-06
36257965	hif	hif1	36257965	53	203	@TERM$1	@TERM$2	whereas the role of  @TERM$1  in promoting glycolysis is well appreciated we find that  @TERM$2  also promotes gluconeogenesis and the generation of antioxidants through the activation of the pck1 pep carboxykinase	0.999998	2.0442546e-06
36257965	pck1	pep carboxykinase	36257965	53	203	@TERM$1	@TERM$2	whereas the role of hif in promoting glycolysis is well appreciated we find that hif1 also promotes gluconeogenesis and the generation of antioxidants through the activation of the  @TERM$1   @TERM$2 	0.99999774	2.2799604e-06
36257965	hif	pep	36257965	53	203	@TERM$1	@TERM$2	whereas the role of  @TERM$1  in promoting glycolysis is well appreciated we find that hif1 also promotes gluconeogenesis and the generation of antioxidants through the activation of the pck1  @TERM$2  carboxykinase	0.99999726	2.7628216e-06
36257965	hif1	pep	36257965	53	203	@TERM$1	@TERM$2	whereas the role of hif in promoting glycolysis is well appreciated we find that  @TERM$1  also promotes gluconeogenesis and the generation of antioxidants through the activation of the pck1  @TERM$2  carboxykinase	0.9999974	2.668636e-06
36257965	pck1	pep	36257965	53	203	@TERM$1	@TERM$2	whereas the role of hif in promoting glycolysis is well appreciated we find that hif1 also promotes gluconeogenesis and the generation of antioxidants through the activation of the  @TERM$1   @TERM$2  carboxykinase	0.9999969	3.1209884e-06
36257965	hif	pck1 pep carboxykinase	36257965	53	203	@TERM$1	@TERM$2	whereas the role of  @TERM$1  in promoting glycolysis is well appreciated we find that hif1 also promotes gluconeogenesis and the generation of antioxidants through the activation of the  @TERM$2 	0.999998	2.0219109e-06
36257965	hif	pck1	36257965	53	203	@TERM$1	@TERM$2	whereas the role of  @TERM$1  in promoting glycolysis is well appreciated we find that hif1 also promotes gluconeogenesis and the generation of antioxidants through the activation of the  @TERM$2  pep carboxykinase	0.99999785	2.1163512e-06
36257965	hif	pep carboxykinase	36257965	53	203	@TERM$1	@TERM$2	whereas the role of  @TERM$1  in promoting glycolysis is well appreciated we find that hif1 also promotes gluconeogenesis and the generation of antioxidants through the activation of the pck1  @TERM$2 	0.99999666	3.3511903e-06
36257965	hif1	pck1 pep carboxykinase	36257965	53	203	@TERM$1	@TERM$2	whereas the role of hif in promoting glycolysis is well appreciated we find that  @TERM$1  also promotes gluconeogenesis and the generation of antioxidants through the activation of the  @TERM$2 	0.99983156	0.00016838584
36257965	hif1	pep carboxykinase	36257965	53	203	@TERM$1	@TERM$2	whereas the role of hif in promoting glycolysis is well appreciated we find that  @TERM$1  also promotes gluconeogenesis and the generation of antioxidants through the activation of the pck1  @TERM$2 	0.9999975	2.4922367e-06
36257965	hif1	hif	36257965	52	219	@TERM$1	@TERM$2	 @TERM$1  is constitutively active in egl9sa307 mutants which we use here in an integrated genomic transcriptomic and metabolomic approach to obtain a holistic and functional description of  @TERM$2  activation in an intact animal	0.9999976	2.3338944e-06
36257965	sitesa	pck1	36257965	87	120	@TERM$1	@TERM$2	2characterizing hif1 binding  @TERM$1  diagram of the  @TERM$2  locus and the different promoters used to drive venus expression	0.99999714	2.8466893e-06
36257965	hif1	antigfp antibodies	36257965	60	192	@TERM$1	@TERM$2	conditionsto identify genes directly regulated by  @TERM$1  we performed chipseq on l4stage prefertile egl9sa307 hif1ia4 odis131hif1gfp animals using  @TERM$2  and highthroughput sequencin	0.9999981	1.932741e-06
36257965	hif1 chipseq	peak	36257965	84	125	@TERM$1	@TERM$2	n which either the complete sequence encoding the  @TERM$1   @TERM$2  was removed peak the 6bp core hre in the peak was delete	0.9999956	4.4274957e-06
36257965	hif1	peak	36257965	84	117	@TERM$1	@TERM$2	n which either the complete sequence encoding the  @TERM$1  chipseq  @TERM$2  was removed peak the 6bp core hre in the peak wa	0.9999919	8.1182425e-06
36257965	egl9	hif1	36257965	82	192	@TERM$1	@TERM$2	elevated levels of venus fluorescence were observed from the transgenes in  @TERM$1  mutants in which  @TERM$2  is active compared to wild type and egl9 hif1 double mutants in which hif1 is inactive fig	0.99999726	2.7058718e-06
36257965	pck1	pep carboxykinase	36257965	81	78	@TERM$1	@TERM$2	4a for one novel target  @TERM$1   @TERM$2  and one established target rhy1	0.9999988	1.2277375e-06
36257965	pck1	pep	36257965	81	78	@TERM$1	@TERM$2	4a for one novel target  @TERM$1   @TERM$2  carboxykinase and one established target rhy1	0.9999976	2.3753505e-06
36257965	hif1	hif1 binding sites	36257965	78	238	@TERM$1	@TERM$2	two key negative regulators of  @TERM$1  rhy1 and egl928 contained some of the highest numbers of  @TERM$2  and were dramatically upregulated by hif1 indicating a strong negative feedback loop as part of the response supplementary fig	0.9999962	3.850252e-06
36257965	egl9	combo 2	36257965	71	215	@TERM$1	@TERM$2	we reasoned that the highest confidence hif1regulated degs would be enriched in the intersection of  @TERM$1  mutants compared to wild type loa combo 1 and in egl9 mutants compared to egl9 hif1 double mutants loa  @TERM$2 	0.99999475	5.286915e-06
36257965	egl9	hif1	36257965	71	215	@TERM$1	@TERM$2	we reasoned that the highest confidence  @TERM$2 regulated degs would be enriched in the intersection of  @TERM$1  mutants compared to wild type loa combo 1 and in egl9 mutants compared to egl9 hif1 double mutants loa combo 2	0.99999356	6.41651e-06
36257965	hif1	combo 2	36257965	71	215	@TERM$1	@TERM$2	we reasoned that the highest confidence  @TERM$1 regulated degs would be enriched in the intersection of egl9 mutants compared to wild type loa combo 1 and in egl9 mutants compared to egl9 hif1 double mutants loa  @TERM$2 	0.99999833	1.6524599e-06
36257965	hif1	hif1 binding sites	36257965	63	165	@TERM$1	@TERM$2	we therefore performed rnaseq to analyze differential gene expression due to  @TERM$1  activation using these data to identify hif1regulated genes near  @TERM$2 	0.9999949	5.1725774e-06
36257965	egl9	hif1	36257965	56	82	@TERM$1	@TERM$2	using an  @TERM$1  null mutant background to activate  @TERM$2  under aerobic conditions fig	0.99999666	3.3126025e-06
36257965	glycolate	cysteine	36257965	218	225	@TERM$1	@TERM$2	the antioxidants  @TERM$1  and nacetyl  @TERM$2  nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued hif1 and pck1 mutants for survival during hypoxia fig	0.99999714	2.9041173e-06
36257965	hif1	pck1	36257965	213	108	@TERM$1	@TERM$2	however both  @TERM$1  and  @TERM$2  single mutants were significantly susceptible to hypoxia compared to wildtype fig	0.99999607	3.946225e-06
36257965	glycolate	nac	36257965	218	225	@TERM$1	@TERM$2	the antioxidants  @TERM$1  and  @TERM$2 etyl cysteine nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued hif1 and pck1 mutants for survival during hypoxia fig	0.9999883	1.1666938e-05
36257965	hif1	or3350	36257965	389	129	@TERM$1	@TERM$2	mber of instances these peaks overlapped with the  @TERM$1  chipseq peaks for  @TERM$2  we developed an r script that is available at htt	0.9999826	1.7417273e-05
36257965	hif1 chipseq	or3350	36257965	389	135	@TERM$1	@TERM$2	mber of instances these peaks overlapped with the  @TERM$1  peaks for  @TERM$2  we developed an r script that is available at httpsgith	0.9999981	1.8662156e-06
36257965	pck1	pep	36257965	398	189	@TERM$1	@TERM$2	 drawn from five independent biological trialsthe  @TERM$1  null mutants were viable under aerobic conditions most likely because two other  @TERM$2  carboxykinases pck2 and pck3 compensate for baseli	0.99999666	3.298304e-06
36257965	pck1	pep carboxykinases	36257965	398	199	@TERM$1	@TERM$2	 drawn from five independent biological trialsthe  @TERM$1  null mutants were viable under aerobic conditions most likely because two other  @TERM$2  pck2 and pck3 compensate for baseline functio	0.99999356	6.4239616e-06
36257965	pep	pck2	36257965	398	114	@TERM$1	@TERM$2	 aerobic conditions most likely because two other  @TERM$1  carboxykinases  @TERM$2  and pck3 compensate for baseline functio	0.9999975	2.5269103e-06
36257965	idr	modencode	36257965	388	203	@TERM$1	@TERM$2	odel streme cutoff of 005binding site coordinates  @TERM$1  thresholded peaks fdr001 for all transcription factors for which chipseq was conducted at the l4 stage were obtained from the  @TERM$2  repository3	0.99999595	4.0854043e-06
36257965	pep carboxykinases	pck2	36257965	398	114	@TERM$1	@TERM$2	 aerobic conditions most likely because two other  @TERM$1   @TERM$2  and pck3 compensate for baseline functio	0.9999976	2.3486823e-06
36257965	pck1	hif1induced	36257965	399	189	@TERM$1	@TERM$2	neither pck2 nor pck3 showed hif1dependent regulation suggesting  @TERM$1  is a specific  @TERM$2  isoformfor hypoxia starvation m9 solution was preequilibrated with 05 o2 for at least an hour	0.99999475	5.256047e-06
36257965	pck2	hif1induced	36257965	399	189	@TERM$1	@TERM$2	neither  @TERM$1  nor pck3 showed hif1dependent regulation suggesting pck1 is a specific  @TERM$2  isoformfor hypoxia starvation m9 solution was preequilibrated with 05 o2 for at least an hour	0.99999523	4.7492786e-06
36257965	pck2	pck1	36257965	399	189	@TERM$1	@TERM$2	neither  @TERM$1  nor pck3 showed hif1dependent regulation suggesting  @TERM$2  is a specific hif1induced isoformfor hypoxia starvation m9 solution was preequilibrated with 05 o2 for at least an hour	0.99999654	3.4284435e-06
36257965	fudr	vwr 102573230	36257965	402	157	@TERM$1	@TERM$2	 @TERM$1  5fluoro2deoxyuridine  @TERM$2  was added at a final concentration of 50m to prevent the production of progeny which would interfere with the assay	0.9999974	2.633765e-06
36257965	fudr	5fluoro2deoxyuridine	36257965	402	157	@TERM$1	@TERM$2	 @TERM$1   @TERM$2  vwr 102573230 was added at a final concentration of 50m to prevent the production of progeny which would interfere with the assay	0.99999607	3.8939024e-06
36257965	5fluoro2deoxyuridine	vwr 102573230	36257965	402	157	@TERM$1	@TERM$2	fudr  @TERM$1   @TERM$2  was added at a final concentration of 50m to prevent the production of progeny which would interfere with the assay	0.9999957	4.2370893e-06
36257965	glycolate	sodium pyruvate	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm  @TERM$1  sigma cds000626  @TERM$2  sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.9999968	3.188541e-06
36257965	pyruvate	pep	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium  @TERM$1  sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic  @TERM$2  acid trisodium salt vwr ic15187283	0.99998295	1.7047494e-05
36257965	pck1	pck2	36257965	398	199	@TERM$1	@TERM$2	 drawn from five independent biological trialsthe  @TERM$1  null mutants were viable under aerobic conditions most likely because two other pep carboxykinases  @TERM$2  and pck3 compensate for baseline functio	0.99999607	3.9477463e-06
36257965	sigma a7250	salt	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium pyruvate sigma p2256 nacetyllcysteine  @TERM$1  or phosphoenol pyruvic pep acid trisodium  @TERM$2  vwr ic15187283	0.99999774	2.2316271e-06
36257965	hif1	peak	36257965	387	172	@TERM$1	@TERM$2	the  @TERM$1   @TERM$2 gene combinations identified this way were labeled beta onlythe sequences for the middle of each chipseq peak  100bp repeat masked with n were extracted from 	0.9999932	6.772964e-06
36257965	egl9	hif1	36257965	380	109	@TERM$1	@TERM$2	tion from a comparison from a separate experiment  @TERM$1   @TERM$2  double mutants vs egl9 single mutants affected in	0.9999976	2.3313962e-06
36257965	protease inhibitor	dtt	36257965	331	186	@TERM$1	@TERM$2	 @TERM$1 s roche cat11697498001 complete protease inhibitor cocktail tablet 125l 100mm pmsf and 25l 1m  @TERM$2  per 25ml fa buffer was added and samples were then transferred 	0.9999814	1.8560984e-05
36257965	pmsf	dtt	36257965	331	123	@TERM$1	@TERM$2	 protease inhibitor cocktail tablet 125l 100mm  @TERM$1  and 25l 1m  @TERM$2  per 25ml fa buffer was added and samples were the	0.99999833	1.6259056e-06
36257965	protease inhibitor	inhibitor	36257965	331	127	@TERM$1	@TERM$2	 @TERM$1 s roche cat11697498001 complete protease  @TERM$2  cocktail tablet 125l 100mm pmsf and 25l 1m dtt per 2	0.9974137	0.0025862935
36257965	protease	pmsf	36257965	331	207	@TERM$1	@TERM$2	 thawed on ice and 750ml of fa buffer containing  @TERM$1  inhibitors roche cat11697498001 complete protease inhibitor cocktail tablet 125l 100mm  @TERM$2  and 25l 1m dtt per 25ml fa buffer was added and s	0.999998	2.0789653e-06
36257965	inhibitor	dtt	36257965	331	168	@TERM$1	@TERM$2	 @TERM$1 s roche cat11697498001 complete protease inhibitor cocktail tablet 125l 100mm pmsf and 25l 1m  @TERM$2  per 25ml fa buffer was added and samples were then tra	0.9999974	2.6239973e-06
36257965	protease	protease inhibitor	36257965	331	168	@TERM$1	@TERM$2	 thawed on ice and 750ml of fa buffer containing  @TERM$1  inhibitors roche cat11697498001 complete  @TERM$2  cocktail tablet 125l 100mm pmsf and 25l 1m 	0.99999833	1.6280173e-06
36257965	protease inhibitor	tablet	36257965	331	146	@TERM$1	@TERM$2	 @TERM$1 s roche cat11697498001 complete protease inhibitor cocktail  @TERM$2  125l 100mm pmsf and 25l 1m dtt per 25ml fa buffer was 	0.99999726	2.7765066e-06
36257965	formaldehyde	tris	36257965	334	113	@TERM$1	@TERM$2	samples were crosslinked with 2  @TERM$1  for 30min at room temperature and then quenched with 1m  @TERM$2  ph 75	0.9999974	2.6272023e-06
36257965	antigfp antibodies	gifts	36257965	335	203	@TERM$1	@TERM$2	samples were then sonicated to shear chromatin into 200800bp dna fragmentsfor each sample 4mg of protein lysate was immunoprecipitated using 15g  @TERM$1   @TERM$2  of tony hyman and kevin white	0.9999943	5.68681e-06
36257965	idr	combo 2	36257965	384	173	@TERM$1	@TERM$2	the input files consisted ofbed files of  @TERM$1  thresholded peaks and differential expression log2fc and fdr values for the overlap intersection between loa combo 1 and  @TERM$2 	0.99999416	5.883701e-06
36257965	proteinase k	sds	36257965	348	177	@TERM$1	@TERM$2	chromatin input samples were incubated at 60c with mild shaking overnight following the addition of  @TERM$1  and  @TERM$2  to final concentrations of 01mgml and 001 respectively	0.99998546	1.4515683e-05
36257965	proteinase k	rnasea	36257965	350	126	@TERM$1	@TERM$2	 @TERM$1  was added to each ip and incubated at 50c for 2h  @TERM$2  was added to the chromatin input to a concentration of 	0.999997	3.0168273e-06
36257965	proteinase	rnasea	36257965	350	124	@TERM$1	@TERM$2	 @TERM$1  k was added to each ip and incubated at 50c for 2h  @TERM$2  was added to the chromatin input to a concentration o	0.9999969	3.0552192e-06
36257965	idr	peak	36257965	361	95	@TERM$1	@TERM$2	 @TERM$2 s above an irreproducibility discovery rate  @TERM$1  of 01 were used to generate final peak sets	0.9999968	3.163818e-06
36257965	egl9	hif1	36257965	375	128	@TERM$1	@TERM$2	 all four of the following pairwise comparisons 1  @TERM$1  vs n2 2 egl9 vs egl9  @TERM$2  3 odis131 egl9 vs n2 4 odis131 egl9 vs egl9 hif	0.99998736	1.2608257e-05
36257965	geo	egl9	36257965	376	177	@TERM$1	@TERM$2	rnaseq datasets are available at nihncbi  @TERM$1  through accession number gse173581two pairwise rnaseq comparisons wildtype vs  @TERM$2  single mutants and wild type vs egl9 hif1 double 	0.9999981	1.8995673e-06
36257965	geo	hif1	36257965	376	219	@TERM$1	@TERM$2	rnaseq datasets are available at nihncbi  @TERM$1  through accession number gse173581two pairwise rnaseq comparisons wildtype vs egl9 single mutants and wild type vs egl9  @TERM$2  double mutants rescued by the odis131 transgene w	0.9999949	5.1063066e-06
36257965	egl9	hif1	36257965	376	146	@TERM$1	@TERM$2	173581two pairwise rnaseq comparisons wildtype vs  @TERM$1  single mutants and wild type vs egl9  @TERM$2  double mutants rescued by the odis131 transgene w	0.9999969	3.144066e-06
36257965	egl9	hif1	36257965	377	237	@TERM$1	@TERM$2	taking a conditional approach the information from the first comparison wildtype vs  @TERM$1  single mutants was examined to see if it affected interpretation in the second wildtype vs egl9  @TERM$2  double mutants rescued by the odis131 transgene	0.008451699	0.99154836
36257965	proteinase	sds	36257965	348	177	@TERM$1	@TERM$2	chromatin input samples were incubated at 60c with mild shaking overnight following the addition of  @TERM$1  k and  @TERM$2  to final concentrations of 01mgml and 001 respectively	0.03355056	0.96644944
36257965	protease	dtt	36257965	331	226	@TERM$1	@TERM$2	 thawed on ice and 750ml of fa buffer containing  @TERM$1  inhibitors roche cat11697498001 complete protease inhibitor cocktail tablet 125l 100mm pmsf and 25l 1m  @TERM$2  per 25ml fa buffer was added and samples were then tr	0.9999988	1.2231925e-06
36257965	nacetyllcysteine	salt	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium pyruvate sigma p2256  @TERM$1  sigma a7250 or phosphoenol pyruvic pep acid trisodium  @TERM$2  vwr ic15187283	0.9999987	1.2748296e-06
36257965	sigma	nacetyllcysteine	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate  @TERM$1  cds000626 sodium pyruvate sigma p2256  @TERM$2  sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.999998	2.0606692e-06
36257965	sigma	sodium pyruvate	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate  @TERM$1  cds000626  @TERM$2  sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.9999976	2.40024e-06
36257965	sodium pyruvate	phosphoenol pyruvic	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  sigma p2256 nacetyllcysteine sigma a7250 or  @TERM$2  pep acid trisodium salt vwr ic15187283	0.9999962	3.819958e-06
36257965	glycolate	nacetyllcysteine	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm  @TERM$1  sigma cds000626 sodium pyruvate sigma p2256  @TERM$2  sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.9999969	3.0908914e-06
36257965	pyruvate	nacetyllcysteine	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium  @TERM$1  sigma p2256  @TERM$2  sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.99999726	2.784809e-06
36257965	pyruvate	salt	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium  @TERM$1  sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium  @TERM$2  vwr ic15187283	0.9999968	3.1640113e-06
36257965	glycolate	salt	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm  @TERM$1  sigma cds000626 sodium pyruvate sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium  @TERM$2  vwr ic15187283	0.9999981	1.9476006e-06
36257965	nacetyllcysteine	sigma a7250	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium pyruvate sigma p2256  @TERM$1   @TERM$2  or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.99999595	3.99585e-06
36257965	nacetyllcysteine	pep	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium pyruvate sigma p2256  @TERM$1  sigma a7250 or phosphoenol pyruvic  @TERM$2  acid trisodium salt vwr ic15187283	0.99999475	5.216333e-06
36257965	sigma	pyruvate	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate  @TERM$1  cds000626 sodium  @TERM$2  sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.999997	2.9465325e-06
36257965	glycolate	sigma	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm  @TERM$1   @TERM$2  cds000626 sodium pyruvate sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.99999046	9.503953e-06
36257965	glycolate	pep	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm  @TERM$1  sigma cds000626 sodium pyruvate sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic  @TERM$2  acid trisodium salt vwr ic15187283	0.999995	5.0098115e-06
36257965	sodium	nacetyllcysteine	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  pyruvate sigma p2256  @TERM$2  sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.9999964	3.6027564e-06
36257965	gsm5266004	gsm5266005	36257965	465	109	@TERM$1	@TERM$2	the input file for or3350 was gsm5266003 whereas the two replicates for or3350 were  @TERM$1  and  @TERM$2 	0.99999523	4.7141625e-06
36257965	or3350	gsm5266005	36257965	465	109	@TERM$1	@TERM$2	the input file for  @TERM$1  was gsm5266003 whereas the two replicates for or3350 were gsm5266004 and  @TERM$2 	0.9999968	3.2376631e-06
36257965	or3350	gsm5266004	36257965	465	109	@TERM$1	@TERM$2	the input file for  @TERM$1  was gsm5266003 whereas the two replicates for or3350 were  @TERM$2  and gsm5266005	0.99998844	1.1620035e-05
36257965	geo	gse173581	36257965	467	137	@TERM$1	@TERM$2	files for rnaseq datasets are available at nihncbi  @TERM$1  through accession number  @TERM$2  httpswwwncbinlmnihgovgeoqueryacccgiaccgse173580	0.9999794	2.060732e-05
36257965	gsm5271171	gsm5271178	36257965	469	142	@TERM$1	@TERM$2	the files gsm5271170  @TERM$1   @TERM$2  and gsm5271179 contain data for four independent biological replicates for hif1ia4 mutant nematodes	0.99999607	3.9097617e-06
36257965	gsm5271171	gsm5271179	36257965	469	142	@TERM$1	@TERM$2	the files gsm5271170  @TERM$1  gsm5271178 and  @TERM$2  contain data for four independent biological replicates for hif1ia4 mutant nematodes	0.9999956	4.3592904e-06
36257965	gsm5271178	gsm5271179	36257965	469	142	@TERM$1	@TERM$2	the files gsm5271170 gsm5271171  @TERM$1  and  @TERM$2  contain data for four independent biological replicates for hif1ia4 mutant nematodes	0.9999919	8.055672e-06
36257965	gsm5271172	gsm5271181	36257965	470	144	@TERM$1	@TERM$2	the files  @TERM$1  gsm5271173 gsm5271180 and  @TERM$2  contain data for four independent biological replicates for egl9sa307 mutant nematodes	0.99999607	3.9163224e-06
36257965	superseries	gse173581	36257965	473	68	@TERM$1	@TERM$2	the  @TERM$1  file of the above subfiles is available at  @TERM$2 	0.99999785	2.099401e-06
36257965	phosphoenol pyruvic	pep	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium pyruvate sigma p2256 nacetyllcysteine sigma a7250 or  @TERM$1   @TERM$2  acid trisodium salt vwr ic15187283	0.99999857	1.3856144e-06
36257965	sodium	salt	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  pyruvate sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium  @TERM$2  vwr ic15187283	0.9999987	1.333856e-06
36257965	glycolate	sodium	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm  @TERM$1  sigma cds000626  @TERM$2  pyruvate sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.99999666	3.3948572e-06
36257965	sigma	phosphoenol pyruvic	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate  @TERM$1  cds000626 sodium pyruvate sigma p2256 nacetyllcysteine sigma a7250 or  @TERM$2  pep acid trisodium salt vwr ic15187283	0.9999988	1.2161889e-06
36257965	sigma a7250	pep	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium pyruvate sigma p2256 nacetyllcysteine  @TERM$1  or phosphoenol pyruvic  @TERM$2  acid trisodium salt vwr ic15187283	0.999998	2.0380878e-06
36257965	sodium	sigma a7250	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  pyruvate sigma p2256 nacetyllcysteine  @TERM$2  or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.99999714	2.9158784e-06
36257965	sodium pyruvate	nacetyllcysteine	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  sigma p2256  @TERM$2  sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.9999155	8.446866e-05
36257965	sodium	pep	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  pyruvate sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic  @TERM$2  acid trisodium salt vwr ic15187283	0.9999958	4.138093e-06
36257965	pyruvate	phosphoenol pyruvic	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium  @TERM$1  sigma p2256 nacetyllcysteine sigma a7250 or  @TERM$2  pep acid trisodium salt vwr ic15187283	0.99999845	1.5672581e-06
36257965	sodium pyruvate	sodium	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid tri @TERM$2  salt vwr ic15187283	0.99999785	2.092812e-06
36257965	glycolate	phosphoenol pyruvic	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm  @TERM$1  sigma cds000626 sodium pyruvate sigma p2256 nacetyllcysteine sigma a7250 or  @TERM$2  pep acid trisodium salt vwr ic15187283	0.9999987	1.2998705e-06
36257965	sigma	sigma a7250	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate  @TERM$1  cds000626 sodium pyruvate sigma p2256 nacetyllcysteine  @TERM$2  or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.99999845	1.4950846e-06
36257965	sigma a7250	phosphoenol pyruvic	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium pyruvate sigma p2256 nacetyllcysteine  @TERM$1  or  @TERM$2  pep acid trisodium salt vwr ic15187283	0.99999833	1.7151431e-06
36257965	sigma	salt	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate  @TERM$1  cds000626 sodium pyruvate sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium  @TERM$2  vwr ic15187283	0.9956119	0.0043880655
36257965	phosphoenol pyruvic	salt	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium pyruvate sigma p2256 nacetyllcysteine sigma a7250 or  @TERM$1  pep acid trisodium  @TERM$2  vwr ic15187283	0.99998856	1.1494707e-05
36257965	sigma	sodium	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate  @TERM$1  cds000626  @TERM$2  pyruvate sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.9999863	1.3669669e-05
36257965	sigma	pep	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate  @TERM$1  cds000626 sodium pyruvate sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic  @TERM$2  acid trisodium salt vwr ic15187283	0.99999416	5.8246724e-06
36257965	pep	salt	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium pyruvate sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic  @TERM$1  acid trisodium  @TERM$2  vwr ic15187283	0.99998593	1.4044275e-05
36257965	sodium pyruvate	salt	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium  @TERM$2  vwr ic15187283	0.9999621	3.7957096e-05
36257965	sodium pyruvate	sigma a7250	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  sigma p2256 nacetyllcysteine  @TERM$2  or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.99999774	2.2110783e-06
36257965	glycolate	pyruvate	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm  @TERM$1  sigma cds000626 sodium  @TERM$2  sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.9999819	1.8108323e-05
36257965	sodium pyruvate	pep	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic  @TERM$2  acid trisodium salt vwr ic15187283	0.99999106	8.944054e-06
36257965	pyruvate	sigma a7250	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium  @TERM$1  sigma p2256 nacetyllcysteine  @TERM$2  or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.99996376	3.6256337e-05
36257965	nacetyl cysteine	nac	36257965	218	225	@TERM$1	@TERM$2	the antioxidants glycolate and  @TERM$1   @TERM$2  can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued hif1 and pck1 mutants for survival during hypoxia fig	0.99999857	1.4333211e-06
36257965	sodium	pyruvate	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1   @TERM$2  sigma p2256 nacetyllcysteine sigma a7250 or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.999995	4.950718e-06
36257965	nacetyllcysteine	phosphoenol pyruvic	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626 sodium pyruvate sigma p2256  @TERM$1  sigma a7250 or  @TERM$2  pep acid trisodium salt vwr ic15187283	0.9999981	1.895248e-06
36257965	sodium	phosphoenol pyruvic	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm glycolate sigma cds000626  @TERM$1  pyruvate sigma p2256 nacetyllcysteine sigma a7250 or  @TERM$2  pep acid trisodium salt vwr ic15187283	0.99999654	3.4515851e-06
36257965	inhibitor	pmsf	36257965	331	149	@TERM$1	@TERM$2	 @TERM$1 s roche cat11697498001 complete protease inhibitor cocktail tablet 125l 100mm  @TERM$2  and 25l 1m dtt per 25ml fa buffer was added and sa	0.99999845	1.6072194e-06
36257965	glycolate	sigma a7250	36257965	425	175	@TERM$1	@TERM$2	the supplements included 10mm  @TERM$1  sigma cds000626 sodium pyruvate sigma p2256 nacetyllcysteine  @TERM$2  or phosphoenol pyruvic pep acid trisodium salt vwr ic15187283	0.99999845	1.5319794e-06
36257965	protease	inhibitor	36257965	331	168	@TERM$1	@TERM$2	 thawed on ice and 750ml of fa buffer containing  @TERM$1   @TERM$2 s roche cat11697498001 complete protease inhibitor cocktail tablet 125l 100mm pmsf and 25l 1m 	0.99999857	1.4677998e-06
36257965	pep carboxykinase	hif1a	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in cysteine and glutathione metabolism suggesting that this  @TERM$1  is a key  @TERM$2  regulatory target depending on tissue or contextfig	0.999995	5.04971e-06
36257965	pck2	hif1a	36257965	230	247	@TERM$1	@TERM$2	indeed  @TERM$1  an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in cysteine and glutathione metabolism suggesting that this pep carboxykinase is a key  @TERM$2  regulatory target depending on tissue or contextfig	0.9999914	8.572933e-06
36257965	cysteine	glutathione	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in  @TERM$1  and  @TERM$2  metabolism suggesting that this pep carboxykinase is a key hif1a regulatory target depending on tissue or contextfig	0.9999944	5.6296935e-06
36257965	cysteine	pep carboxykinase	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in  @TERM$1  and glutathione metabolism suggesting that this  @TERM$2  is a key hif1a regulatory target depending on tissue or contextfig	0.9999981	1.946765e-06
36257965	log2	hif1	36257965	232	151	@TERM$1	@TERM$2	fold change in expression expressed as  @TERM$1  is mapped for individual human orthologs rows of the c elegans  @TERM$2  direct targets identified in this study	0.99999666	3.278484e-06
36257965	pck2	red	36257965	236	87	@TERM$1	@TERM$2	d context or tissuedependent expression including  @TERM$1   @TERM$2  arrowhead an ortholog of pck	0.99997246	2.7590577e-05
36257965	sulfur	glutathione	36257965	237	112	@TERM$1	@TERM$2	these latter clusters were enriched for  @TERM$1  and  @TERM$2  metabolism metabolite transport and chromatin mod	0.99999845	1.5876162e-06
36257965	log2	hif1	36257965	238	151	@TERM$1	@TERM$2	fold change in expression expressed as  @TERM$1  is mapped for individual human orthologs rows of the c elegans  @TERM$2  direct targets identified in this study	0.999992	7.960675e-06
36257965	pck2	red	36257965	242	87	@TERM$1	@TERM$2	d context or tissuedependent expression including  @TERM$1   @TERM$2  arrowhead an ortholog of pck	0.9999976	2.3633881e-06
36257965	sulfur	glutathione	36257965	243	112	@TERM$1	@TERM$2	these latter clusters were enriched for  @TERM$1  and  @TERM$2  metabolism metabolite transport and chromatin mod	0.99999654	3.496527e-06
36257965	hif	atp	36257965	244	115	@TERM$1	@TERM$2	to meet the energy needs of an organism in a hypoxic environment  @TERM$1  promotes  @TERM$2  synthesis by promoting glycolysis	0.9999976	2.330207e-06
36257965	glyoxylate	glutathione	36257965	248	148	@TERM$1	@TERM$2	we show here that it directly promotes lipid metabolism the  @TERM$1  cycle gluconeogenesis the ppp h2shcn detoxification and  @TERM$2  synthesis	0.999998	2.072415e-06
36257965	glyoxylate	ppp	36257965	248	148	@TERM$1	@TERM$2	we show here that it directly promotes lipid metabolism the  @TERM$1  cycle gluconeogenesis the  @TERM$2  h2shcn detoxification and glutathione synthesis	0.99999774	2.2093964e-06
36257965	ppp	glutathione	36257965	248	148	@TERM$1	@TERM$2	we show here that it directly promotes lipid metabolism the glyoxylate cycle gluconeogenesis the  @TERM$1  h2shcn detoxification and  @TERM$2  synthesis	0.9999975	2.5572797e-06
36257965	hif	hif1	36257965	249	213	@TERM$1	@TERM$2	abolomic approaches to characterize the action of  @TERM$1  activation in vivoa simple approach to discern true functional targets of transcription factors tfs like  @TERM$2  has been to integrate binding site identification	0.99999833	1.6860837e-06
36257965	egl9	hif1	36257965	258	243	@TERM$1	@TERM$2	degs in a given condition eg wild type versus the  @TERM$1  mutant is informative about the state of the same genes in another similar condition eg wildtype versus the egl9 mutant that also contains a  @TERM$2  mutation and the rescuing hif1gfp transgen	0.99981874	0.00018130051
36257965	pck2	pep carboxykinase	36257965	230	247	@TERM$1	@TERM$2	indeed  @TERM$1  an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in cysteine and glutathione metabolism suggesting that this  @TERM$2  is a key hif1a regulatory target depending on tissue or contextfig	0.9999969	3.1040424e-06
36257965	glutathione	pep	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in cysteine and  @TERM$1  metabolism suggesting that this  @TERM$2  carboxykinase is a key hif1a regulatory target depending on tissue or contextfig	0.9999976	2.3998875e-06
36257965	pck1	pep	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans  @TERM$1  belonged to such a cluster that also included genes involved in cysteine and glutathione metabolism suggesting that this  @TERM$2  carboxykinase is a key hif1a regulatory target depending on tissue or contextfig	0.9999963	3.7176303e-06
36257965	pck1	cysteine	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans  @TERM$1  belonged to such a cluster that also included genes involved in  @TERM$2  and glutathione metabolism suggesting that this pep carboxykinase is a key hif1a regulatory target depending on tissue or contextfig	0.99999714	2.884506e-06
36257965	tablet	pmsf	36257965	331	127	@TERM$1	@TERM$2	t11697498001 complete protease inhibitor cocktail  @TERM$1  125l 100mm  @TERM$2  and 25l 1m dtt per 25ml fa buffer was added and	0.999997	2.9948237e-06
36257965	cysteine	hif1	36257965	218	225	@TERM$1	@TERM$2	the antioxidants glycolate and nacetyl  @TERM$1  nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued  @TERM$2  and pck1 mutants for survival during hypoxia fig	0.99999726	2.6985222e-06
36257965	hif1	pck1	36257965	218	225	@TERM$1	@TERM$2	the antioxidants glycolate and nacetyl cysteine nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued  @TERM$1  and  @TERM$2  mutants for survival during hypoxia fig	0.99999404	6.0124557e-06
36257965	nacetyl cysteine	pck1	36257965	218	225	@TERM$1	@TERM$2	the antioxidants glycolate and  @TERM$1  nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued hif1 and  @TERM$2  mutants for survival during hypoxia fig	0.9999968	3.180405e-06
36257965	cysteine	pck1	36257965	218	225	@TERM$1	@TERM$2	the antioxidants glycolate and nacetyl  @TERM$1  nac can reduce oxidative stress when fed to c elegans5051 and we found that supplementation with these antioxidants rescued hif1 and  @TERM$2  mutants for survival during hypoxia fig	0.99999833	1.7055488e-06
36257965	superoxide	paraquat	36257965	222	171	@TERM$1	@TERM$2	in addition we found that pck1 mutants are sensitive to oxidative stress as they showed poor survival to exposure to the  @TERM$1  generator  @TERM$2  supplementary fig7f	0.9999974	2.62593e-06
36257965	pck1	superoxide	36257965	222	171	@TERM$1	@TERM$2	in addition we found that  @TERM$1  mutants are sensitive to oxidative stress as they showed poor survival to exposure to the  @TERM$2  generator paraquat supplementary fig7f	0.9999933	6.6775683e-06
36257965	pck1	paraquat	36257965	222	171	@TERM$1	@TERM$2	in addition we found that  @TERM$1  mutants are sensitive to oxidative stress as they showed poor survival to exposure to the superoxide generator  @TERM$2  supplementary fig7f	0.9999939	6.1046803e-06
36257965	pck1	egl9	36257965	223	118	@TERM$1	@TERM$2	mutations in  @TERM$1  did not suppress the egg retention or extended lifespan phenotypes of  @TERM$2  mutants supplementary fig	0.9999976	2.3366158e-06
36257965	pck1	hif1	36257965	224	81	@TERM$1	@TERM$2	8 indicating that the upregulation of  @TERM$1  does not mediate all functions of  @TERM$2 	0.99997604	2.3975812e-05
36257965	hif1a	hif1	36257965	227	220	@TERM$1	@TERM$2	although only 03 of human genes showed consistent upregulation by  @TERM$1  68 of putative human orthologs to c elegans  @TERM$2  direct targets showed consistent upregulation a 23fold enrichment p value101016 proportion test	0.9999969	3.070897e-06
36257965	pck2	cysteine	36257965	230	247	@TERM$1	@TERM$2	indeed  @TERM$1  an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in  @TERM$2  and glutathione metabolism suggesting that this pep carboxykinase is a key hif1a regulatory target depending on tissue or contextfig	0.9999981	1.9539111e-06
36257965	pck1	glutathione	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans  @TERM$1  belonged to such a cluster that also included genes involved in cysteine and  @TERM$2  metabolism suggesting that this pep carboxykinase is a key hif1a regulatory target depending on tissue or contextfig	0.99999845	1.529448e-06
36257965	pck1	pep carboxykinase	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans  @TERM$1  belonged to such a cluster that also included genes involved in cysteine and glutathione metabolism suggesting that this  @TERM$2  is a key hif1a regulatory target depending on tissue or contextfig	0.99999666	3.2897465e-06
36257965	cysteine	pep	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in  @TERM$1  and glutathione metabolism suggesting that this  @TERM$2  carboxykinase is a key hif1a regulatory target depending on tissue or contextfig	0.99479973	0.0052003046
36257965	pck2	pep	36257965	230	247	@TERM$1	@TERM$2	indeed  @TERM$1  an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in cysteine and glutathione metabolism suggesting that this  @TERM$2  carboxykinase is a key hif1a regulatory target depending on tissue or contextfig	0.9999918	8.230803e-06
36257965	glutathione	pep carboxykinase	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in cysteine and  @TERM$1  metabolism suggesting that this  @TERM$2  is a key hif1a regulatory target depending on tissue or contextfig	0.99999774	2.2724691e-06
36257965	pck2	glutathione	36257965	230	247	@TERM$1	@TERM$2	indeed  @TERM$1  an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in cysteine and  @TERM$2  metabolism suggesting that this pep carboxykinase is a key hif1a regulatory target depending on tissue or contextfig	0.9999964	3.545406e-06
36257965	pck2	pck1	36257965	230	247	@TERM$1	@TERM$2	indeed  @TERM$1  an ortholog of c elegans  @TERM$2  belonged to such a cluster that also included genes involved in cysteine and glutathione metabolism suggesting that this pep carboxykinase is a key hif1a regulatory target depending on tissue or contextfig	0.99999726	2.7649855e-06
36257965	cysteine	hif1a	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in  @TERM$1  and glutathione metabolism suggesting that this pep carboxykinase is a key  @TERM$2  regulatory target depending on tissue or contextfig	0.9999981	1.8624002e-06
36257965	pck1	hif1a	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans  @TERM$1  belonged to such a cluster that also included genes involved in cysteine and glutathione metabolism suggesting that this pep carboxykinase is a key  @TERM$2  regulatory target depending on tissue or contextfig	0.99999774	2.2856557e-06
36257965	glutathione	hif1a	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in cysteine and  @TERM$1  metabolism suggesting that this pep carboxykinase is a key  @TERM$2  regulatory target depending on tissue or contextfig	0.999997	2.9506743e-06
36257965	tf binding sites	highoccupancy target hot	36257965	261	237	@TERM$1	@TERM$2	2a banother complication in identifying functional  @TERM$1  is the presence of  @TERM$2  sites which are overrepresented binding peaks found across multiple independent chipseq studies scattered across the genome43	0.99999845	1.5832467e-06
36257965	pep	hif1a	36257965	230	247	@TERM$1	@TERM$2	indeed pck2 an ortholog of c elegans pck1 belonged to such a cluster that also included genes involved in cysteine and glutathione metabolism suggesting that this  @TERM$1  carboxykinase is a key  @TERM$2  regulatory target depending on tissue or contextfig	0.99977535	0.00022470971
36257965	pck1	hif1a	36257965	277	164	@TERM$1	@TERM$2	our metaanalysis of human expression profile data suggests that pck2 an ortholog of  @TERM$1  is part of a group of new contextdependent targets regulated by  @TERM$2  fig5	0.9999964	3.5941837e-06
36257965	pck2	hif1a	36257965	277	164	@TERM$1	@TERM$2	our metaanalysis of human expression profile data suggests that  @TERM$1  an ortholog of pck1 is part of a group of new contextdependent targets regulated by  @TERM$2  fig5	0.9999939	6.124828e-06
36257965	pck2	pck1	36257965	277	164	@TERM$1	@TERM$2	our metaanalysis of human expression profile data suggests that  @TERM$1  an ortholog of  @TERM$2  is part of a group of new contextdependent targets regulated by hif1a fig5	0.99999416	5.8291403e-06
36257965	chloramphenicol	streptomycin	36257965	286	196	@TERM$1	@TERM$2	the polyclonal stab culture was streaked out under triple selection  @TERM$1   @TERM$2  nourseothricin and individual clones were selected for transgene construct validation by sequencing	0.9999975	2.5603251e-06
36257965	ppck1venus	atg	36257965	292	227	@TERM$1	@TERM$2	at least two independent lines were examined for each experimentto generate  @TERM$1  transgenic animals 2816bp upstream of the  @TERM$2  of pck1 was amplified and cloned upstream of a venus coding sequence present in ppd9577mvenus	0.99999774	2.3194698e-06
36257965	atg	pck1	36257965	292	227	@TERM$1	@TERM$2	at least two independent lines were examined for each experimentto generate p @TERM$2 venus transgenic animals 2816bp upstream of the  @TERM$1  of pck1 was amplified and cloned upstream of a venus coding sequence present in ppd9577mvenus	0.9999813	1.8740557e-05
36257965	ppck1venus	pck1	36257965	292	227	@TERM$1	@TERM$2	at least two independent lines were examined for each experimentto generate  @TERM$1  transgenic animals 2816bp upstream of the atg of  @TERM$2  was amplified and cloned upstream of a venus coding sequence present in ppd9577mvenus	0.9998641	0.00013582272
36257965	q5site	peak	36257965	293	201	@TERM$1	@TERM$2	using  @TERM$1  directed mutagenesis life technologies ltd the  @TERM$2  1084912 upstream of start and the hre 10191003 upstream of start were deleted to yield ppck1peakvenus and ppck1hrevenus respectively	0.9999958	4.113105e-06
36257965	prhy1venus	atg	36257965	294	163	@TERM$1	@TERM$2	myo2mcherry 50ngl coinjection markerto generate  @TERM$1  transgenic animals1510bp upstream of the  @TERM$2  of rhy1 was amplified and cloned upstream of a venus cod	0.9999963	3.7110135e-06
36257965	q5site	peak	36257965	295	235	@TERM$1	@TERM$2	 @TERM$1  directed mutagenesis life technologies ltd was used for the removal of the  @TERM$2  1170617bp upstream of start hre1 971956bp upstream of start hre2 946  931bp upstream of start and min 591 p to start variants of the promoter	0.99999845	1.5580141e-06
36257965	agarose	tetramisole	36257965	297	136	@TERM$1	@TERM$2	fluorescence was analyzed as abovefluorescent proteins were visualized in nematodes by mounting on 2  @TERM$1  pads with 10mm  @TERM$2 	0.9999982	1.8228927e-06
36257965	ppck1venus	m1m	36257965	299	184	@TERM$1	@TERM$2	fluorescent images of transgenic animals containing the odis131hif1gfp  @TERM$1  prhy1venus andor pmyo2mcherry transgenes were observed using an axioimager  @TERM$2  carl zeiss thornwood ny	0.9999988	1.2191036e-06
36257965	prhy1venus	m1m	36257965	299	184	@TERM$1	@TERM$2	fluorescent images of transgenic animals containing the odis131hif1gfp ppck1venus  @TERM$1  andor pmyo2mcherry transgenes were observed using an axioimager  @TERM$2  carl zeiss thornwood ny	0.9999982	1.7466291e-06
36257965	ppck1venus	prhy1venus	36257965	299	184	@TERM$1	@TERM$2	fluorescent images of transgenic animals containing the odis131hif1gfp  @TERM$1   @TERM$2  andor pmyo2mcherry transgenes were observed using an axioimager m1m carl zeiss thornwood ny	0.99999857	1.4497134e-06
36257965	actin	act1	36257965	319	116	@TERM$1	@TERM$2	the results were analyzed using the cq method with  @TERM$1   @TERM$2  as a normalization control unless otherwise specified	0.9999976	2.4285541e-06
36257965	protease inhibitor	pmsf	36257965	331	167	@TERM$1	@TERM$2	 @TERM$1 s roche cat11697498001 complete protease inhibitor cocktail tablet 125l 100mm  @TERM$2  and 25l 1m dtt per 25ml fa buffer was added and samples wer	0.99999857	1.4295424e-06
36257965	protease	tablet	36257965	331	186	@TERM$1	@TERM$2	 thawed on ice and 750ml of fa buffer containing  @TERM$1  inhibitors roche cat11697498001 complete protease inhibitor cocktail  @TERM$2  125l 100mm pmsf and 25l 1m dtt per 25ml fa b	0.9999982	1.7739619e-06
36257965	inhibitor	tablet	36257965	331	128	@TERM$1	@TERM$2	 @TERM$1 s roche cat11697498001 complete protease inhibitor cocktail  @TERM$2  125l 100mm pmsf and 25l 1m dtt per 25ml fa bu	0.9999974	2.637163e-06
36257965	tablet	dtt	36257965	331	146	@TERM$1	@TERM$2	t11697498001 complete protease inhibitor cocktail  @TERM$1  125l 100mm pmsf and 25l 1m  @TERM$2  per 25ml fa buffer was added and samples were then 	0.99999475	5.2624823e-06
36257965	hif1	pep	36257965	275	151	@TERM$1	@TERM$2	indeed we found that pck1 mutants survive hypoxic stress as poorly as  @TERM$1  mutants and both mutants are rescued by supplemental  @TERM$2  the product of pck1	0.99999654	3.4234674e-06
36257965	pck1	hif1	36257965	275	151	@TERM$1	@TERM$2	indeed we found that  @TERM$1  mutants survive hypoxic stress as poorly as  @TERM$2  mutants and both mutants are rescued by supplemental pep the product of pck1	0.9999987	1.3102267e-06
36257965	unc119	or3350	36257965	289	117	@TERM$1	@TERM$2	r chipseq or3349  @TERM$1 ed3 hif1ia4 odis131hif1gfp unc119 and  @TERM$2  unc119ed3 egl9sa307 hif1ia4 odis131hif1gfp unc119	0.9999988	1.1595022e-06
36257965	glutathione	nadph	36257965	274	150	@TERM$1	@TERM$2	gluconeogenesis provides the metabolites needed to make  @TERM$1  and produce  @TERM$2  reducing equivalents required to combat ros and oxidative stress	0.9996049	0.00039509014
36257965	deg	hif1 target	36257965	268	241	@TERM$1	@TERM$2	n contain at least two comparative conditions for  @TERM$1  identification with subsequent analysis of the deg lists from those comparisons performed by a combination of loa and betathe  @TERM$2  genes we identified were enriched with factors in	0.9999982	1.7589201e-06
36257965	deg	betathe hif1	36257965	268	234	@TERM$1	@TERM$2	n contain at least two comparative conditions for  @TERM$1  identification with subsequent analysis of the deg lists from those comparisons performed by a combination of loa and  @TERM$2  target genes we identified were enriched with fac	0.99999714	2.8107247e-06
36257965	deg	hif1	36257965	268	234	@TERM$1	@TERM$2	n contain at least two comparative conditions for  @TERM$1  identification with subsequent analysis of the deg lists from those comparisons performed by a combination of loa and betathe  @TERM$2  target genes we identified were enriched with fac	0.9999683	3.1704803e-05
36257965	hif1	pep carboxykinase	36257965	273	171	@TERM$1	@TERM$2	we observed that  @TERM$1  directly promotes the expression of the pck1  @TERM$2  a key mediator of gluconeogenesis as well as metabolic flux through the pathway fig4f	0.00045630848	0.9995436
36257965	hif1	pck1 pep carboxykinase	36257965	273	171	@TERM$1	@TERM$2	we observed that  @TERM$1  directly promotes the expression of the  @TERM$2  a key mediator of gluconeogenesis as well as metabolic flux through the pathway fig4f	0.9999974	2.6809566e-06
36257965	pck1	pep	36257965	275	151	@TERM$1	@TERM$2	indeed we found that  @TERM$1  mutants survive hypoxic stress as poorly as hif1 mutants and both mutants are rescued by supplemental  @TERM$2  the product of pck1	0.99998593	1.4014706e-05
36257965	pck1 pep carboxykinase	flux	36257965	273	171	@TERM$1	@TERM$2	we observed that hif1 directly promotes the expression of the  @TERM$1  a key mediator of gluconeogenesis as well as metabolic  @TERM$2  through the pathway fig4f	0.99999523	4.784223e-06
36257965	hif1	pep	36257965	273	171	@TERM$1	@TERM$2	we observed that  @TERM$1  directly promotes the expression of the pck1  @TERM$2  carboxykinase a key mediator of gluconeogenesis as well as metabolic flux through the pathway fig4f	0.9999982	1.774935e-06
36257965	pck1	pep carboxykinase	36257965	273	171	@TERM$1	@TERM$2	we observed that hif1 directly promotes the expression of the  @TERM$1   @TERM$2  a key mediator of gluconeogenesis as well as metabolic flux through the pathway fig4f	0.99999714	2.8533457e-06
36257965	pck1	pep	36257965	273	171	@TERM$1	@TERM$2	we observed that hif1 directly promotes the expression of the  @TERM$1   @TERM$2  carboxykinase a key mediator of gluconeogenesis as well as metabolic flux through the pathway fig4f	0.9999988	1.1923518e-06
36257965	glutathione	ros	36257965	274	150	@TERM$1	@TERM$2	gluconeogenesis provides the metabolites needed to make  @TERM$1  and produce nadph reducing equivalents required to combat  @TERM$2  and oxidative stress	0.99999785	2.0953046e-06
36257965	hif1	flux	36257965	273	171	@TERM$1	@TERM$2	we observed that  @TERM$1  directly promotes the expression of the pck1 pep carboxykinase a key mediator of gluconeogenesis as well as metabolic  @TERM$2  through the pathway fig4f	0.99999833	1.642574e-06
36257965	hif1	pck1	36257965	273	171	@TERM$1	@TERM$2	we observed that  @TERM$1  directly promotes the expression of the  @TERM$2  pep carboxykinase a key mediator of gluconeogenesis as well as metabolic flux through the pathway fig4f	0.9999982	1.8113791e-06
36257965	pep carboxykinase	flux	36257965	273	171	@TERM$1	@TERM$2	we observed that hif1 directly promotes the expression of the pck1  @TERM$1  a key mediator of gluconeogenesis as well as metabolic  @TERM$2  through the pathway fig4f	0.99999857	1.3709363e-06
36257965	pck1	flux	36257965	273	171	@TERM$1	@TERM$2	we observed that hif1 directly promotes the expression of the  @TERM$1  pep carboxykinase a key mediator of gluconeogenesis as well as metabolic  @TERM$2  through the pathway fig4f	0.99999857	1.4593373e-06
36257965	nadph	ros	36257965	274	150	@TERM$1	@TERM$2	gluconeogenesis provides the metabolites needed to make glutathione and produce  @TERM$1  reducing equivalents required to combat  @TERM$2  and oxidative stress	0.99106556	0.008934459
36257965	pep	flux	36257965	273	171	@TERM$1	@TERM$2	we observed that hif1 directly promotes the expression of the pck1  @TERM$1  carboxykinase a key mediator of gluconeogenesis as well as metabolic  @TERM$2  through the pathway fig4f	0.99999785	2.1181481e-06
37432911	muehlbauer lk	jen a	37432911	367	121	@TERM$1	@TERM$2	 @TERM$1   @TERM$2  zhu y he y shishkova e overmyer ka coon jj rapid multiomics  sample preparation for mass spectrometry	0.99999416	5.8277506e-06
37432911	ryu d	moullan	37432911	375	148	@TERM$1	@TERM$2	houtkooper rh mouchiroud l  @TERM$1   @TERM$2  n katsyuba e knott g williams rw  auwerx j mitonuclear protein imbalance as a conserved longevity mechanism	0.9999987	1.282791e-06
37432911	gao	hof	37432911	385	241	@TERM$1	@TERM$2	 @TERM$1  aw el alam g lalou a li ty molenaars m zhu y overmyer ka shishkova e   @TERM$2  k sleiman mb houtkooper rh coon jj auwerx j multiomics analysis identifies  essential regulators of mitochondrial stress response in two wildtype c elegans strains	0.9999974	2.6585994e-06
37432911	alam g	hof	37432911	385	241	@TERM$1	@TERM$2	gao aw el  @TERM$1  lalou a li ty molenaars m zhu y overmyer ka shishkova e   @TERM$2  k sleiman mb houtkooper rh coon jj auwerx j multiomics analysis identifies  essential regulators of mitochondrial stress response in two wildtype c elegans strains	0.9999988	1.1539754e-06
37432911	gao	shishkova e	37432911	385	241	@TERM$1	@TERM$2	 @TERM$1  aw el alam g lalou a li ty molenaars m zhu y overmyer ka  @TERM$2   hof k sleiman mb houtkooper rh coon jj auwerx j multiomics analysis identifies  essential regulators of mitochondrial stress response in two wildtype c elegans strains	0.99999845	1.552319e-06
37432911	gao	alam g	37432911	385	241	@TERM$1	@TERM$2	 @TERM$1  aw el  @TERM$2  lalou a li ty molenaars m zhu y overmyer ka shishkova e  hof k sleiman mb houtkooper rh coon jj auwerx j multiomics analysis identifies  essential regulators of mitochondrial stress response in two wildtype c elegans strains	0.9771905	0.02280948
37432911	alam g	shishkova e	37432911	385	241	@TERM$1	@TERM$2	gao aw el  @TERM$1  lalou a li ty molenaars m zhu y overmyer ka  @TERM$2   hof k sleiman mb houtkooper rh coon jj auwerx j multiomics analysis identifies  essential regulators of mitochondrial stress response in two wildtype c elegans strains	0.846294	0.15370603
37432911	shishkova e	hof	37432911	385	241	@TERM$1	@TERM$2	gao aw el alam g lalou a li ty molenaars m zhu y overmyer ka  @TERM$1    @TERM$2  k sleiman mb houtkooper rh coon jj auwerx j multiomics analysis identifies  essential regulators of mitochondrial stress response in two wildtype c elegans strains	0.99999774	2.286737e-06
37432911	shishkova e	psi	37432911	388	147	@TERM$1	@TERM$2	 @TERM$1  hebert as westphall ms coon jj ultrahigh pressure 30000  @TERM$2  packing  of capillary columns enhancing depth of shotgun proteomic analyses	0.99997985	2.0089974e-05
37432911	jen a	shishkova e	37432911	367	121	@TERM$1	@TERM$2	muehlbauer lk  @TERM$1  zhu y he y  @TERM$2  overmyer ka coon jj rapid multiomics  sample preparation for mass spectrometry	0.99999833	1.7264962e-06
37432911	ky k	maccoss mj	37432911	403	197	@TERM$1	@TERM$2	adams kj pratt b bose n dubois lg st johnwilliams l perrott km  @TERM$1  kapahi  p sharma v  @TERM$2  moseley ma colton ca maclean bx schilling b thompson  jw alzheimers disease metabolomics consortium	0.99999464	5.398505e-06
37432911	hutchins	lipidex	37432911	398	110	@TERM$1	@TERM$2	 @TERM$1  pd russell jd coon jj  @TERM$2  an integrated software package for high confidence lipid identification	0.99999845	1.6085166e-06
37432911	ky k	sharma v	37432911	403	197	@TERM$1	@TERM$2	adams kj pratt b bose n dubois lg st johnwilliams l perrott km  @TERM$1  kapahi  p  @TERM$2  maccoss mj moseley ma colton ca maclean bx schilling b thompson  jw alzheimers disease metabolomics consortium	0.9999987	1.2944657e-06
37432911	muehlbauer lk	shishkova e	37432911	367	121	@TERM$1	@TERM$2	 @TERM$1  jen a zhu y he y  @TERM$2  overmyer ka coon jj rapid multiomics  sample preparation for mass spectrometry	0.99999547	4.547007e-06
37432911	hutchins	guo	37432911	275	130	@TERM$1	@TERM$2	hards al jochem a rush mjp ulbrich a  robinson kp  @TERM$1  pd veling mt  @TERM$2  x kemmerer za connors kj trujillo ea sokol  j marx h w	0.99999845	1.4970192e-06
37432911	liebisch g	ether	37432911	325	133	@TERM$1	@TERM$2	matyash v  @TERM$1  kurzchalia tv shevchenko a schwudke d lipid extraction by  methyltertbutyl  @TERM$2  for highthroughput lipidomics s	0.99999654	3.4669981e-06
37432911	linke v	covid19	37432911	272	197	@TERM$1	@TERM$2	 manuscriptpaulson b brademan dr zhu y serrano lr  @TERM$1  drake la adam ap schwartz bs  singer ha swanson s mosher df stewart r coon jj jaitovich a largescale multiomic  analysis of  @TERM$2  severit	0.9999987	1.3038796e-06
37432911	linke v	adam	37432911	272	124	@TERM$1	@TERM$2	 manuscriptpaulson b brademan dr zhu y serrano lr  @TERM$1  drake la  @TERM$2  ap schwartz bs  singer ha swanson s mosher df stewar	0.9999981	1.9320241e-06
37432911	adam	covid19	37432911	272	180	@TERM$1	@TERM$2	n b brademan dr zhu y serrano lr linke v drake la  @TERM$1  ap schwartz bs  singer ha swanson s mosher df stewart r coon jj jaitovich a largescale multiomic  analysis of  @TERM$2  severit	0.9999958	4.153477e-06
37432911	bose	maccoss mj	37432911	403	197	@TERM$1	@TERM$2	adams kj pratt b  @TERM$1  n dubois lg st johnwilliams l perrott km ky k kapahi  p sharma v  @TERM$2  moseley ma colton ca maclean bx schilling b thompson  jw alzheimers disease metabolomics consortium	0.99999833	1.6466079e-06
37432911	sverchkov y	linke v	37432911	280	198	@TERM$1	@TERM$2	rensvold jw shishkova e  @TERM$1  miller ij cetinkaya a pyle a manicki m brademan  dr alanay y raiman j jochem a hutchins pd peters sr  @TERM$2  overmyer ka salome  az hebert as vincent ce kwiecien 	0.9999988	1.1591694e-06
37432911	shishkova e	hutchins	37432911	280	176	@TERM$1	@TERM$2	rensvold jw  @TERM$1  sverchkov y miller ij cetinkaya a pyle a manicki m brademan  dr alanay y raiman j jochem a  @TERM$2  pd peters sr linke v overmyer ka salome  az hebert a	0.9999988	1.1391854e-06
37432911	shishkova e	linke v	37432911	280	198	@TERM$1	@TERM$2	rensvold jw  @TERM$1  sverchkov y miller ij cetinkaya a pyle a manicki m brademan  dr alanay y raiman j jochem a hutchins pd peters sr  @TERM$2  overmyer ka salome  az hebert as vincent ce kwiecien 	0.999998	2.0184912e-06
37432911	sverchkov y	hutchins	37432911	280	176	@TERM$1	@TERM$2	rensvold jw shishkova e  @TERM$1  miller ij cetinkaya a pyle a manicki m brademan  dr alanay y raiman j jochem a  @TERM$2  pd peters sr linke v overmyer ka salome  az hebert a	0.99305975	0.0069402945
37432911	shishkova e	sverchkov y	37432911	280	85	@TERM$1	@TERM$2	rensvold jw  @TERM$1   @TERM$2  miller ij cetinkaya a pyle a manicki m brademan  	0.9999932	6.843795e-06
37432911	gao	vervaart mat	37432911	303	106	@TERM$1	@TERM$2	molenaars m schomakers bv elfrink hl  @TERM$1  aw  @TERM$2  prasraves ml luyf  ac smith rl sterken mg kammeng	0.9999963	3.6929937e-06
37432911	gao	prasraves	37432911	303	116	@TERM$1	@TERM$2	molenaars m schomakers bv elfrink hl  @TERM$1  aw vervaart mat  @TERM$2  ml luyf  ac smith rl sterken mg kammenga je van k	0.99999833	1.6812763e-06
37432911	vervaart mat	prasraves	37432911	303	119	@TERM$1	@TERM$2	molenaars m schomakers bv elfrink hl gao aw  @TERM$1   @TERM$2  ml luyf  ac smith rl sterken mg kammenga je van kamp	0.9999976	2.4333226e-06
37432911	hutchins	linke v	37432911	280	130	@TERM$1	@TERM$2	manicki m brademan  dr alanay y raiman j jochem a  @TERM$1  pd peters sr  @TERM$2  overmyer ka salome  az hebert as vincent ce kwieci	0.9999988	1.1666365e-06
37432911	bose	sharma v	37432911	403	197	@TERM$1	@TERM$2	adams kj pratt b  @TERM$1  n dubois lg st johnwilliams l perrott km ky k kapahi  p  @TERM$2  maccoss mj moseley ma colton ca maclean bx schilling b thompson  jw alzheimers disease metabolomics consortium	0.9999933	6.6580023e-06
37432911	13c	sigma	37432911	81	193	@TERM$1	@TERM$2	author manuscript author manuscript author manuscript author manuscriptsample extraction to each tube of worms we added 10 l of splash avanti and 10 l of  @TERM$1  amino acid  isotope mixture  @TERM$2 	0.99999857	1.469974e-06
37432911	sharma v	maccoss mj	37432911	403	197	@TERM$1	@TERM$2	adams kj pratt b bose n dubois lg st johnwilliams l perrott km ky k kapahi  p  @TERM$1   @TERM$2  moseley ma colton ca maclean bx schilling b thompson  jw alzheimers disease metabolomics consortium	0.99999845	1.4903783e-06
37432911	13c amino acid	sigma	37432911	81	193	@TERM$1	@TERM$2	author manuscript author manuscript author manuscript author manuscriptsample extraction to each tube of worms we added 10 l of splash avanti and 10 l of  @TERM$1   isotope mixture  @TERM$2 	0.99999344	6.5633185e-06
37432911	doxycycline	dox	37432911	72	134	@TERM$1	@TERM$2	 @TERM$1   @TERM$2  given throughout life dosedependently  also induces uprmt in worms24 and alters the proteomic and lipidomic landscape2	0.99998426	1.5739995e-05
37432911	doxycycline	uprmt	37432911	72	134	@TERM$1	@TERM$2	 @TERM$1  dox given throughout life dosedependently  also induces  @TERM$2  in worms24 and alters the proteomic and lipidomic landscape2	0.99999475	5.202497e-06
37432911	dox	uprmt	37432911	72	134	@TERM$1	@TERM$2	 @TERM$1 ycycline dox given throughout life dosedependently  also induces  @TERM$2  in worms24 and alters the proteomic and lipidomic landscape2	0.999997	2.9711325e-06
37432911	cytochrome	mrps5	37432911	71	180	@TERM$1	@TERM$2	knocking down electron transfer component etc gene cco1 encoding  @TERM$1  c  oxidase1 subunit vbcox4 and  @TERM$2  encoding mitochondrial ribosome protein s5  mrps5 induces uprmt2426	0.9999981	1.930293e-06
37432911	cco1	mrps5	37432911	71	180	@TERM$1	@TERM$2	knocking down electron transfer component etc gene  @TERM$1  encoding cytochrome c  oxidase1 subunit vbcox4 and  @TERM$2  encoding mitochondrial ribosome protein s5  mrps5 induces uprmt2426	0.99999774	2.227209e-06
37432911	cco1	cytochrome	37432911	71	180	@TERM$1	@TERM$2	knocking down electron transfer component etc gene  @TERM$1  encoding  @TERM$2  c  oxidase1 subunit vbcox4 and mrps5 encoding mitochondrial ribosome protein s5  mrps5 induces uprmt2426	0.99999666	3.3516858e-06
37432911	nbutanol	acn	37432911	61	96	@TERM$1	@TERM$2	used a combination of  @TERM$1   @TERM$2  and water baw  to extract both lipids and polar metabolites22	0.9999975	2.5086354e-06
37432911	acetonitrile	acn	37432911	58	169	@TERM$1	@TERM$2	author manuscript author manuscript author manuscript author manuscriptmeoh  @TERM$1   @TERM$2  and water exhibited improved extraction efficiencies for plant  metabolome20	0.9996908	0.00030929202
37432911	methyl tertbutyl	ether	37432911	50	244	@TERM$1	@TERM$2	adopted the use of  @TERM$1   @TERM$2  mtbe  instead of potentially carcinogenic chloroform13 in combination with meoh and water and  the resulting approach has become the mainstream method to extract proteins lipids and  polar metabolites14	0.99999845	1.5702727e-06
37432911	methyl tertbutyl	meoh	37432911	50	244	@TERM$1	@TERM$2	adopted the use of  @TERM$1  ether mtbe  instead of potentially carcinogenic chloroform13 in combination with  @TERM$2  and water and  the resulting approach has become the mainstream method to extract proteins lipids and  polar metabolites14	0.99999	9.965468e-06
37432911	muehlbauer lk	chopra a	37432911	269	168	@TERM$1	@TERM$2	overmyer ka shishkova e miller ij balnis j bernstein mn petersclarke tm meyer jg  quan q  @TERM$1  trujillo ea he y  @TERM$2  chieng hc tiwari a judson ma  zhu et al	0.99999774	2.2795082e-06
37432911	ether	meoh	37432911	50	244	@TERM$1	@TERM$2	adopted the use of methyl tertbutyl  @TERM$1  mtbe  instead of potentially carcinogenic chloroform13 in combination with  @TERM$2  and water and  the resulting approach has become the mainstream method to extract proteins lipids and  polar metabolites14	0.99999857	1.4084375e-06
37432911	methyl tertbutyl	mtbe	37432911	50	244	@TERM$1	@TERM$2	adopted the use of  @TERM$1  ether  @TERM$2   instead of potentially carcinogenic chloroform13 in combination with meoh and water and  the resulting approach has become the mainstream method to extract proteins lipids and  polar metabolites14	0.99999857	1.4756005e-06
37432911	meoh	mtbe	37432911	82	212	@TERM$1	@TERM$2	then one of following extraction solvents were added to samples  and maintained at 4c through lysis and extraction specific procedures are detailed in the  figure caption orimat14 sequential addition of  @TERM$1   @TERM$2 	0.9999958	4.136278e-06
37432911	bose	ky k	37432911	403	197	@TERM$1	@TERM$2	adams kj pratt b  @TERM$1  n dubois lg st johnwilliams l perrott km  @TERM$2  kapahi  p sharma v maccoss mj moseley ma colton ca maclean bx schilling b thompson  jw alzheimers disease metabolomics consortium	0.9999982	1.8446831e-06
37432911	h2o	1241	37432911	83	34	@TERM$1	@TERM$2	and  @TERM$1   @TERM$2  11625 l final volume	0.99999785	2.187191e-06
37432911	mrps5	hsp60	37432911	448	57	@TERM$1	@TERM$2	c the expression levels of cox4  @TERM$1  hsp6   @TERM$2  and dox	0.99999785	2.0926645e-06
37432911	ba w	orimat	37432911	432	84	@TERM$1	@TERM$2	comparison of different extraction strategies including  @TERM$1  ma w modmat and   @TERM$2 	0.99999595	4.0573864e-06
37432911	ba w	ma w	37432911	432	84	@TERM$1	@TERM$2	comparison of different extraction strategies including  @TERM$1   @TERM$2  modmat and  orimat	0.99999785	2.1020455e-06
37432911	ma w	orimat	37432911	432	84	@TERM$1	@TERM$2	comparison of different extraction strategies including ba w  @TERM$1  modmat and   @TERM$2 	0.999998	2.043327e-06
37432911	acylcarnitines	glycerophospholipids	37432911	434	111	@TERM$1	@TERM$2	b the lipid class compositions  @TERM$1   ac glycerolipids gl  @TERM$2  gpl or sphingolipids sl	0.99999714	2.8211523e-06
37432911	acylcarnitines	glycerolipids	37432911	434	111	@TERM$1	@TERM$2	b the lipid class compositions  @TERM$1   ac  @TERM$2  gl glycerophospholipids gpl or sphingolipids sl	0.9999974	2.6402686e-06
37432911	glycerolipids	glycerophospholipids	37432911	434	111	@TERM$1	@TERM$2	b the lipid class compositions acylcarnitines  ac  @TERM$1  gl  @TERM$2  gpl or sphingolipids sl	0.99999726	2.7360556e-06
37432911	log2	orimat	37432911	437	80	@TERM$1	@TERM$2	d the  @TERM$1  intensity fold change of heavy lipid  standards against  @TERM$2  method	0.99999356	6.4611704e-06
37432911	cox4	hsp6	37432911	448	57	@TERM$1	@TERM$2	c the expression levels of  @TERM$1  mrps5  @TERM$2   hsp60 and dox	0.9999949	5.07106e-06
37432911	cox4	mrps5	37432911	448	57	@TERM$1	@TERM$2	c the expression levels of  @TERM$1   @TERM$2  hsp6  hsp60 and dox	0.99999166	8.3364785e-06
37432911	hsp6	hsp60	37432911	448	57	@TERM$1	@TERM$2	c the expression levels of cox4 mrps5  @TERM$1    @TERM$2  and dox	0.99999356	6.485815e-06
37432911	mrps5	dox	37432911	448	57	@TERM$1	@TERM$2	c the expression levels of cox4  @TERM$1  hsp6  hsp60 and  @TERM$2 	0.9999505	4.9453756e-05
37432911	hsp6	dox	37432911	448	57	@TERM$1	@TERM$2	c the expression levels of cox4 mrps5  @TERM$1   hsp60 and  @TERM$2 	0.9999974	2.5648262e-06
37432911	cox4	dox	37432911	448	57	@TERM$1	@TERM$2	c the expression levels of  @TERM$1  mrps5 hsp6  hsp60 and  @TERM$2 	0.99934167	0.0006583362
37432911	cox4	hsp60	37432911	448	57	@TERM$1	@TERM$2	c the expression levels of  @TERM$1  mrps5 hsp6   @TERM$2  and dox	0.9999982	1.7938614e-06
37432911	hsp60	dox	37432911	448	57	@TERM$1	@TERM$2	c the expression levels of cox4 mrps5 hsp6   @TERM$1  and  @TERM$2 	0.9999919	8.080032e-06
37432911	lipidex	v 11030	37432911	109	184	@TERM$1	@TERM$2	author manuscript author manuscript author manuscript author manuscriptuntargeted analysis lcms files were processed using compound discoverer 31 thermo  scientific and  @TERM$1   @TERM$2 	0.9999982	1.7854949e-06
37432911	shishkova e	chopra a	37432911	269	168	@TERM$1	@TERM$2	overmyer ka  @TERM$1  miller ij balnis j bernstein mn petersclarke tm meyer jg  quan q muehlbauer lk trujillo ea he y  @TERM$2  chieng hc tiwari a judson ma  zhu et al	0.99999356	6.4432334e-06
37432911	pca	mrps5	37432911	195	159	@TERM$1	@TERM$2	protein  @TERM$1  showed that cco1 and  @TERM$2  rnai  groups clustered together suggesting that the knockdown of the two genes similarly affected  the proteome profiles	0.99999726	2.7007698e-06
37432911	gao	alam g	37432911	266	244	@TERM$1	@TERM$2	 @TERM$1  aw el  @TERM$2  lalou a li ty molenaars m zhu y overmyer ka shishkova e hof k  bou sleiman m houtkooper rh coon jj auwerx j multiomics analysis identifies essential  regulators of mitochondrial stress response in two wildtype c elegans strains	0.99999845	1.6030037e-06
37432911	uprmt	hsp60	37432911	192	142	@TERM$1	@TERM$2	we then checked  the abundance of  @TERM$1  marker heat shock protein 6 hsp6 and heat shock protein  60  @TERM$2  to check whether uprmt was activated	0.99999845	1.5027093e-06
37432911	uprmt	hsp6	37432911	192	142	@TERM$1	@TERM$2	we then checked  the abundance of  @TERM$1  marker heat shock protein 6  @TERM$2  and heat shock protein  60 hsp60 to check whether uprmt was activated	0.99999714	2.8170282e-06
37432911	hsp6	hsp60	37432911	193	244	@TERM$1	@TERM$2	as a result abundances of  @TERM$1   and  @TERM$2  were significantly increased by the three treatments but to differing degrees  suggesting that uprmt was activated differentially by the three generated significantly  different molecular signatures fig	0.99997854	2.1465266e-05
37432911	hsp60	uprmt	37432911	193	244	@TERM$1	@TERM$2	as a result abundances of hsp6  and  @TERM$1  were significantly increased by the three treatments but to differing degrees  suggesting that  @TERM$2  was activated differentially by the three generated significantly  different molecular signatures fig	0.9981166	0.0018834397
37432911	hsp6	uprmt	37432911	193	244	@TERM$1	@TERM$2	as a result abundances of  @TERM$1   and hsp60 were significantly increased by the three treatments but to differing degrees  suggesting that  @TERM$2  was activated differentially by the three generated significantly  different molecular signatures fig	0.999998	2.0299465e-06
37432911	pca	cco1	37432911	195	159	@TERM$1	@TERM$2	protein  @TERM$1  showed that  @TERM$2  and mrps5 rnai  groups clustered together suggesting that the knockdown of the two genes similarly affected  the proteome profiles	0.99999595	4.0444056e-06
37432911	cco1	mrps5	37432911	195	159	@TERM$1	@TERM$2	protein pca showed that  @TERM$1  and  @TERM$2  rnai  groups clustered together suggesting that the knockdown of the two genes similarly affected  the proteome profiles	0.99998844	1.1530861e-05
37432911	cco1	signature	37432911	196	132	@TERM$1	@TERM$2	meanwhile dox treated samples deviated away from  @TERM$1  and  mrps5 rnai groups implying a unique proteomic  @TERM$2  of this treatment	0.9999933	6.6426283e-06
37432911	dox	mrps5	37432911	196	132	@TERM$1	@TERM$2	meanwhile  @TERM$1  treated samples deviated away from cco1 and   @TERM$2  rnai groups implying a unique proteomic signature of this treatment	0.99999607	3.9008305e-06
37432911	dox	cco1	37432911	196	132	@TERM$1	@TERM$2	meanwhile  @TERM$1  treated samples deviated away from  @TERM$2  and  mrps5 rnai groups implying a unique proteomic signature of this treatment	0.9999932	6.821334e-06
37432911	dox	signature	37432911	196	132	@TERM$1	@TERM$2	meanwhile  @TERM$1  treated samples deviated away from cco1 and  mrps5 rnai groups implying a unique proteomic  @TERM$2  of this treatment	0.9999976	2.3730636e-06
37432911	cco1	mrps5	37432911	196	132	@TERM$1	@TERM$2	meanwhile dox treated samples deviated away from  @TERM$1  and   @TERM$2  rnai groups implying a unique proteomic signature of this treatment	0.99999833	1.7173527e-06
37432911	mrps5	signature	37432911	196	132	@TERM$1	@TERM$2	meanwhile dox treated samples deviated away from cco1 and   @TERM$1  rnai groups implying a unique proteomic  @TERM$2  of this treatment	0.99996686	3.3141612e-05
37432911	cco1	mrps5	37432911	206	216	@TERM$1	@TERM$2	in addition the  lipidome and metabolome of  @TERM$1  and  @TERM$2  rnai groups were more divergent from  each other than proteome suggesting metabolite and lipid abundances can divert despite  the similar proteomic landscape	0.99998224	1.7735285e-05
37432911	dox	signature	37432911	207	93	@TERM$1	@TERM$2	 @TERM$1  treatment again generated a distinct lipidmetabolome   @TERM$2  from the other two groups	0.9999956	4.380591e-06
37432911	hsp6	hsp60	37432911	192	142	@TERM$1	@TERM$2	we then checked  the abundance of uprmt marker heat shock protein 6  @TERM$1  and heat shock protein  60  @TERM$2  to check whether uprmt was activated	0.9999839	1.605674e-05
37432911	cco1	dox	37432911	212	145	@TERM$1	@TERM$2	the enrichment analysis verified the ample resemblance between  @TERM$1  and mrps5  rnai treatment and more discrepancies induced by  @TERM$2  treatment fig	0.9999976	2.4118413e-06
37432911	mrps5	dox	37432911	191	102	@TERM$1	@TERM$2	 @TERM$1  knockdown and  @TERM$2  treatment  also significantly but to a lesser extent decreased cox4 expression	0.99999726	2.784493e-06
37432911	mrps5	cox4	37432911	191	102	@TERM$1	@TERM$2	 @TERM$1  knockdown and dox treatment  also significantly but to a lesser extent decreased  @TERM$2  expression	0.99999857	1.4298943e-06
37432911	ether	mtbe	37432911	50	244	@TERM$1	@TERM$2	adopted the use of methyl tertbutyl  @TERM$1   @TERM$2   instead of potentially carcinogenic chloroform13 in combination with meoh and water and  the resulting approach has become the mainstream method to extract proteins lipids and  polar metabolites14		
37432911	triglyceride	cholesterol ester	37432911	164	199	@TERM$1	@TERM$2	not surprisingly maw had significantly lower extraction efficiencies for more hydrophobic  molecules such as phosphatidic acid pa 150181  @TERM$1  tg 150181150 and   @TERM$2  ce 181 fig		
37432911	phosphatidic acid	cholesterol ester	37432911	164	199	@TERM$1	@TERM$2	not surprisingly maw had significantly lower extraction efficiencies for more hydrophobic  molecules such as  @TERM$1  pa 150181 triglyceride tg 150181150 and   @TERM$2  ce 181 fig		
37432911	phosphatidic acid	triglyceride	37432911	164	199	@TERM$1	@TERM$2	not surprisingly maw had significantly lower extraction efficiencies for more hydrophobic  molecules such as  @TERM$1  pa 150181  @TERM$2  tg 150181150 and  cholesterol ester ce 181 fig		
37432911	log2	hochberg	37432911	169	208	@TERM$1	@TERM$2	inimal effect on heavy amino acid intensities the  @TERM$1  fold change fc of intensity was  negligible and the differences had no statistical significance after benjamini   @TERM$2   fdr correction supplemental fi		
37432911	uprmt	mrps5	37432911	182	108	@TERM$1	@TERM$2	rategy to profile the biomolecular signatures  of  @TERM$1  induced by cco1 rnai  @TERM$2  rnai and dox treatment fi		
37432911	uprmt	cco1	37432911	182	108	@TERM$1	@TERM$2	rategy to profile the biomolecular signatures  of  @TERM$1  induced by  @TERM$2  rnai mrps5 rnai and dox treatment fi		
37432911	mrps5	dox	37432911	182	81	@TERM$1	@TERM$2	lecular signatures  of uprmt induced by cco1 rnai  @TERM$1  rnai and  @TERM$2  treatment fi		
37432911	cco1	dox	37432911	182	91	@TERM$1	@TERM$2	 the biomolecular signatures  of uprmt induced by  @TERM$1  rnai mrps5 rnai and  @TERM$2  treatment fi		
37432911	uprmt	dox	37432911	182	108	@TERM$1	@TERM$2	rategy to profile the biomolecular signatures  of  @TERM$1  induced by cco1 rnai mrps5 rnai and  @TERM$2  treatment fi		
37432911	cco1	mrps5	37432911	182	91	@TERM$1	@TERM$2	 the biomolecular signatures  of uprmt induced by  @TERM$1  rnai  @TERM$2  rnai and dox treatment fi		
37432911	cox4	mrps5	37432911	188	119	@TERM$1	@TERM$2	to confirm the knockdowns were effective we first analyzed the proteomic data for the  abundances of  @TERM$1  and  @TERM$2  fig		
37432911	cco1	mrps5	37432911	190	84	@TERM$1	@TERM$2	these data demonstrate that the rnai was  successful in knocking down  @TERM$1  and  @TERM$2 		
37432911	dox	cox4	37432911	191	102	@TERM$1	@TERM$2	mrps5 knockdown and  @TERM$1  treatment  also significantly but to a lesser extent decreased  @TERM$2  expression		
37432911	shishkova e	muehlbauer lk	37432911	269	168	@TERM$1	@TERM$2	overmyer ka  @TERM$1  miller ij balnis j bernstein mn petersclarke tm meyer jg  quan q  @TERM$2  trujillo ea he y chopra a chieng hc tiwari a judson ma  zhu et al		
37432911	mrps5	dox	37432911	212	145	@TERM$1	@TERM$2	the enrichment analysis verified the ample resemblance between cco1 and  @TERM$1   rnai treatment and more discrepancies induced by  @TERM$2  treatment fig		
37432911	cco1	mrps5	37432911	214	102	@TERM$1	@TERM$2	for the top  10 stimulated biological processes bp  @TERM$1  and  @TERM$2  rnai treatment shared seven  of them		
37432911	acetylcarnitine	larginine	37432911	230	207	@TERM$1	@TERM$2	the top 50 metabolites that contributed to the  separation of four conditions included five identified ones  @TERM$1   @TERM$2   lmethionine lphenylalanine and trans3indoleacrylic acid supplemental fig		
37432911	acetylcarnitine	lphenylalanine	37432911	230	207	@TERM$1	@TERM$2	the top 50 metabolites that contributed to the  separation of four conditions included five identified ones  @TERM$1  larginine  lmethionine  @TERM$2  and trans3indoleacrylic acid supplemental fig		
37432911	acetylcarnitine	lmethionine	37432911	230	207	@TERM$1	@TERM$2	the top 50 metabolites that contributed to the  separation of four conditions included five identified ones  @TERM$1  larginine   @TERM$2  lphenylalanine and trans3indoleacrylic acid supplemental fig		
37432911	lphenylalanine	trans3indoleacrylic acid	37432911	230	207	@TERM$1	@TERM$2	the top 50 metabolites that contributed to the  separation of four conditions included five identified ones acetylcarnitine larginine  lmethionine  @TERM$1  and  @TERM$2  supplemental fig		
37432911	acetylcarnitine	trans3indoleacrylic acid	37432911	230	207	@TERM$1	@TERM$2	the top 50 metabolites that contributed to the  separation of four conditions included five identified ones  @TERM$1  larginine  lmethionine lphenylalanine and  @TERM$2  supplemental fig		
37432911	larginine	lphenylalanine	37432911	230	207	@TERM$1	@TERM$2	the top 50 metabolites that contributed to the  separation of four conditions included five identified ones acetylcarnitine  @TERM$1   lmethionine  @TERM$2  and trans3indoleacrylic acid supplemental fig		
37432911	crossome	lipidsmetabolites	37432911	234	150	@TERM$1	@TERM$2	to further integrate multiomics data a  @TERM$1   correlation between 106 iir proteins and identified  @TERM$2  was performed  supplemental fig		
37432911	gao	hof	37432911	266	244	@TERM$1	@TERM$2	 @TERM$1  aw el alam g lalou a li ty molenaars m zhu y overmyer ka shishkova e  @TERM$2  k  bou sleiman m houtkooper rh coon jj auwerx j multiomics analysis identifies essential  regulators of mitochondrial stress response in two wildtype c elegans strains		
37432911	alam g	hof	37432911	266	244	@TERM$1	@TERM$2	gao aw el  @TERM$1  lalou a li ty molenaars m zhu y overmyer ka shishkova e  @TERM$2  k  bou sleiman m houtkooper rh coon jj auwerx j multiomics analysis identifies essential  regulators of mitochondrial stress response in two wildtype c elegans strains		
37432911	gao	shishkova e	37432911	266	244	@TERM$1	@TERM$2	 @TERM$1  aw el alam g lalou a li ty molenaars m zhu y overmyer ka  @TERM$2  hof k  bou sleiman m houtkooper rh coon jj auwerx j multiomics analysis identifies essential  regulators of mitochondrial stress response in two wildtype c elegans strains		
37432911	alam g	shishkova e	37432911	266	244	@TERM$1	@TERM$2	gao aw el  @TERM$1  lalou a li ty molenaars m zhu y overmyer ka  @TERM$2  hof k  bou sleiman m houtkooper rh coon jj auwerx j multiomics analysis identifies essential  regulators of mitochondrial stress response in two wildtype c elegans strains		
37432911	shishkova e	hof	37432911	266	244	@TERM$1	@TERM$2	gao aw el alam g lalou a li ty molenaars m zhu y overmyer ka  @TERM$1   @TERM$2  k  bou sleiman m houtkooper rh coon jj auwerx j multiomics analysis identifies essential  regulators of mitochondrial stress response in two wildtype c elegans strains		
37432911	lmethionine	trans3indoleacrylic acid	37432911	230	207	@TERM$1	@TERM$2	the top 50 metabolites that contributed to the  separation of four conditions included five identified ones acetylcarnitine larginine   @TERM$1  lphenylalanine and  @TERM$2  supplemental fig		
37432911	cco1	mrps5	37432911	212	145	@TERM$1	@TERM$2	the enrichment analysis verified the ample resemblance between  @TERM$1  and  @TERM$2   rnai treatment and more discrepancies induced by dox treatment fig		
37432911	larginine	trans3indoleacrylic acid	37432911	230	207	@TERM$1	@TERM$2	the top 50 metabolites that contributed to the  separation of four conditions included five identified ones acetylcarnitine  @TERM$1   lmethionine lphenylalanine and  @TERM$2  supplemental fig		
37432911	larginine	lmethionine	37432911	230	207	@TERM$1	@TERM$2	the top 50 metabolites that contributed to the  separation of four conditions included five identified ones acetylcarnitine  @TERM$1    @TERM$2  lphenylalanine and trans3indoleacrylic acid supplemental fig		
37432911	uprmt	dox	37432911	217	229	@TERM$1	@TERM$2	iir has been reported to be triggered upon  @TERM$1  activation2  with  @TERM$2  treatment and iir stimulation in three treatment conditions underscored the  common linkage between the innate immunity and mitochondrial dysfunction in worms		
37432911	bps	cco1	37432911	219	125	@TERM$1	@TERM$2	four repressed  @TERM$1  related to translation and ribosome biogenesis  and assembly were shared between  @TERM$2  and mrps5 rnai group		
37432911	cco1	mrps5	37432911	219	125	@TERM$1	@TERM$2	four repressed bps related to translation and ribosome biogenesis  and assembly were shared between  @TERM$1  and  @TERM$2  rnai group		
37432911	bps	mrps5	37432911	219	125	@TERM$1	@TERM$2	four repressed  @TERM$1  related to translation and ribosome biogenesis  and assembly were shared between cco1 and  @TERM$2  rnai group		
37432911	dox	bps	37432911	220	116	@TERM$1	@TERM$2	 @TERM$1  treatment elicited  a different repertoire of repressed  @TERM$2  than cco1 rnai but shared three bps with mrps5  rnai		
37432911	dox	mrps5	37432911	220	116	@TERM$1	@TERM$2	 @TERM$1  treatment elicited  a different repertoire of repressed bps than cco1 rnai but shared three bps with  @TERM$2   rnai		
37432911	dox	cco1	37432911	220	116	@TERM$1	@TERM$2	 @TERM$1  treatment elicited  a different repertoire of repressed bps than  @TERM$2  rnai but shared three bps with mrps5  rnai		
37432911	bps	cco1	37432911	220	116	@TERM$1	@TERM$2	dox treatment elicited  a different repertoire of repressed  @TERM$1  than  @TERM$2  rnai but shared three bps with mrps5  rnai		
37432911	bps	mrps5	37432911	220	116	@TERM$1	@TERM$2	dox treatment elicited  a different repertoire of repressed  @TERM$1  than cco1 rnai but shared three bps with  @TERM$2   rnai		
37432911	cco1	mrps5	37432911	220	116	@TERM$1	@TERM$2	dox treatment elicited  a different repertoire of repressed bps than  @TERM$1  rnai but shared three bps with  @TERM$2   rnai		
37432911	dox	cerns	37432911	224	108	@TERM$1	@TERM$2	 @TERM$1  treatment exerted a broad inhibitory effect on multiple lipid  classes including tg pe pc pcoh and  @TERM$2 		
37432911	cco1	cerns	37432911	225	51	@TERM$1	@TERM$2	 @TERM$1  rnai reduced the abundance  of tg  @TERM$2  and pc		
37432911	dox	uprmt	37432911	229	213	@TERM$1	@TERM$2	 @TERM$1   treatment reduced the abundance of tgs in worm n2 and cb4856 strain2 and the same  changes of tgs in the two gene knockdown groups implied a conserved feature of  @TERM$2   in worms induced by different stressors		
37432911	cb4856	uprmt	37432911	229	213	@TERM$1	@TERM$2	dox  treatment reduced the abundance of tgs in worm n2 and  @TERM$1  strain2 and the same  changes of tgs in the two gene knockdown groups implied a conserved feature of  @TERM$2   in worms induced by different stressors		
37432911	dox	cb4856	37432911	229	213	@TERM$1	@TERM$2	 @TERM$1   treatment reduced the abundance of tgs in worm n2 and  @TERM$2  strain2 and the same  changes of tgs in the two gene knockdown groups implied a conserved feature of uprmt  in worms induced by different stressors		
37432911	lmethionine	lphenylalanine	37432911	230	207	@TERM$1	@TERM$2	the top 50 metabolites that contributed to the  separation of four conditions included five identified ones acetylcarnitine larginine   @TERM$1   @TERM$2  and trans3indoleacrylic acid supplemental fig		
37432911	mtbe	meoh	37432911	50	244	@TERM$1	@TERM$2	adopted the use of methyl tertbutyl ether  @TERM$1   instead of potentially carcinogenic chloroform13 in combination with  @TERM$2  and water and  the resulting approach has become the mainstream method to extract proteins lipids and  polar metabolites14		
37432911	dox	pca	37432911	453	67	@TERM$1	@TERM$2	 @TERM$1  was excluded from the  metabolomics dataset before  @TERM$2  analysis		
37432911	methanol	meoh	37432911	48	133	@TERM$1	@TERM$2	the classic biphasic method  is the folch or bligh and dyer method that uses a combination of chloroform  @TERM$1    @TERM$2  and water1112		
37432911	chloroform	meoh	37432911	48	133	@TERM$1	@TERM$2	the classic biphasic method  is the folch or bligh and dyer method that uses a combination of  @TERM$1  methanol   @TERM$2  and water1112		
37432911	katherine a	arwen w	37432911	0	135	@TERM$1	@TERM$2	  set of c elegans samples yunyun zhu1 annie jen1  @TERM$1  overmyer234  @TERM$2  gao5 evgenia  shishkova12 johan auwerx5 joshua j coon		
37432911	jen1	arwen w	37432911	0	136	@TERM$1	@TERM$2	ingle  set of c elegans samples yunyun zhu1 annie  @TERM$1  katherine a overmyer234  @TERM$2  gao5 evgenia  shishkova12 johan auwerx5 joshua j 		
37432911	uprmt	mrps5	37432911	9	219	@TERM$1	@TERM$2	 light on mitochondrial unfolded protein response  @TERM$1  induced by three unique stressors   knocking down electron transfer chain element cco1 mitochondrial ribosome protein s5  @TERM$2   and antibiotic treatment doxycyclin		
37432911	uprmt	cco1	37432911	9	193	@TERM$1	@TERM$2	 light on mitochondrial unfolded protein response  @TERM$1  induced by three unique stressors   knocking down electron transfer chain element  @TERM$2  mitochondrial ribosome protein s5 mrps5  and antib		
37432911	jen1	katherine a	37432911	0	116	@TERM$1	@TERM$2	ingle  set of c elegans samples yunyun zhu1 annie  @TERM$1   @TERM$2  overmyer234 arwen w gao5 evgenia  shishkova12 joh		
37432911	cco1	mrps5	37432911	9	131	@TERM$1	@TERM$2	s   knocking down electron transfer chain element  @TERM$1  mitochondrial ribosome protein s5  @TERM$2   and antibiotic treatment doxycyclin		
37432911	jcoonchemwiscedu	arwen w	37432911	10	166	@TERM$1	@TERM$2	n wisconsin 53515 united states phone 608 8900763  @TERM$1  fax 608 8900167present addresses  @TERM$2  gaos present address is laboratory genetic metabolic disea		
37432911	collagen	glycoprotein	37432911	41	175	@TERM$1	@TERM$2	these cuticles are made of layers of highly structured and crosslinked   @TERM$1  and other insoluble proteins covered with layers of lipidrich and  @TERM$2  rich materials8		
37432911	chloroform	methanol	37432911	48	133	@TERM$1	@TERM$2	the classic biphasic method  is the folch or bligh and dyer method that uses a combination of  @TERM$1   @TERM$2   meoh and water1112		
37432911	mrps5	hsp6	37432911	448	57	@TERM$1	@TERM$2	c the expression levels of cox4  @TERM$1   @TERM$2   hsp60 and dox		
38563104	lysozymerelated	lys7	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response ctype lectinrelated genes clec41 clec86 clec62 clec186 and clec187 and  @TERM$1  genes lys1 lys2 lys5  @TERM$2  and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	clec86	lysozymerelated	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response ctype lectinrelated genes clec41  @TERM$1  clec62 clec186 and clec187 and  @TERM$2  genes lys1 lys2 lys5 lys7 and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	ctype lectinrelated	lys7	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response  @TERM$1  genes clec41 clec86 clec62 clec186 and clec187 and lysozymerelated genes lys1 lys2 lys5  @TERM$2  and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	lys5	lys7	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response ctype lectinrelated genes clec41 clec86 clec62 clec186 and clec187 and lysozymerelated genes lys1 lys2  @TERM$1   @TERM$2  and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	lysozymerelated	lys1	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response ctype lectinrelated genes clec41 clec86 clec62 clec186 and clec187 and  @TERM$1  genes  @TERM$2  lys2 lys5 lys7 and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	clec86	lys7	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response ctype lectinrelated genes clec41  @TERM$1  clec62 clec186 and clec187 and lysozymerelated genes lys1 lys2 lys5  @TERM$2  and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	clec	clec genes 38	38563104	176	175	@TERM$1	@TERM$2	the previous study has demonstrated that  @TERM$1  genes exhibit a pathogenspecific response with specific pathogen infections leading to the upregulation of specific  @TERM$2 		
38563104	lysozymerelated	lys5	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response ctype lectinrelated genes clec41 clec86 clec62 clec186 and clec187 and  @TERM$1  genes lys1 lys2  @TERM$2  lys7 and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	lys1	lys5	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response ctype lectinrelated genes clec41 clec86 clec62 clec186 and clec187 and lysozymerelated genes  @TERM$1  lys2  @TERM$2  lys7 and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	ctld	clec	38563104	174	119	@TERM$1	@TERM$2	ctype lectinlike domain  @TERM$1  proteins encoded by  @TERM$2  genes play diverse roles including immune response in vertebrates		
38563104	pathogenspecific	clec genes 38	38563104	176	175	@TERM$1	@TERM$2	the previous study has demonstrated that clec genes exhibit a  @TERM$1  response with specific pathogen infections leading to the upregulation of specific  @TERM$2 		
38563104	clec86	lys5	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response ctype lectinrelated genes clec41  @TERM$1  clec62 clec186 and clec187 and lysozymerelated genes lys1 lys2  @TERM$2  lys7 and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	clec	pathogenspecific	38563104	176	175	@TERM$1	@TERM$2	the previous study has demonstrated that  @TERM$1  genes exhibit a  @TERM$2  response with specific pathogen infections leading to the upregulation of specific clec genes 38		
38563104	ctype lectinrelated	lysozymerelated	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response  @TERM$1  genes clec41 clec86 clec62 clec186 and clec187 and  @TERM$2  genes lys1 lys2 lys5 lys7 and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	ctype lectinrelated	lys1	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response  @TERM$1  genes clec41 clec86 clec62 clec186 and clec187 and lysozymerelated genes  @TERM$2  lys2 lys5 lys7 and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	lactobacilli	28 29	38563104	155	146	@TERM$1	@TERM$2	 @TERM$1  are grampositive bacteria and produce lactic acid through carbohydrate fermentation which is known as an antimicrobial compound  @TERM$2 		
38563104	clec86	lys1	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response ctype lectinrelated genes clec41  @TERM$1  clec62 clec186 and clec187 and lysozymerelated genes  @TERM$2  lys2 lys5 lys7 and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	ctype lectinrelated	lys5	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response  @TERM$1  genes clec41 clec86 clec62 clec186 and clec187 and lysozymerelated genes lys1 lys2  @TERM$2  lys7 and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	ctype lectinrelated	clec86	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response  @TERM$1  genes clec41  @TERM$2  clec62 clec186 and clec187 and lysozymerelated genes lys1 lys2 lys5 lys7 and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	lactic acid	28 29	38563104	155	146	@TERM$1	@TERM$2	lactobacilli are grampositive bacteria and produce  @TERM$1  through carbohydrate fermentation which is known as an antimicrobial compound  @TERM$2 		
38563104	lactobacilli	lactic acid	38563104	155	146	@TERM$1	@TERM$2	 @TERM$1  are grampositive bacteria and produce  @TERM$2  through carbohydrate fermentation which is known as an antimicrobial compound 28 29		
38563104	clec86	ctype lectinrelated	38563104	183	158	@TERM$1	@TERM$2	in agreement with the previous study  @TERM$1  was the most significantly upregulated  @TERM$2  gene after preconditioning with 3201 compared with op50		
38563104	succinic acid	alanine	38563104	150	177	@TERM$1	@TERM$2	the result showed that four metabolites namely fumaric acid  @TERM$1   @TERM$2  and lactic acid were quantitatively increased in c elegans fed with 3201 compared with op50 fig		
38563104	fumaric acid	succinic acid	38563104	150	177	@TERM$1	@TERM$2	the result showed that four metabolites namely  @TERM$1   @TERM$2  alanine and lactic acid were quantitatively increased in c elegans fed with 3201 compared with op50 fig		
38563104	fumaric acid	alanine	38563104	150	177	@TERM$1	@TERM$2	the result showed that four metabolites namely  @TERM$1  succinic acid  @TERM$2  and lactic acid were quantitatively increased in c elegans fed with 3201 compared with op50 fig		
38563104	alanine	lactic acid	38563104	150	177	@TERM$1	@TERM$2	the result showed that four metabolites namely fumaric acid succinic acid  @TERM$1  and  @TERM$2  were quantitatively increased in c elegans fed with 3201 compared with op50 fig		
38563104	succinic acid	lactic acid	38563104	150	177	@TERM$1	@TERM$2	the result showed that four metabolites namely fumaric acid  @TERM$1  alanine and  @TERM$2  were quantitatively increased in c elegans fed with 3201 compared with op50 fig		
38563104	fumaric acid	lactic acid	38563104	150	177	@TERM$1	@TERM$2	the result showed that four metabolites namely  @TERM$1  succinic acid alanine and  @TERM$2  were quantitatively increased in c elegans fed with 3201 compared with op50 fig		
38563104	succinic acid	lactic acid	38563104	147	185	@TERM$1	@TERM$2	further analysis through the top 25 enriched heatmap data revealed consistent elevation of  @TERM$1  and  @TERM$2  in all samples of c elegans fed with 3201 compared with op50 fig		
38563104	succinic acid	alanine	38563104	145	218	@TERM$1	@TERM$2	notably six metabolites including fumaric acid  @TERM$1   @TERM$2  lactic acid 3oxaoct4en2imine and diethylcarbamate were significantly upregulated in c elegans treated with 3201 compared with those fed with op50 fig		
38563104	lys1	lys7	38563104	173	239	@TERM$1	@TERM$2	among the genes associated with the innate immune response ctype lectinrelated genes clec41 clec86 clec62 clec186 and clec187 and lysozymerelated genes  @TERM$1  lys2 lys5  @TERM$2  and lys8 showed significant upregulation in c elegans fed with 3201		
38563104	clec86	clec187 38	38563104	184	197	@TERM$1	@TERM$2	furthermore the previous study revealed that infection with the gramnegative pathogenic bacteria pseudomonas aeruiginosa upregulated clec genes including clec41 clec62  @TERM$1  clec186 and  @TERM$2 		
38563104	lysozymerelated	lys7	38563104	187	150	@TERM$1	@TERM$2	a previous study suggested that  @TERM$1  genes particularly lys1 lys3 and  @TERM$2  contribute significantly to the defense response in c elegans 38		
38563104	clec	clec187 38	38563104	184	197	@TERM$1	@TERM$2	furthermore the previous study revealed that infection with the gramnegative pathogenic bacteria pseudomonas aeruiginosa upregulated  @TERM$1  genes including clec41 clec62 clec86 clec186 and  @TERM$2 		
38563104	rhamnosus	lgg	38563104	216	94	@TERM$1	@TERM$2	e killing assay using listeria monocytogenes egde op50 e coli 3201 l  @TERM$1   @TERM$2  l rhamnosus		
38563104	egde	lgg	38563104	216	94	@TERM$1	@TERM$2	e killing assay using listeria monocytogenes  @TERM$1  op50 e coli 3201 l rhamnosus  @TERM$2  l rhamnosus		
38563104	fer	lgg	38563104	211	203	@TERM$1	@TERM$2	the killing assay of c elegans strain  @TERM$1  15fem1 preconditioned with op50 3201 or  @TERM$2  for 48 h then infected with each of four foodborne pathogenic bacteria two of each gramnegative and positive bacteria		
38563104	rhamnosus	lgg	38563104	207	57	@TERM$1	@TERM$2	op50 e coli 3201 l  @TERM$1  idcc 3201  @TERM$2  l rhamnosus gg		
38563104	fisheries	mest	38563104	204	216	@TERM$1	@TERM$2	n for technology in food agriculture forestry and  @TERM$1  ipet3210375 and by a national research foundation of korea grant funded by the korean government  @TERM$2  nrf2021r1a2c3011051 and cooperative research program f		
38563104	succinic acid	lactic acid	38563104	203	214	@TERM$1	@TERM$2	metabolome analysis revealed elevated levels of fumaric acid  @TERM$1  and  @TERM$2  in c elegans fed with 3201 suggesting a potential mechanism for extending lifespan and fortifying defense against pathogens		
38563104	fumaric acid	lactic acid	38563104	203	214	@TERM$1	@TERM$2	metabolome analysis revealed elevated levels of  @TERM$1  succinic acid and  @TERM$2  in c elegans fed with 3201 suggesting a potential mechanism for extending lifespan and fortifying defense against pathogens		
38563104	fumaric acid	succinic acid	38563104	203	214	@TERM$1	@TERM$2	metabolome analysis revealed elevated levels of  @TERM$1   @TERM$2  and lactic acid in c elegans fed with 3201 suggesting a potential mechanism for extending lifespan and fortifying defense against pathogens		
38563104	ctype lectinrelated	lysozymerelated	38563104	202	248	@TERM$1	@TERM$2	transcriptome analysis unveiled a significant upregulation of genes associated with the innate immune response particularly  @TERM$1  and  @TERM$2  genes indicating a potential molecular mechanism for the observed immune enhancement		
38563104	fumaric acid	succinic acid	38563104	198	201	@TERM$1	@TERM$2	in summary the increased levels of  @TERM$1  and  @TERM$2  by feeding 3201 may have played a role in extending the lifespan of c elegans potentially through their impact on the citric acid cycle		
38563104	fumaric acid	citric acid	38563104	198	201	@TERM$1	@TERM$2	in summary the increased levels of  @TERM$1  and succinic acid by feeding 3201 may have played a role in extending the lifespan of c elegans potentially through their impact on the  @TERM$2  cycle		
38563104	succinic acid	citric acid	38563104	198	201	@TERM$1	@TERM$2	in summary the increased levels of fumaric acid and  @TERM$1  by feeding 3201 may have played a role in extending the lifespan of c elegans potentially through their impact on the  @TERM$2  cycle		
38563104	lactic acid	bacteriocin	38563104	196	120	@TERM$1	@TERM$2	including l rhamnosus have the capability to produce antimicrobial compounds such as  @TERM$1   @TERM$2  and h2o2 46		
38563104	rhamnosus	bacteriocin	38563104	196	120	@TERM$1	@TERM$2	including l  @TERM$1  have the capability to produce antimicrobial compounds such as lactic acid  @TERM$2  and h2o2 46		
38563104	bacteriocin	h2o2	38563104	196	120	@TERM$1	@TERM$2	including l rhamnosus have the capability to produce antimicrobial compounds such as lactic acid  @TERM$1  and  @TERM$2  46		
38563104	rhamnosus	lactic acid	38563104	196	120	@TERM$1	@TERM$2	including l  @TERM$1  have the capability to produce antimicrobial compounds such as  @TERM$2  bacteriocin and h2o2 46		
38563104	lactic acid	h2o2	38563104	196	120	@TERM$1	@TERM$2	including l rhamnosus have the capability to produce antimicrobial compounds such as  @TERM$1  bacteriocin and  @TERM$2  46		
38563104	lysozymerelated	lys3	38563104	187	150	@TERM$1	@TERM$2	a previous study suggested that  @TERM$1  genes particularly lys1  @TERM$2  and lys7 contribute significantly to the defense response in c elegans 38		
38563104	lys1	lys7	38563104	187	150	@TERM$1	@TERM$2	a previous study suggested that lysozymerelated genes particularly  @TERM$1  lys3 and  @TERM$2  contribute significantly to the defense response in c elegans 38		
38563104	lys1	lys3	38563104	187	150	@TERM$1	@TERM$2	a previous study suggested that lysozymerelated genes particularly  @TERM$1   @TERM$2  and lys7 contribute significantly to the defense response in c elegans 38		
38563104	lysozymerelated	lys1	38563104	187	150	@TERM$1	@TERM$2	a previous study suggested that  @TERM$1  genes particularly  @TERM$2  lys3 and lys7 contribute significantly to the defense response in c elegans 38		
38563104	fumaric acid	succinic acid	38563104	145	218	@TERM$1	@TERM$2	notably six metabolites including  @TERM$1   @TERM$2  alanine lactic acid 3oxaoct4en2imine and diethylcarbamate were significantly upregulated in c elegans treated with 3201 compared with those fed with op50 fig		
38563104	lys3	lys7	38563104	187	150	@TERM$1	@TERM$2	a previous study suggested that lysozymerelated genes particularly lys1  @TERM$1  and  @TERM$2  contribute significantly to the defense response in c elegans 38		
38563104	clec	clec86	38563104	184	197	@TERM$1	@TERM$2	furthermore the previous study revealed that infection with the gramnegative pathogenic bacteria pseudomonas aeruiginosa upregulated  @TERM$1  genes including clec41 clec62  @TERM$2  clec186 and clec187 38		
38563104	lys1	lys7	38563104	188	163	@TERM$1	@TERM$2	consistent with the previous study the expression of  @TERM$1  and  @TERM$2  genes was significantly upregulated in c elegans fed with 3201 compared with those fed with op50		
38563104	fumaric acid	citric acid	38563104	189	143	@TERM$1	@TERM$2	 metabolome analysis revealed increased levels of  @TERM$1  and succinic acid metabolites of the  @TERM$2  cycle in c elegans fed with 320		
38563104	fumaric acid	succinic acid	38563104	189	130	@TERM$1	@TERM$2	 metabolome analysis revealed increased levels of  @TERM$1  and  @TERM$2  metabolites of the citric acid cycle in c elegans		
38563104	ctype lectinrelated	lysozymerelated	38563104	189	142	@TERM$1	@TERM$2	we speculated that increased expression of  @TERM$1  genes and  @TERM$2  induced by feeding with 3201 may contribute to an enh		
38563104	citric acid	nadnadh	38563104	192	144	@TERM$1	@TERM$2	increasing the  @TERM$1  cycle is known as the increasing  @TERM$2  ratio which may be crucial for the mechanism of the lifespan of c elegans 45		
38563104	fumaric acid	nadnadh	38563104	193	174	@TERM$1	@TERM$2	in this study increased  @TERM$1  by feeding 3201 may have increased mitochondrial respiration and enhanced  @TERM$2  ratio which may have extended the lifespan of c elegans		
38563104	rhamnosus	h2o2	38563104	196	120	@TERM$1	@TERM$2	including l  @TERM$1  have the capability to produce antimicrobial compounds such as lactic acid bacteriocin and  @TERM$2  46		
38563104	succinic acid	citric acid	38563104	189	126	@TERM$1	@TERM$2	sis revealed increased levels of fumaric acid and  @TERM$1  metabolites of the  @TERM$2  cycle in c elegans fed with 320		
38563104	lactic acid	diethylcarbamate	38563104	145	218	@TERM$1	@TERM$2	notably six metabolites including fumaric acid succinic acid alanine  @TERM$1  3oxaoct4en2imine and  @TERM$2  were significantly upregulated in c elegans treated with 3201 compared with those fed with op50 fig		
38563104	glycine	serine	38563104	139	115	@TERM$1	@TERM$2	etabolism biosynthesis of unsaturated fatty acids  @TERM$1   @TERM$2  and threonine metabolism tryptophan metabolism lys		
38563104	fumaric acid	alanine	38563104	145	218	@TERM$1	@TERM$2	notably six metabolites including  @TERM$1  succinic acid  @TERM$2  lactic acid 3oxaoct4en2imine and diethylcarbamate were significantly upregulated in c elegans treated with 3201 compared with those fed with op50 fig		
38563104	ctype lectinrelated	lys7	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62 clec86 clec186 and clec187  @TERM$1  and lys1 lys2 lys5  @TERM$2  and lys8 lysozymerelated were upregulated with 3201 feeding table 2		
38563104	alanine	lactic acid	38563104	145	218	@TERM$1	@TERM$2	notably six metabolites including fumaric acid succinic acid  @TERM$1   @TERM$2  3oxaoct4en2imine and diethylcarbamate were significantly upregulated in c elegans treated with 3201 compared with those fed with op50 fig		
38563104	clec86	lys5	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62  @TERM$1  clec186 and clec187 ctype lectinrelated and lys1 lys2  @TERM$2  lys7 and lys8 lysozymerelated were upregulated with 3201 feeding table 2		
38563104	ctype lectinrelated	lys1	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62 clec86 clec186 and clec187  @TERM$1  and  @TERM$2  lys2 lys5 lys7 and lys8 lysozymerelated were upregulated with 3201 feeding table 2		
38563104	lys1	lys7	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62 clec86 clec186 and clec187 ctype lectinrelated and  @TERM$1  lys2 lys5  @TERM$2  and lys8 lysozymerelated were upregulated with 3201 feeding table 2		
38563104	clec86	lys1	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62  @TERM$1  clec186 and clec187 ctype lectinrelated and  @TERM$2  lys2 lys5 lys7 and lys8 lysozymerelated were upregulated with 3201 feeding table 2		
38563104	ctype lectinrelated	lys5	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62 clec86 clec186 and clec187  @TERM$1  and lys1 lys2  @TERM$2  lys7 and lys8 lysozymerelated were upregulated with 3201 feeding table 2		
38563104	clec86	ctype lectinrelated	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62  @TERM$1  clec186 and clec187  @TERM$2  and lys1 lys2 lys5 lys7 and lys8 lysozymerelated were upregulated with 3201 feeding table 2		
38563104	carrier	160	38563104	81	124	@TERM$1	@TERM$2	the sample was injected at 300c and helium was used as the  @TERM$1  gas with a flow rate of 15 mlmin and a split ratio of  @TERM$2 		
38563104	helium	carrier	38563104	81	124	@TERM$1	@TERM$2	the sample was injected at 300c and  @TERM$1  was used as the  @TERM$2  gas with a flow rate of 15 mlmin and a split ratio of 160		
38563104	helium	160	38563104	81	124	@TERM$1	@TERM$2	the sample was injected at 300c and  @TERM$1  was used as the carrier gas with a flow rate of 15 mlmin and a split ratio of  @TERM$2 		
38563104	methoxyamine hydrochloride	pyridine	38563104	77	214	@TERM$1	@TERM$2	for gas chromatographymass spectrometry gcms analysis 30 l of  @TERM$1  sigmaaldrich usa in  @TERM$2  20 mgml was added to each sample to dissolve and then incubated at 30c for 90 min to derivatize		
38563104	hydrochloride	pyridine	38563104	77	214	@TERM$1	@TERM$2	for gas chromatographymass spectrometry gcms analysis 30 l of methoxyamine  @TERM$1  sigmaaldrich usa in  @TERM$2  20 mgml was added to each sample to dissolve and then incubated at 30c for 90 min to derivatize		
38563104	polyvinylidene	whatman	38563104	76	114	@TERM$1	@TERM$2	then the supernatants were filtered with 02 m  @TERM$1  fluoride syringe filters  @TERM$2  uk and vacuum dried		
38563104	fluoride	whatman	38563104	76	114	@TERM$1	@TERM$2	then the supernatants were filtered with 02 m polyvinylidene  @TERM$1  syringe filters  @TERM$2  uk and vacuum dried		
38563104	polyvinylidene	fluoride	38563104	76	114	@TERM$1	@TERM$2	then the supernatants were filtered with 02 m  @TERM$1   @TERM$2  syringe filters whatman uk and vacuum dried		
38563104	platinum	lgg	38563104	42	183	@TERM$1	@TERM$2	then c elegans were individually transferred with a  @TERM$1  wire onto 35mmdiameter ngm agar plates seeded with op50 80  109 cfuml 3201 80  109 cfuml or  @TERM$2  80  109 cfuml respectively		
38563104	triton x100	glass	38563104	38	155	@TERM$1	@TERM$2	next worms were transferred to a 15 ml eppendorf tube containing m9 buffer with  @TERM$1  and were mechanically disrupted using a pestle kontes  @TERM$2  usa		
38563104	sodium	hypochloritesodium	38563104	34	109	@TERM$1	@TERM$2	after the worms got eggs in their body eggs were extracted using  @TERM$1   @TERM$2  hydroxide solution		
38563104	rhamnosus	lgg	38563104	29	89	@TERM$1	@TERM$2	l  @TERM$1  gg referred to as  @TERM$2  was used as a positive control feed for c elegans and i		
38563104	fumaric acid	succinic acid	38563104	9	162	@TERM$1	@TERM$2	metabolome analysis revealed increased levels of  @TERM$1  and  @TERM$2  metabolites of the citric acid cycle in c elegans fed with 3201 compared with op50		
38563104	fumaric acid	citric acid	38563104	9	162	@TERM$1	@TERM$2	metabolome analysis revealed increased levels of  @TERM$1  and succinic acid metabolites of the  @TERM$2  cycle in c elegans fed with 3201 compared with op50		
38563104	succinic acid	citric acid	38563104	9	162	@TERM$1	@TERM$2	metabolome analysis revealed increased levels of fumaric acid and  @TERM$1  metabolites of the  @TERM$2  cycle in c elegans fed with 3201 compared with op50		
38563104	ctype lectinrelated	lysozymerelated	38563104	7	161	@TERM$1	@TERM$2	 @TERM$1  genes and  @TERM$2  genes crucial components of the immune system showed significant upregulation after feeding 3201 compared with op50		
38563104	rhamnosus	lgg	38563104	222	44	@TERM$1	@TERM$2	op50 e coli 3201 l  @TERM$1   @TERM$2  l rhamnosus		
38563104	lys5	lys7	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62 clec86 clec186 and clec187 ctype lectinrelated and lys1 lys2  @TERM$1   @TERM$2  and lys8 lysozymerelated were upregulated with 3201 feeding table 2		
38563104	lys1	lysozymerelated	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62 clec86 clec186 and clec187 ctype lectinrelated and  @TERM$1  lys2 lys5 lys7 and lys8  @TERM$2  were upregulated with 3201 feeding table 2		
38563104	clec86	lysozymerelated	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62  @TERM$1  clec186 and clec187 ctype lectinrelated and lys1 lys2 lys5 lys7 and lys8  @TERM$2  were upregulated with 3201 feeding table 2		
38563104	lys7	lysozymerelated	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62 clec86 clec186 and clec187 ctype lectinrelated and lys1 lys2 lys5  @TERM$1  and lys8  @TERM$2  were upregulated with 3201 feeding table 2		
38563104	fumaric acid	diethylcarbamate	38563104	145	218	@TERM$1	@TERM$2	notably six metabolites including  @TERM$1  succinic acid alanine lactic acid 3oxaoct4en2imine and  @TERM$2  were significantly upregulated in c elegans treated with 3201 compared with those fed with op50 fig		
38563104	succinic acid	lactic acid	38563104	145	218	@TERM$1	@TERM$2	notably six metabolites including fumaric acid  @TERM$1  alanine  @TERM$2  3oxaoct4en2imine and diethylcarbamate were significantly upregulated in c elegans treated with 3201 compared with those fed with op50 fig		
38563104	fumaric acid	lactic acid	38563104	145	218	@TERM$1	@TERM$2	notably six metabolites including  @TERM$1  succinic acid alanine  @TERM$2  3oxaoct4en2imine and diethylcarbamate were significantly upregulated in c elegans treated with 3201 compared with those fed with op50 fig		
38563104	alanine	diethylcarbamate	38563104	145	218	@TERM$1	@TERM$2	notably six metabolites including fumaric acid succinic acid  @TERM$1  lactic acid 3oxaoct4en2imine and  @TERM$2  were significantly upregulated in c elegans treated with 3201 compared with those fed with op50 fig		
38563104	succinic acid	diethylcarbamate	38563104	145	218	@TERM$1	@TERM$2	notably six metabolites including fumaric acid  @TERM$1  alanine lactic acid 3oxaoct4en2imine and  @TERM$2  were significantly upregulated in c elegans treated with 3201 compared with those fed with op50 fig		
38563104	glycine serine	tryptophan	38563104	139	154	@TERM$1	@TERM$2	etabolism biosynthesis of unsaturated fatty acids  @TERM$1  and threonine metabolism  @TERM$2  metabolism lysosome peroxisome steroid biosynthesis l		
38563104	glycine	threonine	38563104	139	128	@TERM$1	@TERM$2	etabolism biosynthesis of unsaturated fatty acids  @TERM$1  serine and  @TERM$2  metabolism tryptophan metabolism lysosome peroxis		
38563104	fatty	serine	38563104	139	126	@TERM$1	@TERM$2	amely drug metabolism biosynthesis of unsaturated  @TERM$1  acids glycine  @TERM$2  and threonine metabolism tryptophan metabolism ly		
38563104	fatty	threonine	38563104	139	140	@TERM$1	@TERM$2	amely drug metabolism biosynthesis of unsaturated  @TERM$1  acids glycine serine and  @TERM$2  metabolism tryptophan metabolism lysosome peroxis		
38563104	glycine	tryptophan	38563104	139	150	@TERM$1	@TERM$2	etabolism biosynthesis of unsaturated fatty acids  @TERM$1  serine and threonine metabolism  @TERM$2  metabolism lysosome peroxisome steroid biosynthes		
38563104	clec86	lys7	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62  @TERM$1  clec186 and clec187 ctype lectinrelated and lys1 lys2 lys5  @TERM$2  and lys8 lysozymerelated were upregulated with 3201 feeding table 2		
38563104	fatty	tryptophan	38563104	139	162	@TERM$1	@TERM$2	amely drug metabolism biosynthesis of unsaturated  @TERM$1  acids glycine serine and threonine metabolism  @TERM$2  metabolism lysosome peroxisome steroid biosynthes		
38563104	serine	retinol	38563104	139	199	@TERM$1	@TERM$2	m biosynthesis of unsaturated fatty acids glycine  @TERM$1  and threonine metabolism tryptophan metabolism lysosome peroxisome steroid biosynthesis longevity regulating pathway and  @TERM$2  metabolism fi		
38563104	threonine	retinol	38563104	139	188	@TERM$1	@TERM$2	sis of unsaturated fatty acids glycine serine and  @TERM$1  metabolism tryptophan metabolism lysosome peroxisome steroid biosynthesis longevity regulating pathway and  @TERM$2  metabolism fi		
38563104	glycine serine	retinol	38563104	139	207	@TERM$1	@TERM$2	etabolism biosynthesis of unsaturated fatty acids  @TERM$1  and threonine metabolism tryptophan metabolism lysosome peroxisome steroid biosynthesis longevity regulating pathway and  @TERM$2  metabolism fi		
38563104	serine	threonine	38563104	139	120	@TERM$1	@TERM$2	m biosynthesis of unsaturated fatty acids glycine  @TERM$1  and  @TERM$2  metabolism tryptophan metabolism lysosome peroxis		
38563104	ctype lectinrelated	lysozymerelated	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62 clec86 clec186 and clec187  @TERM$1  and lys1 lys2 lys5 lys7 and lys8  @TERM$2  were upregulated with 3201 feeding table 2		
38563104	lys5	lysozymerelated	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62 clec86 clec186 and clec187 ctype lectinrelated and lys1 lys2  @TERM$1  lys7 and lys8  @TERM$2  were upregulated with 3201 feeding table 2		
38563104	glycine	retinol	38563104	139	207	@TERM$1	@TERM$2	etabolism biosynthesis of unsaturated fatty acids  @TERM$1  serine and threonine metabolism tryptophan metabolism lysosome peroxisome steroid biosynthesis longevity regulating pathway and  @TERM$2  metabolism fi		
38563104	fatty	glycine serine	38563104	139	126	@TERM$1	@TERM$2	amely drug metabolism biosynthesis of unsaturated  @TERM$1  acids  @TERM$2  and threonine metabolism tryptophan metabolism ly		
38563104	glycine serine	threonine	38563104	139	133	@TERM$1	@TERM$2	etabolism biosynthesis of unsaturated fatty acids  @TERM$1  and  @TERM$2  metabolism tryptophan metabolism lysosome peroxisome s		
38563104	lys1	lys5	38563104	137	208	@TERM$1	@TERM$2	within the innate immune response pathway genes such as clec41 clec62 clec86 clec186 and clec187 ctype lectinrelated and  @TERM$1  lys2  @TERM$2  lys7 and lys8 lysozymerelated were upregulated with 3201 feeding table 2		
38563104	fatty	glycine	38563104	139	119	@TERM$1	@TERM$2	amely drug metabolism biosynthesis of unsaturated  @TERM$1  acids  @TERM$2  serine and threonine metabolism tryptophan metabo		
38563104	tryptophan	retinol	38563104	139	167	@TERM$1	@TERM$2	tty acids glycine serine and threonine metabolism  @TERM$1  metabolism lysosome peroxisome steroid biosynthesis longevity regulating pathway and  @TERM$2  metabolism fi		
38563104	fatty	retinol	38563104	139	219	@TERM$1	@TERM$2	amely drug metabolism biosynthesis of unsaturated  @TERM$1  acids glycine serine and threonine metabolism tryptophan metabolism lysosome peroxisome steroid biosynthesis longevity regulating pathway and  @TERM$2  metabolism fi		
38563104	threonine	tryptophan	38563104	139	131	@TERM$1	@TERM$2	sis of unsaturated fatty acids glycine serine and  @TERM$1  metabolism  @TERM$2  metabolism lysosome peroxisome steroid biosynthes		
38563104	serine	tryptophan	38563104	139	142	@TERM$1	@TERM$2	m biosynthesis of unsaturated fatty acids glycine  @TERM$1  and threonine metabolism  @TERM$2  metabolism lysosome peroxisome steroid biosynthes		
38563104	egde	rhamnosus	38563104	216	94	@TERM$1	@TERM$2	e killing assay using listeria monocytogenes  @TERM$1  op50 e coli 3201 l  @TERM$2  lgg l rhamnosus		
38964319	nidogen	mec4	38964319	4	183	@TERM$1	@TERM$2	we show that membranematrix complexes containing laminin  @TERM$1  and the  @TERM$2  mechanoelectrical transduction channel reside at this interface and are central to proper touch sensation		
38964319	laminin	mec4	38964319	4	183	@TERM$1	@TERM$2	we show that membranematrix complexes containing  @TERM$1  nidogen and the  @TERM$2  mechanoelectrical transduction channel reside at this interface and are central to proper touch sensation		
38964319	laminin	nidogen	38964319	4	183	@TERM$1	@TERM$2	we show that membranematrix complexes containing  @TERM$1   @TERM$2  and the mec4 mechanoelectrical transduction channel reside at this interface and are central to proper touch sensation		
38964319	nidogen	laminin	38964319	9	151	@TERM$1	@TERM$2	unlike the basal lamina ensheathing the pharynx and body wall muscle  @TERM$1  recruitment to the puncta along trns is not dependent upon  @TERM$2  binding		
38964319	mec4	nidogen	38964319	10	140	@TERM$1	@TERM$2	 @TERM$1  but not laminin or  @TERM$2  is destabilized by point mutations in the cterminal kunitz domain of the extracellular matrix component mec1		
38964319	mec4	laminin	38964319	10	140	@TERM$1	@TERM$2	 @TERM$1  but not  @TERM$2  or nidogen is destabilized by point mutations in the cterminal kunitz domain of the extracellular matrix component mec1		
38964319	laminin	nidogen	38964319	10	140	@TERM$1	@TERM$2	mec4 but not  @TERM$1  or  @TERM$2  is destabilized by point mutations in the cterminal kunitz domain of the extracellular matrix component mec1		
